data_2lz4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lz4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.711 0.291 . . . . 152.00999999999999 110.732 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.9 mt -64.0 -52.58 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.399 -0.364 . . . . 368.69 111.76 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 tp -67.08 -42.19 88.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.188 -0.605 . . . . 159.72999999999999 109.617 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.97 -47.34 19.79 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.301 -1.12 . . . . 58.229999999999997 110.301 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.7 tp -70.68 -37.27 73.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.753 0.311 . . . . 531.36000000000001 110.536 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -57.74 10.48 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.948 0.404 . . . . 129.15000000000001 110.874 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.54 -17.78 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.941 -0.572 . . . . 168.15000000000001 111.284 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.52 -42.57 7.78 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.849 -0.901 . . . . 24.27 110.849 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.48 -53.26 32.9 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.381 -1.088 . . . . 25.059999999999999 110.381 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.5 m -46.09 -52.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.884 -0.327 . . . . 107.28 110.171 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.8 t -56.03 -46.08 80.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.526 -0.47 . . . . 131.62 110.954 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.37 -47.17 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.021 -0.671 . . . . 290.73000000000002 109.603 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.88 -40.02 69.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.647 -0.706 . . . . 100.39 110.017 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.9 p -70.19 -20.01 63.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 209.63999999999999 111.022 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.58 -34.9 27.57 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.508 -0.477 . . . . 120.51000000000001 110.888 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.7 -44.86 93.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 120.816 -0.354 . . . . 150.12 111.064 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.1 m -61.78 -35.8 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.596 -0.442 . . . . 147.55000000000001 110.85 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.53 -23.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.66 -0.496 . . . . 230.88 109.66 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.12 -47.59 12.37 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.002 -0.74 . . . . 241.81999999999999 109.002 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.453 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 1.8 tm? -47.79 -36.27 11.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.547 0.689 . . . . 276.41000000000003 109.432 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.66 -65.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.741 -0.663 . . . . 251.71000000000001 110.221 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 82.7 mtp -48.21 -26.83 2.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.673 -0.694 . . . . 640.88999999999999 110.769 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 54.6 mt -75.09 -19.91 59.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.461 -0.336 . . . . 215.74000000000001 111.121 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -51.16 -22.33 2.5 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.596 -0.442 . . . . 999.99000000000001 110.825 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -105.01 22.05 15.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.646 0.26 . . . . 999.99000000000001 110.574 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.961 -1.018 . . . . 999.99000000000001 110.564 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 mttt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.398 -0.593 . . . . 999.99000000000001 109.398 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.56 -19.75 79.74 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.235 -0.746 . . . . 205.28 111.235 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.82 81.75 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.719 -0.392 . . . . 152.03999999999999 110.759 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 21.9 mt -64.02 -52.55 55.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.332 -0.395 . . . . 370.69 111.807 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 tp -67.09 -42.24 88.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.174 -0.611 . . . . 159.02000000000001 109.569 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -47.02 -47.25 20.14 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.312 -1.115 . . . . 57.75 110.312 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.7 tp -70.66 -37.34 73.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 120.737 0.303 . . . . 530.52999999999997 110.47 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -57.72 10.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.957 0.408 . . . . 129.94 110.902 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 m -66.53 -17.69 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.902 -0.59 . . . . 168.44 111.33 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.56 -42.51 7.79 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.843 -0.903 . . . . 24.170000000000002 110.843 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.56 -53.26 33.18 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.401 -1.08 . . . . 25.140000000000001 110.401 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 m -46.12 -52.0 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.802 -0.359 . . . . 107.23 110.202 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.01 -46.08 80.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.568 -0.453 . . . . 132.25999999999999 110.961 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 90.2 mt -63.36 -47.22 92.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.031 -0.668 . . . . 289.97000000000003 109.659 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.75 -40.08 68.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.577 -0.738 . . . . 100.45999999999999 110.108 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 29.9 p -70.13 -20.0 63.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 209.36000000000001 111.024 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.62 -34.91 27.43 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.546 -0.462 . . . . 121.2 110.844 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.75 -44.83 93.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 120.833 -0.347 . . . . 152.55000000000001 111.051 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.72 -35.93 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.599 -0.44 . . . . 147.47 110.847 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -23.01 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.463 -0.495 . . . . 231.75 109.71 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.11 -47.61 12.35 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.997 -0.742 . . . . 243.65000000000001 108.997 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 1.8 tm? -47.82 -36.21 11.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.518 0.675 . . . . 277.13 109.41 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.68 -65.72 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.75 -0.659 . . . . 252.77000000000001 110.281 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 82.7 mtp -48.23 -26.89 2.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 642.52999999999997 110.765 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 55.0 mt -75.03 -19.89 59.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.446 -0.343 . . . . 215.84999999999999 111.165 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -51.16 -22.32 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.542 -0.463 . . . . 999.99000000000001 110.811 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -105.03 22.05 16.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 121.065 -0.254 . . . . 999.99000000000001 110.522 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.933 -1.032 . . . . 999.99000000000001 110.497 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.605 0.241 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 8' ' ' ILE . 97.7 mt -63.3 -43.7 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.9 tp -61.01 -36.76 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 109.793 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.63 -66.38 2.88 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.409 ' N ' ' CD2' ' A' ' 11' ' ' LEU . 4.2 mm? -60.16 -32.79 71.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 110.982 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.23 -63.84 1.16 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 120.863 0.363 . . . . 0.0 110.97 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 12.6 m -68.39 -20.82 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.35 -39.81 12.09 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.93 -54.33 26.09 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.7 m -44.51 -49.79 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.95 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -60.49 -42.88 92.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.057 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.423 HG22 HD13 ' A' ' 18' ' ' ILE . 96.7 mt -63.0 -51.35 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.465 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.43 -36.8 76.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.149 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -18.52 58.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.998 0.428 . . . . 0.0 110.401 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -32.64 36.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.397 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.7 -46.34 92.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.375 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.465 ' C ' ' N ' ' A' ' 25' ' ' THR . 29.6 m -66.13 -35.56 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.329 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -49.07 -20.41 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.465 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -74.74 -40.69 61.1 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.649 179.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.471 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.92 -25.37 42.78 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 121.396 0.617 . . . . 0.0 109.959 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.1 t -66.42 -46.47 86.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.738 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.6 mtt -68.3 -33.31 74.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.266 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.9 mt -82.58 -3.37 55.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.265 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -61.83 -37.04 82.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.092 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.8 23.26 4.24 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.58 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.377 179.566 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.08 -32.61 84.77 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.34 -21.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.582 0.229 . . . . 0.0 110.94 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.2 -43.74 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 5.9 tp -60.9 -36.74 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.813 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.68 -66.38 2.88 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.18 -32.82 71.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 0.0 111.015 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.4 tpt -60.05 -63.89 1.14 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 120.901 0.381 . . . . 0.0 111.004 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.45 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 12.5 m -68.36 -20.83 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.44 -39.78 12.0 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.86 -54.35 25.78 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.7 m -44.57 -49.69 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.618 -0.291 . . . . 0.0 110.904 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.59 -42.87 93.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.007 0.432 . . . . 0.0 111.144 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.9 -51.37 72.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.549 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.83 76.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.18 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.12 -18.46 57.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.942 0.401 . . . . 0.0 110.359 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.68 -32.59 35.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.449 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.61 -46.41 92.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.365 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.457 ' C ' ' N ' ' B' ' 25' ' ' THR . 29.6 m -66.2 -35.39 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.328 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -49.15 -20.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.457 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -74.65 -40.73 61.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.631 179.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.47 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -55.95 -25.21 42.53 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 121.367 0.603 . . . . 0.0 109.94 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 15.2 t -66.55 -46.37 86.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.781 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 59.4 mtt -68.48 -33.27 73.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.176 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.52 -3.46 55.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.205 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -61.82 -37.08 83.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.081 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.71 23.2 4.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.585 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.324 179.623 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.687 0.28 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.23 -53.44 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.472 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 3.6 tp -71.07 -42.17 76.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.167 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.43 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -39.5 -46.97 2.87 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 46.9 tp -72.56 -39.48 67.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.735 0.302 . . . . 0.0 110.702 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -59.21 4.46 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.936 0.398 . . . . 0.0 111.47 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.13 -22.18 29.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.034 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.58 -45.36 18.17 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.72 -54.15 29.39 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 m -48.23 -51.54 9.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.198 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.461 ' O ' ' OG1' ' A' ' 20' ' ' THR . 91.9 t -59.06 -45.0 92.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.095 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.1 -46.93 95.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.181 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.01 -39.04 71.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.248 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 17' ' ' VAL . 46.3 p -67.15 -21.32 65.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.182 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.44 -38.6 19.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.2 mt -69.64 -45.13 78.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.552 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.2 m -51.8 -37.86 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.713 0.292 . . . . 0.0 111.054 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.6 mm -48.25 -45.9 13.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.417 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.29 -52.35 65.63 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.461 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 2.0 tm? -51.04 -40.97 59.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.051 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.0 t -65.94 -65.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm -48.54 -26.16 2.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.976 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 31' ' ' LYS . 20.2 mt -72.15 -28.03 62.98 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.354 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -45.53 -14.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.671 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 29' ' ' LEU . 98.9 mttt -98.27 20.18 12.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 29' ' ' LEU . 32.7 ttpt . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.523 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 56.6 tttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.99 -25.08 67.58 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.54 84.07 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.357 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.2 -53.54 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.433 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' B' ' 10' ' ' GLY . 3.6 tp -70.95 -42.23 77.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 110.193 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' B' ' 9' ' ' ILE . . . -39.51 -46.91 2.86 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -72.59 -39.63 67.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.749 0.309 . . . . 0.0 110.605 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -59.06 4.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 111.52 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -66.33 -22.02 29.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.994 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.65 -45.39 17.77 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.51 -54.38 27.68 Favored Glycine 0 C--O 1.224 -0.514 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.4 m -47.95 -51.59 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.325 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.457 ' O ' ' OG1' ' B' ' 20' ' ' THR . 91.9 t -59.24 -44.89 93.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.041 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.14 -47.04 95.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.629 0.728 . . . . 0.0 109.158 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.86 70.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.287 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' B' ' 17' ' ' VAL . 46.7 p -67.24 -21.33 65.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.19 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.55 -38.48 19.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 93.1 mt -69.82 -45.21 77.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.485 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 m -51.64 -37.72 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.69 0.281 . . . . 0.0 111.088 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 37.8 mm -48.48 -45.8 14.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.338 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.42 -52.49 65.0 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 2.0 tm? -50.95 -40.81 58.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.054 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.02 -65.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm -48.46 -26.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.01 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 32' ' ' LYS . 20.5 mt -72.22 -27.94 62.85 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.343 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -45.62 -14.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.691 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 98.9 mttt -98.32 20.2 13.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 29' ' ' LEU . 32.8 ttpt . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.498 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.767 0.317 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.05 -49.46 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -82.05 -25.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.338 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.8 -45.81 55.08 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.97 -35.26 32.35 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.577 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -54.74 17.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 120.963 0.411 . . . . 0.0 111.28 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.413 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 34.5 m -67.62 -20.92 26.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.766 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.28 -48.8 7.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.284 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.0 -54.39 14.74 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 5.0 m -46.28 -49.54 5.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.17 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.454 ' O ' ' OG1' ' A' ' 20' ' ' THR . 92.4 t -58.79 -45.55 91.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.771 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -62.09 -48.41 88.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.324 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.86 65.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.454 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 17' ' ' VAL . 44.8 p -68.9 -21.15 64.25 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.171 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.2 mmt -82.8 -38.19 23.46 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.16 -45.76 74.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.824 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 24' ' ' ILE . 26.2 m -51.25 -37.31 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 120.698 0.285 . . . . 0.0 110.867 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.411 ' H ' HG23 ' A' ' 23' ' ' VAL . 39.3 mm -48.08 -45.79 12.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.438 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -61.84 -52.67 63.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.452 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 2.2 tm? -49.66 -41.45 42.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.123 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 30' ' ' LYS . 99.6 t -65.93 -65.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.2 mmm -48.59 -24.28 1.28 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 32' ' ' LYS . 25.0 mt -74.69 -26.45 59.84 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.607 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 27' ' ' VAL . 67.1 mttm -44.44 -15.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 71.4 mmtt -100.5 22.85 11.12 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 110.095 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . 22.8 pttp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.718 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' B' ' 10' ' ' GLY . . . -62.75 -24.19 66.14 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.98 82.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.777 0.322 . . . . 0.0 110.197 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.81 -50.16 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.797 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -81.28 -26.07 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.467 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 6' ' ' GLY . . . -51.71 -46.1 54.34 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.77 -35.12 33.61 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -54.8 17.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.955 0.407 . . . . 0.0 111.193 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 34.4 m -67.45 -20.87 27.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.838 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.58 -48.65 7.83 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.0 -54.45 14.51 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 5.1 m -46.19 -49.6 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.202 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.462 ' O ' ' OG1' ' B' ' 20' ' ' THR . 91.7 t -58.69 -45.64 90.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.775 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.0 -48.42 88.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.411 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.6 -37.1 65.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.467 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' B' ' 17' ' ' VAL . 44.3 p -68.64 -21.2 64.48 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.151 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.1 mmt -82.85 -38.19 23.33 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 92.3 mt -70.06 -45.78 75.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.827 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.419 HG23 ' H ' ' B' ' 24' ' ' ILE . 25.4 m -51.19 -37.49 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.734 0.302 . . . . 0.0 110.815 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.419 ' H ' HG23 ' B' ' 23' ' ' VAL . 39.2 mm -47.88 -45.9 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.428 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -61.74 -52.68 63.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 2.2 tm? -49.67 -41.69 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.154 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' B' ' 30' ' ' LYS . 96.9 t -65.6 -65.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 93.2 mmm -48.44 -24.27 1.21 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.692 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' B' ' 32' ' ' LYS . 24.3 mt -74.74 -26.68 59.95 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.57 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' B' ' 27' ' ' VAL . 67.1 mttm -44.14 -15.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.962 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 71.3 mmtt -100.14 23.01 10.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.922 0.392 . . . . 0.0 110.174 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 29' ' ' LEU . 22.8 pttp . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.617 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.865 0.364 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.32 -48.08 86.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' MET . 5.2 tp -67.98 -43.16 85.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.104 0.478 . . . . 0.0 109.976 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -36.45 -43.32 0.73 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.612 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.3 mt -78.23 -35.1 48.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.998 0.427 . . . . 0.0 110.609 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -58.98 -63.73 1.19 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.191 -179.261 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.79 -22.45 21.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.134 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.41 -47.81 20.89 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.31 -51.87 44.44 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 m -50.78 -48.24 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.098 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.441 ' O ' ' OG1' ' A' ' 20' ' ' THR . 80.5 t -58.75 -45.36 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.034 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mm -63.08 -45.72 97.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.4 -38.11 71.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.642 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 17' ' ' VAL . 44.3 p -68.23 -26.01 65.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.396 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.7 mmt -85.92 -38.54 17.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -69.16 -45.96 78.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 24' ' ' ILE . 31.7 m -56.85 -34.67 44.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 23' ' ' VAL . 26.2 mm -43.58 -38.99 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.227 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -62.34 -52.2 64.57 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.734 179.035 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 25' ' ' THR . 1.7 tm? -48.43 -40.48 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.115 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 t -66.14 -66.17 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.215 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mmm -49.8 -24.79 2.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.017 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 31' ' ' LYS . 34.6 mt -73.92 -25.59 60.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.155 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -45.56 -13.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.724 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . 8.6 mtmp? -97.53 20.57 11.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.287 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 29' ' ' LEU . 17.2 mtmm . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.447 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.63 -22.32 69.74 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.42 -21.85 35.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.898 0.38 . . . . 0.0 110.214 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.17 -48.2 86.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.074 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' B' ' 12' ' ' MET . 5.2 tp -67.97 -43.26 85.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.115 0.483 . . . . 0.0 109.952 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' B' ' 9' ' ' ILE . . . -36.35 -43.14 0.69 Allowed Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.708 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt -78.38 -35.15 47.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.989 0.423 . . . . 0.0 110.613 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' MET . . . . . 0.516 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -58.94 -63.7 1.21 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.231 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.63 -22.43 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.138 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.5 -47.74 20.65 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.26 -51.87 44.23 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.79 -48.31 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.064 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.429 ' O ' ' OG1' ' B' ' 20' ' ' THR . 80.4 t -58.93 -45.25 92.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.982 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mm -63.14 -45.72 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.01 70.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.678 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' B' ' 17' ' ' VAL . 44.5 p -68.36 -25.9 65.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 24.7 mmt -86.09 -38.43 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -69.28 -45.92 78.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.932 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 32.3 m -56.92 -34.65 44.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mm -43.65 -38.76 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.262 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' B' ' 26' ' ' LEU . 0.6 OUTLIER -62.61 -52.03 64.96 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.721 179.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.478 ' N ' ' CG2' ' B' ' 25' ' ' THR . 1.7 tm? -48.67 -40.39 27.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.091 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 t -66.13 -66.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.246 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mmm -49.82 -24.73 2.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.062 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 32' ' ' LYS . 34.9 mt -73.99 -25.46 59.92 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.117 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -45.6 -13.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.588 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' B' ' 29' ' ' LEU . 8.6 mtmp? -97.6 20.7 11.4 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 29' ' ' LEU . 17.2 mtmm . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.497 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.801 0.334 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.49 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.0 mp -65.23 -53.89 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.213 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' MET . 3.9 tp -70.88 -41.91 77.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.932 0.396 . . . . 0.0 110.537 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -36.42 -46.26 1.03 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 11' ' ' LEU . 4.3 mm? -77.1 -32.51 56.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.48 0.181 . . . . 0.0 110.947 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -60.92 -62.49 1.82 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.793 0.33 . . . . 0.0 111.341 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -66.72 -21.93 29.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.817 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.85 -45.93 10.07 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.513 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.4 -53.07 37.04 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.5 m -47.36 -51.35 6.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.187 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.478 ' O ' ' OG1' ' A' ' 20' ' ' THR . 73.9 t -58.01 -45.11 88.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.568 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.12 -48.07 90.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.674 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.14 -36.77 68.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.268 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 17' ' ' VAL . 44.8 p -67.79 -21.61 65.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.031 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.9 -38.3 23.05 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.328 0.392 . . . . 0.0 111.742 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.37 -46.19 72.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.874 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG21 ' H ' ' A' ' 24' ' ' ILE . 31.5 m -50.47 -37.24 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.819 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.403 ' H ' HG21 ' A' ' 23' ' ' VAL . 38.7 mm -47.96 -46.28 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 m -60.95 -52.71 63.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.468 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 2.3 tm? -50.53 -41.1 53.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.339 0.59 . . . . 0.0 109.939 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 30' ' ' LYS . 84.2 t -66.48 -66.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.874 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.1 mtp -47.96 -24.03 0.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.665 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 32' ' ' LYS . 19.8 mt -73.61 -26.92 61.02 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.711 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 27' ' ' VAL . 66.9 mttm -44.9 -14.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.707 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 29' ' ' LEU . 53.0 mtmt -99.18 21.93 11.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.767 0.318 . . . . 0.0 110.395 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 29' ' ' LEU . 66.0 tttm . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.623 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.0 -27.66 72.53 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.97 -34.69 78.56 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.281 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.496 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 2.0 mp -65.5 -53.95 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.182 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 12' ' ' MET . 3.8 tp -70.92 -41.8 77.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.853 0.358 . . . . 0.0 110.502 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.417 ' N ' ' CG2' ' B' ' 9' ' ' ILE . . . -36.55 -45.9 1.03 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' B' ' 11' ' ' LEU . 4.3 mm? -77.51 -32.41 54.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.178 . . . . 0.0 110.887 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' MET . . . . . 0.528 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -61.08 -62.73 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.748 0.308 . . . . 0.0 111.273 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 m -66.37 -22.03 29.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.815 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.82 -45.96 10.08 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.452 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.35 -53.08 36.8 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 4.6 m -47.34 -51.44 6.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.125 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.471 ' O ' ' OG1' ' B' ' 20' ' ' THR . 73.4 t -57.98 -45.1 87.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.6 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.25 -47.89 90.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.739 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.15 -37.05 68.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.22 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' B' ' 17' ' ' VAL . 45.9 p -67.61 -21.63 65.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.075 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.91 -38.21 23.15 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.242 0.339 . . . . 0.0 111.72 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 94.7 mt -70.36 -46.13 72.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.97 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.42 HG21 ' H ' ' B' ' 24' ' ' ILE . 31.6 m -50.64 -37.44 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.712 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.42 ' H ' HG21 ' B' ' 23' ' ' VAL . 38.9 mm -47.73 -46.34 11.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -60.86 -52.58 64.46 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.466 ' C ' ' CD1' ' B' ' 26' ' ' LEU . 2.3 tm? -50.73 -41.32 56.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.867 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' B' ' 30' ' ' LYS . 84.0 t -66.19 -66.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.914 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 96.9 mtp -47.88 -24.04 0.91 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.657 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 32' ' ' LYS . 19.5 mt -73.66 -27.12 61.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.654 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' B' ' 27' ' ' VAL . 66.9 mttm -44.68 -14.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.771 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 53.3 mtmt -99.19 22.02 11.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.822 0.344 . . . . 0.0 110.346 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.9 tttm . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.595 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.694 0.283 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.05 -48.9 83.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.024 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' MET . 3.8 tp -69.84 -44.14 79.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.295 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -36.58 -47.56 1.2 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 11' ' ' LEU . 4.3 mm? -73.3 -36.26 66.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.726 0.298 . . . . 0.0 110.706 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -57.44 -63.16 1.32 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.925 0.393 . . . . 0.0 111.567 -179.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.74 -21.98 26.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.218 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.49 -47.64 10.14 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.264 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.21 -52.45 31.78 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 m -47.86 -48.58 11.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.793 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.529 ' O ' ' SD ' ' A' ' 21' ' ' MET . 93.9 t -59.21 -46.52 92.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.994 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.6 -47.49 93.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.8 -38.47 61.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.375 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.502 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 39.7 p -69.39 -24.38 63.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.221 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -79.97 -39.94 29.06 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.7 mt -70.43 -45.36 75.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.94 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -54.77 -37.78 41.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.039 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -46.54 -47.21 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.11 -53.24 60.06 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.458 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 1.9 tm? -49.99 -38.07 35.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.702 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.83 -68.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.648 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 16.1 ptm -48.81 -20.86 0.54 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.222 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 32' ' ' LYS . 8.6 mt -74.61 -25.85 59.52 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.126 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -45.23 -15.01 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.45 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' LEU . 98.9 mttt -99.86 23.86 9.19 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.079 0.466 . . . . 0.0 109.86 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 29' ' ' LEU . 24.8 mtmm . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.9 71.07 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.81 43.55 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.416 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 37.7 mm -63.91 -49.08 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.03 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' B' ' 12' ' ' MET . 3.8 tp -69.71 -44.06 79.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.383 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG2' ' B' ' 9' ' ' ILE . . . -36.83 -47.2 1.24 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' B' ' 11' ' ' LEU . 4.3 mm? -73.57 -36.2 65.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 110.698 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' MET . . . . . 0.497 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -57.45 -63.35 1.26 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 120.96 0.41 . . . . 0.0 111.512 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -68.73 -21.89 26.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.171 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.32 -47.78 10.28 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.286 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.25 33.39 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 m -47.85 -48.7 11.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.765 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.531 ' O ' ' SD ' ' B' ' 21' ' ' MET . 93.8 t -59.18 -46.41 92.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.038 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mm -61.74 -47.42 93.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.83 -38.51 61.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.359 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' THR . . . . . 0.509 ' OG1' ' SD ' ' B' ' 21' ' ' MET . 40.3 p -69.27 -24.43 63.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.263 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -80.02 -39.91 28.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 92.7 mt -70.44 -45.35 75.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.936 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 m -54.8 -37.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.97 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -46.46 -47.04 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.24 -53.15 61.12 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.451 ' C ' ' CD1' ' B' ' 26' ' ' LEU . 1.9 tm? -50.12 -38.06 37.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.697 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' B' ' 30' ' ' LYS . 58.7 t -63.85 -68.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.653 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 16.2 ptm -48.82 -20.95 0.55 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.214 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 32' ' ' LYS . 8.5 mt -74.62 -25.78 59.46 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.027 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' B' ' 27' ' ' VAL . 56.0 mttp -45.35 -14.69 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.452 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 99.0 mttt -100.13 23.74 9.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.092 0.472 . . . . 0.0 109.874 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' B' ' 29' ' ' LEU . 24.8 mtmm . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.801 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.872 0.367 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.524 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.4 mp -63.6 -45.07 98.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.073 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.48 -25.22 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.051 0.453 . . . . 0.0 110.693 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.05 -43.49 62.16 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.591 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -82.16 -27.01 32.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 110.646 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -61.68 2.4 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.65 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.35 -23.5 28.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.063 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.37 -43.21 79.68 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.27 -61.42 6.98 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.0 m -50.02 -26.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.185 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.32 -46.92 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.2 mt -67.91 -45.0 84.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.863 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.58 -40.81 72.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.676 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 t -75.93 -27.5 57.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.22 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.6 mmt -72.16 -40.15 68.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.76 -46.15 79.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.682 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 m -65.24 -33.48 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -43.78 -50.09 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.904 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.454 ' OG1' ' CD1' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -66.22 -49.7 66.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.837 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.466 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 2.1 tm? -41.97 -37.84 1.44 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.079 0.466 . . . . 0.0 110.684 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.01 -58.27 6.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 73.9 mtm -59.68 -22.21 61.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.41 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.454 ' CD1' ' OG1' ' A' ' 25' ' ' THR . 74.8 mt -79.91 -5.98 56.58 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.37 -9.49 8.38 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.833 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -102.74 19.87 18.38 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.65 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.848 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.99 -37.78 83.71 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.28 -22.47 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 0.0 110.801 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 1.4 mp -63.45 -45.08 98.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.077 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.45 -25.38 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.081 0.467 . . . . 0.0 110.728 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.94 -43.3 61.23 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.72 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -82.37 -26.92 32.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.856 0.36 . . . . 0.0 110.75 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -61.85 2.26 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.17 -23.38 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.058 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.32 -43.28 79.83 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.2 -60.97 7.41 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 m -50.47 -26.27 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 122.695 -0.297 . . . . 0.0 111.191 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -82.23 -46.92 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.061 0.458 . . . . 0.0 111.229 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.11 -44.98 84.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.931 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.54 -40.78 72.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.736 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 3.8 t -75.85 -27.59 57.89 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.269 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 29.6 mmt -72.18 -40.23 68.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.78 -46.1 79.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.724 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 m -65.33 -33.58 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.478 -0.489 . . . . 0.0 112.277 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -43.66 -50.14 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 120.491 -0.483 . . . . 0.0 109.867 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.456 ' OG1' ' CD1' ' B' ' 29' ' ' LEU . 0.5 OUTLIER -66.3 -49.56 66.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.923 179.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.465 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 2.1 tm? -42.16 -37.77 1.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.637 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.0 -58.34 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 74.1 mtm -59.54 -22.39 61.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.438 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.456 ' CD1' ' OG1' ' B' ' 25' ' ' THR . 74.7 mt -79.86 -5.88 56.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -62.48 -9.39 8.39 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -102.83 19.68 18.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.712 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.792 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.608 0.242 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.498 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.5 mp -62.36 -44.0 98.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.15 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tp -51.64 -32.5 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.43 99.06 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.227 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.46 -24.92 34.01 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.36 -63.83 1.16 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.177 0.513 . . . . 0.0 110.593 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.1 m -67.42 -22.23 28.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.863 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.79 -40.04 15.77 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.34 -54.91 29.39 Favored Glycine 0 C--N 1.331 0.262 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.5 m -45.6 -51.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.551 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.4 -42.1 89.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.21 -50.12 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.321 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.76 -34.22 69.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.426 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.2 p -74.6 -20.53 59.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.584 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.9 mmt -82.45 -31.55 29.39 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.373 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.98 -47.46 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.951 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.9 m -63.94 -31.71 54.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.695 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -54.64 -21.02 6.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.42 -43.89 59.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.028 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -58.92 -27.33 65.17 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.273 0.558 . . . . 0.0 110.625 -179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.458 ' CG1' ' HZ2' ' B' ' 30' ' ' LYS . 66.4 t -65.26 -44.83 94.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.955 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.6 mtp -72.53 -29.21 63.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.365 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.47 -3.28 33.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.319 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.451 ' HZ2' ' CG1' ' B' ' 27' ' ' VAL . 51.7 mtmt -68.57 -18.18 64.29 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.494 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 32' ' ' LYS . 46.8 tttp -95.65 15.3 20.36 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.664 0.269 . . . . 0.0 110.717 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 31' ' ' LYS . 22.0 pttp . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.957 -1.02 . . . . 0.0 111.696 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.98 -33.12 86.4 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.99 -25.38 58.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.63 0.252 . . . . 0.0 111.199 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.5 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 1.5 mp -62.33 -43.95 98.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.168 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tp -51.54 -32.57 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.41 -43.45 99.04 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.19 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.48 -24.92 33.96 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.877 0.37 . . . . 0.0 110.892 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.35 -63.82 1.17 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.622 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 23.4 m -67.45 -22.16 28.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.884 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.93 -39.79 15.95 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.236 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.28 -55.08 28.3 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 6.5 m -45.52 -51.81 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.549 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.5 -42.09 90.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.067 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.14 -50.21 81.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.321 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.75 -34.09 69.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.572 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 33.8 p -74.7 -20.35 59.89 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.651 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.9 mmt -82.49 -31.59 29.22 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.343 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.87 -47.6 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.017 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.79 -31.73 54.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.795 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -20.99 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -43.93 59.1 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.954 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.478 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 0.3 OUTLIER -58.91 -27.33 65.15 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.245 0.545 . . . . 0.0 110.662 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.451 ' CG1' ' HZ2' ' A' ' 30' ' ' LYS . 66.7 t -65.3 -44.82 94.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.983 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 77.7 mtp -72.53 -29.1 63.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.364 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.7 -3.14 33.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.22 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.458 ' HZ2' ' CG1' ' A' ' 27' ' ' VAL . 51.7 mtmt -68.64 -18.07 64.22 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.547 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' B' ' 32' ' ' LYS . 46.9 tttp -95.74 15.3 20.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.688 0.28 . . . . 0.0 110.664 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' B' ' 31' ' ' LYS . 22.0 pttp . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.755 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.43 -53.2 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.484 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.1 tp -70.91 -42.8 77.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.458 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.434 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -35.71 -48.58 0.99 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mt -72.81 -38.27 67.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.825 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.501 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -55.74 -61.56 2.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 120.745 0.307 . . . . 0.0 111.636 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.99 -22.63 30.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.74 -45.85 16.03 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.389 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.34 -53.83 32.89 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -49.22 -50.71 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.013 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.522 ' O ' ' SD ' ' A' ' 21' ' ' MET . 58.2 t -57.84 -45.62 87.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.642 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.39 -46.44 96.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.383 0.611 . . . . 0.0 109.827 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.25 71.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.139 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.535 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 41.7 p -67.31 -25.4 66.01 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.678 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -80.86 -39.13 26.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -71.23 -46.59 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -51.31 -37.11 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.946 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mp -47.44 -46.2 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -60.15 -53.3 59.41 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.585 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.452 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 2.2 tm? -50.75 -40.91 56.0 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.133 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.94 -67.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.62 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.9 mtt -48.7 -23.07 0.91 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.214 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 31' ' ' LYS . 16.3 mt -72.53 -26.63 61.82 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.702 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -45.78 -13.2 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.762 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 29' ' ' LEU . 27.9 ttpt -98.28 19.56 14.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.85 0.357 . . . . 0.0 110.252 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LEU . 65.2 tttm . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.631 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.63 -27.22 72.41 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.48 84.49 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.283 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.04 -53.27 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.473 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.1 tp -70.94 -42.71 77.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.429 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' B' ' 9' ' ' ILE . . . -36.06 -48.13 1.07 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.7 mt -73.15 -38.19 66.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.824 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -55.59 -61.72 2.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.793 0.33 . . . . 0.0 111.622 -179.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.91 -22.39 30.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.795 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.92 -45.92 15.14 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.381 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.37 -53.75 33.34 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 4.9 m -49.04 -50.93 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.057 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.526 ' O ' ' SD ' ' B' ' 21' ' ' MET . 58.8 t -57.77 -45.55 87.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.72 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.45 -46.54 96.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.833 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.41 -38.44 71.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.059 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' THR . . . . . 0.533 ' OG1' ' SD ' ' B' ' 21' ' ' MET . 41.2 p -67.05 -25.37 66.22 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.802 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.533 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -80.93 -39.19 26.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.18 -46.69 64.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.096 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -51.24 -37.16 17.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.872 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mp -47.42 -46.01 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -60.4 -53.13 61.24 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.458 ' C ' ' CD1' ' B' ' 26' ' ' LEU . 2.2 tm? -50.88 -40.85 57.54 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.079 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.98 -67.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.549 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 68.0 mtt -48.5 -23.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.207 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' B' ' 31' ' ' LYS . 15.8 mt -72.43 -26.69 61.94 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.686 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -45.67 -13.33 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.803 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' B' ' 29' ' ' LEU . 27.9 ttpt -98.33 19.74 13.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 110.281 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.1 tttm . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.616 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.688 0.28 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.495 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.8 mp -68.56 -54.61 20.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.876 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.2 tp -69.67 -41.99 80.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.254 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -34.31 -60.73 0.58 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.66 -29.26 70.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.591 0.234 . . . . 0.0 111.242 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -66.05 -63.66 1.03 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.084 0.469 . . . . 0.0 111.267 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.88 -20.01 23.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.547 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.84 -40.59 5.87 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.48 -49.23 57.95 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.6 m -44.98 -49.64 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.725 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.68 -43.41 87.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.862 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.98 -49.1 86.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.39 -36.28 71.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.962 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.2 p -73.16 -18.43 61.27 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.696 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.7 -31.74 28.41 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.399 -0.52 . . . . 0.0 109.987 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.35 -46.17 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.381 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' LEU . 27.2 m -64.41 -35.04 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.345 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -46.87 -20.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.453 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.7 OUTLIER -76.24 -40.68 51.36 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.207 178.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.8 OUTLIER -54.4 -31.54 55.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.278 0.561 . . . . 0.0 109.87 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.7 t -63.25 -29.96 48.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.473 0.654 . . . . 0.0 109.826 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.9 mtp -84.38 -32.98 23.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.788 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 31' ' ' LYS . 59.2 mt -66.6 -41.88 87.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -49.43 -10.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.718 0.294 . . . . 0.0 111.001 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 29' ' ' LEU . 99.5 mttt -96.24 12.27 31.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.109 0.48 . . . . 0.0 109.982 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' LEU . 32.5 ttpt . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.301 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.63 -33.6 87.68 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.44 74.85 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.516 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.508 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 1.8 mp -68.67 -54.58 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.86 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.2 tp -69.6 -42.09 80.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.22 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' B' ' 9' ' ' ILE . . . -34.23 -61.08 0.55 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.4 -28.95 70.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.804 -0.198 . . . . 0.0 111.253 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' MET . . . . . 0.52 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -66.37 -63.79 1.0 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 111.203 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.76 -20.05 23.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.528 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.76 -40.6 5.89 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.44 -49.23 57.83 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 9.4 m -44.98 -49.75 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.217 -0.491 . . . . 0.0 110.698 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.55 -43.48 87.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.872 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.92 -49.18 85.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.37 -36.18 70.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.052 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 30.7 p -73.26 -18.29 61.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.653 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.72 -31.7 28.35 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.047 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.47 -46.21 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.322 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' B' ' 26' ' ' LEU . 27.1 m -64.29 -35.25 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.389 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -46.7 -20.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.454 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -76.45 -40.62 50.0 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.161 178.358 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.8 OUTLIER -54.5 -31.59 56.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.327 0.584 . . . . 0.0 109.825 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -63.21 -30.02 48.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.454 0.645 . . . . 0.0 109.778 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.1 mtp -84.28 -33.03 24.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.842 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' B' ' 31' ' ' LYS . 59.3 mt -66.62 -41.8 87.79 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -49.48 -10.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.699 0.285 . . . . 0.0 110.921 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' B' ' 29' ' ' LEU . 99.4 mttt -96.07 12.49 30.42 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.204 0.526 . . . . 0.0 110.014 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' B' ' 29' ' ' LEU . 32.4 ttpt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.339 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.816 0.341 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.27 -42.84 96.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.455 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 tp -58.74 -37.67 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.0 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.56 -42.91 52.36 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.1 tp -73.38 -26.91 61.19 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.746 -0.267 . . . . 0.0 111.084 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.53 -60.25 3.69 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 120.802 0.334 . . . . 0.0 110.847 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -55.33 -23.47 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.024 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.19 -40.5 29.05 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.343 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.19 -43.67 95.26 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.366 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 m -61.74 -24.15 33.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.606 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.455 ' O ' ' SD ' ' A' ' 21' ' ' MET . 54.3 t -86.08 -39.97 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 123.461 0.476 . . . . 0.0 111.341 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.84 -52.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.635 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.67 -46.39 74.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.779 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.42 ' O ' HG12 ' A' ' 24' ' ' ILE . 4.2 t -68.96 -17.62 63.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.48 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.455 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -85.0 -29.04 25.33 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.288 0.367 . . . . 0.0 111.373 -179.029 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.31 -39.19 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' LEU . 13.6 m -56.57 -39.24 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.105 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' VAL . 37.2 mm -40.73 -49.77 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -60.28 -41.02 92.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.972 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' VAL . 2.5 tm? -60.07 -48.36 82.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.866 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.19 -42.92 97.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.344 0.592 . . . . 0.0 109.996 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.9 mmm -63.55 -18.56 63.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.761 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 31' ' ' LYS . 34.6 mt -87.5 -49.86 6.92 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.427 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -55.76 -4.28 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.535 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 29' ' ' LEU . 16.9 tptm -156.29 60.64 0.56 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.117 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.471 179.498 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' B' ' 8' ' ' ILE . . . -61.8 -34.01 87.23 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.41 -19.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.735 0.303 . . . . 0.0 110.657 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.432 ' N ' ' C ' ' B' ' 6' ' ' GLY . 96.9 mt -64.16 -42.9 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.414 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 tp -58.72 -37.53 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.002 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.64 -42.96 52.92 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.3 tp -73.4 -26.91 61.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.749 -0.265 . . . . 0.0 111.118 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -60.28 3.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.791 0.329 . . . . 0.0 110.763 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 29.8 m -55.36 -23.34 13.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.104 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.23 -40.61 28.54 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.352 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.02 -43.65 94.96 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.434 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.401 ' O ' ' CG2' ' B' ' 20' ' ' THR . 10.8 m -61.83 -24.11 33.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.596 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.453 ' O ' ' SD ' ' B' ' 21' ' ' MET . 54.8 t -86.23 -39.93 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 123.517 0.511 . . . . 0.0 111.324 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.83 -52.61 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.587 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.59 -46.4 73.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.743 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' THR . . . . . 0.417 ' O ' HG12 ' B' ' 24' ' ' ILE . 4.1 t -68.87 -17.64 64.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.407 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.1 OUTLIER -85.13 -29.08 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.325 0.39 . . . . 0.0 111.285 -178.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.14 -39.37 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 111.199 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' B' ' 26' ' ' LEU . 13.5 m -56.37 -39.35 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.058 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.417 HG12 ' O ' ' B' ' 20' ' ' THR . 37.0 mm -40.65 -49.85 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -60.29 -41.01 92.47 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.978 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' B' ' 23' ' ' VAL . 2.5 tm? -60.01 -48.4 81.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.851 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -62.21 -42.87 96.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.216 0.532 . . . . 0.0 110.055 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 94.2 mmm -63.52 -18.72 64.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.785 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.544 ' C ' ' H ' ' B' ' 31' ' ' LYS . 34.5 mt -87.43 -49.76 7.0 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.432 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -55.8 -4.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.54 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' B' ' 29' ' ' LEU . 16.9 tptm -156.51 60.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.122 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.432 179.526 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.687 0.279 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -62.71 -44.1 99.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.59 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.0 tp -56.12 -33.78 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.8 -45.06 96.99 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.005 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.55 -29.56 37.1 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 120.905 0.383 . . . . 0.0 111.097 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.3 tpt -64.31 -63.61 1.1 Allowed 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.489 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.7 m -66.84 -22.15 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.528 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.04 -41.48 10.35 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.23 -54.25 35.38 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.3 m -45.57 -51.04 3.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.874 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.512 ' O ' ' SD ' ' A' ' 21' ' ' MET . 85.8 t -59.1 -43.59 89.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.947 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.8 -49.05 85.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.686 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.28 -34.18 68.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.396 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.528 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 33.2 p -74.16 -20.67 60.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.63 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' OG1' ' A' ' 20' ' ' THR . 0.0 OUTLIER -81.9 -31.7 31.31 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.622 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.91 -48.56 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.524 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.434 ' C ' ' N ' ' A' ' 25' ' ' THR . 23.8 m -63.3 -31.99 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.968 0.413 . . . . 0.0 110.759 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.19 -19.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.434 ' N ' ' C ' ' A' ' 23' ' ' VAL . 1.2 t -74.56 -42.08 59.42 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.348 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.435 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -56.39 -29.92 62.08 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.244 0.545 . . . . 0.0 110.436 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.74 -46.49 92.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.378 0.608 . . . . 0.0 109.711 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 90.0 mtp -70.28 -33.97 72.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.031 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.36 -2.95 54.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.32 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -61.45 -37.51 83.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.95 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.66 23.2 3.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.269 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.383 179.406 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.22 -26.52 70.55 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.54 -23.03 14.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.72 0.295 . . . . 0.0 110.639 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -62.67 -44.13 99.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.62 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 6.0 tp -56.13 -33.8 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.71 -45.2 96.75 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.059 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.47 -29.57 37.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.86 0.362 . . . . 0.0 111.123 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 8.3 tpt -64.3 -63.64 1.09 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.545 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 4.7 m -66.76 -22.28 29.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.513 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.01 -41.36 10.49 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.22 -54.3 35.0 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 m -45.59 -50.99 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.953 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.508 ' O ' ' SD ' ' B' ' 21' ' ' MET . 85.3 t -59.13 -43.65 89.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.904 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.421 HD11 HG22 ' B' ' 18' ' ' ILE . 96.8 mt -61.72 -49.07 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.681 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.32 -34.23 68.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.341 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' THR . . . . . 0.53 ' OG1' ' SD ' ' B' ' 21' ' ' MET . 33.4 p -74.16 -20.74 60.12 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.693 0.282 . . . . 0.0 110.607 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.53 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -81.82 -31.67 31.61 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.626 179.261 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.97 -48.52 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.499 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.431 ' C ' ' N ' ' B' ' 25' ' ' THR . 24.3 m -63.34 -31.91 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.936 0.398 . . . . 0.0 110.829 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.18 -19.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.431 ' N ' ' C ' ' B' ' 23' ' ' VAL . 1.2 t -74.5 -42.05 59.61 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.309 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.434 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 0.8 OUTLIER -56.43 -29.89 62.16 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.284 0.564 . . . . 0.0 110.48 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.81 -46.38 92.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.277 0.561 . . . . 0.0 109.714 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 89.8 mtp -70.38 -33.85 71.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.977 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 93.2 mt -82.42 -2.92 54.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.298 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -61.51 -37.55 84.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.878 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.6 23.24 3.11 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.323 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.307 179.479 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.629 0.252 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 91.9 mt -62.7 -43.61 98.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.23 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 tp -60.0 -33.2 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.146 0.498 . . . . 0.0 109.799 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.75 -68.72 1.55 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.319 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -60.98 -27.49 68.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.051 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.07 -63.84 1.05 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 120.854 0.359 . . . . 0.0 110.727 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 m -70.21 -21.16 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.05 -39.32 8.61 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.72 -53.17 40.88 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -45.45 -48.4 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.9 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.524 ' O ' ' SD ' ' A' ' 21' ' ' MET . 97.4 t -58.72 -44.09 89.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.755 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.44 -48.02 90.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.58 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.65 68.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.543 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.51 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 31.1 p -74.81 -18.95 60.38 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.653 0.263 . . . . 0.0 110.783 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -83.75 -30.84 26.35 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.221 179.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.99 -48.24 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.368 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.438 ' C ' ' N ' ' A' ' 25' ' ' THR . 25.0 m -63.77 -32.64 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.078 0.466 . . . . 0.0 110.72 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.82 -21.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.438 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.7 OUTLIER -75.84 -41.19 53.22 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.611 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -56.72 -30.25 63.3 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.451 0.643 . . . . 0.0 110.389 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.2 t -61.84 -38.65 81.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.51 0.672 . . . . 0.0 109.391 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.5 mmm -72.88 -28.43 62.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.79 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.75 -6.59 56.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.013 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.14 -39.01 91.15 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.782 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -94.0 18.03 11.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.793 0.33 . . . . 0.0 110.42 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.647 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.82 -33.39 87.12 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.4 -23.03 46.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.69 0.281 . . . . 0.0 110.85 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.55 -43.65 98.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.288 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.97 -33.22 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.169 0.509 . . . . 0.0 109.817 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.81 -68.71 1.56 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.257 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' B' ' 11' ' ' LEU . 4.2 mm? -60.96 -27.5 68.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.034 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.16 -63.82 1.05 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 120.841 0.353 . . . . 0.0 110.724 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 7.3 m -70.1 -21.13 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.14 -39.38 8.52 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.58 -53.16 40.52 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 4.8 m -45.49 -48.35 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.877 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.515 ' O ' ' SD ' ' B' ' 21' ' ' MET . 97.2 t -58.91 -43.85 89.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.765 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.61 -48.02 90.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.504 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.71 69.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.47 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' THR . . . . . 0.515 ' OG1' ' SD ' ' B' ' 21' ' ' MET . 31.0 p -74.68 -19.08 60.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.817 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -83.54 -30.99 26.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.279 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.91 -48.22 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.453 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.449 ' C ' ' N ' ' B' ' 25' ' ' THR . 25.5 m -63.73 -32.65 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.158 0.504 . . . . 0.0 110.751 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.91 -20.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.449 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -75.95 -41.21 52.22 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.594 179.058 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.446 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 0.8 OUTLIER -56.66 -30.15 63.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.424 0.63 . . . . 0.0 110.43 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.3 t -61.93 -39.05 82.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.49 0.662 . . . . 0.0 109.291 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.5 mmm -72.39 -28.52 63.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.825 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.79 -6.48 56.05 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.992 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.26 -38.86 90.9 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.708 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -94.03 17.91 11.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.771 0.32 . . . . 0.0 110.396 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.554 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.13 -53.77 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.52 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 tp -70.17 -38.56 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 109.976 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.5 -46.12 8.61 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.5 tp -73.03 -38.47 66.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 121.189 -0.204 . . . . 0.0 110.79 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -57.27 8.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.982 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 27.0 m -65.4 -20.72 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.211 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.15 -40.81 10.93 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.53 -54.89 25.25 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.7 m -44.49 -51.29 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.452 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.13 -42.24 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.58 -49.91 60.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.374 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.22 77.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.869 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.2 t -80.07 -17.25 53.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 110.235 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.36 -31.81 43.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.53 -46.81 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.066 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.457 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' C ' ' N ' ' A' ' 25' ' ' THR . 33.6 m -64.8 -35.12 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.061 0.457 . . . . 0.0 110.198 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 tp -45.05 -22.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.463 ' N ' ' C ' ' A' ' 23' ' ' VAL . 1.3 t -72.07 -41.04 67.83 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.669 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -53.0 -30.49 35.5 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.875 0.47 . . . . 0.0 110.688 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.96 -45.93 93.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.28 0.562 . . . . 0.0 109.493 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.7 mtt -71.47 -34.67 70.41 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.917 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.8 mt -83.75 -2.96 57.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.78 -37.44 86.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.77 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.59 23.79 4.44 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.398 179.749 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.41 -25.35 64.88 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.19 83.47 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.104 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.17 -54.03 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.463 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 6.0 tp -70.02 -38.58 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.129 0.49 . . . . 0.0 109.944 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.39 -46.48 8.51 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 44.8 tp -72.66 -38.52 67.6 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.848 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' MET . . . . . 0.401 ' SD ' ' C ' ' B' ' 12' ' ' MET . 0.0 OUTLIER -50.53 -57.23 8.6 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.058 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 27.0 m -65.4 -20.75 28.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.12 -40.77 11.02 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.59 -54.87 25.53 Favored Glycine 0 C--O 1.223 -0.587 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.7 m -44.59 -51.22 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.49 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 69.5 t -56.21 -42.11 72.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.771 0.319 . . . . 0.0 110.874 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.79 -49.76 61.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.33 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.25 77.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.801 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 14.3 t -80.04 -17.38 52.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.212 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.19 -31.93 43.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.49 -46.78 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.074 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.55 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.455 ' C ' ' N ' ' B' ' 25' ' ' THR . 32.7 m -64.83 -34.98 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.187 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 tp -45.21 -22.93 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.492 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.455 ' N ' ' C ' ' B' ' 23' ' ' VAL . 1.3 t -71.83 -41.14 68.53 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.742 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.0 OUTLIER -52.84 -30.59 34.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.956 0.502 . . . . 0.0 110.657 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 t -64.96 -45.92 93.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 65.4 mtt -71.59 -34.79 70.21 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.835 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -83.7 -2.68 56.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.749 0.309 . . . . 0.0 110.563 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -63.06 -37.31 86.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.746 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.66 23.59 4.61 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.059 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.4 179.687 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.6 0.238 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.28 -44.04 98.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.26 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.4 tp -59.76 -35.8 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.83 -69.21 1.34 Allowed Glycine 0 CA--C 1.532 1.153 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.66 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.84 -28.41 68.81 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 120.79 0.329 . . . . 0.0 111.062 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.9 tpt -63.54 -63.64 1.12 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.002 0.43 . . . . 0.0 110.545 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 10.5 m -67.84 -20.63 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.82 -39.83 7.4 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.5 -52.04 44.02 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.4 m -44.72 -49.04 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.579 -0.311 . . . . 0.0 110.725 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.0 t -58.63 -43.63 87.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.02 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.22 -49.66 83.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -35.9 70.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.166 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.2 p -73.52 -18.51 61.09 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.955 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -84.3 -31.94 24.62 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.124 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.45 -47.66 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.447 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.447 ' C ' ' N ' ' A' ' 25' ' ' THR . 29.9 m -63.37 -34.92 70.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.172 0.51 . . . . 0.0 110.532 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -46.04 -22.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.447 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -79.26 -42.31 26.15 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.774 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.443 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 1.1 tm? -51.35 -31.19 21.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.324 0.583 . . . . 0.0 110.393 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 t -64.67 -35.69 75.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.515 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mtp -71.94 -29.6 64.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.28 -9.63 59.31 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.235 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.17 -36.49 82.02 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.723 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -89.54 18.66 5.16 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.674 0.273 . . . . 0.0 110.674 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.25 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.62 -33.46 87.3 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.88 -22.6 38.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.669 0.271 . . . . 0.0 110.674 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 89.2 mt -62.23 -43.98 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.252 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 5.4 tp -59.74 -35.88 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.78 -69.18 1.34 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.687 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -60.78 -28.51 68.8 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 8.9 tpt -63.49 -63.74 1.1 Allowed 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.012 0.434 . . . . 0.0 110.457 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 10.4 m -67.81 -20.59 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.41 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.75 -39.9 7.41 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.5 -52.06 43.91 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.4 m -44.71 -49.12 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.66 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 64.3 t -58.64 -43.57 87.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.004 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.22 -49.65 83.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.74 70.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.213 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 30.4 p -73.59 -18.49 61.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.845 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -84.3 -31.85 24.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.132 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.48 -47.66 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.473 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.439 ' C ' ' N ' ' B' ' 25' ' ' THR . 30.1 m -63.35 -35.0 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.168 0.509 . . . . 0.0 110.502 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -45.98 -22.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.439 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -79.24 -42.33 26.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.79 178.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.436 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 1.1 tm? -51.28 -31.27 20.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.322 0.582 . . . . 0.0 110.423 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 t -64.6 -35.69 75.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.595 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.8 mtp -71.9 -29.6 64.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.726 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.25 -9.53 59.26 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.247 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.31 -36.57 82.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.694 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -89.45 18.6 5.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.622 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.312 179.879 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.599 0.238 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.505 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.8 mp -70.54 -55.77 13.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.775 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.1 tp -69.28 -42.31 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.238 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.423 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -36.49 -58.46 1.1 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 11' ' ' LEU . 4.2 mm? -64.97 -29.03 69.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.819 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -66.09 -63.78 1.0 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 0.0 111.205 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 26.1 m -67.07 -20.12 26.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.871 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.16 -41.09 6.33 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.24 -49.82 54.67 Favored Glycine 0 C--N 1.333 0.369 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 5.1 m -44.6 -51.03 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.647 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.4 t -57.64 -43.8 84.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.745 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.98 -49.87 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -36.75 68.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.866 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.9 p -72.59 -18.51 61.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.045 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.3 mmt -82.44 -32.57 28.91 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.218 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.53 -46.57 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.633 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 25' ' ' THR . 30.1 m -63.12 -36.1 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.283 0.563 . . . . 0.0 110.571 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -43.77 -22.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.7 OUTLIER -81.57 -42.78 19.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.504 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.2 tm? -47.44 -33.73 6.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.617 0.723 . . . . 0.0 110.475 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 30' ' ' LYS . 48.5 t -66.0 -42.56 91.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.164 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.402 ' N ' ' O ' ' A' ' 25' ' ' THR . 67.3 mtt -65.97 -33.66 76.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.412 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.59 0.75 11.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.356 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 27' ' ' VAL . 24.6 mmtp -62.01 -38.17 87.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.554 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -132.74 17.33 4.28 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.821 0.344 . . . . 0.0 110.479 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.041 179.566 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.04 -34.15 89.16 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.89 -29.94 70.54 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.468 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.515 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 1.8 mp -70.56 -55.79 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.738 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.0 tp -69.36 -42.31 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.269 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . 0.432 ' N ' ' CG2' ' B' ' 9' ' ' ILE . . . -36.44 -58.35 1.1 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.424 ' N ' ' CD2' ' B' ' 11' ' ' LEU . 4.2 mm? -65.16 -28.92 69.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.792 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' MET . . . . . 0.505 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -66.17 -63.84 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.997 0.427 . . . . 0.0 111.239 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 26.4 m -67.06 -20.07 26.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.861 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.1 -41.12 6.34 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.21 -49.76 54.82 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 m -44.9 -50.86 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.641 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.66 -43.91 84.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.697 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.89 -49.81 83.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.97 68.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.959 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 28.9 p -72.43 -18.55 61.7 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.967 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.3 mmt -82.37 -32.76 29.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.203 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.22 -46.7 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.672 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' B' ' 25' ' ' THR . 30.1 m -63.14 -36.11 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.339 0.59 . . . . 0.0 110.629 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -43.79 -22.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.582 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.467 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -81.62 -42.65 19.72 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.498 179.444 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.2 tm? -47.66 -33.6 7.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.745 0.783 . . . . 0.0 110.513 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' B' ' 30' ' ' LYS . 50.0 t -66.02 -42.54 91.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.18 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 67.3 mtt -65.86 -33.78 76.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.471 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.5 0.6 11.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.333 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' B' ' 27' ' ' VAL . 24.7 mmtp -61.78 -38.4 87.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.543 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -132.59 17.48 4.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.888 0.375 . . . . 0.0 110.492 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.057 179.579 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.601 0.239 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.474 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.8 mp -65.8 -53.09 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.91 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 5.5 tp -71.15 -41.68 75.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.05 0.452 . . . . 0.0 110.308 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -39.97 -46.24 3.13 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.1 tp -73.82 -41.95 61.58 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.652 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.01 -54.23 13.63 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.083 0.468 . . . . 0.0 111.013 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.17 -21.83 27.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.818 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.58 -46.61 14.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -50.97 -54.82 21.09 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.9 m -48.23 -49.26 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.26 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.509 ' O ' ' SD ' ' A' ' 21' ' ' MET . 85.4 t -59.81 -45.03 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.929 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.29 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.765 -0.774 . . . . 0.0 108.966 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.18 -38.26 73.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.671 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.526 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 66.4 p -68.05 -24.98 65.14 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.054 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' OG1' ' A' ' 20' ' ' THR . 0.0 OUTLIER -82.04 -38.9 24.28 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.319 0.387 . . . . 0.0 112.038 -179.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.3 mt -69.08 -46.54 78.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.761 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.5 m -52.69 -34.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.939 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.5 mm -49.0 -45.99 16.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 29' ' ' LEU . 1.5 m -59.6 -55.08 38.96 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.457 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 1.6 tm? -46.93 -37.67 9.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.246 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.3 -56.67 9.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.395 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.522 ' O ' ' N ' ' A' ' 32' ' ' LYS . 98.6 mmm -58.11 -29.54 65.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.697 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 31' ' ' LYS . 3.5 tt -63.79 -36.0 82.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.994 0.426 . . . . 0.0 109.87 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -45.4 -11.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.258 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 29' ' ' LEU . 34.1 ttmt -156.72 -13.43 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.371 0.605 . . . . 0.0 110.12 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' MET . 55.1 mtpt . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.483 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.78 69.21 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.29 -35.04 79.06 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.594 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 1.8 mp -66.0 -53.16 40.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.908 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 5.5 tp -70.94 -41.73 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.297 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -40.07 -46.06 3.18 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 43.0 tp -74.05 -41.92 61.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.709 0.29 . . . . 0.0 110.661 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 -54.29 13.04 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.106 0.479 . . . . 0.0 110.967 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.0 m -68.16 -21.78 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.846 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.55 -46.63 14.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.1 -54.89 21.2 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 7.1 m -47.98 -49.34 11.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.383 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.525 ' O ' ' SD ' ' B' ' 21' ' ' MET . 85.9 t -59.88 -44.98 95.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.939 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.33 -45.97 97.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.16 -38.26 73.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.615 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' THR . . . . . 0.529 ' OG1' ' SD ' ' B' ' 21' ' ' MET . 69.1 p -68.06 -24.93 65.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.096 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.529 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -82.11 -38.9 24.1 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.42 0.45 . . . . 0.0 112.032 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.13 -46.51 77.96 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.765 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 31.9 m -52.67 -34.91 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.013 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -49.1 -45.9 17.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.427 ' O ' ' N ' ' B' ' 29' ' ' LEU . 1.5 m -59.71 -55.31 35.97 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.46 ' C ' ' CD1' ' B' ' 26' ' ' LEU . 1.6 tm? -46.79 -37.49 8.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.295 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.45 -56.53 10.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.466 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' MET . . . . . 0.528 ' O ' ' N ' ' B' ' 32' ' ' LYS . 98.6 mmm -58.23 -29.4 65.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.715 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' B' ' 31' ' ' LYS . 3.5 tt -63.84 -36.14 82.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.024 0.44 . . . . 0.0 109.861 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -45.29 -11.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.361 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' B' ' 29' ' ' LEU . 34.0 ttmt -156.73 -13.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.241 0.543 . . . . 0.0 109.965 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' B' ' 28' ' ' MET . 55.0 mtpt . . . . . 0 C--N 1.322 -0.63 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.43 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.532 0.206 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.02 -59.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 6.0 tp -66.09 -39.75 85.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.22 0.533 . . . . 0.0 110.198 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -42.62 -45.99 5.7 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.75 -33.65 64.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 111.204 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.436 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.1 OUTLIER -57.23 -62.94 1.41 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.302 -179.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 m -58.27 -21.91 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.178 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.13 -38.45 39.98 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.31 -55.25 30.5 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.2 m -51.05 -21.72 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.19 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.1 t -85.56 -47.77 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.205 0.526 . . . . 0.0 111.376 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.419 HG21 HD12 ' A' ' 18' ' ' ILE . 42.8 mm -69.7 -47.14 72.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.02 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.5 -41.11 65.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.707 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.0 t -78.88 -19.93 50.72 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.047 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.0 mmt -78.33 -35.14 48.01 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.951 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.92 -48.45 87.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.65 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 25' ' ' THR . 34.1 m -63.87 -34.71 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 110.3 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -43.59 -22.44 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -79.46 -43.03 24.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.57 178.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.5 tm? -47.83 -31.83 5.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.67 0.747 . . . . 0.0 110.479 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.6 t -64.46 -40.59 89.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.292 0.567 . . . . 0.0 109.501 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 25' ' ' THR . 67.4 mtt -67.45 -31.34 71.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.876 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.1 mt -76.06 -8.62 57.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.025 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -60.97 -36.79 80.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.716 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -101.98 17.12 23.98 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.731 0.3 . . . . 0.0 110.59 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.602 179.832 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.78 -22.72 66.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.06 -30.86 68.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.661 0.267 . . . . 0.0 111.056 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.13 -59.48 3.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 6.0 tp -65.93 -39.53 84.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.228 0.537 . . . . 0.0 110.23 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -42.99 -45.68 6.05 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.96 -33.54 63.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.747 0.308 . . . . 0.0 111.193 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' B' ' 12' ' ' MET . 0.1 OUTLIER -57.29 -63.04 1.36 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.28 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -58.24 -21.81 18.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.197 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.05 -38.52 40.19 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.3 -55.09 31.3 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.5 m -51.2 -21.66 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 122.874 -0.192 . . . . 0.0 111.182 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 70.3 t -85.6 -47.8 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.239 0.542 . . . . 0.0 111.401 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.76 -47.15 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.943 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.54 -41.17 66.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.642 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 4.0 t -78.76 -19.93 51.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.105 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 22.0 mmt -78.35 -35.16 47.85 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.975 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.91 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.713 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' B' ' 25' ' ' THR . 34.1 m -63.72 -34.76 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.093 0.473 . . . . 0.0 110.314 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -43.82 -22.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.479 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.0 OUTLIER -79.56 -43.0 23.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.622 178.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.5 tm? -47.81 -31.96 5.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.661 0.744 . . . . 0.0 110.55 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 12.3 t -64.43 -40.61 89.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.582 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' MET . . . . . 0.426 ' N ' ' O ' ' B' ' 25' ' ' THR . 67.5 mtt -67.42 -31.35 71.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.871 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 82.0 mt -75.95 -8.84 57.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.032 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -60.88 -36.8 80.15 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.728 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -101.92 17.17 23.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.544 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.615 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.765 0.317 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.17 -42.91 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.246 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -41.2 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.297 0.57 . . . . 0.0 109.532 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.8 -59.56 8.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 48.4 tp -72.89 -28.21 62.35 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.405 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.0 OUTLIER -42.48 -53.92 4.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 16' ' ' VAL . 34.2 m -72.92 -51.63 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.4 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.572 ' C ' ' H ' ' A' ' 16' ' ' VAL . . . -29.48 -47.15 0.1 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 123.694 0.621 . . . . 0.0 112.65 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.4 -1.79 0.21 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.593 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.572 ' H ' ' C ' ' A' ' 14' ' ' GLY . 33.6 m -80.71 -51.13 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.494 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 86.8 t -43.43 -37.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.828 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.53 -49.54 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.848 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.84 -52.04 67.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.534 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.93 -19.09 65.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.609 0.242 . . . . 0.0 110.705 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -82.03 -36.82 27.35 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.306 178.683 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.96 -44.27 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.131 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 26' ' ' LEU . 14.0 m -62.96 -40.58 89.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 CA-C-O 121.143 0.497 . . . . 0.0 110.516 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tp -40.83 -24.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.306 0.575 . . . . 0.0 110.195 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -82.47 -37.64 25.07 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.381 179.041 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.5 tm? -48.83 -40.42 29.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.704 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.74 -44.7 99.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.33 0.586 . . . . 0.0 109.685 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 82.2 mmm -65.4 -37.32 86.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.485 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.8 -5.65 59.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 110.405 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -61.85 -32.34 72.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.856 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.65 37.35 2.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.169 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.526 179.707 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.44 -34.17 89.18 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.16 -24.41 54.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.713 0.292 . . . . 0.0 110.7 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.11 -42.91 96.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.241 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.99 -41.24 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 121.288 0.566 . . . . 0.0 109.495 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.71 -59.53 8.48 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 48.7 tp -72.95 -28.28 62.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' MET . . . . . 0.404 ' C ' ' SD ' ' B' ' 12' ' ' MET . 0.0 OUTLIER -42.53 -53.78 4.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -178.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' B' ' 16' ' ' VAL . 34.1 m -72.95 -51.82 25.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.379 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.572 ' C ' ' H ' ' B' ' 16' ' ' VAL . . . -29.38 -47.04 0.09 OUTLIER Glycine 0 CA--C 1.531 1.061 0 O-C-N 123.764 0.665 . . . . 0.0 112.63 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.41 -1.92 0.22 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.524 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.572 ' H ' ' C ' ' B' ' 14' ' ' GLY . 33.5 m -80.74 -51.03 16.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.014 0.435 . . . . 0.0 109.874 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.497 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 86.0 t -43.48 -37.97 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.726 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.43 -49.48 80.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.798 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -51.89 67.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.661 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.87 -19.2 65.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.694 0.283 . . . . 0.0 110.781 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -82.05 -36.63 27.51 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.272 178.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 90.0 mt -65.09 -44.22 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.133 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' B' ' 26' ' ' LEU . 13.9 m -62.96 -40.69 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.139 0.495 . . . . 0.0 110.463 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' B' ' 23' ' ' VAL . 2.1 tp -40.83 -24.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.199 0.523 . . . . 0.0 110.167 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.506 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -82.43 -37.63 25.18 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.355 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.5 tm? -48.85 -40.28 28.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.783 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.84 -44.71 99.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.289 0.566 . . . . 0.0 109.623 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 82.3 mmm -65.45 -37.27 86.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.451 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.87 -5.65 59.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.794 0.33 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -61.96 -32.45 72.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.934 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.36 37.17 2.16 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.219 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.559 179.744 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.798 0.332 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 mm -63.17 -49.83 81.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.498 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.54 -40.36 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.429 0.633 . . . . 0.0 110.226 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.41 -60.54 5.69 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 11' ' ' LEU . 4.2 mm? -70.24 -29.39 66.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.2 -58.0 3.12 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 120.669 0.271 . . . . 0.0 111.671 -178.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 16' ' ' VAL . 17.1 m -75.49 -49.69 26.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.604 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' A' ' 16' ' ' VAL . . . -30.94 -45.98 0.13 Allowed Glycine 0 CA--C 1.527 0.808 0 O-C-N 123.427 0.455 . . . . 0.0 112.284 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.51 -0.51 0.14 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.641 -178.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.595 ' H ' ' C ' ' A' ' 14' ' ' GLY . 35.1 m -82.47 -50.22 16.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.459 ' H ' HG23 ' A' ' 16' ' ' VAL . 79.6 t -42.88 -37.08 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.048 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.66 -49.29 78.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.913 -179.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.96 -52.09 66.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.268 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -18.35 64.19 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.006 -178.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.63 -38.24 20.1 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.29 0.369 . . . . 0.0 110.889 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.78 -43.15 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.354 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 26' ' ' LEU . 35.2 m -55.76 -41.9 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.547 -178.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 23' ' ' VAL . 39.8 mm -40.3 -46.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.154 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -63.59 -43.16 97.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.35 178.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 23' ' ' VAL . 2.4 tm? -56.06 -45.12 79.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.011 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.9 -44.14 97.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.448 0.642 . . . . 0.0 109.59 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 91.0 mtp -61.13 -30.52 70.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.233 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 31' ' ' LYS . 41.6 mt -71.22 -33.11 69.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.844 178.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -44.29 -15.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.798 -179.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 65.0 mttp -103.9 27.88 7.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.734 0.302 . . . . 0.0 110.336 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 29' ' ' LEU . 29.2 mmtp . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.267 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.3 mttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.54 -20.78 78.21 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.0 -24.98 35.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.754 0.312 . . . . 0.0 110.269 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.13 -49.83 81.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.591 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.69 -40.3 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.454 0.645 . . . . 0.0 110.154 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.28 -60.5 5.65 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' B' ' 11' ' ' LEU . 4.2 mm? -70.52 -29.09 65.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -58.0 3.22 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.669 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 13' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' B' ' 16' ' ' VAL . 17.5 m -75.33 -49.91 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.594 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' B' ' 16' ' ' VAL . . . -30.69 -45.9 0.12 Allowed Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.569 0.543 . . . . 0.0 112.395 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.61 -0.73 0.15 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.57 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.584 ' H ' ' C ' ' B' ' 14' ' ' GLY . 35.1 m -82.08 -50.29 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 120.698 0.285 . . . . 0.0 110.241 179.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.462 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 73.2 t -42.97 -36.97 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.052 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.8 -49.08 79.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.96 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.07 -52.29 66.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.256 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -18.24 63.92 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.054 -178.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.76 -38.16 19.98 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.309 0.381 . . . . 0.0 110.935 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.82 -43.23 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.353 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' B' ' 26' ' ' LEU . 35.9 m -55.72 -41.97 67.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.502 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 24' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' B' ' 23' ' ' VAL . 39.5 mm -40.04 -46.74 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.168 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -63.74 -43.2 97.19 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.375 178.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' B' ' 23' ' ' VAL . 2.4 tm? -56.05 -45.1 79.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.982 -179.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -63.91 -44.19 97.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.463 0.649 . . . . 0.0 109.545 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 91.0 mtp -61.06 -30.34 70.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.212 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' B' ' 32' ' ' LYS . 43.0 mt -71.4 -33.1 69.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.898 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -44.28 -15.64 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.777 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.1 mttp -103.93 27.97 7.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.703 0.287 . . . . 0.0 110.378 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 32' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 29' ' ' LEU . 28.9 mmtp . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.268 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.2 mttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.393 -0.595 . . . . 999.99000000000001 109.393 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.66 -19.72 79.74 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.176 -0.77 . . . . 205.16999999999999 111.176 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.8 81.71 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.706 -0.397 . . . . 152.00999999999999 110.732 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.9 mt -64.0 -52.58 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.399 -0.364 . . . . 368.69 111.76 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 tp -67.08 -42.19 88.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.188 -0.605 . . . . 159.72999999999999 109.617 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.97 -47.34 19.79 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.301 -1.12 . . . . 58.229999999999997 110.301 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.7 tp -70.68 -37.27 73.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.753 0.311 . . . . 531.36000000000001 110.536 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -57.74 10.48 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.948 0.404 . . . . 129.15000000000001 110.874 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 m -66.54 -17.78 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.941 -0.572 . . . . 168.15000000000001 111.284 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.52 -42.57 7.78 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.849 -0.901 . . . . 24.27 110.849 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.48 -53.26 32.9 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.381 -1.088 . . . . 25.059999999999999 110.381 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.5 m -46.09 -52.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.884 -0.327 . . . . 107.28 110.171 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 94.8 t -56.03 -46.08 80.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.526 -0.47 . . . . 131.62 110.954 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.37 -47.17 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.021 -0.671 . . . . 290.73000000000002 109.603 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.88 -40.02 69.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.647 -0.706 . . . . 100.39 110.017 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.9 p -70.19 -20.01 63.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 209.63999999999999 111.022 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.58 -34.9 27.57 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.508 -0.477 . . . . 120.51000000000001 110.888 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.7 -44.86 93.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 120.816 -0.354 . . . . 150.12 111.064 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.1 m -61.78 -35.8 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.596 -0.442 . . . . 147.55000000000001 110.85 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.53 -23.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.66 -0.496 . . . . 230.88 109.66 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.12 -47.59 12.37 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.002 -0.74 . . . . 241.81999999999999 109.002 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.453 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 1.8 tm? -47.79 -36.27 11.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.547 0.689 . . . . 276.41000000000003 109.432 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.66 -65.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.741 -0.663 . . . . 251.71000000000001 110.221 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 82.7 mtp -48.21 -26.83 2.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.673 -0.694 . . . . 640.88999999999999 110.769 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 54.6 mt -75.09 -19.91 59.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.461 -0.336 . . . . 215.74000000000001 111.121 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -51.16 -22.33 2.5 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.596 -0.442 . . . . 999.99000000000001 110.825 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -105.01 22.05 15.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.646 0.26 . . . . 999.99000000000001 110.574 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.961 -1.018 . . . . 999.99000000000001 110.564 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 mttt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.398 -0.593 . . . . 999.99000000000001 109.398 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.56 -19.75 79.74 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.235 -0.746 . . . . 205.28 111.235 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.82 81.75 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.719 -0.392 . . . . 152.03999999999999 110.759 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 21.9 mt -64.02 -52.55 55.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.332 -0.395 . . . . 370.69 111.807 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 tp -67.09 -42.24 88.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.174 -0.611 . . . . 159.02000000000001 109.569 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -47.02 -47.25 20.14 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.312 -1.115 . . . . 57.75 110.312 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 18.7 tp -70.66 -37.34 73.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 120.737 0.303 . . . . 530.52999999999997 110.47 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -57.72 10.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.957 0.408 . . . . 129.94 110.902 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 m -66.53 -17.69 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.902 -0.59 . . . . 168.44 111.33 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.56 -42.51 7.79 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.843 -0.903 . . . . 24.170000000000002 110.843 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.56 -53.26 33.18 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.401 -1.08 . . . . 25.140000000000001 110.401 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 m -46.12 -52.0 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.802 -0.359 . . . . 107.23 110.202 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.01 -46.08 80.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.568 -0.453 . . . . 132.25999999999999 110.961 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 90.2 mt -63.36 -47.22 92.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.031 -0.668 . . . . 289.97000000000003 109.659 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.75 -40.08 68.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.577 -0.738 . . . . 100.45999999999999 110.108 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 29.9 p -70.13 -20.0 63.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 209.36000000000001 111.024 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.62 -34.91 27.43 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.546 -0.462 . . . . 121.2 110.844 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.75 -44.83 93.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 120.833 -0.347 . . . . 152.55000000000001 111.051 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.72 -35.93 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.599 -0.44 . . . . 147.47 110.847 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.49 -23.01 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.463 -0.495 . . . . 231.75 109.71 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.11 -47.61 12.35 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.997 -0.742 . . . . 243.65000000000001 108.997 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 1.8 tm? -47.82 -36.21 11.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.518 0.675 . . . . 277.13 109.41 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 74.3 t -63.68 -65.72 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.75 -0.659 . . . . 252.77000000000001 110.281 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 82.7 mtp -48.23 -26.89 2.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 642.52999999999997 110.765 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 55.0 mt -75.03 -19.89 59.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.446 -0.343 . . . . 215.84999999999999 111.165 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -51.16 -22.32 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.542 -0.463 . . . . 999.99000000000001 110.811 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -105.03 22.05 16.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 121.065 -0.254 . . . . 999.99000000000001 110.522 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.933 -1.032 . . . . 999.99000000000001 110.497 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.04 -32.66 84.93 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.35 -21.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.605 0.241 . . . . 0.0 111.001 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.423 HG21 HD12 ' A' ' 8' ' ' ILE . 97.7 mt -63.3 -43.7 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.9 tp -61.01 -36.76 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 109.793 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.63 -66.38 2.88 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.409 ' N ' ' CD2' ' A' ' 11' ' ' LEU . 4.2 mm? -60.16 -32.79 71.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 110.982 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.23 -63.84 1.16 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 120.863 0.363 . . . . 0.0 110.97 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 12.6 m -68.39 -20.82 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.35 -39.81 12.09 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.93 -54.33 26.09 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.7 m -44.51 -49.79 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.95 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -60.49 -42.88 92.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.057 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.423 HG22 HD13 ' A' ' 18' ' ' ILE . 96.7 mt -63.0 -51.35 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.465 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.43 -36.8 76.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.149 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -18.52 58.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.998 0.428 . . . . 0.0 110.401 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -32.64 36.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.397 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.7 -46.34 92.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.375 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.465 ' C ' ' N ' ' A' ' 25' ' ' THR . 29.6 m -66.13 -35.56 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.329 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -49.07 -20.41 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.465 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -74.74 -40.69 61.1 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.649 179.137 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.471 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.92 -25.37 42.78 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 121.396 0.617 . . . . 0.0 109.959 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.1 t -66.42 -46.47 86.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.738 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.6 mtt -68.3 -33.31 74.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.266 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.9 mt -82.58 -3.37 55.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.265 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -61.83 -37.04 82.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.092 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.8 23.26 4.24 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.58 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.377 179.566 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.08 -32.61 84.77 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.34 -21.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.582 0.229 . . . . 0.0 110.94 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.2 -43.74 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 5.9 tp -60.9 -36.74 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.813 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.68 -66.38 2.88 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.18 -32.82 71.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 0.0 111.015 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.4 tpt -60.05 -63.89 1.14 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 120.901 0.381 . . . . 0.0 111.004 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.45 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 12.5 m -68.36 -20.83 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.44 -39.78 12.0 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.86 -54.35 25.78 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.7 m -44.57 -49.69 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.618 -0.291 . . . . 0.0 110.904 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.59 -42.87 93.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.007 0.432 . . . . 0.0 111.144 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.9 -51.37 72.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.549 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.83 76.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.18 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.12 -18.46 57.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.942 0.401 . . . . 0.0 110.359 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.68 -32.59 35.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.449 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.61 -46.41 92.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.365 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.457 ' C ' ' N ' ' B' ' 25' ' ' THR . 29.6 m -66.2 -35.39 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.328 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -49.15 -20.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.457 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -74.65 -40.73 61.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.631 179.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.47 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 0.0 OUTLIER -55.95 -25.21 42.53 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 121.367 0.603 . . . . 0.0 109.94 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 15.2 t -66.55 -46.37 86.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.781 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 59.4 mtt -68.48 -33.27 73.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.176 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.52 -3.46 55.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.205 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -61.82 -37.08 83.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.081 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.71 23.2 4.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.585 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.324 179.623 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.6 tttp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.01 -24.97 67.5 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.43 -36.64 84.41 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.296 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.23 -53.44 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.472 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 3.6 tp -71.07 -42.17 76.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.167 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.43 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -39.5 -46.97 2.87 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 46.9 tp -72.56 -39.48 67.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.735 0.302 . . . . 0.0 110.702 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -59.21 4.46 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.936 0.398 . . . . 0.0 111.47 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.13 -22.18 29.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.034 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.58 -45.36 18.17 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.72 -54.15 29.39 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 m -48.23 -51.54 9.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.198 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.461 ' O ' ' OG1' ' A' ' 20' ' ' THR . 91.9 t -59.06 -45.0 92.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.095 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.1 -46.93 95.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.181 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.01 -39.04 71.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.248 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 17' ' ' VAL . 46.3 p -67.15 -21.32 65.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.182 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.44 -38.6 19.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.2 mt -69.64 -45.13 78.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.552 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.2 m -51.8 -37.86 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.713 0.292 . . . . 0.0 111.054 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.6 mm -48.25 -45.9 13.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.417 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.29 -52.35 65.63 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.461 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 2.0 tm? -51.04 -40.97 59.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.051 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.0 t -65.94 -65.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm -48.54 -26.16 2.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.976 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 31' ' ' LYS . 20.2 mt -72.15 -28.03 62.98 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.354 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -45.53 -14.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.671 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 29' ' ' LEU . 98.9 mttt -98.27 20.18 12.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 29' ' ' LEU . 32.7 ttpt . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.523 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 56.6 tttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.99 -25.08 67.58 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.54 84.07 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.357 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.2 -53.54 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.433 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' B' ' 10' ' ' GLY . 3.6 tp -70.95 -42.23 77.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 110.193 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' B' ' 9' ' ' ILE . . . -39.51 -46.91 2.86 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -72.59 -39.63 67.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.749 0.309 . . . . 0.0 110.605 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -59.06 4.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 111.52 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -66.33 -22.02 29.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.994 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.65 -45.39 17.77 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.51 -54.38 27.68 Favored Glycine 0 C--O 1.224 -0.514 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.4 m -47.95 -51.59 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.325 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.457 ' O ' ' OG1' ' B' ' 20' ' ' THR . 91.9 t -59.24 -44.89 93.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.041 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.14 -47.04 95.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.629 0.728 . . . . 0.0 109.158 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.92 -38.86 70.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.287 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' B' ' 17' ' ' VAL . 46.7 p -67.24 -21.33 65.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.19 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.55 -38.48 19.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 93.1 mt -69.82 -45.21 77.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.485 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 m -51.64 -37.72 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.69 0.281 . . . . 0.0 111.088 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 37.8 mm -48.48 -45.8 14.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.338 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.42 -52.49 65.0 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 2.0 tm? -50.95 -40.81 58.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.054 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 92.8 t -66.02 -65.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm -48.46 -26.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.01 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 32' ' ' LYS . 20.5 mt -72.22 -27.94 62.85 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.343 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -45.62 -14.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.691 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 98.9 mttt -98.32 20.2 13.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 29' ' ' LEU . 32.8 ttpt . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.498 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 10' ' ' GLY . . . -62.66 -24.08 65.84 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.94 81.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.767 0.317 . . . . 0.0 110.239 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.05 -49.46 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -82.05 -25.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.338 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . -51.8 -45.81 55.08 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.97 -35.26 32.35 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.577 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -54.74 17.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 120.963 0.411 . . . . 0.0 111.28 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.413 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 34.5 m -67.62 -20.92 26.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.766 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.28 -48.8 7.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.284 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.0 -54.39 14.74 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 5.0 m -46.28 -49.54 5.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.17 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.454 ' O ' ' OG1' ' A' ' 20' ' ' THR . 92.4 t -58.79 -45.55 91.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.771 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -62.09 -48.41 88.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.324 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.65 -36.86 65.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.454 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 17' ' ' VAL . 44.8 p -68.9 -21.15 64.25 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.171 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.2 mmt -82.8 -38.19 23.46 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.16 -45.76 74.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.824 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 24' ' ' ILE . 26.2 m -51.25 -37.31 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 120.698 0.285 . . . . 0.0 110.867 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.411 ' H ' HG23 ' A' ' 23' ' ' VAL . 39.3 mm -48.08 -45.79 12.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.438 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -61.84 -52.67 63.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 2.2 tm? -49.66 -41.45 42.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.123 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 30' ' ' LYS . 99.6 t -65.93 -65.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.2 mmm -48.59 -24.28 1.28 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 32' ' ' LYS . 25.0 mt -74.69 -26.45 59.84 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.607 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 27' ' ' VAL . 67.1 mttm -44.44 -15.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 71.4 mmtt -100.5 22.85 11.12 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 110.095 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . 22.8 pttp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.718 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' B' ' 10' ' ' GLY . . . -62.75 -24.19 66.14 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.98 82.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.777 0.322 . . . . 0.0 110.197 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.81 -50.16 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.797 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -81.28 -26.07 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.467 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 6' ' ' GLY . . . -51.71 -46.1 54.34 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.77 -35.12 33.61 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -54.8 17.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.955 0.407 . . . . 0.0 111.193 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 34.4 m -67.45 -20.87 27.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.838 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.58 -48.65 7.83 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.0 -54.45 14.51 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 5.1 m -46.19 -49.6 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.202 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.462 ' O ' ' OG1' ' B' ' 20' ' ' THR . 91.7 t -58.69 -45.64 90.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.775 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.0 -48.42 88.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.411 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.6 -37.1 65.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.467 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' B' ' 17' ' ' VAL . 44.3 p -68.64 -21.2 64.48 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.151 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.1 mmt -82.85 -38.19 23.33 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 92.3 mt -70.06 -45.78 75.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.827 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.419 HG23 ' H ' ' B' ' 24' ' ' ILE . 25.4 m -51.19 -37.49 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.734 0.302 . . . . 0.0 110.815 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.419 ' H ' HG23 ' B' ' 23' ' ' VAL . 39.2 mm -47.88 -45.9 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.428 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -61.74 -52.68 63.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 2.2 tm? -49.67 -41.69 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.154 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' B' ' 30' ' ' LYS . 96.9 t -65.6 -65.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 93.2 mmm -48.44 -24.27 1.21 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.692 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' B' ' 32' ' ' LYS . 24.3 mt -74.74 -26.68 59.95 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.57 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' B' ' 27' ' ' VAL . 67.1 mttm -44.14 -15.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.962 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 71.3 mmtt -100.14 23.01 10.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.922 0.392 . . . . 0.0 110.174 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 29' ' ' LEU . 22.8 pttp . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.617 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.77 -22.26 69.95 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.39 -21.85 35.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.865 0.364 . . . . 0.0 110.2 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.32 -48.08 86.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' MET . 5.2 tp -67.98 -43.16 85.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.104 0.478 . . . . 0.0 109.976 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -36.45 -43.32 0.73 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.612 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.3 mt -78.23 -35.1 48.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.998 0.427 . . . . 0.0 110.609 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -58.98 -63.73 1.19 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.191 -179.261 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.79 -22.45 21.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.134 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.41 -47.81 20.89 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.31 -51.87 44.44 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 m -50.78 -48.24 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.098 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.441 ' O ' ' OG1' ' A' ' 20' ' ' THR . 80.5 t -58.75 -45.36 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.034 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mm -63.08 -45.72 97.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.4 -38.11 71.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.642 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 17' ' ' VAL . 44.3 p -68.23 -26.01 65.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.396 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.7 mmt -85.92 -38.54 17.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -69.16 -45.96 78.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 24' ' ' ILE . 31.7 m -56.85 -34.67 44.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 23' ' ' VAL . 26.2 mm -43.58 -38.99 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.227 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -62.34 -52.2 64.57 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.734 179.035 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.484 ' N ' ' CG2' ' A' ' 25' ' ' THR . 1.7 tm? -48.43 -40.48 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.115 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 t -66.14 -66.17 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.215 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mmm -49.8 -24.79 2.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.017 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 31' ' ' LYS . 34.6 mt -73.92 -25.59 60.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.155 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -45.56 -13.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.724 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . 8.6 mtmp? -97.53 20.57 11.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.287 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 29' ' ' LEU . 17.2 mtmm . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.447 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.63 -22.32 69.74 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.42 -21.85 35.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.898 0.38 . . . . 0.0 110.214 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.17 -48.2 86.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.074 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' B' ' 12' ' ' MET . 5.2 tp -67.97 -43.26 85.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.115 0.483 . . . . 0.0 109.952 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.458 ' N ' ' CG2' ' B' ' 9' ' ' ILE . . . -36.35 -43.14 0.69 Allowed Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.708 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt -78.38 -35.15 47.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.989 0.423 . . . . 0.0 110.613 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' MET . . . . . 0.516 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -58.94 -63.7 1.21 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.231 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.63 -22.43 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.138 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.5 -47.74 20.65 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.26 -51.87 44.23 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 m -50.79 -48.31 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.064 -178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.429 ' O ' ' OG1' ' B' ' 20' ' ' THR . 80.4 t -58.93 -45.25 92.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.982 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mm -63.14 -45.72 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.01 70.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.678 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' B' ' 17' ' ' VAL . 44.5 p -68.36 -25.9 65.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 24.7 mmt -86.09 -38.43 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -69.28 -45.92 78.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.932 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 32.3 m -56.92 -34.65 44.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mm -43.65 -38.76 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.262 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' B' ' 26' ' ' LEU . 0.6 OUTLIER -62.61 -52.03 64.96 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.721 179.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.478 ' N ' ' CG2' ' B' ' 25' ' ' THR . 1.7 tm? -48.67 -40.39 27.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.091 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 t -66.13 -66.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.246 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mmm -49.82 -24.73 2.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.062 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 32' ' ' LYS . 34.9 mt -73.99 -25.46 59.92 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.117 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -45.6 -13.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.588 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' B' ' 29' ' ' LEU . 8.6 mtmp? -97.6 20.7 11.4 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 29' ' ' LEU . 17.2 mtmm . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.497 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.1 -27.3 72.15 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.13 -34.96 79.24 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.357 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.49 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 2.0 mp -65.23 -53.89 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.213 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' MET . 3.9 tp -70.88 -41.91 77.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.932 0.396 . . . . 0.0 110.537 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -36.42 -46.26 1.03 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' A' ' 11' ' ' LEU . 4.3 mm? -77.1 -32.51 56.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.48 0.181 . . . . 0.0 110.947 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -60.92 -62.49 1.82 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.793 0.33 . . . . 0.0 111.341 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -66.72 -21.93 29.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.817 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.85 -45.93 10.07 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.513 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.4 -53.07 37.04 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.5 m -47.36 -51.35 6.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.187 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.478 ' O ' ' OG1' ' A' ' 20' ' ' THR . 73.9 t -58.01 -45.11 88.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.568 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.12 -48.07 90.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.674 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.14 -36.77 68.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.268 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 17' ' ' VAL . 44.8 p -67.79 -21.61 65.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.031 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.9 -38.3 23.05 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.328 0.392 . . . . 0.0 111.742 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.37 -46.19 72.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.874 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.403 HG21 ' H ' ' A' ' 24' ' ' ILE . 31.5 m -50.47 -37.24 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.819 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.403 ' H ' HG21 ' A' ' 23' ' ' VAL . 38.7 mm -47.96 -46.28 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 m -60.95 -52.71 63.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.468 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 2.3 tm? -50.53 -41.1 53.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.339 0.59 . . . . 0.0 109.939 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 30' ' ' LYS . 84.2 t -66.48 -66.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.874 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.1 mtp -47.96 -24.03 0.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.665 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 32' ' ' LYS . 19.8 mt -73.61 -26.92 61.02 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.711 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 27' ' ' VAL . 66.9 mttm -44.9 -14.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.707 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 29' ' ' LEU . 53.0 mtmt -99.18 21.93 11.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.767 0.318 . . . . 0.0 110.395 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 29' ' ' LEU . 66.0 tttm . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.623 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.0 -27.66 72.53 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.97 -34.69 78.56 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.281 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.496 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 2.0 mp -65.5 -53.95 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.182 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 12' ' ' MET . 3.8 tp -70.92 -41.8 77.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.853 0.358 . . . . 0.0 110.502 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.417 ' N ' ' CG2' ' B' ' 9' ' ' ILE . . . -36.55 -45.9 1.03 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' B' ' 11' ' ' LEU . 4.3 mm? -77.51 -32.41 54.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.178 . . . . 0.0 110.887 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' MET . . . . . 0.528 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -61.08 -62.73 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.748 0.308 . . . . 0.0 111.273 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 m -66.37 -22.03 29.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.815 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.82 -45.96 10.08 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.452 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.35 -53.08 36.8 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 4.6 m -47.34 -51.44 6.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.125 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.471 ' O ' ' OG1' ' B' ' 20' ' ' THR . 73.4 t -57.98 -45.1 87.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.6 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.25 -47.89 90.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.739 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.15 -37.05 68.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.22 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' B' ' 17' ' ' VAL . 45.9 p -67.61 -21.63 65.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.075 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.91 -38.21 23.15 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.242 0.339 . . . . 0.0 111.72 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 94.7 mt -70.36 -46.13 72.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.97 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.42 HG21 ' H ' ' B' ' 24' ' ' ILE . 31.6 m -50.64 -37.44 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.712 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.42 ' H ' HG21 ' B' ' 23' ' ' VAL . 38.9 mm -47.73 -46.34 11.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -60.86 -52.58 64.46 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.466 ' C ' ' CD1' ' B' ' 26' ' ' LEU . 2.3 tm? -50.73 -41.32 56.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.867 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' B' ' 30' ' ' LYS . 84.0 t -66.19 -66.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.914 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 96.9 mtp -47.88 -24.04 0.91 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.657 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 32' ' ' LYS . 19.5 mt -73.66 -27.12 61.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.654 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' B' ' 27' ' ' VAL . 66.9 mttm -44.68 -14.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.771 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 53.3 mtmt -99.19 22.02 11.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.822 0.344 . . . . 0.0 110.346 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.9 tttm . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.595 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.92 -23.9 71.27 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.2 -23.76 43.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.43 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.05 -48.9 83.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.024 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' MET . 3.8 tp -69.84 -44.14 79.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.295 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -36.58 -47.56 1.2 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.405 ' N ' ' CD2' ' A' ' 11' ' ' LEU . 4.3 mm? -73.3 -36.26 66.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.726 0.298 . . . . 0.0 110.706 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -57.44 -63.16 1.32 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.925 0.393 . . . . 0.0 111.567 -179.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.74 -21.98 26.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.218 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.49 -47.64 10.14 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.264 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.21 -52.45 31.78 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 m -47.86 -48.58 11.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.793 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.529 ' O ' ' SD ' ' A' ' 21' ' ' MET . 93.9 t -59.21 -46.52 92.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.994 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.6 -47.49 93.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.8 -38.47 61.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.375 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.502 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 39.7 p -69.39 -24.38 63.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.221 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -79.97 -39.94 29.06 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.7 mt -70.43 -45.36 75.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.94 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -54.77 -37.78 41.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.039 -177.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -46.54 -47.21 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.11 -53.24 60.06 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.458 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 1.9 tm? -49.99 -38.07 35.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.702 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.83 -68.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.648 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 16.1 ptm -48.81 -20.86 0.54 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.222 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 32' ' ' LYS . 8.6 mt -74.61 -25.85 59.52 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.126 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -45.23 -15.01 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.45 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' LEU . 98.9 mttt -99.86 23.86 9.19 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.079 0.466 . . . . 0.0 109.86 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 29' ' ' LEU . 24.8 mtmm . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.9 71.07 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.81 43.55 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.416 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 37.7 mm -63.91 -49.08 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.03 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' B' ' 12' ' ' MET . 3.8 tp -69.71 -44.06 79.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.383 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG2' ' B' ' 9' ' ' ILE . . . -36.83 -47.2 1.24 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.401 ' N ' ' CD2' ' B' ' 11' ' ' LEU . 4.3 mm? -73.57 -36.2 65.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 110.698 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' MET . . . . . 0.497 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -57.45 -63.35 1.26 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 120.96 0.41 . . . . 0.0 111.512 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -68.73 -21.89 26.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.171 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.32 -47.78 10.28 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.286 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.25 33.39 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 m -47.85 -48.7 11.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.765 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.531 ' O ' ' SD ' ' B' ' 21' ' ' MET . 93.8 t -59.18 -46.41 92.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.038 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mm -61.74 -47.42 93.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.83 -38.51 61.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.359 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' THR . . . . . 0.509 ' OG1' ' SD ' ' B' ' 21' ' ' MET . 40.3 p -69.27 -24.43 63.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.263 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -80.02 -39.91 28.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 92.7 mt -70.44 -45.35 75.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.936 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 m -54.8 -37.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.97 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -46.46 -47.04 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.24 -53.15 61.12 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.451 ' C ' ' CD1' ' B' ' 26' ' ' LEU . 1.9 tm? -50.12 -38.06 37.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.697 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' B' ' 30' ' ' LYS . 58.7 t -63.85 -68.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.653 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 16.2 ptm -48.82 -20.95 0.55 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.214 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 32' ' ' LYS . 8.5 mt -74.62 -25.78 59.46 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.027 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' B' ' 27' ' ' VAL . 56.0 mttp -45.35 -14.69 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.452 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 99.0 mttt -100.13 23.74 9.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.092 0.472 . . . . 0.0 109.874 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' B' ' 29' ' ' LEU . 24.8 mtmm . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.801 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.19 -37.75 81.8 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.21 -22.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.872 0.367 . . . . 0.0 110.853 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.524 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.4 mp -63.6 -45.07 98.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.073 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.48 -25.22 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.051 0.453 . . . . 0.0 110.693 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.05 -43.49 62.16 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.591 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -82.16 -27.01 32.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 110.646 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -61.68 2.4 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.65 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.35 -23.5 28.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.063 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.37 -43.21 79.68 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.27 -61.42 6.98 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.0 m -50.02 -26.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.185 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.32 -46.92 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.2 mt -67.91 -45.0 84.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.863 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.58 -40.81 72.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.676 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 t -75.93 -27.5 57.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.22 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.6 mmt -72.16 -40.15 68.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.76 -46.15 79.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.682 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.9 m -65.24 -33.48 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -43.78 -50.09 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.904 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.454 ' OG1' ' CD1' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -66.22 -49.7 66.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.837 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.466 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 2.1 tm? -41.97 -37.84 1.44 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.079 0.466 . . . . 0.0 110.684 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.01 -58.27 6.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 73.9 mtm -59.68 -22.21 61.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.41 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.454 ' CD1' ' OG1' ' A' ' 25' ' ' THR . 74.8 mt -79.91 -5.98 56.58 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.37 -9.49 8.38 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.833 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -102.74 19.87 18.38 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.65 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.848 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.99 -37.78 83.71 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.28 -22.47 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 0.0 110.801 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 1.4 mp -63.45 -45.08 98.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.077 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.45 -25.38 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.081 0.467 . . . . 0.0 110.728 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.94 -43.3 61.23 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.72 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -82.37 -26.92 32.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.856 0.36 . . . . 0.0 110.75 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -61.85 2.26 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.17 -23.38 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.058 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.32 -43.28 79.83 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.2 -60.97 7.41 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 m -50.47 -26.27 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 122.695 -0.297 . . . . 0.0 111.191 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -82.23 -46.92 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.061 0.458 . . . . 0.0 111.229 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.11 -44.98 84.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.931 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.54 -40.78 72.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.736 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 3.8 t -75.85 -27.59 57.89 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.269 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 29.6 mmt -72.18 -40.23 68.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.78 -46.1 79.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.724 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 m -65.33 -33.58 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.478 -0.489 . . . . 0.0 112.277 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -43.66 -50.14 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 120.491 -0.483 . . . . 0.0 109.867 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.456 ' OG1' ' CD1' ' B' ' 29' ' ' LEU . 0.5 OUTLIER -66.3 -49.56 66.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.923 179.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.465 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 2.1 tm? -42.16 -37.77 1.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.637 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.0 -58.34 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 74.1 mtm -59.54 -22.39 61.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.438 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.456 ' CD1' ' OG1' ' B' ' 25' ' ' THR . 74.7 mt -79.86 -5.88 56.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -62.48 -9.39 8.39 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -102.83 19.68 18.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.712 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.792 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.96 -33.19 86.58 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.94 -25.32 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.608 0.242 . . . . 0.0 111.223 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.498 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.5 mp -62.36 -44.0 98.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.15 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tp -51.64 -32.5 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.43 99.06 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.227 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.46 -24.92 34.01 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.36 -63.83 1.16 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.177 0.513 . . . . 0.0 110.593 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.1 m -67.42 -22.23 28.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.863 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.79 -40.04 15.77 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.34 -54.91 29.39 Favored Glycine 0 C--N 1.331 0.262 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.5 m -45.6 -51.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.551 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.4 -42.1 89.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.21 -50.12 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.321 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.76 -34.22 69.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.426 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 34.2 p -74.6 -20.53 59.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.584 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.9 mmt -82.45 -31.55 29.39 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.373 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.98 -47.46 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.951 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.9 m -63.94 -31.71 54.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.695 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -54.64 -21.02 6.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.42 -43.89 59.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.028 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -58.92 -27.33 65.17 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.273 0.558 . . . . 0.0 110.625 -179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.458 ' CG1' ' HZ2' ' B' ' 30' ' ' LYS . 66.4 t -65.26 -44.83 94.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.955 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.6 mtp -72.53 -29.21 63.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.365 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.47 -3.28 33.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.319 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.451 ' HZ2' ' CG1' ' B' ' 27' ' ' VAL . 51.7 mtmt -68.57 -18.18 64.29 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.494 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 32' ' ' LYS . 46.8 tttp -95.65 15.3 20.36 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.664 0.269 . . . . 0.0 110.717 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 31' ' ' LYS . 22.0 pttp . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.957 -1.02 . . . . 0.0 111.696 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.98 -33.12 86.4 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.99 -25.38 58.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.63 0.252 . . . . 0.0 111.199 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.5 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 1.5 mp -62.33 -43.95 98.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.168 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tp -51.54 -32.57 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.41 -43.45 99.04 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.19 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.48 -24.92 33.96 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.877 0.37 . . . . 0.0 110.892 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.35 -63.82 1.17 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.622 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 23.4 m -67.45 -22.16 28.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.884 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.93 -39.79 15.95 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.236 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.28 -55.08 28.3 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 6.5 m -45.52 -51.81 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.549 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.5 -42.09 90.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.067 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.14 -50.21 81.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.321 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.75 -34.09 69.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.572 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 33.8 p -74.7 -20.35 59.89 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.651 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.9 mmt -82.49 -31.59 29.22 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.343 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.87 -47.6 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.017 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.79 -31.73 54.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.795 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -54.6 -20.99 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -43.93 59.1 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.954 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.478 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 0.3 OUTLIER -58.91 -27.33 65.15 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.245 0.545 . . . . 0.0 110.662 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.451 ' CG1' ' HZ2' ' A' ' 30' ' ' LYS . 66.7 t -65.3 -44.82 94.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.983 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 77.7 mtp -72.53 -29.1 63.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.364 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.7 -3.14 33.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.22 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.458 ' HZ2' ' CG1' ' A' ' 27' ' ' VAL . 51.7 mtmt -68.64 -18.07 64.22 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.547 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' B' ' 32' ' ' LYS . 46.9 tttp -95.74 15.3 20.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.688 0.28 . . . . 0.0 110.664 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' B' ' 31' ' ' LYS . 22.0 pttp . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.755 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.48 -26.95 72.05 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.22 83.58 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.205 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.43 -53.2 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.484 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.1 tp -70.91 -42.8 77.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.458 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.434 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -35.71 -48.58 0.99 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mt -72.81 -38.27 67.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.825 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.501 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -55.74 -61.56 2.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 120.745 0.307 . . . . 0.0 111.636 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.99 -22.63 30.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.74 -45.85 16.03 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.389 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.34 -53.83 32.89 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -49.22 -50.71 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.013 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.522 ' O ' ' SD ' ' A' ' 21' ' ' MET . 58.2 t -57.84 -45.62 87.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.642 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.39 -46.44 96.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.383 0.611 . . . . 0.0 109.827 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.51 -38.25 71.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.139 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.535 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 41.7 p -67.31 -25.4 66.01 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.678 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -80.86 -39.13 26.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -71.23 -46.59 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -51.31 -37.11 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.946 -178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mp -47.44 -46.2 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -60.15 -53.3 59.41 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.585 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 2.2 tm? -50.75 -40.91 56.0 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.133 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.94 -67.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.62 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.9 mtt -48.7 -23.07 0.91 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.214 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 31' ' ' LYS . 16.3 mt -72.53 -26.63 61.82 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.702 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -45.78 -13.2 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.762 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 29' ' ' LEU . 27.9 ttpt -98.28 19.56 14.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.85 0.357 . . . . 0.0 110.252 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LEU . 65.2 tttm . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.631 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.63 -27.22 72.41 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.48 84.49 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.283 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.04 -53.27 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.473 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.1 tp -70.94 -42.71 77.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.429 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.424 ' N ' ' CG2' ' B' ' 9' ' ' ILE . . . -36.06 -48.13 1.07 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.7 mt -73.15 -38.19 66.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.824 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -55.59 -61.72 2.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.793 0.33 . . . . 0.0 111.622 -179.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.91 -22.39 30.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.795 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.92 -45.92 15.14 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.381 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.37 -53.75 33.34 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 4.9 m -49.04 -50.93 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.057 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.526 ' O ' ' SD ' ' B' ' 21' ' ' MET . 58.8 t -57.77 -45.55 87.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.72 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.45 -46.54 96.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.833 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.41 -38.44 71.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.059 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' THR . . . . . 0.533 ' OG1' ' SD ' ' B' ' 21' ' ' MET . 41.2 p -67.05 -25.37 66.22 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.802 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.533 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -80.93 -39.19 26.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.18 -46.69 64.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.096 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 m -51.24 -37.16 17.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.872 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 mp -47.42 -46.01 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -60.4 -53.13 61.24 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.458 ' C ' ' CD1' ' B' ' 26' ' ' LEU . 2.2 tm? -50.88 -40.85 57.54 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.079 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.98 -67.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.549 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 68.0 mtt -48.5 -23.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.207 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' B' ' 31' ' ' LYS . 15.8 mt -72.43 -26.69 61.94 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.686 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -45.67 -13.33 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.803 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' B' ' 29' ' ' LEU . 27.9 ttpt -98.33 19.74 13.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 110.281 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.1 tttm . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.616 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.6 -33.56 87.56 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.55 75.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.465 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.495 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.8 mp -68.56 -54.61 20.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.876 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.2 tp -69.67 -41.99 80.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.254 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -34.31 -60.73 0.58 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.66 -29.26 70.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.591 0.234 . . . . 0.0 111.242 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -66.05 -63.66 1.03 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.084 0.469 . . . . 0.0 111.267 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.88 -20.01 23.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.547 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.84 -40.59 5.87 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.48 -49.23 57.95 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.6 m -44.98 -49.64 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.725 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 62.9 t -58.68 -43.41 87.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.862 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.98 -49.1 86.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.39 -36.28 71.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.962 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.2 p -73.16 -18.43 61.27 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.696 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.7 -31.74 28.41 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.399 -0.52 . . . . 0.0 109.987 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.35 -46.17 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.381 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' LEU . 27.2 m -64.41 -35.04 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.345 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -46.87 -20.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.453 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.7 OUTLIER -76.24 -40.68 51.36 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.207 178.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.8 OUTLIER -54.4 -31.54 55.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.278 0.561 . . . . 0.0 109.87 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.7 t -63.25 -29.96 48.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.473 0.654 . . . . 0.0 109.826 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.9 mtp -84.38 -32.98 23.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.788 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 31' ' ' LYS . 59.2 mt -66.6 -41.88 87.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -49.43 -10.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.718 0.294 . . . . 0.0 111.001 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 29' ' ' LEU . 99.5 mttt -96.24 12.27 31.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.109 0.48 . . . . 0.0 109.982 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' LEU . 32.5 ttpt . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.301 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.63 -33.6 87.68 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.44 74.85 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.516 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.508 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 1.8 mp -68.67 -54.58 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.86 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.2 tp -69.6 -42.09 80.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.22 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' B' ' 9' ' ' ILE . . . -34.23 -61.08 0.55 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.4 -28.95 70.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.804 -0.198 . . . . 0.0 111.253 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' MET . . . . . 0.52 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -66.37 -63.79 1.0 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 111.203 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.76 -20.05 23.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.528 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.76 -40.6 5.89 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.44 -49.23 57.83 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 9.4 m -44.98 -49.75 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.217 -0.491 . . . . 0.0 110.698 -179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.55 -43.48 87.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.872 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.92 -49.18 85.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.37 -36.18 70.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.052 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 30.7 p -73.26 -18.29 61.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.653 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.72 -31.7 28.35 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.047 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.47 -46.21 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.322 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' B' ' 26' ' ' LEU . 27.1 m -64.29 -35.25 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.389 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.1 mp -46.7 -20.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.454 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -76.45 -40.62 50.0 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.161 178.358 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.8 OUTLIER -54.5 -31.59 56.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.327 0.584 . . . . 0.0 109.825 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -63.21 -30.02 48.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.454 0.645 . . . . 0.0 109.778 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.1 mtp -84.28 -33.03 24.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.842 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' B' ' 31' ' ' LYS . 59.3 mt -66.62 -41.8 87.79 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -49.48 -10.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.699 0.285 . . . . 0.0 110.921 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' B' ' 29' ' ' LEU . 99.4 mttt -96.07 12.49 30.42 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.204 0.526 . . . . 0.0 110.014 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' B' ' 29' ' ' LEU . 32.4 ttpt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.339 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 8' ' ' ILE . . . -61.92 -34.03 87.47 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.41 -19.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 110.593 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.441 ' N ' ' O ' ' A' ' 6' ' ' GLY . 97.2 mt -64.27 -42.84 96.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.455 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 tp -58.74 -37.67 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.0 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.56 -42.91 52.36 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.1 tp -73.38 -26.91 61.19 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.746 -0.267 . . . . 0.0 111.084 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.53 -60.25 3.69 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 120.802 0.334 . . . . 0.0 110.847 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -55.33 -23.47 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.024 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.19 -40.5 29.05 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.343 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.19 -43.67 95.26 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.366 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 m -61.74 -24.15 33.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.606 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.455 ' O ' ' SD ' ' A' ' 21' ' ' MET . 54.3 t -86.08 -39.97 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 123.461 0.476 . . . . 0.0 111.341 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.84 -52.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.635 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.67 -46.39 74.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.779 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.42 ' O ' HG12 ' A' ' 24' ' ' ILE . 4.2 t -68.96 -17.62 63.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.48 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.455 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -85.0 -29.04 25.33 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.288 0.367 . . . . 0.0 111.373 -179.029 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.31 -39.19 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' A' ' 26' ' ' LEU . 13.6 m -56.57 -39.24 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.105 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.428 ' C ' ' O ' ' A' ' 23' ' ' VAL . 37.2 mm -40.73 -49.77 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -60.28 -41.02 92.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.972 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 23' ' ' VAL . 2.5 tm? -60.07 -48.36 82.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.866 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.19 -42.92 97.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.344 0.592 . . . . 0.0 109.996 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.9 mmm -63.55 -18.56 63.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.761 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 31' ' ' LYS . 34.6 mt -87.5 -49.86 6.92 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.427 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -55.76 -4.28 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.535 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 29' ' ' LEU . 16.9 tptm -156.29 60.64 0.56 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.117 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.471 179.498 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' B' ' 8' ' ' ILE . . . -61.8 -34.01 87.23 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.41 -19.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.735 0.303 . . . . 0.0 110.657 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.432 ' N ' ' C ' ' B' ' 6' ' ' GLY . 96.9 mt -64.16 -42.9 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.414 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 tp -58.72 -37.53 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.002 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.64 -42.96 52.92 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.3 tp -73.4 -26.91 61.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.749 -0.265 . . . . 0.0 111.118 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -60.28 3.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.791 0.329 . . . . 0.0 110.763 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 29.8 m -55.36 -23.34 13.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.104 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.23 -40.61 28.54 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.352 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.02 -43.65 94.96 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.434 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.401 ' O ' ' CG2' ' B' ' 20' ' ' THR . 10.8 m -61.83 -24.11 33.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.596 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.453 ' O ' ' SD ' ' B' ' 21' ' ' MET . 54.8 t -86.23 -39.93 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 123.517 0.511 . . . . 0.0 111.324 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.83 -52.61 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.587 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.59 -46.4 73.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.743 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' THR . . . . . 0.417 ' O ' HG12 ' B' ' 24' ' ' ILE . 4.1 t -68.87 -17.64 64.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.407 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.1 OUTLIER -85.13 -29.08 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.325 0.39 . . . . 0.0 111.285 -178.898 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.14 -39.37 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 111.199 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' B' ' 26' ' ' LEU . 13.5 m -56.37 -39.35 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.058 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.417 HG12 ' O ' ' B' ' 20' ' ' THR . 37.0 mm -40.65 -49.85 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -60.29 -41.01 92.47 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.978 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' B' ' 23' ' ' VAL . 2.5 tm? -60.01 -48.4 81.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.851 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 96.1 t -62.21 -42.87 96.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.216 0.532 . . . . 0.0 110.055 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 94.2 mmm -63.52 -18.72 64.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.785 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.544 ' C ' ' H ' ' B' ' 31' ' ' LYS . 34.5 mt -87.43 -49.76 7.0 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.432 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -55.8 -4.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.54 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' B' ' 29' ' ' LEU . 16.9 tptm -156.51 60.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.122 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.432 179.526 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.25 -26.42 70.51 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.6 -23.07 15.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.687 0.279 . . . . 0.0 110.652 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -62.71 -44.1 99.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.59 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.0 tp -56.12 -33.78 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.8 -45.06 96.99 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.005 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.55 -29.56 37.1 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 120.905 0.383 . . . . 0.0 111.097 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.3 tpt -64.31 -63.61 1.1 Allowed 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.489 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.7 m -66.84 -22.15 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.528 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.04 -41.48 10.35 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.23 -54.25 35.38 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.3 m -45.57 -51.04 3.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.874 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.512 ' O ' ' SD ' ' A' ' 21' ' ' MET . 85.8 t -59.1 -43.59 89.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.947 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.8 -49.05 85.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.686 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.28 -34.18 68.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.396 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.528 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 33.2 p -74.16 -20.67 60.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.63 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' OG1' ' A' ' 20' ' ' THR . 0.0 OUTLIER -81.9 -31.7 31.31 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.622 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.91 -48.56 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.524 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.434 ' C ' ' N ' ' A' ' 25' ' ' THR . 23.8 m -63.3 -31.99 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.968 0.413 . . . . 0.0 110.759 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.19 -19.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.434 ' N ' ' C ' ' A' ' 23' ' ' VAL . 1.2 t -74.56 -42.08 59.42 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.348 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.435 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -56.39 -29.92 62.08 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.244 0.545 . . . . 0.0 110.436 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.74 -46.49 92.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.378 0.608 . . . . 0.0 109.711 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 90.0 mtp -70.28 -33.97 72.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.031 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.36 -2.95 54.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.32 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -61.45 -37.51 83.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.95 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.66 23.2 3.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.269 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.383 179.406 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.22 -26.52 70.55 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.54 -23.03 14.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.72 0.295 . . . . 0.0 110.639 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -62.67 -44.13 99.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.62 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 6.0 tp -56.13 -33.8 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.71 -45.2 96.75 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.059 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.47 -29.57 37.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.86 0.362 . . . . 0.0 111.123 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 8.3 tpt -64.3 -63.64 1.09 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.545 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 4.7 m -66.76 -22.28 29.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.513 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.01 -41.36 10.49 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.22 -54.3 35.0 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 6.6 m -45.59 -50.99 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.953 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.508 ' O ' ' SD ' ' B' ' 21' ' ' MET . 85.3 t -59.13 -43.65 89.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.904 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.421 HD11 HG22 ' B' ' 18' ' ' ILE . 96.8 mt -61.72 -49.07 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.681 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.32 -34.23 68.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.341 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' THR . . . . . 0.53 ' OG1' ' SD ' ' B' ' 21' ' ' MET . 33.4 p -74.16 -20.74 60.12 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.693 0.282 . . . . 0.0 110.607 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.53 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -81.82 -31.67 31.61 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.626 179.261 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.8 mt -62.97 -48.52 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.499 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.431 ' C ' ' N ' ' B' ' 25' ' ' THR . 24.3 m -63.34 -31.91 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.936 0.398 . . . . 0.0 110.829 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -50.18 -19.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.431 ' N ' ' C ' ' B' ' 23' ' ' VAL . 1.2 t -74.5 -42.05 59.61 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.309 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.434 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 0.8 OUTLIER -56.43 -29.89 62.16 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.284 0.564 . . . . 0.0 110.48 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.81 -46.38 92.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.277 0.561 . . . . 0.0 109.714 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 89.8 mtp -70.38 -33.85 71.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.977 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 93.2 mt -82.42 -2.92 54.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.298 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -61.51 -37.55 84.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.878 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.6 23.24 3.11 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.323 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.307 179.479 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.546 ' HZ2' ' HZ2' ' B' ' 5' ' ' LYS . 32.2 mmtp . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.76 -33.37 87.06 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.4 -22.99 46.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.629 0.252 . . . . 0.0 110.827 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 91.9 mt -62.7 -43.61 98.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.23 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 tp -60.0 -33.2 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.146 0.498 . . . . 0.0 109.799 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.75 -68.72 1.55 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.319 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -60.98 -27.49 68.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.051 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.07 -63.84 1.05 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 120.854 0.359 . . . . 0.0 110.727 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 m -70.21 -21.16 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.05 -39.32 8.61 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.72 -53.17 40.88 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.8 m -45.45 -48.4 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.9 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.524 ' O ' ' SD ' ' A' ' 21' ' ' MET . 97.4 t -58.72 -44.09 89.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.755 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.44 -48.02 90.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.58 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.65 68.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.543 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.51 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 31.1 p -74.81 -18.95 60.38 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.653 0.263 . . . . 0.0 110.783 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -83.75 -30.84 26.35 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.221 179.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.99 -48.24 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.368 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.438 ' C ' ' N ' ' A' ' 25' ' ' THR . 25.0 m -63.77 -32.64 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.078 0.466 . . . . 0.0 110.72 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.82 -21.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.438 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.7 OUTLIER -75.84 -41.19 53.22 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.611 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.449 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -56.72 -30.25 63.3 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.451 0.643 . . . . 0.0 110.389 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.2 t -61.84 -38.65 81.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.51 0.672 . . . . 0.0 109.391 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.5 mmm -72.88 -28.43 62.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.79 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.75 -6.59 56.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.013 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.14 -39.01 91.15 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.782 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -94.0 18.03 11.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.793 0.33 . . . . 0.0 110.42 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.647 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . 0.546 ' HZ2' ' HZ2' ' A' ' 5' ' ' LYS . 32.1 mmtp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.82 -33.39 87.12 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.4 -23.03 46.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.69 0.281 . . . . 0.0 110.85 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.55 -43.65 98.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.288 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.97 -33.22 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.169 0.509 . . . . 0.0 109.817 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.81 -68.71 1.56 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.257 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' B' ' 11' ' ' LEU . 4.2 mm? -60.96 -27.5 68.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.034 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.16 -63.82 1.05 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 120.841 0.353 . . . . 0.0 110.724 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 7.3 m -70.1 -21.13 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.14 -39.38 8.52 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.58 -53.16 40.52 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 4.8 m -45.49 -48.35 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.877 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.515 ' O ' ' SD ' ' B' ' 21' ' ' MET . 97.2 t -58.91 -43.85 89.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.765 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.61 -48.02 90.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.504 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.71 69.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.47 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' THR . . . . . 0.515 ' OG1' ' SD ' ' B' ' 21' ' ' MET . 31.0 p -74.68 -19.08 60.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.817 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -83.54 -30.99 26.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.279 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.91 -48.22 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.453 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.449 ' C ' ' N ' ' B' ' 25' ' ' THR . 25.5 m -63.73 -32.65 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.158 0.504 . . . . 0.0 110.751 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -48.91 -20.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.449 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -75.95 -41.21 52.22 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.594 179.058 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.446 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 0.8 OUTLIER -56.66 -30.15 63.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.424 0.63 . . . . 0.0 110.43 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.3 t -61.93 -39.05 82.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.49 0.662 . . . . 0.0 109.291 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.5 mmm -72.39 -28.52 63.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.825 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.79 -6.48 56.05 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.992 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.26 -38.86 90.9 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.708 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -94.03 17.91 11.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.771 0.32 . . . . 0.0 110.396 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.554 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.37 -25.66 65.21 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.3 83.93 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.168 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.13 -53.77 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.52 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 tp -70.17 -38.56 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 109.976 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.5 -46.12 8.61 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.5 tp -73.03 -38.47 66.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 121.189 -0.204 . . . . 0.0 110.79 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -57.27 8.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.982 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 27.0 m -65.4 -20.72 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.211 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.15 -40.81 10.93 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.53 -54.89 25.25 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.7 m -44.49 -51.29 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.452 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.13 -42.24 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.58 -49.91 60.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.374 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.22 77.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.869 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.2 t -80.07 -17.25 53.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 110.235 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.36 -31.81 43.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.53 -46.81 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.066 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.457 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' C ' ' N ' ' A' ' 25' ' ' THR . 33.6 m -64.8 -35.12 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.061 0.457 . . . . 0.0 110.198 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 tp -45.05 -22.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.463 ' N ' ' C ' ' A' ' 23' ' ' VAL . 1.3 t -72.07 -41.04 67.83 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.669 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -53.0 -30.49 35.5 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.875 0.47 . . . . 0.0 110.688 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 t -64.96 -45.93 93.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.28 0.562 . . . . 0.0 109.493 177.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.7 mtt -71.47 -34.67 70.41 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.917 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.8 mt -83.75 -2.96 57.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.78 -37.44 86.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.77 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.59 23.79 4.44 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.398 179.749 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.41 -25.35 64.88 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.19 83.47 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.104 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.17 -54.03 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.463 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 6.0 tp -70.02 -38.58 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.129 0.49 . . . . 0.0 109.944 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.39 -46.48 8.51 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 44.8 tp -72.66 -38.52 67.6 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.848 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' MET . . . . . 0.401 ' SD ' ' C ' ' B' ' 12' ' ' MET . 0.0 OUTLIER -50.53 -57.23 8.6 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.058 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 27.0 m -65.4 -20.75 28.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.12 -40.77 11.02 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.59 -54.87 25.53 Favored Glycine 0 C--O 1.223 -0.587 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.7 m -44.59 -51.22 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.49 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 69.5 t -56.21 -42.11 72.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.771 0.319 . . . . 0.0 110.874 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.79 -49.76 61.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.33 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.25 77.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.801 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 14.3 t -80.04 -17.38 52.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.212 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.19 -31.93 43.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.49 -46.78 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.074 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.55 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.455 ' C ' ' N ' ' B' ' 25' ' ' THR . 32.7 m -64.83 -34.98 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.187 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.6 tp -45.21 -22.93 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.492 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.455 ' N ' ' C ' ' B' ' 23' ' ' VAL . 1.3 t -71.83 -41.14 68.53 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.742 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.0 OUTLIER -52.84 -30.59 34.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.956 0.502 . . . . 0.0 110.657 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 t -64.96 -45.92 93.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 65.4 mtt -71.59 -34.79 70.21 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.835 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -83.7 -2.68 56.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.749 0.309 . . . . 0.0 110.563 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -63.06 -37.31 86.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.746 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.66 23.59 4.61 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.059 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.4 179.687 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.51 -33.49 87.4 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.76 -22.54 36.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.6 0.238 . . . . 0.0 110.733 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.28 -44.04 98.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.26 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.4 tp -59.76 -35.8 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.83 -69.21 1.34 Allowed Glycine 0 CA--C 1.532 1.153 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.66 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.84 -28.41 68.81 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 120.79 0.329 . . . . 0.0 111.062 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.9 tpt -63.54 -63.64 1.12 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.002 0.43 . . . . 0.0 110.545 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 10.5 m -67.84 -20.63 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.82 -39.83 7.4 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.5 -52.04 44.02 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.4 m -44.72 -49.04 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.579 -0.311 . . . . 0.0 110.725 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.0 t -58.63 -43.63 87.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.02 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.22 -49.66 83.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -35.9 70.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.166 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.2 p -73.52 -18.51 61.09 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.955 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -84.3 -31.94 24.62 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.124 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.45 -47.66 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.447 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.447 ' C ' ' N ' ' A' ' 25' ' ' THR . 29.9 m -63.37 -34.92 70.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.172 0.51 . . . . 0.0 110.532 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -46.04 -22.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.447 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -79.26 -42.31 26.15 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.774 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.443 ' CD1' ' C ' ' A' ' 26' ' ' LEU . 1.1 tm? -51.35 -31.19 21.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.324 0.583 . . . . 0.0 110.393 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 t -64.67 -35.69 75.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.515 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mtp -71.94 -29.6 64.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.28 -9.63 59.31 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.235 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.17 -36.49 82.02 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.723 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -89.54 18.66 5.16 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.674 0.273 . . . . 0.0 110.674 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.25 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.62 -33.46 87.3 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.88 -22.6 38.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.669 0.271 . . . . 0.0 110.674 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 89.2 mt -62.23 -43.98 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.252 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 5.4 tp -59.74 -35.88 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.78 -69.18 1.34 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.687 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -60.78 -28.51 68.8 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 8.9 tpt -63.49 -63.74 1.1 Allowed 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.012 0.434 . . . . 0.0 110.457 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 10.4 m -67.81 -20.59 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.41 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.75 -39.9 7.41 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.5 -52.06 43.91 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.4 m -44.71 -49.12 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.66 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 64.3 t -58.64 -43.57 87.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.004 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.22 -49.65 83.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.74 70.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.213 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 30.4 p -73.59 -18.49 61.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.845 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -84.3 -31.85 24.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.132 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.48 -47.66 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.473 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.439 ' C ' ' N ' ' B' ' 25' ' ' THR . 30.1 m -63.35 -35.0 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.168 0.509 . . . . 0.0 110.502 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -45.98 -22.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.439 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -79.24 -42.33 26.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.79 178.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.436 ' CD1' ' C ' ' B' ' 26' ' ' LEU . 1.1 tm? -51.28 -31.27 20.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.322 0.582 . . . . 0.0 110.423 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 t -64.6 -35.69 75.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.595 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.8 mtp -71.9 -29.6 64.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.726 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.25 -9.53 59.26 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.247 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.31 -36.57 82.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.694 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -89.45 18.6 5.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.622 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.312 179.879 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.2 -34.07 88.94 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.87 -30.01 70.57 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.505 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.505 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.8 mp -70.54 -55.77 13.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.775 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.1 tp -69.28 -42.31 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.238 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -36.49 -58.46 1.1 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 11' ' ' LEU . 4.2 mm? -64.97 -29.03 69.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.819 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -66.09 -63.78 1.0 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 0.0 111.205 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 26.1 m -67.07 -20.12 26.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.871 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.16 -41.09 6.33 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.24 -49.82 54.67 Favored Glycine 0 C--N 1.333 0.369 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 5.1 m -44.6 -51.03 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.647 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.4 t -57.64 -43.8 84.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.745 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.98 -49.87 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -36.75 68.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.866 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.9 p -72.59 -18.51 61.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.045 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.3 mmt -82.44 -32.57 28.91 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.218 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.53 -46.57 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.633 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 25' ' ' THR . 30.1 m -63.12 -36.1 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.283 0.563 . . . . 0.0 110.571 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -43.77 -22.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.7 OUTLIER -81.57 -42.78 19.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.504 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.2 tm? -47.44 -33.73 6.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.617 0.723 . . . . 0.0 110.475 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 30' ' ' LYS . 48.5 t -66.0 -42.56 91.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.164 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.402 ' N ' ' O ' ' A' ' 25' ' ' THR . 67.3 mtt -65.97 -33.66 76.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.412 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.59 0.75 11.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.356 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 27' ' ' VAL . 24.6 mmtp -62.01 -38.17 87.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.554 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -132.74 17.33 4.28 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.821 0.344 . . . . 0.0 110.479 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.041 179.566 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.04 -34.15 89.16 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.89 -29.94 70.54 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.468 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.515 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 1.8 mp -70.56 -55.79 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.738 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.0 tp -69.36 -42.31 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.269 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . 0.432 ' N ' ' CG2' ' B' ' 9' ' ' ILE . . . -36.44 -58.35 1.1 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.424 ' N ' ' CD2' ' B' ' 11' ' ' LEU . 4.2 mm? -65.16 -28.92 69.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.792 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' MET . . . . . 0.505 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -66.17 -63.84 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.997 0.427 . . . . 0.0 111.239 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 26.4 m -67.06 -20.07 26.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.861 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.1 -41.12 6.34 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.21 -49.76 54.82 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 m -44.9 -50.86 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.641 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.66 -43.91 84.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.697 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.89 -49.81 83.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.97 68.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.959 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 28.9 p -72.43 -18.55 61.7 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.967 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.3 mmt -82.37 -32.76 29.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.203 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.22 -46.7 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.672 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' B' ' 25' ' ' THR . 30.1 m -63.14 -36.11 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.339 0.59 . . . . 0.0 110.629 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -43.79 -22.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.582 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.467 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -81.62 -42.65 19.72 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.498 179.444 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.2 tm? -47.66 -33.6 7.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.745 0.783 . . . . 0.0 110.513 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' B' ' 30' ' ' LYS . 50.0 t -66.02 -42.54 91.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.18 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 67.3 mtt -65.86 -33.78 76.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.471 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.5 0.6 11.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.333 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' B' ' 27' ' ' VAL . 24.7 mmtp -61.78 -38.4 87.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.543 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -132.59 17.48 4.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.888 0.375 . . . . 0.0 110.492 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.057 179.579 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.8 -25.62 69.28 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.16 79.51 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.55 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.474 ' N ' ' CD1' ' A' ' 8' ' ' ILE . 1.8 mp -65.8 -53.09 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.91 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 5.5 tp -71.15 -41.68 75.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.05 0.452 . . . . 0.0 110.308 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -39.97 -46.24 3.13 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.1 tp -73.82 -41.95 61.58 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.652 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.01 -54.23 13.63 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.083 0.468 . . . . 0.0 111.013 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.17 -21.83 27.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.818 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.58 -46.61 14.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -50.97 -54.82 21.09 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.9 m -48.23 -49.26 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.26 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.509 ' O ' ' SD ' ' A' ' 21' ' ' MET . 85.4 t -59.81 -45.03 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.929 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.29 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.765 -0.774 . . . . 0.0 108.966 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.18 -38.26 73.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.671 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.526 ' OG1' ' SD ' ' A' ' 21' ' ' MET . 66.4 p -68.05 -24.98 65.14 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.054 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' OG1' ' A' ' 20' ' ' THR . 0.0 OUTLIER -82.04 -38.9 24.28 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.319 0.387 . . . . 0.0 112.038 -179.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.3 mt -69.08 -46.54 78.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.761 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.5 m -52.69 -34.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.939 -178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.5 mm -49.0 -45.99 16.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 29' ' ' LEU . 1.5 m -59.6 -55.08 38.96 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.457 ' C ' ' CD1' ' A' ' 26' ' ' LEU . 1.6 tm? -46.93 -37.67 9.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.246 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.3 -56.67 9.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.395 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.522 ' O ' ' N ' ' A' ' 32' ' ' LYS . 98.6 mmm -58.11 -29.54 65.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.697 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 31' ' ' LYS . 3.5 tt -63.79 -36.0 82.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.994 0.426 . . . . 0.0 109.87 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -45.4 -11.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.258 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 29' ' ' LEU . 34.1 ttmt -156.72 -13.43 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.371 0.605 . . . . 0.0 110.12 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' MET . 55.1 mtpt . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.483 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.78 69.21 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.29 -35.04 79.06 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.594 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 1.8 mp -66.0 -53.16 40.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.908 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 5.5 tp -70.94 -41.73 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.297 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -40.07 -46.06 3.18 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 43.0 tp -74.05 -41.92 61.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.709 0.29 . . . . 0.0 110.661 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 -54.29 13.04 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.106 0.479 . . . . 0.0 110.967 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.0 m -68.16 -21.78 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.846 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.55 -46.63 14.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.1 -54.89 21.2 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 7.1 m -47.98 -49.34 11.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.383 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.525 ' O ' ' SD ' ' B' ' 21' ' ' MET . 85.9 t -59.88 -44.98 95.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.939 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.33 -45.97 97.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.16 -38.26 73.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.615 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' THR . . . . . 0.529 ' OG1' ' SD ' ' B' ' 21' ' ' MET . 69.1 p -68.06 -24.93 65.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.096 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.529 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -82.11 -38.9 24.1 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.42 0.45 . . . . 0.0 112.032 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.13 -46.51 77.96 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.765 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 31.9 m -52.67 -34.91 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.013 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mm -49.1 -45.9 17.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.427 ' O ' ' N ' ' B' ' 29' ' ' LEU . 1.5 m -59.71 -55.31 35.97 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.46 ' C ' ' CD1' ' B' ' 26' ' ' LEU . 1.6 tm? -46.79 -37.49 8.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.295 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.45 -56.53 10.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.466 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' MET . . . . . 0.528 ' O ' ' N ' ' B' ' 32' ' ' LYS . 98.6 mmm -58.23 -29.4 65.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.715 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' B' ' 31' ' ' LYS . 3.5 tt -63.84 -36.14 82.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.024 0.44 . . . . 0.0 109.861 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -45.29 -11.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.361 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' B' ' 29' ' ' LEU . 34.0 ttmt -156.73 -13.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.241 0.543 . . . . 0.0 109.965 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' B' ' 28' ' ' MET . 55.0 mtpt . . . . . 0 C--N 1.322 -0.63 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.43 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.72 -22.65 66.42 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.17 -31.03 68.63 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.996 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.02 -59.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.402 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 6.0 tp -66.09 -39.75 85.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.22 0.533 . . . . 0.0 110.198 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 9' ' ' ILE . . . -42.62 -45.99 5.7 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.75 -33.65 64.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 111.204 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.436 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.1 OUTLIER -57.23 -62.94 1.41 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.302 -179.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 m -58.27 -21.91 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.178 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.13 -38.45 39.98 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.31 -55.25 30.5 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.2 m -51.05 -21.72 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.19 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.1 t -85.56 -47.77 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.205 0.526 . . . . 0.0 111.376 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.419 HG21 HD12 ' A' ' 18' ' ' ILE . 42.8 mm -69.7 -47.14 72.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.02 -178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.5 -41.11 65.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.707 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.0 t -78.88 -19.93 50.72 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.047 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.0 mmt -78.33 -35.14 48.01 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.951 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.92 -48.45 87.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.65 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 25' ' ' THR . 34.1 m -63.87 -34.71 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 110.3 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -43.59 -22.44 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -79.46 -43.03 24.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.57 178.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.5 tm? -47.83 -31.83 5.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.67 0.747 . . . . 0.0 110.479 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.6 t -64.46 -40.59 89.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.292 0.567 . . . . 0.0 109.501 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 25' ' ' THR . 67.4 mtt -67.45 -31.34 71.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.876 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.1 mt -76.06 -8.62 57.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.025 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -60.97 -36.79 80.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.716 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -101.98 17.12 23.98 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.731 0.3 . . . . 0.0 110.59 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.602 179.832 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.78 -22.72 66.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.06 -30.86 68.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.661 0.267 . . . . 0.0 111.056 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.13 -59.48 3.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 6.0 tp -65.93 -39.53 84.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.228 0.537 . . . . 0.0 110.23 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -42.99 -45.68 6.05 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.96 -33.54 63.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.747 0.308 . . . . 0.0 111.193 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' MET . . . . . 0.437 ' SD ' ' C ' ' B' ' 12' ' ' MET . 0.1 OUTLIER -57.29 -63.04 1.36 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.28 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -58.24 -21.81 18.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.197 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.05 -38.52 40.19 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.3 -55.09 31.3 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.5 m -51.2 -21.66 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 122.874 -0.192 . . . . 0.0 111.182 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 70.3 t -85.6 -47.8 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.239 0.542 . . . . 0.0 111.401 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.76 -47.15 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.943 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.54 -41.17 66.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.642 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 4.0 t -78.76 -19.93 51.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.105 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 22.0 mmt -78.35 -35.16 47.85 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.975 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.91 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.713 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' B' ' 25' ' ' THR . 34.1 m -63.72 -34.76 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.093 0.473 . . . . 0.0 110.314 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -43.82 -22.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.479 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.0 OUTLIER -79.56 -43.0 23.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.622 178.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.5 tm? -47.81 -31.96 5.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.661 0.744 . . . . 0.0 110.55 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 12.3 t -64.43 -40.61 89.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.582 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' MET . . . . . 0.426 ' N ' ' O ' ' B' ' 25' ' ' THR . 67.5 mtt -67.42 -31.35 71.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.871 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 82.0 mt -75.95 -8.84 57.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.032 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -60.88 -36.8 80.15 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.728 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -101.92 17.17 23.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.544 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.615 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.36 89.71 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.05 -24.45 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.765 0.317 . . . . 0.0 110.769 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.17 -42.91 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.246 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.91 -41.2 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.297 0.57 . . . . 0.0 109.532 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.8 -59.56 8.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 48.4 tp -72.89 -28.21 62.35 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.405 ' C ' ' SD ' ' A' ' 12' ' ' MET . 0.0 OUTLIER -42.48 -53.92 4.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 16' ' ' VAL . 34.2 m -72.92 -51.63 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.4 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.572 ' C ' ' H ' ' A' ' 16' ' ' VAL . . . -29.48 -47.15 0.1 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 123.694 0.621 . . . . 0.0 112.65 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.4 -1.79 0.21 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.593 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.572 ' H ' ' C ' ' A' ' 14' ' ' GLY . 33.6 m -80.71 -51.13 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.494 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 86.8 t -43.43 -37.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.828 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.53 -49.54 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.848 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.84 -52.04 67.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.534 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.93 -19.09 65.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.609 0.242 . . . . 0.0 110.705 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -82.03 -36.82 27.35 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.306 178.683 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.96 -44.27 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.131 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 26' ' ' LEU . 14.0 m -62.96 -40.58 89.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 CA-C-O 121.143 0.497 . . . . 0.0 110.516 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tp -40.83 -24.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.306 0.575 . . . . 0.0 110.195 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -82.47 -37.64 25.07 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.381 179.041 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.5 tm? -48.83 -40.42 29.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.704 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.74 -44.7 99.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.33 0.586 . . . . 0.0 109.685 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 82.2 mmm -65.4 -37.32 86.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.485 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.8 -5.65 59.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 110.405 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -61.85 -32.34 72.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.856 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.65 37.35 2.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.169 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.526 179.707 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.44 -34.17 89.18 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.16 -24.41 54.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.713 0.292 . . . . 0.0 110.7 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.11 -42.91 96.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.241 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.99 -41.24 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 121.288 0.566 . . . . 0.0 109.495 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.71 -59.53 8.48 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 48.7 tp -72.95 -28.28 62.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' MET . . . . . 0.404 ' C ' ' SD ' ' B' ' 12' ' ' MET . 0.0 OUTLIER -42.53 -53.78 4.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -178.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.504 ' O ' ' N ' ' B' ' 16' ' ' VAL . 34.1 m -72.95 -51.82 25.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.379 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.572 ' C ' ' H ' ' B' ' 16' ' ' VAL . . . -29.38 -47.04 0.09 OUTLIER Glycine 0 CA--C 1.531 1.061 0 O-C-N 123.764 0.665 . . . . 0.0 112.63 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.41 -1.92 0.22 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.524 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.572 ' H ' ' C ' ' B' ' 14' ' ' GLY . 33.5 m -80.74 -51.03 16.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.014 0.435 . . . . 0.0 109.874 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.497 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 86.0 t -43.48 -37.97 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.726 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.43 -49.48 80.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.798 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -51.89 67.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.661 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.87 -19.2 65.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.694 0.283 . . . . 0.0 110.781 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -82.05 -36.63 27.51 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.272 178.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 90.0 mt -65.09 -44.22 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.133 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' B' ' 26' ' ' LEU . 13.9 m -62.96 -40.69 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.139 0.495 . . . . 0.0 110.463 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.402 ' C ' ' O ' ' B' ' 23' ' ' VAL . 2.1 tp -40.83 -24.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.199 0.523 . . . . 0.0 110.167 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.506 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -82.43 -37.63 25.18 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.355 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.574 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.5 tm? -48.85 -40.28 28.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.783 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 89.4 t -61.84 -44.71 99.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.289 0.566 . . . . 0.0 109.623 178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 82.3 mmm -65.45 -37.27 86.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.451 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.87 -5.65 59.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.794 0.33 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -61.96 -32.45 72.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.934 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.36 37.17 2.16 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.219 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.559 179.744 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.2 mttp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.02 -20.76 77.31 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.21 -24.79 34.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.317 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 mm -63.17 -49.83 81.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.498 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.54 -40.36 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.429 0.633 . . . . 0.0 110.226 179.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.41 -60.54 5.69 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 11' ' ' LEU . 4.2 mm? -70.24 -29.39 66.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.2 -58.0 3.12 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 120.669 0.271 . . . . 0.0 111.671 -178.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 16' ' ' VAL . 17.1 m -75.49 -49.69 26.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.604 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' A' ' 16' ' ' VAL . . . -30.94 -45.98 0.13 Allowed Glycine 0 CA--C 1.527 0.808 0 O-C-N 123.427 0.455 . . . . 0.0 112.284 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.51 -0.51 0.14 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.641 -178.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.595 ' H ' ' C ' ' A' ' 14' ' ' GLY . 35.1 m -82.47 -50.22 16.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.459 ' H ' HG23 ' A' ' 16' ' ' VAL . 79.6 t -42.88 -37.08 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.048 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.66 -49.29 78.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.913 -179.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.96 -52.09 66.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.268 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -18.35 64.19 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.006 -178.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.63 -38.24 20.1 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.29 0.369 . . . . 0.0 110.889 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.78 -43.15 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.354 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 26' ' ' LEU . 35.2 m -55.76 -41.9 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.547 -178.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' A' ' 23' ' ' VAL . 39.8 mm -40.3 -46.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.154 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -63.59 -43.16 97.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.35 178.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 23' ' ' VAL . 2.4 tm? -56.06 -45.12 79.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.011 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.8 t -63.9 -44.14 97.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.448 0.642 . . . . 0.0 109.59 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 91.0 mtp -61.13 -30.52 70.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.233 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 31' ' ' LYS . 41.6 mt -71.22 -33.11 69.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.844 178.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -44.29 -15.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.798 -179.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 65.0 mttp -103.9 27.88 7.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.734 0.302 . . . . 0.0 110.336 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 29' ' ' LEU . 29.2 mmtp . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.267 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.3 mttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.54 -20.78 78.21 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.0 -24.98 35.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.754 0.312 . . . . 0.0 110.269 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.13 -49.83 81.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.591 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 11.0 tp -68.69 -40.3 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.454 0.645 . . . . 0.0 110.154 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.28 -60.5 5.65 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' B' ' 11' ' ' LEU . 4.2 mm? -70.52 -29.09 65.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -58.0 3.22 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.669 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 13' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' B' ' 16' ' ' VAL . 17.5 m -75.33 -49.91 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.594 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.584 ' C ' ' H ' ' B' ' 16' ' ' VAL . . . -30.69 -45.9 0.12 Allowed Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.569 0.543 . . . . 0.0 112.395 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.61 -0.73 0.15 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.57 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.584 ' H ' ' C ' ' B' ' 14' ' ' GLY . 35.1 m -82.08 -50.29 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 120.698 0.285 . . . . 0.0 110.241 179.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.462 ' N ' ' CG2' ' B' ' 16' ' ' VAL . 73.2 t -42.97 -36.97 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.052 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.8 -49.08 79.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.96 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.07 -52.29 66.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.256 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -18.24 63.92 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.054 -178.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.76 -38.16 19.98 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.309 0.381 . . . . 0.0 110.935 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.82 -43.23 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.353 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' B' ' 26' ' ' LEU . 35.9 m -55.72 -41.97 67.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.502 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 24' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' B' ' 23' ' ' VAL . 39.5 mm -40.04 -46.74 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.168 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -63.74 -43.2 97.19 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.375 178.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' B' ' 23' ' ' VAL . 2.4 tm? -56.05 -45.1 79.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.982 -179.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -63.91 -44.19 97.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.463 0.649 . . . . 0.0 109.545 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 91.0 mtp -61.06 -30.34 70.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.212 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' B' ' 32' ' ' LYS . 43.0 mt -71.4 -33.1 69.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.898 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -44.28 -15.64 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.777 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.1 mttp -103.93 27.97 7.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.703 0.287 . . . . 0.0 110.378 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 32' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 29' ' ' LEU . 28.9 mmtp . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.268 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.711 0.291 . . . . 71.6 110.732 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.9 mt -64.0 -52.58 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.399 -0.364 . . . . 200.66 111.76 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.441 HG23 ' N ' ' A' ' 10' ' ' GLY . 8.4 tp -67.08 -42.19 88.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.188 -0.605 . . . . 74.61 109.617 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -46.97 -47.34 19.79 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.301 -1.12 . . . . 50.55 110.301 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 11' ' ' LEU . 18.7 tp -70.68 -37.27 73.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.753 0.311 . . . . 340.02 110.536 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -57.74 10.48 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.948 0.404 . . . . 67.5 110.874 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 9' ' ' ILE . 21.4 m -66.54 -17.78 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.941 -0.572 . . . . 56.2 111.284 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.52 -42.57 7.78 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.849 -0.901 . . . . 17.23 110.849 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.48 -53.26 32.9 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.381 -1.088 . . . . 25.06 110.381 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.901 ' O ' HG23 ' A' ' 20' ' ' THR . 23.5 m -46.09 -52.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.884 -0.327 . . . . 30.97 110.171 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.547 ' N ' HG23 ' A' ' 16' ' ' VAL . 94.8 t -56.03 -46.08 80.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.526 -0.47 . . . . 35.41 110.954 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.37 -47.17 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.021 -0.671 . . . . 142.96 109.603 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.88 -40.02 69.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.647 -0.706 . . . . 25.01 110.017 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 16' ' ' VAL . 29.9 p -70.19 -20.01 63.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 130.55 111.022 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.58 -34.9 27.57 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.508 -0.477 . . . . 113.59 110.888 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.7 -44.86 93.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 120.816 -0.354 . . . . 72.54 111.064 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.56 HG11 ' HB ' ' B' ' 20' ' ' THR . 30.1 m -61.78 -35.8 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.596 -0.442 . . . . 28.81 110.85 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.634 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -48.53 -23.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.66 -0.496 . . . . 102.06 109.66 178.602 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.12 -47.59 12.37 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.002 -0.74 . . . . 114.84 109.002 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.71 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.8 tm? -47.79 -36.27 11.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.547 0.689 . . . . 154.31 109.432 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.695 HG21 HG21 ' B' ' 27' ' ' VAL . 74.0 t -63.66 -65.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.741 -0.663 . . . . 155.81 110.221 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 82.7 mtp -48.21 -26.83 2.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.673 -0.694 . . . . 479.64 110.769 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 54.6 mt -75.09 -19.91 59.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.461 -0.336 . . . . 94.79 111.121 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -51.16 -22.33 2.5 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.596 -0.442 . . . . 870.34 110.825 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -105.01 22.05 15.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.646 0.26 . . . . 892.32 110.574 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.961 -1.018 . . . . 999.99 110.564 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 mttt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.398 -0.593 . . . . 957.99 109.398 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.56 -19.75 79.74 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.235 -0.746 . . . . 165.68 111.235 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.82 81.75 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.719 -0.392 . . . . 71.79 110.759 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 21.9 mt -64.02 -52.55 55.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.332 -0.395 . . . . 202.4 111.807 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.432 ' O ' HG22 ' B' ' 13' ' ' VAL . 8.4 tp -67.09 -42.24 88.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.174 -0.611 . . . . 74.94 109.569 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.432 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -47.02 -47.25 20.14 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.312 -1.115 . . . . 50.24 110.312 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' B' ' 11' ' ' LEU . 18.7 tp -70.66 -37.34 73.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 120.737 0.303 . . . . 339.95 110.47 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -57.72 10.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.957 0.408 . . . . 66.95 110.902 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.432 HG22 ' O ' ' B' ' 9' ' ' ILE . 21.7 m -66.53 -17.69 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.902 -0.59 . . . . 56.24 111.33 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.56 -42.51 7.79 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.843 -0.903 . . . . 17.19 110.843 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.56 -53.26 33.18 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.401 -1.08 . . . . 25.14 110.401 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.905 ' O ' HG23 ' B' ' 20' ' ' THR . 23.6 m -46.12 -52.0 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.802 -0.359 . . . . 30.99 110.202 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.545 ' N ' HG23 ' B' ' 16' ' ' VAL . 94.3 t -56.01 -46.08 80.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.568 -0.453 . . . . 35.55 110.961 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 90.2 mt -63.36 -47.22 92.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.031 -0.668 . . . . 142.35 109.659 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.75 -40.08 68.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.577 -0.738 . . . . 25.02 110.108 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.905 HG23 ' O ' ' B' ' 16' ' ' VAL . 29.9 p -70.13 -20.0 63.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 129.97 111.024 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.62 -34.91 27.43 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.546 -0.462 . . . . 113.52 110.844 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.75 -44.83 93.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 120.833 -0.347 . . . . 73.86 111.051 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.582 HG11 ' HB ' ' A' ' 20' ' ' THR . 30.2 m -61.72 -35.93 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.599 -0.44 . . . . 28.73 110.847 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.651 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -48.49 -23.01 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.463 -0.495 . . . . 102.81 109.71 178.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.11 -47.61 12.35 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.997 -0.742 . . . . 116.39 108.997 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.715 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.8 tm? -47.82 -36.21 11.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.518 0.675 . . . . 155.23 109.41 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.695 HG21 HG21 ' A' ' 27' ' ' VAL . 74.3 t -63.68 -65.72 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.75 -0.659 . . . . 156.82 110.281 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 82.7 mtp -48.23 -26.89 2.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 481.58 110.765 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 55.0 mt -75.03 -19.89 59.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.446 -0.343 . . . . 95.14 111.165 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -51.16 -22.32 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.542 -0.463 . . . . 870.37 110.811 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -105.03 22.05 16.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 121.065 -0.254 . . . . 889.68 110.522 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.933 -1.032 . . . . 999.99 110.497 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.605 0.241 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.564 HD13 HD13 ' B' ' 8' ' ' ILE . 97.7 mt -63.3 -43.7 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.482 ' O ' HG22 ' A' ' 13' ' ' VAL . 5.9 tp -61.01 -36.76 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 109.793 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.63 -66.38 2.88 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 11' ' ' LEU . 4.2 mm? -60.16 -32.79 71.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 110.982 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.23 -63.84 1.16 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 120.863 0.363 . . . . 0.0 110.97 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 9' ' ' ILE . 12.6 m -68.39 -20.82 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.35 -39.81 12.09 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.93 -54.33 26.09 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.7 m -44.51 -49.79 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.95 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -60.49 -42.88 92.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.057 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.0 -51.35 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.465 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.43 -36.8 76.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.149 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -18.52 58.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.998 0.428 . . . . 0.0 110.401 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -32.64 36.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.397 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.434 ' O ' HG22 ' A' ' 25' ' ' THR . 96.7 mt -64.7 -46.34 92.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.375 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.465 ' C ' ' N ' ' A' ' 25' ' ' THR . 29.6 m -66.13 -35.56 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.329 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 24' ' ' ILE . 1.2 tp -49.07 -20.41 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.465 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -74.74 -40.69 61.1 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.649 179.137 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.913 HD22 ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.92 -25.37 42.78 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 121.396 0.617 . . . . 0.0 109.959 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.569 ' N ' HD13 ' A' ' 26' ' ' LEU . 15.1 t -66.42 -46.47 86.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.738 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.6 mtt -68.3 -33.31 74.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.266 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.9 mt -82.58 -3.37 55.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.265 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -61.83 -37.04 82.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.092 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.8 23.26 4.24 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.58 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.377 179.566 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.08 -32.61 84.77 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.34 -21.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.582 0.229 . . . . 0.0 110.94 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.564 HD13 HD13 ' A' ' 8' ' ' ILE . 97.8 mt -63.2 -43.74 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.493 ' O ' HG22 ' B' ' 13' ' ' VAL . 5.9 tp -60.9 -36.74 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.813 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.68 -66.38 2.88 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.426 ' N ' HD22 ' B' ' 11' ' ' LEU . 4.2 mm? -60.18 -32.82 71.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 0.0 111.015 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.4 tpt -60.05 -63.89 1.14 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 120.901 0.381 . . . . 0.0 111.004 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.493 HG22 ' O ' ' B' ' 9' ' ' ILE . 12.5 m -68.36 -20.83 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.44 -39.78 12.0 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.86 -54.35 25.78 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.7 m -44.57 -49.69 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.618 -0.291 . . . . 0.0 110.904 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.59 -42.87 93.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.007 0.432 . . . . 0.0 111.144 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.9 -51.37 72.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.549 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.83 76.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.18 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.12 -18.46 57.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.942 0.401 . . . . 0.0 110.359 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.68 -32.59 35.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.449 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.433 ' O ' HG22 ' B' ' 25' ' ' THR . 96.7 mt -64.61 -46.41 92.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.365 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.457 ' C ' ' N ' ' B' ' 25' ' ' THR . 29.6 m -66.2 -35.39 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.328 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' B' ' 24' ' ' ILE . 1.2 tp -49.15 -20.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.457 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -74.65 -40.73 61.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.631 179.191 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.914 ' O ' HD22 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -55.95 -25.21 42.53 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 121.367 0.603 . . . . 0.0 109.94 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.557 ' N ' HD13 ' B' ' 26' ' ' LEU . 15.2 t -66.55 -46.37 86.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.781 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 59.4 mtt -68.48 -33.27 73.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.176 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.52 -3.46 55.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.205 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -61.82 -37.08 83.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.081 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.71 23.2 4.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.585 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.324 179.623 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.687 0.28 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.23 -53.44 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.472 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 10' ' ' GLY . 3.6 tp -71.07 -42.17 76.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.167 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -39.5 -46.97 2.87 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 46.9 tp -72.56 -39.48 67.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.735 0.302 . . . . 0.0 110.702 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -59.21 4.46 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.936 0.398 . . . . 0.0 111.47 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.13 -22.18 29.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.034 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.58 -45.36 18.17 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.72 -54.15 29.39 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 20' ' ' THR . 5.5 m -48.23 -51.54 9.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.198 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.408 ' O ' ' OG1' ' A' ' 20' ' ' THR . 91.9 t -59.06 -45.0 92.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.095 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.1 -46.93 95.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.181 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.542 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.01 -39.04 71.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.248 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 16' ' ' VAL . 46.3 p -67.15 -21.32 65.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.182 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.44 -38.6 19.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.2 mt -69.64 -45.13 78.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.552 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.909 HG21 HG21 ' B' ' 23' ' ' VAL . 29.2 m -51.8 -37.86 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.713 0.292 . . . . 0.0 111.054 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.47 ' N ' HG23 ' A' ' 23' ' ' VAL . 37.6 mm -48.25 -45.9 13.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.417 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.29 -52.35 65.63 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.0 tm? -51.04 -40.97 59.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.051 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG11 HG11 ' B' ' 27' ' ' VAL . 92.0 t -65.94 -65.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm -48.54 -26.16 2.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.976 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 32' ' ' LYS . 20.2 mt -72.15 -28.03 62.98 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.354 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -45.53 -14.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.671 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 29' ' ' LEU . 98.9 mttt -98.27 20.18 12.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 32.7 ttpt . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.523 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 56.6 tttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.99 -25.08 67.58 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.54 84.07 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.357 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.2 -53.54 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.433 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.459 HG23 ' N ' ' B' ' 10' ' ' GLY . 3.6 tp -70.95 -42.23 77.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 110.193 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.459 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -39.51 -46.91 2.86 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -72.59 -39.63 67.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.749 0.309 . . . . 0.0 110.605 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -59.06 4.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 111.52 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -66.33 -22.02 29.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.994 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.65 -45.39 17.77 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.51 -54.38 27.68 Favored Glycine 0 C--O 1.224 -0.514 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.882 ' O ' HG23 ' B' ' 20' ' ' THR . 5.4 m -47.95 -51.59 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.325 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.404 ' H ' HG23 ' B' ' 16' ' ' VAL . 91.9 t -59.24 -44.89 93.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.041 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.14 -47.04 95.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.629 0.728 . . . . 0.0 109.158 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.538 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -55.92 -38.86 70.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.287 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.882 HG23 ' O ' ' B' ' 16' ' ' VAL . 46.7 p -67.24 -21.33 65.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.19 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.55 -38.48 19.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 93.1 mt -69.82 -45.21 77.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.485 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.909 HG21 HG21 ' A' ' 23' ' ' VAL . 29.7 m -51.64 -37.72 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.69 0.281 . . . . 0.0 111.088 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.463 ' N ' HG23 ' B' ' 23' ' ' VAL . 37.8 mm -48.48 -45.8 14.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.338 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.42 -52.49 65.0 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.717 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.0 tm? -50.95 -40.81 58.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.054 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.402 HG11 HG11 ' A' ' 27' ' ' VAL . 92.8 t -66.02 -65.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm -48.46 -26.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.01 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 32' ' ' LYS . 20.5 mt -72.22 -27.94 62.85 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.343 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -45.62 -14.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.691 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 98.9 mttt -98.32 20.2 13.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 29' ' ' LEU . 32.8 ttpt . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.498 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.767 0.317 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.05 -49.46 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -82.05 -25.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.338 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.8 -45.81 55.08 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.97 -35.26 32.35 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.577 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -54.74 17.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 120.963 0.411 . . . . 0.0 111.28 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.413 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 34.5 m -67.62 -20.92 26.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.766 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.28 -48.8 7.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.284 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.0 -54.39 14.74 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.885 ' O ' HG23 ' A' ' 20' ' ' THR . 5.0 m -46.28 -49.54 5.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.17 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.4 t -58.79 -45.55 91.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.771 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -62.09 -48.41 88.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.324 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -54.65 -36.86 65.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.454 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 16' ' ' VAL . 44.8 p -68.9 -21.15 64.25 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.171 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.2 mmt -82.8 -38.19 23.46 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.16 -45.76 74.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.824 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.889 HG21 HG21 ' B' ' 23' ' ' VAL . 26.2 m -51.25 -37.31 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 120.698 0.285 . . . . 0.0 110.867 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.473 ' N ' HG23 ' A' ' 23' ' ' VAL . 39.3 mm -48.08 -45.79 12.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.438 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -61.84 -52.67 63.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.2 tm? -49.66 -41.45 42.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.123 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 30' ' ' LYS . 99.6 t -65.93 -65.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.2 mmm -48.59 -24.28 1.28 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 32' ' ' LYS . 25.0 mt -74.69 -26.45 59.84 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.607 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 27' ' ' VAL . 67.1 mttm -44.44 -15.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 71.4 mmtt -100.5 22.85 11.12 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 110.095 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . 22.8 pttp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.718 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' B' ' 10' ' ' GLY . . . -62.75 -24.19 66.14 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.98 82.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.777 0.322 . . . . 0.0 110.197 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.81 -50.16 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.797 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -81.28 -26.07 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.467 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 6' ' ' GLY . . . -51.71 -46.1 54.34 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.77 -35.12 33.61 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -54.8 17.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.955 0.407 . . . . 0.0 111.193 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 34.4 m -67.45 -20.87 27.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.838 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.58 -48.65 7.83 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.0 -54.45 14.51 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.895 ' O ' HG23 ' B' ' 20' ' ' THR . 5.1 m -46.19 -49.6 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.202 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 91.7 t -58.69 -45.64 90.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.775 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.0 -48.42 88.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.411 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.545 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -54.6 -37.1 65.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.467 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.895 HG23 ' O ' ' B' ' 16' ' ' VAL . 44.3 p -68.64 -21.2 64.48 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.151 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.1 mmt -82.85 -38.19 23.33 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 92.3 mt -70.06 -45.78 75.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.827 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 23' ' ' VAL . 25.4 m -51.19 -37.49 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.734 0.302 . . . . 0.0 110.815 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.483 ' N ' HG23 ' B' ' 23' ' ' VAL . 39.2 mm -47.88 -45.9 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.428 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -61.74 -52.68 63.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.693 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.2 tm? -49.67 -41.69 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.154 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.6 -65.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 93.2 mmm -48.44 -24.27 1.21 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.692 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' B' ' 32' ' ' LYS . 24.3 mt -74.74 -26.68 59.95 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.57 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -44.14 -15.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.962 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 71.3 mmtt -100.14 23.01 10.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.922 0.392 . . . . 0.0 110.174 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 29' ' ' LEU . 22.8 pttp . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.617 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.865 0.364 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.32 -48.08 86.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' MET . 5.2 tp -67.98 -43.16 85.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.104 0.478 . . . . 0.0 109.976 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.45 -43.32 0.73 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.612 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.3 mt -78.23 -35.1 48.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.998 0.427 . . . . 0.0 110.609 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -58.98 -63.73 1.19 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.191 -179.261 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.79 -22.45 21.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.134 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.41 -47.81 20.89 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.31 -51.87 44.44 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.889 ' O ' HG23 ' A' ' 20' ' ' THR . 6.6 m -50.78 -48.24 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.098 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.5 t -58.75 -45.36 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.034 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mm -63.08 -45.72 97.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.586 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.4 -38.11 71.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.642 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.889 HG23 ' O ' ' A' ' 16' ' ' VAL . 44.3 p -68.23 -26.01 65.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.396 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.7 mmt -85.92 -38.54 17.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -69.16 -45.96 78.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.587 HG21 HG21 ' B' ' 23' ' ' VAL . 31.7 m -56.85 -34.67 44.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 23' ' ' VAL . 26.2 mm -43.58 -38.99 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.227 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -62.34 -52.2 64.57 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.734 179.035 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.741 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.7 tm? -48.43 -40.48 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.115 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 t -66.14 -66.17 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.215 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mmm -49.8 -24.79 2.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.017 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 31' ' ' LYS . 34.6 mt -73.92 -25.59 60.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.155 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -45.56 -13.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.724 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . 8.6 mtmp? -97.53 20.57 11.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.287 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 29' ' ' LEU . 17.2 mtmm . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.447 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.63 -22.32 69.74 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.42 -21.85 35.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.898 0.38 . . . . 0.0 110.214 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.17 -48.2 86.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.074 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' B' ' 12' ' ' MET . 5.2 tp -67.97 -43.26 85.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.115 0.483 . . . . 0.0 109.952 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.502 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.35 -43.14 0.69 Allowed Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.708 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt -78.38 -35.15 47.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.989 0.423 . . . . 0.0 110.613 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' MET . . . . . 0.516 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -58.94 -63.7 1.21 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.231 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.63 -22.43 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.138 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.5 -47.74 20.65 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.26 -51.87 44.23 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.904 ' O ' HG23 ' B' ' 20' ' ' THR . 6.2 m -50.79 -48.31 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.064 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 80.4 t -58.93 -45.25 92.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.982 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mm -63.14 -45.72 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.581 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -56.39 -38.01 70.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.678 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.904 HG23 ' O ' ' B' ' 16' ' ' VAL . 44.5 p -68.36 -25.9 65.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 24.7 mmt -86.09 -38.43 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -69.28 -45.92 78.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.932 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.587 HG21 HG21 ' A' ' 23' ' ' VAL . 32.3 m -56.92 -34.65 44.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mm -43.65 -38.76 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.262 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' B' ' 26' ' ' LEU . 0.6 OUTLIER -62.61 -52.03 64.96 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.721 179.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.739 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.7 tm? -48.67 -40.39 27.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.091 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 t -66.13 -66.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.246 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mmm -49.82 -24.73 2.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.062 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 32' ' ' LYS . 34.9 mt -73.99 -25.46 59.92 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.117 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -45.6 -13.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.588 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' B' ' 29' ' ' LEU . 8.6 mtmp? -97.6 20.7 11.4 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 29' ' ' LEU . 17.2 mtmm . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.497 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.801 0.334 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.706 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.0 mp -65.23 -53.89 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.213 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' MET . 3.9 tp -70.88 -41.91 77.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.932 0.396 . . . . 0.0 110.537 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.42 -46.26 1.03 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.471 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.3 mm? -77.1 -32.51 56.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.48 0.181 . . . . 0.0 110.947 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -60.92 -62.49 1.82 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.793 0.33 . . . . 0.0 111.341 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -66.72 -21.93 29.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.817 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.85 -45.93 10.07 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.513 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.4 -53.07 37.04 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.883 ' O ' HG23 ' A' ' 20' ' ' THR . 4.5 m -47.36 -51.35 6.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.187 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.45 ' H ' HG23 ' A' ' 16' ' ' VAL . 73.9 t -58.01 -45.11 88.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.568 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.12 -48.07 90.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.674 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.14 -36.77 68.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.268 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 16' ' ' VAL . 44.8 p -67.79 -21.61 65.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.031 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.9 -38.3 23.05 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.328 0.392 . . . . 0.0 111.742 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.37 -46.19 72.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.874 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.958 HG21 HG21 ' B' ' 23' ' ' VAL . 31.5 m -50.47 -37.24 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.819 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.488 ' N ' HG23 ' A' ' 23' ' ' VAL . 38.7 mm -47.96 -46.28 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 m -60.95 -52.71 63.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.715 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.3 tm? -50.53 -41.1 53.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.339 0.59 . . . . 0.0 109.939 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.528 HG11 HG11 ' B' ' 27' ' ' VAL . 84.2 t -66.48 -66.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.874 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.1 mtp -47.96 -24.03 0.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.665 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 32' ' ' LYS . 19.8 mt -73.61 -26.92 61.02 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.711 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 27' ' ' VAL . 66.9 mttm -44.9 -14.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.707 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 29' ' ' LEU . 53.0 mtmt -99.18 21.93 11.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.767 0.318 . . . . 0.0 110.395 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 29' ' ' LEU . 66.0 tttm . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.623 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.0 -27.66 72.53 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.97 -34.69 78.56 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.281 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.69 HD12 ' N ' ' B' ' 8' ' ' ILE . 2.0 mp -65.5 -53.95 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.182 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 12' ' ' MET . 3.8 tp -70.92 -41.8 77.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.853 0.358 . . . . 0.0 110.502 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.464 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.55 -45.9 1.03 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.467 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.3 mm? -77.51 -32.41 54.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.178 . . . . 0.0 110.887 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' MET . . . . . 0.528 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -61.08 -62.73 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.748 0.308 . . . . 0.0 111.273 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 m -66.37 -22.03 29.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.815 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.82 -45.96 10.08 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.452 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.35 -53.08 36.8 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.89 ' O ' HG23 ' B' ' 20' ' ' THR . 4.6 m -47.34 -51.44 6.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.125 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.471 ' O ' ' OG1' ' B' ' 20' ' ' THR . 73.4 t -57.98 -45.1 87.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.6 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.25 -47.89 90.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.739 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.536 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -56.15 -37.05 68.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.22 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.89 HG23 ' O ' ' B' ' 16' ' ' VAL . 45.9 p -67.61 -21.63 65.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.075 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.91 -38.21 23.15 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.242 0.339 . . . . 0.0 111.72 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 94.7 mt -70.36 -46.13 72.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.97 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.958 HG21 HG21 ' A' ' 23' ' ' VAL . 31.6 m -50.64 -37.44 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.712 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.49 ' N ' HG23 ' B' ' 23' ' ' VAL . 38.9 mm -47.73 -46.34 11.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -60.86 -52.58 64.46 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.729 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.3 tm? -50.73 -41.32 56.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.867 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.528 HG11 HG11 ' A' ' 27' ' ' VAL . 84.0 t -66.19 -66.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.914 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 96.9 mtp -47.88 -24.04 0.91 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.657 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 32' ' ' LYS . 19.5 mt -73.66 -27.12 61.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.654 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -44.68 -14.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.771 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 53.3 mtmt -99.19 22.02 11.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.822 0.344 . . . . 0.0 110.346 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.9 tttm . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.595 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.694 0.283 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.05 -48.9 83.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.024 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 10' ' ' GLY . 3.8 tp -69.84 -44.14 79.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.295 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.58 -47.56 1.2 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.431 ' N ' HD22 ' A' ' 11' ' ' LEU . 4.3 mm? -73.3 -36.26 66.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.726 0.298 . . . . 0.0 110.706 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -57.44 -63.16 1.32 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.925 0.393 . . . . 0.0 111.567 -179.08 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.74 -21.98 26.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.218 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.49 -47.64 10.14 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.264 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.21 -52.45 31.78 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.887 ' O ' HG23 ' A' ' 20' ' ' THR . 5.5 m -47.86 -48.58 11.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.793 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.529 ' O ' ' SD ' ' A' ' 21' ' ' MET . 93.9 t -59.21 -46.52 92.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.994 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.6 -47.49 93.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -52.8 -38.47 61.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.375 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.887 HG23 ' O ' ' A' ' 16' ' ' VAL . 39.7 p -69.39 -24.38 63.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.221 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -79.97 -39.94 29.06 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.7 mt -70.43 -45.36 75.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.94 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.754 HG21 HG21 ' B' ' 23' ' ' VAL . 28.8 m -54.77 -37.78 41.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.039 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -46.54 -47.21 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.617 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 29' ' ' LEU . 2.5 m -60.11 -53.24 60.06 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.707 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.9 tm? -49.99 -38.07 35.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.702 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.545 HG11 HG11 ' B' ' 27' ' ' VAL . 58.9 t -63.83 -68.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.648 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 16.1 ptm -48.81 -20.86 0.54 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.222 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 32' ' ' LYS . 8.6 mt -74.61 -25.85 59.52 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.126 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -45.23 -15.01 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.45 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' LEU . 98.9 mttt -99.86 23.86 9.19 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.079 0.466 . . . . 0.0 109.86 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 29' ' ' LEU . 24.8 mtmm . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.9 71.07 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.81 43.55 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.416 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 37.7 mm -63.91 -49.08 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.03 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.509 HG23 ' N ' ' B' ' 10' ' ' GLY . 3.8 tp -69.71 -44.06 79.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.383 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.509 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.83 -47.2 1.24 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.433 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.3 mm? -73.57 -36.2 65.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 110.698 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' MET . . . . . 0.497 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -57.45 -63.35 1.26 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 120.96 0.41 . . . . 0.0 111.512 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -68.73 -21.89 26.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.171 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.32 -47.78 10.28 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.286 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.25 33.39 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.877 ' O ' HG23 ' B' ' 20' ' ' THR . 5.5 m -47.85 -48.7 11.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.765 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.531 ' O ' ' SD ' ' B' ' 21' ' ' MET . 93.8 t -59.18 -46.41 92.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.038 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mm -61.74 -47.42 93.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.521 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -52.83 -38.51 61.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.359 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.877 HG23 ' O ' ' B' ' 16' ' ' VAL . 40.3 p -69.27 -24.43 63.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.263 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -80.02 -39.91 28.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 92.7 mt -70.44 -45.35 75.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.936 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 23' ' ' VAL . 29.7 m -54.8 -37.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.97 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.586 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -46.46 -47.04 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.683 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.434 HG22 HD12 ' B' ' 29' ' ' LEU . 2.5 m -60.24 -53.15 61.12 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.715 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.9 tm? -50.12 -38.06 37.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.697 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 27' ' ' VAL . 58.7 t -63.85 -68.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.653 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 16.2 ptm -48.82 -20.95 0.55 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.214 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 32' ' ' LYS . 8.5 mt -74.62 -25.78 59.46 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.027 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -45.35 -14.69 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.452 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 99.0 mttt -100.13 23.74 9.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.092 0.472 . . . . 0.0 109.874 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' B' ' 29' ' ' LEU . 24.8 mtmm . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.801 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.872 0.367 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.4 mp -63.6 -45.07 98.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.073 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.48 -25.22 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.051 0.453 . . . . 0.0 110.693 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.05 -43.49 62.16 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.591 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -82.16 -27.01 32.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 110.646 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -61.68 2.4 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.65 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.35 -23.5 28.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.063 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.37 -43.21 79.68 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.27 -61.42 6.98 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.0 m -50.02 -26.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.185 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.32 -46.92 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.2 mt -67.91 -45.0 84.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.863 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.58 -40.81 72.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.676 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.888 ' OG1' HG11 ' B' ' 23' ' ' VAL . 4.2 t -75.93 -27.5 57.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.22 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.6 mmt -72.16 -40.15 68.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.76 -46.15 79.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.682 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.918 HG11 ' OG1' ' B' ' 20' ' ' THR . 21.9 m -65.24 -33.48 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -43.78 -50.09 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.904 -179.314 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.466 ' OG1' HD11 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -66.22 -49.7 66.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.837 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.712 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.1 tm? -41.97 -37.84 1.44 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.079 0.466 . . . . 0.0 110.684 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.622 HG11 HG11 ' B' ' 27' ' ' VAL . 58.2 t -69.01 -58.27 6.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 73.9 mtm -59.68 -22.21 61.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.41 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.466 HD11 ' OG1' ' A' ' 25' ' ' THR . 74.8 mt -79.91 -5.98 56.58 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.37 -9.49 8.38 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.833 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -102.74 19.87 18.38 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.65 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.848 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.99 -37.78 83.71 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.28 -22.47 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 0.0 110.801 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.555 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.4 mp -63.45 -45.08 98.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.077 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.45 -25.38 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.081 0.467 . . . . 0.0 110.728 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.94 -43.3 61.23 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.72 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -82.37 -26.92 32.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.856 0.36 . . . . 0.0 110.75 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -61.85 2.26 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.17 -23.38 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.058 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.32 -43.28 79.83 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.2 -60.97 7.41 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 m -50.47 -26.27 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 122.695 -0.297 . . . . 0.0 111.191 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -82.23 -46.92 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.061 0.458 . . . . 0.0 111.229 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.11 -44.98 84.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.931 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.54 -40.78 72.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.736 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.918 ' OG1' HG11 ' A' ' 23' ' ' VAL . 3.8 t -75.85 -27.59 57.89 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.269 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 29.6 mmt -72.18 -40.23 68.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.78 -46.1 79.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.724 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.888 HG11 ' OG1' ' A' ' 20' ' ' THR . 22.1 m -65.33 -33.58 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.478 -0.489 . . . . 0.0 112.277 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.555 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -43.66 -50.14 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 120.491 -0.483 . . . . 0.0 109.867 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.467 ' OG1' HD11 ' B' ' 29' ' ' LEU . 0.5 OUTLIER -66.3 -49.56 66.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.923 179.426 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.724 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.1 tm? -42.16 -37.77 1.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.637 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.622 HG11 HG11 ' A' ' 27' ' ' VAL . 58.7 t -69.0 -58.34 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 74.1 mtm -59.54 -22.39 61.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.438 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.467 HD11 ' OG1' ' B' ' 25' ' ' THR . 74.7 mt -79.86 -5.88 56.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -62.48 -9.39 8.39 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -102.83 19.68 18.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.712 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.792 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.608 0.242 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.586 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.5 mp -62.36 -44.0 98.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.15 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tp -51.64 -32.5 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.43 99.06 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.227 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.46 -24.92 34.01 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.36 -63.83 1.16 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.177 0.513 . . . . 0.0 110.593 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.1 m -67.42 -22.23 28.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.863 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.79 -40.04 15.77 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.34 -54.91 29.39 Favored Glycine 0 C--N 1.331 0.262 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.915 ' O ' HG23 ' A' ' 20' ' ' THR . 6.5 m -45.6 -51.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.551 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.4 -42.1 89.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.21 -50.12 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.321 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.76 -34.22 69.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.426 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.915 HG23 ' O ' ' A' ' 16' ' ' VAL . 34.2 p -74.6 -20.53 59.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.584 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.9 mmt -82.45 -31.55 29.39 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.373 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.98 -47.46 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.951 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.47 HG11 ' HB ' ' B' ' 20' ' ' THR . 18.9 m -63.94 -31.71 54.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.695 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 20' ' ' THR . 0.9 OUTLIER -54.64 -21.02 6.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.42 -43.89 59.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.028 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.738 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -58.92 -27.33 65.17 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.273 0.558 . . . . 0.0 110.625 -179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.4 t -65.26 -44.83 94.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.955 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.6 mtp -72.53 -29.21 63.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.365 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.47 -3.28 33.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.319 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -68.57 -18.18 64.29 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.494 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 32' ' ' LYS . 46.8 tttp -95.65 15.3 20.36 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.664 0.269 . . . . 0.0 110.717 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 31' ' ' LYS . 22.0 pttp . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.957 -1.02 . . . . 0.0 111.696 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.405 ' O ' HG22 ' B' ' 9' ' ' ILE . . . -64.98 -33.12 86.4 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.99 -25.38 58.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.63 0.252 . . . . 0.0 111.199 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.566 ' N ' HD12 ' B' ' 8' ' ' ILE . 1.5 mp -62.33 -43.95 98.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.168 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.405 HG22 ' O ' ' B' ' 6' ' ' GLY . 2.5 tp -51.54 -32.57 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.41 -43.45 99.04 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.19 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.48 -24.92 33.96 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.877 0.37 . . . . 0.0 110.892 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.35 -63.82 1.17 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.622 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 23.4 m -67.45 -22.16 28.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.884 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.93 -39.79 15.95 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.236 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.28 -55.08 28.3 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.915 ' O ' HG23 ' B' ' 20' ' ' THR . 6.5 m -45.52 -51.81 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.549 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.5 -42.09 90.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.067 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.14 -50.21 81.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.321 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.75 -34.09 69.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.572 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.915 HG23 ' O ' ' B' ' 16' ' ' VAL . 33.8 p -74.7 -20.35 59.89 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.651 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.9 mmt -82.49 -31.59 29.22 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.343 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.87 -47.6 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.017 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.47 HG11 ' HB ' ' A' ' 20' ' ' THR . 19.0 m -63.79 -31.73 54.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.795 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.625 HD13 ' O ' ' B' ' 20' ' ' THR . 0.9 OUTLIER -54.6 -20.99 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -43.93 59.1 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.954 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.736 HD13 ' C ' ' B' ' 26' ' ' LEU . 0.3 OUTLIER -58.91 -27.33 65.15 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.245 0.545 . . . . 0.0 110.662 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.3 -44.82 94.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.983 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 77.7 mtp -72.53 -29.1 63.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.364 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.7 -3.14 33.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.22 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -68.64 -18.07 64.22 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.547 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' B' ' 32' ' ' LYS . 46.9 tttp -95.74 15.3 20.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.688 0.28 . . . . 0.0 110.664 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' B' ' 31' ' ' LYS . 22.0 pttp . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.755 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.43 -53.2 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.484 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.1 tp -70.91 -42.8 77.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.458 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -35.71 -48.58 0.99 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mt -72.81 -38.27 67.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.825 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.501 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -55.74 -61.56 2.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 120.745 0.307 . . . . 0.0 111.636 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.99 -22.63 30.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.74 -45.85 16.03 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.389 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.34 -53.83 32.89 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.879 ' O ' HG23 ' A' ' 20' ' ' THR . 4.8 m -49.22 -50.71 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.013 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.522 ' O ' ' SD ' ' A' ' 21' ' ' MET . 58.2 t -57.84 -45.62 87.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.642 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.39 -46.44 96.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.383 0.611 . . . . 0.0 109.827 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.514 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.51 -38.25 71.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.139 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.879 HG23 ' O ' ' A' ' 16' ' ' VAL . 41.7 p -67.31 -25.4 66.01 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.678 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -80.86 -39.13 26.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -71.23 -46.59 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.8 HG21 HG21 ' B' ' 23' ' ' VAL . 34.8 m -51.31 -37.11 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.946 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 20' ' ' THR . 1.2 mp -47.44 -46.2 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -60.15 -53.3 59.41 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.585 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.713 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.2 tm? -50.75 -40.91 56.0 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.133 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.94 -67.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.62 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.9 mtt -48.7 -23.07 0.91 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.214 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 31' ' ' LYS . 16.3 mt -72.53 -26.63 61.82 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.702 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -45.78 -13.2 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.762 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 29' ' ' LEU . 27.9 ttpt -98.28 19.56 14.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.85 0.357 . . . . 0.0 110.252 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LEU . 65.2 tttm . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.631 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.63 -27.22 72.41 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.48 84.49 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.283 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.04 -53.27 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.473 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.1 tp -70.94 -42.71 77.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.429 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.48 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.06 -48.13 1.07 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.7 mt -73.15 -38.19 66.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.824 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -55.59 -61.72 2.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.793 0.33 . . . . 0.0 111.622 -179.353 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.91 -22.39 30.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.795 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.92 -45.92 15.14 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.381 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.37 -53.75 33.34 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.886 ' O ' HG23 ' B' ' 20' ' ' THR . 4.9 m -49.04 -50.93 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.057 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.526 ' O ' ' SD ' ' B' ' 21' ' ' MET . 58.8 t -57.77 -45.55 87.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.72 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.45 -46.54 96.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.833 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.498 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -56.41 -38.44 71.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.059 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.886 HG23 ' O ' ' B' ' 16' ' ' VAL . 41.2 p -67.05 -25.37 66.22 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.802 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.533 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -80.93 -39.19 26.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.18 -46.69 64.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.096 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.8 HG21 HG21 ' A' ' 23' ' ' VAL . 35.1 m -51.24 -37.16 17.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.872 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.692 HD13 ' O ' ' B' ' 20' ' ' THR . 1.2 mp -47.42 -46.01 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -60.4 -53.13 61.24 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.707 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.2 tm? -50.88 -40.85 57.54 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.079 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.98 -67.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.549 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 68.0 mtt -48.5 -23.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.207 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' B' ' 32' ' ' LYS . 15.8 mt -72.43 -26.69 61.94 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.686 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -45.67 -13.33 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.803 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' B' ' 29' ' ' LEU . 27.9 ttpt -98.33 19.74 13.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 110.281 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.1 tttm . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.616 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.688 0.28 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.682 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.8 mp -68.56 -54.61 20.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.876 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.2 tp -69.67 -41.99 80.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.254 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -34.31 -60.73 0.58 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.66 -29.26 70.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.591 0.234 . . . . 0.0 111.242 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -66.05 -63.66 1.03 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.084 0.469 . . . . 0.0 111.267 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.88 -20.01 23.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.547 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.84 -40.59 5.87 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.48 -49.23 57.95 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 20' ' ' THR . 9.6 m -44.98 -49.64 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.725 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.406 ' N ' HG23 ' A' ' 16' ' ' VAL . 62.9 t -58.68 -43.41 87.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.862 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.98 -49.1 86.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.39 -36.28 71.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.962 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.893 HG23 ' O ' ' A' ' 16' ' ' VAL . 31.2 p -73.16 -18.43 61.27 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.696 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.7 -31.74 28.41 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.399 -0.52 . . . . 0.0 109.987 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 25' ' ' THR . 97.1 mt -63.35 -46.17 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.381 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' LEU . 27.2 m -64.41 -35.04 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.345 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 20' ' ' THR . 1.1 mp -46.87 -20.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -76.24 -40.68 51.36 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.207 178.316 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.717 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -54.4 -31.54 55.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.278 0.561 . . . . 0.0 109.87 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.7 t -63.25 -29.96 48.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.473 0.654 . . . . 0.0 109.826 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.9 mtp -84.38 -32.98 23.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.788 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 32' ' ' LYS . 59.2 mt -66.6 -41.88 87.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -49.43 -10.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.718 0.294 . . . . 0.0 111.001 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 29' ' ' LEU . 99.5 mttt -96.24 12.27 31.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.109 0.48 . . . . 0.0 109.982 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' LEU . 32.5 ttpt . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.301 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.63 -33.6 87.68 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.44 74.85 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.516 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.677 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.8 mp -68.67 -54.58 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.86 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.2 tp -69.6 -42.09 80.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.22 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.432 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -34.23 -61.08 0.55 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.4 -28.95 70.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.804 -0.198 . . . . 0.0 111.253 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' MET . . . . . 0.52 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -66.37 -63.79 1.0 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 111.203 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.76 -20.05 23.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.528 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.76 -40.6 5.89 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.44 -49.23 57.83 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.901 ' O ' HG23 ' B' ' 20' ' ' THR . 9.4 m -44.98 -49.75 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.217 -0.491 . . . . 0.0 110.698 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.41 ' N ' HG23 ' B' ' 16' ' ' VAL . 65.5 t -58.55 -43.48 87.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.872 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.92 -49.18 85.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.37 -36.18 70.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.052 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.901 HG23 ' O ' ' B' ' 16' ' ' VAL . 30.7 p -73.26 -18.29 61.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.653 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.72 -31.7 28.35 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.047 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.459 ' O ' HG22 ' B' ' 25' ' ' THR . 97.1 mt -63.47 -46.21 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' B' ' 26' ' ' LEU . 27.1 m -64.29 -35.25 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.389 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.656 HD13 ' O ' ' B' ' 20' ' ' THR . 1.1 mp -46.7 -20.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.459 HG22 ' O ' ' B' ' 22' ' ' ILE . 0.7 OUTLIER -76.45 -40.62 50.0 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.161 178.358 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.723 ' C ' HD13 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -54.5 -31.59 56.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.327 0.584 . . . . 0.0 109.825 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -63.21 -30.02 48.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.454 0.645 . . . . 0.0 109.778 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.1 mtp -84.28 -33.03 24.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.842 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' B' ' 31' ' ' LYS . 59.3 mt -66.62 -41.8 87.79 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -49.48 -10.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.699 0.285 . . . . 0.0 110.921 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' B' ' 29' ' ' LEU . 99.4 mttt -96.07 12.49 30.42 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.204 0.526 . . . . 0.0 110.014 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' B' ' 29' ' ' LEU . 32.4 ttpt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.339 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.816 0.341 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.27 -42.84 96.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.455 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 tp -58.74 -37.67 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.0 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.56 -42.91 52.36 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.1 tp -73.38 -26.91 61.19 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.746 -0.267 . . . . 0.0 111.084 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.53 -60.25 3.69 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 120.802 0.334 . . . . 0.0 110.847 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -55.33 -23.47 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.024 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.19 -40.5 29.05 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.343 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.441 ' C ' HG12 ' B' ' 16' ' ' VAL . . . -58.19 -43.67 95.26 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.366 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 20' ' ' THR . 11.0 m -61.74 -24.15 33.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.606 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.455 ' O ' ' SD ' ' A' ' 21' ' ' MET . 54.3 t -86.08 -39.97 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 123.461 0.476 . . . . 0.0 111.341 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.84 -52.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.635 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.839 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -54.67 -46.39 74.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.779 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.862 ' OG1' HG11 ' B' ' 23' ' ' VAL . 4.2 t -68.96 -17.62 63.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.48 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.455 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -85.0 -29.04 25.33 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.288 0.367 . . . . 0.0 111.373 -179.029 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.31 -39.19 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.863 HG11 ' OG1' ' B' ' 20' ' ' THR . 13.6 m -56.57 -39.24 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.105 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.498 ' N ' HG23 ' A' ' 23' ' ' VAL . 37.2 mm -40.73 -49.77 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -60.28 -41.02 92.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.972 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.736 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.5 tm? -60.07 -48.36 82.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.866 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.541 HG11 HG11 ' B' ' 27' ' ' VAL . 93.2 t -62.19 -42.92 97.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.344 0.592 . . . . 0.0 109.996 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.9 mmm -63.55 -18.56 63.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.761 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 31' ' ' LYS . 34.6 mt -87.5 -49.86 6.92 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.427 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.612 ' HE2' HD11 ' A' ' 26' ' ' LEU . 66.2 mttm -55.76 -4.28 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.535 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 29' ' ' LEU . 16.9 tptm -156.29 60.64 0.56 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.117 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.471 179.498 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 6' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' B' ' 8' ' ' ILE . . . -61.8 -34.01 87.23 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.41 -19.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.735 0.303 . . . . 0.0 110.657 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.432 ' N ' ' C ' ' B' ' 6' ' ' GLY . 96.9 mt -64.16 -42.9 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.414 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.404 HG22 ' O ' ' B' ' 6' ' ' GLY . 3.0 tp -58.72 -37.53 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.002 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.64 -42.96 52.92 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.3 tp -73.4 -26.91 61.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.749 -0.265 . . . . 0.0 111.118 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -60.28 3.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.791 0.329 . . . . 0.0 110.763 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 29.8 m -55.36 -23.34 13.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.104 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.23 -40.61 28.54 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.352 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.434 ' C ' HG12 ' A' ' 16' ' ' VAL . . . -58.02 -43.65 94.96 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.434 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.614 ' O ' HG22 ' B' ' 20' ' ' THR . 10.8 m -61.83 -24.11 33.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.596 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.453 ' O ' ' SD ' ' B' ' 21' ' ' MET . 54.8 t -86.23 -39.93 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 123.517 0.511 . . . . 0.0 111.324 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.83 -52.61 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.587 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.848 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -54.59 -46.4 73.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.743 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.863 ' OG1' HG11 ' A' ' 23' ' ' VAL . 4.1 t -68.87 -17.64 64.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.407 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.1 OUTLIER -85.13 -29.08 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.325 0.39 . . . . 0.0 111.285 -178.898 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.14 -39.37 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 111.199 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.862 HG11 ' OG1' ' A' ' 20' ' ' THR . 13.5 m -56.37 -39.35 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.058 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.493 ' N ' HG23 ' B' ' 23' ' ' VAL . 37.0 mm -40.65 -49.85 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -60.29 -41.01 92.47 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.978 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.718 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.5 tm? -60.01 -48.4 81.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.851 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.541 HG11 HG11 ' A' ' 27' ' ' VAL . 96.1 t -62.21 -42.87 96.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.216 0.532 . . . . 0.0 110.055 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 94.2 mmm -63.52 -18.72 64.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.785 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' B' ' 31' ' ' LYS . 34.5 mt -87.43 -49.76 7.0 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.432 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.594 ' HE2' HD11 ' B' ' 26' ' ' LEU . 66.4 mttm -55.8 -4.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.54 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' B' ' 29' ' ' LEU . 16.9 tptm -156.51 60.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.122 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.432 179.526 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.687 0.279 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -62.71 -44.1 99.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.59 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.498 ' O ' HG22 ' A' ' 13' ' ' VAL . 6.0 tp -56.12 -33.78 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.8 -45.06 96.99 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.005 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.55 -29.56 37.1 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 120.905 0.383 . . . . 0.0 111.097 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.3 tpt -64.31 -63.61 1.1 Allowed 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.489 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 9' ' ' ILE . 4.7 m -66.84 -22.15 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.528 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.04 -41.48 10.35 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.23 -54.25 35.38 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.888 ' O ' HG23 ' A' ' 20' ' ' THR . 6.3 m -45.57 -51.04 3.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.874 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.512 ' O ' ' SD ' ' A' ' 21' ' ' MET . 85.8 t -59.1 -43.59 89.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.947 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.8 -49.05 85.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.686 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.28 -34.18 68.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.396 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.888 HG23 ' O ' ' A' ' 16' ' ' VAL . 33.2 p -74.16 -20.67 60.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.63 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' OG1' ' A' ' 20' ' ' THR . 0.0 OUTLIER -81.9 -31.7 31.31 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.622 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 25' ' ' THR . 96.8 mt -62.91 -48.56 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.524 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.434 ' C ' ' N ' ' A' ' 25' ' ' THR . 23.8 m -63.3 -31.99 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.968 0.413 . . . . 0.0 110.759 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.597 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -50.19 -19.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.401 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 22' ' ' ILE . 1.2 t -74.56 -42.08 59.42 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.348 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.706 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -56.39 -29.92 62.08 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.244 0.545 . . . . 0.0 110.436 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.74 -46.49 92.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.378 0.608 . . . . 0.0 109.711 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 90.0 mtp -70.28 -33.97 72.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.031 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.36 -2.95 54.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.32 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -61.45 -37.51 83.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.95 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.66 23.2 3.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.269 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.383 179.406 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.22 -26.52 70.55 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.54 -23.03 14.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.72 0.295 . . . . 0.0 110.639 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -62.67 -44.13 99.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.62 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.495 ' O ' HG22 ' B' ' 13' ' ' VAL . 6.0 tp -56.13 -33.8 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.71 -45.2 96.75 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.059 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.47 -29.57 37.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.86 0.362 . . . . 0.0 111.123 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 8.3 tpt -64.3 -63.64 1.09 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.545 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 9' ' ' ILE . 4.7 m -66.76 -22.28 29.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.513 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.01 -41.36 10.49 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.22 -54.3 35.0 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.89 ' O ' HG23 ' B' ' 20' ' ' THR . 6.6 m -45.59 -50.99 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.953 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.508 ' O ' ' SD ' ' B' ' 21' ' ' MET . 85.3 t -59.13 -43.65 89.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.904 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.72 -49.07 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.681 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.32 -34.23 68.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.341 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.89 HG23 ' O ' ' B' ' 16' ' ' VAL . 33.4 p -74.16 -20.74 60.12 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.693 0.282 . . . . 0.0 110.607 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.53 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -81.82 -31.67 31.61 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.626 179.261 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.487 ' O ' HG22 ' B' ' 25' ' ' THR . 96.8 mt -62.97 -48.52 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.499 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.431 ' C ' ' N ' ' B' ' 25' ' ' THR . 24.3 m -63.34 -31.91 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.936 0.398 . . . . 0.0 110.829 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.598 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -50.18 -19.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.317 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.487 HG22 ' O ' ' B' ' 22' ' ' ILE . 1.2 t -74.5 -42.05 59.61 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.309 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.707 ' C ' HD13 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -56.43 -29.89 62.16 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.284 0.564 . . . . 0.0 110.48 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.81 -46.38 92.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.277 0.561 . . . . 0.0 109.714 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 89.8 mtp -70.38 -33.85 71.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.977 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 93.2 mt -82.42 -2.92 54.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.298 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -61.51 -37.55 84.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.878 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.6 23.24 3.11 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.323 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.307 179.479 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.629 0.252 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.496 HD13 HD13 ' B' ' 8' ' ' ILE . 91.9 mt -62.7 -43.61 98.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.23 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 13' ' ' VAL . 5.1 tp -60.0 -33.2 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.146 0.498 . . . . 0.0 109.799 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.75 -68.72 1.55 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.319 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -60.98 -27.49 68.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.051 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.07 -63.84 1.05 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 120.854 0.359 . . . . 0.0 110.727 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 9' ' ' ILE . 7.5 m -70.21 -21.16 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.05 -39.32 8.61 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.72 -53.17 40.88 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.885 ' O ' HG23 ' A' ' 20' ' ' THR . 4.8 m -45.45 -48.4 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.9 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.524 ' O ' ' SD ' ' A' ' 21' ' ' MET . 97.4 t -58.72 -44.09 89.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.755 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.44 -48.02 90.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.58 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.65 68.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.543 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 16' ' ' VAL . 31.1 p -74.81 -18.95 60.38 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.653 0.263 . . . . 0.0 110.783 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -83.75 -30.84 26.35 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.221 179.227 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 25' ' ' THR . 96.7 mt -62.99 -48.24 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.368 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.438 ' C ' ' N ' ' A' ' 25' ' ' THR . 25.0 m -63.77 -32.64 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.078 0.466 . . . . 0.0 110.72 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -48.82 -21.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.582 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -75.84 -41.19 53.22 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.611 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.729 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -56.72 -30.25 63.3 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.451 0.643 . . . . 0.0 110.389 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.2 t -61.84 -38.65 81.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.51 0.672 . . . . 0.0 109.391 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.5 mmm -72.88 -28.43 62.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.79 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.75 -6.59 56.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.013 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.14 -39.01 91.15 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.782 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -94.0 18.03 11.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.793 0.33 . . . . 0.0 110.42 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.647 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.82 -33.39 87.12 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.4 -23.03 46.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.69 0.281 . . . . 0.0 110.85 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.496 HD13 HD13 ' A' ' 8' ' ' ILE . 91.3 mt -62.55 -43.65 98.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.288 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.466 ' O ' HG22 ' B' ' 13' ' ' VAL . 5.1 tp -59.97 -33.22 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.169 0.509 . . . . 0.0 109.817 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.81 -68.71 1.56 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.257 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.484 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.2 mm? -60.96 -27.5 68.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.034 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.16 -63.82 1.05 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 120.841 0.353 . . . . 0.0 110.724 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.466 HG22 ' O ' ' B' ' 9' ' ' ILE . 7.3 m -70.1 -21.13 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.14 -39.38 8.52 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.58 -53.16 40.52 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.884 ' O ' HG23 ' B' ' 20' ' ' THR . 4.8 m -45.49 -48.35 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.877 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.515 ' O ' ' SD ' ' B' ' 21' ' ' MET . 97.2 t -58.91 -43.85 89.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.765 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.61 -48.02 90.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.504 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.71 69.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.47 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.884 HG23 ' O ' ' B' ' 16' ' ' VAL . 31.0 p -74.68 -19.08 60.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.817 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -83.54 -30.99 26.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.279 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.44 ' O ' HG22 ' B' ' 25' ' ' THR . 96.7 mt -62.91 -48.22 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.453 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.449 ' C ' ' N ' ' B' ' 25' ' ' THR . 25.5 m -63.73 -32.65 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.158 0.504 . . . . 0.0 110.751 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.552 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -48.91 -20.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.624 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.449 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -75.95 -41.21 52.22 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.594 179.058 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.727 ' C ' HD13 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -56.66 -30.15 63.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.424 0.63 . . . . 0.0 110.43 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.3 t -61.93 -39.05 82.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.49 0.662 . . . . 0.0 109.291 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.5 mmm -72.39 -28.52 63.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.825 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.79 -6.48 56.05 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.992 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.26 -38.86 90.9 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.708 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -94.03 17.91 11.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.771 0.32 . . . . 0.0 110.396 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.554 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.13 -53.77 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.52 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 tp -70.17 -38.56 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 109.976 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.5 -46.12 8.61 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.5 tp -73.03 -38.47 66.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 121.189 -0.204 . . . . 0.0 110.79 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -57.27 8.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.982 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 27.0 m -65.4 -20.72 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.211 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.15 -40.81 10.93 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.53 -54.89 25.25 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.7 m -44.49 -51.29 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.452 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.13 -42.24 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.58 -49.91 60.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.374 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.22 77.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.869 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.429 ' OG1' HG11 ' B' ' 23' ' ' VAL . 14.2 t -80.07 -17.25 53.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 110.235 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.44 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -79.36 -31.81 43.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.284 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 25' ' ' THR . 97.1 mt -63.53 -46.81 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.066 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.457 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' C ' ' N ' ' A' ' 25' ' ' THR . 33.6 m -64.8 -35.12 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.061 0.457 . . . . 0.0 110.198 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 21' ' ' MET . 1.6 tp -45.05 -22.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 22' ' ' ILE . 1.3 t -72.07 -41.04 67.83 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.669 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.691 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -53.0 -30.49 35.5 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.875 0.47 . . . . 0.0 110.688 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.572 HG22 HG22 ' B' ' 27' ' ' VAL . 11.0 t -64.96 -45.93 93.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.28 0.562 . . . . 0.0 109.493 177.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.7 mtt -71.47 -34.67 70.41 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.917 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.8 mt -83.75 -2.96 57.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.78 -37.44 86.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.77 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.59 23.79 4.44 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.398 179.749 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.41 -25.35 64.88 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.19 83.47 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.104 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.17 -54.03 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.463 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.4 HG23 ' N ' ' B' ' 10' ' ' GLY . 6.0 tp -70.02 -38.58 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.129 0.49 . . . . 0.0 109.944 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.4 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -44.39 -46.48 8.51 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 44.8 tp -72.66 -38.52 67.6 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.848 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' MET . . . . . 0.401 ' SD ' ' C ' ' B' ' 12' ' ' MET . 0.0 OUTLIER -50.53 -57.23 8.6 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.058 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 27.0 m -65.4 -20.75 28.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.12 -40.77 11.02 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.59 -54.87 25.53 Favored Glycine 0 C--O 1.223 -0.587 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.7 m -44.59 -51.22 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.49 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.401 ' H ' HG23 ' B' ' 16' ' ' VAL . 69.5 t -56.21 -42.11 72.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.771 0.319 . . . . 0.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.79 -49.76 61.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.33 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.25 77.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.801 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.43 ' OG1' HG11 ' A' ' 23' ' ' VAL . 14.3 t -80.04 -17.38 52.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.212 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.451 ' O ' HG22 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -79.19 -31.93 43.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.341 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.523 ' O ' HG22 ' B' ' 25' ' ' THR . 97.5 mt -63.49 -46.78 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.074 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.55 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.455 ' C ' ' N ' ' B' ' 25' ' ' THR . 32.7 m -64.83 -34.98 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.187 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.451 HG22 ' O ' ' B' ' 21' ' ' MET . 1.6 tp -45.21 -22.93 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.492 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.523 HG22 ' O ' ' B' ' 22' ' ' ILE . 1.3 t -71.83 -41.14 68.53 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.742 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.691 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.0 OUTLIER -52.84 -30.59 34.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.956 0.502 . . . . 0.0 110.657 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 27' ' ' VAL . 10.7 t -64.96 -45.92 93.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 65.4 mtt -71.59 -34.79 70.21 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.835 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -83.7 -2.68 56.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.749 0.309 . . . . 0.0 110.563 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -63.06 -37.31 86.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.746 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.66 23.59 4.61 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.059 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.4 179.687 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.6 0.238 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.56 HD13 HD13 ' B' ' 8' ' ' ILE . 88.4 mt -62.28 -44.04 98.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.26 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 13' ' ' VAL . 5.4 tp -59.76 -35.8 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.83 -69.21 1.34 Allowed Glycine 0 CA--C 1.532 1.153 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.66 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.84 -28.41 68.81 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 120.79 0.329 . . . . 0.0 111.062 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.9 tpt -63.54 -63.64 1.12 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.002 0.43 . . . . 0.0 110.545 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 9' ' ' ILE . 10.5 m -67.84 -20.63 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.82 -39.83 7.4 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.5 -52.04 44.02 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.894 ' O ' HG23 ' A' ' 20' ' ' THR . 3.4 m -44.72 -49.04 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.579 -0.311 . . . . 0.0 110.725 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.0 t -58.63 -43.63 87.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.02 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.22 -49.66 83.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -35.9 70.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.166 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.894 HG23 ' O ' ' A' ' 16' ' ' VAL . 30.2 p -73.52 -18.51 61.09 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.955 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -84.3 -31.94 24.62 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.124 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.45 -47.66 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.447 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.447 ' C ' ' N ' ' A' ' 25' ' ' THR . 29.9 m -63.37 -34.92 70.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.172 0.51 . . . . 0.0 110.532 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 20' ' ' THR . 0.9 OUTLIER -46.04 -22.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.447 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -79.26 -42.31 26.15 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.774 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.1 tm? -51.35 -31.19 21.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.324 0.583 . . . . 0.0 110.393 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.444 HG11 ' NZ ' ' B' ' 30' ' ' LYS . 14.0 t -64.67 -35.69 75.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.515 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mtp -71.94 -29.6 64.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.28 -9.63 59.31 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.235 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' NZ ' HG11 ' B' ' 27' ' ' VAL . 97.3 mttt -62.17 -36.49 82.02 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.723 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -89.54 18.66 5.16 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.674 0.273 . . . . 0.0 110.674 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.25 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.62 -33.46 87.3 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.88 -22.6 38.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.669 0.271 . . . . 0.0 110.674 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.56 HD13 HD13 ' A' ' 8' ' ' ILE . 89.2 mt -62.23 -43.98 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.252 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.483 ' O ' HG22 ' B' ' 13' ' ' VAL . 5.4 tp -59.74 -35.88 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.78 -69.18 1.34 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.687 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -60.78 -28.51 68.8 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 8.9 tpt -63.49 -63.74 1.1 Allowed 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.012 0.434 . . . . 0.0 110.457 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.483 HG22 ' O ' ' B' ' 9' ' ' ILE . 10.4 m -67.81 -20.59 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.41 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.75 -39.9 7.41 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.5 -52.06 43.91 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.886 ' O ' HG23 ' B' ' 20' ' ' THR . 3.4 m -44.71 -49.12 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.66 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 64.3 t -58.64 -43.57 87.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.004 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.22 -49.65 83.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.74 70.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.213 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.886 HG23 ' O ' ' B' ' 16' ' ' VAL . 30.4 p -73.59 -18.49 61.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.845 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -84.3 -31.85 24.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.132 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.48 -47.66 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.473 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.445 HG11 ' HB ' ' A' ' 20' ' ' THR . 30.1 m -63.35 -35.0 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.168 0.509 . . . . 0.0 110.502 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.414 HD13 ' O ' ' B' ' 20' ' ' THR . 0.9 OUTLIER -45.98 -22.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.819 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.439 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -79.24 -42.33 26.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.79 178.795 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.71 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.1 tm? -51.28 -31.27 20.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.322 0.582 . . . . 0.0 110.423 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.442 HG11 ' NZ ' ' A' ' 30' ' ' LYS . 14.2 t -64.6 -35.69 75.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.595 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.8 mtp -71.9 -29.6 64.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.726 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.25 -9.53 59.26 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.247 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.444 ' NZ ' HG11 ' A' ' 27' ' ' VAL . 97.3 mttt -62.31 -36.57 82.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.694 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -89.45 18.6 5.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.622 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.312 179.879 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.599 0.238 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.695 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.8 mp -70.54 -55.77 13.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.775 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.1 tp -69.28 -42.31 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.238 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.49 -58.46 1.1 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -64.97 -29.03 69.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.819 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -66.09 -63.78 1.0 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 0.0 111.205 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 26.1 m -67.07 -20.12 26.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.871 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.16 -41.09 6.33 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.24 -49.82 54.67 Favored Glycine 0 C--N 1.333 0.369 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 20' ' ' THR . 5.1 m -44.6 -51.03 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.647 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 16' ' ' VAL . 91.4 t -57.64 -43.8 84.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.745 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.98 -49.87 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -36.75 68.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.866 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 16' ' ' VAL . 28.9 p -72.59 -18.51 61.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.045 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.3 mmt -82.44 -32.57 28.91 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.218 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 25' ' ' THR . 97.1 mt -63.53 -46.57 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.633 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 25' ' ' THR . 30.1 m -63.12 -36.1 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.283 0.563 . . . . 0.0 110.571 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -43.77 -22.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.7 OUTLIER -81.57 -42.78 19.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.504 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.679 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.2 tm? -47.44 -33.73 6.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.617 0.723 . . . . 0.0 110.475 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 30' ' ' LYS . 48.5 t -66.0 -42.56 91.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.164 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.402 ' N ' ' O ' ' A' ' 25' ' ' THR . 67.3 mtt -65.97 -33.66 76.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.412 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.59 0.75 11.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.356 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 27' ' ' VAL . 24.6 mmtp -62.01 -38.17 87.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.554 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -132.74 17.33 4.28 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.821 0.344 . . . . 0.0 110.479 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.041 179.566 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.04 -34.15 89.16 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.89 -29.94 70.54 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.468 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.695 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.8 mp -70.56 -55.79 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.738 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.0 tp -69.36 -42.31 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.269 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.452 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.44 -58.35 1.1 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.465 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.2 mm? -65.16 -28.92 69.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.792 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' MET . . . . . 0.505 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -66.17 -63.84 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.997 0.427 . . . . 0.0 111.239 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 26.4 m -67.06 -20.07 26.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.861 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.1 -41.12 6.34 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.21 -49.76 54.82 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.905 ' O ' HG23 ' B' ' 20' ' ' THR . 5.3 m -44.9 -50.86 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.641 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 16' ' ' VAL . 91.8 t -57.66 -43.91 84.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.697 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.89 -49.81 83.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.97 68.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.959 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.905 HG23 ' O ' ' B' ' 16' ' ' VAL . 28.9 p -72.43 -18.55 61.7 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.967 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.3 mmt -82.37 -32.76 29.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.203 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.406 ' O ' HG22 ' B' ' 25' ' ' THR . 97.0 mt -63.22 -46.7 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.672 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' B' ' 25' ' ' THR . 30.1 m -63.14 -36.11 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.339 0.59 . . . . 0.0 110.629 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -43.79 -22.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.582 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.467 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -81.62 -42.65 19.72 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.498 179.444 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.682 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.2 tm? -47.66 -33.6 7.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.745 0.783 . . . . 0.0 110.513 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' B' ' 30' ' ' LYS . 50.0 t -66.02 -42.54 91.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.18 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 67.3 mtt -65.86 -33.78 76.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.471 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.5 0.6 11.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.333 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' B' ' 27' ' ' VAL . 24.7 mmtp -61.78 -38.4 87.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.543 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -132.59 17.48 4.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.888 0.375 . . . . 0.0 110.492 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.057 179.579 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.601 0.239 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.644 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.8 mp -65.8 -53.09 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.91 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.5 tp -71.15 -41.68 75.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.05 0.452 . . . . 0.0 110.308 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -39.97 -46.24 3.13 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.1 tp -73.82 -41.95 61.58 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.652 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.01 -54.23 13.63 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.083 0.468 . . . . 0.0 111.013 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.17 -21.83 27.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.818 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.58 -46.61 14.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -50.97 -54.82 21.09 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.874 ' O ' HG23 ' A' ' 20' ' ' THR . 6.9 m -48.23 -49.26 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.26 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.509 ' O ' ' SD ' ' A' ' 21' ' ' MET . 85.4 t -59.81 -45.03 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.929 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.29 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.765 -0.774 . . . . 0.0 108.966 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.523 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -57.18 -38.26 73.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.671 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 16' ' ' VAL . 66.4 p -68.05 -24.98 65.14 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.054 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' OG1' ' A' ' 20' ' ' THR . 0.0 OUTLIER -82.04 -38.9 24.28 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.319 0.387 . . . . 0.0 112.038 -179.616 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.3 mt -69.08 -46.54 78.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.761 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.83 HG21 HG21 ' B' ' 23' ' ' VAL . 31.5 m -52.69 -34.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.939 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.439 ' N ' HG23 ' A' ' 23' ' ' VAL . 33.5 mm -49.0 -45.99 16.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -59.6 -55.08 38.96 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.6 tm? -46.93 -37.67 9.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.246 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.434 HG11 HG11 ' B' ' 27' ' ' VAL . 58.9 t -71.3 -56.67 9.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.395 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.522 ' O ' ' N ' ' A' ' 32' ' ' LYS . 98.6 mmm -58.11 -29.54 65.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.697 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.746 ' O ' HD23 ' A' ' 29' ' ' LEU . 3.5 tt -63.79 -36.0 82.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.994 0.426 . . . . 0.0 109.87 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -45.4 -11.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.258 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 29' ' ' LEU . 34.1 ttmt -156.72 -13.43 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.371 0.605 . . . . 0.0 110.12 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' MET . 55.1 mtpt . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.483 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.78 69.21 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.29 -35.04 79.06 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.594 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.647 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.8 mp -66.0 -53.16 40.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.908 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.453 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.5 tp -70.94 -41.73 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.297 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.453 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -40.07 -46.06 3.18 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 43.0 tp -74.05 -41.92 61.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.709 0.29 . . . . 0.0 110.661 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 -54.29 13.04 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.106 0.479 . . . . 0.0 110.967 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.0 m -68.16 -21.78 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.846 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.55 -46.63 14.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.1 -54.89 21.2 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.873 ' O ' HG23 ' B' ' 20' ' ' THR . 7.1 m -47.98 -49.34 11.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.383 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.525 ' O ' ' SD ' ' B' ' 21' ' ' MET . 85.9 t -59.88 -44.98 95.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.939 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.33 -45.97 97.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.518 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -57.16 -38.26 73.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.615 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.873 HG23 ' O ' ' B' ' 16' ' ' VAL . 69.1 p -68.06 -24.93 65.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.096 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.529 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -82.11 -38.9 24.1 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.42 0.45 . . . . 0.0 112.032 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.13 -46.51 77.96 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.765 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.83 HG21 HG21 ' A' ' 23' ' ' VAL . 31.9 m -52.67 -34.91 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.013 -178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.431 ' N ' HG23 ' B' ' 23' ' ' VAL . 33.0 mm -49.1 -45.9 17.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.427 ' O ' ' N ' ' B' ' 29' ' ' LEU . 1.5 m -59.71 -55.31 35.97 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.707 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.6 tm? -46.79 -37.49 8.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.295 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 27' ' ' VAL . 59.6 t -71.45 -56.53 10.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.466 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' MET . . . . . 0.528 ' O ' ' N ' ' B' ' 32' ' ' LYS . 98.6 mmm -58.23 -29.4 65.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.715 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.737 ' O ' HD23 ' B' ' 29' ' ' LEU . 3.5 tt -63.84 -36.14 82.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.024 0.44 . . . . 0.0 109.861 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -45.29 -11.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.361 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' B' ' 29' ' ' LEU . 34.0 ttmt -156.73 -13.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.241 0.543 . . . . 0.0 109.965 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' B' ' 28' ' ' MET . 55.0 mtpt . . . . . 0 C--N 1.322 -0.63 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.43 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.532 0.206 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.02 -59.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 10' ' ' GLY . 6.0 tp -66.09 -39.75 85.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.22 0.533 . . . . 0.0 110.198 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -42.62 -45.99 5.7 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.75 -33.65 64.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 111.204 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.436 ' SD ' ' C ' ' A' ' 12' ' ' MET . 0.1 OUTLIER -57.23 -62.94 1.41 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.302 -179.548 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 m -58.27 -21.91 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.178 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.13 -38.45 39.98 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.31 -55.25 30.5 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 20' ' ' THR . 23.2 m -51.05 -21.72 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.19 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.1 t -85.56 -47.77 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.205 0.526 . . . . 0.0 111.376 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.8 mm -69.7 -47.14 72.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.02 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.5 -41.11 65.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.707 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.703 ' OG1' HG11 ' B' ' 23' ' ' VAL . 4.0 t -78.88 -19.93 50.72 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.047 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.0 mmt -78.33 -35.14 48.01 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.951 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.482 ' O ' HG22 ' A' ' 25' ' ' THR . 96.9 mt -62.92 -48.45 87.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.65 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.703 HG11 ' OG1' ' B' ' 20' ' ' THR . 34.1 m -63.87 -34.71 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 110.3 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -43.59 -22.44 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -79.46 -43.03 24.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.57 178.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.702 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.5 tm? -47.83 -31.83 5.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.67 0.747 . . . . 0.0 110.479 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.445 HG13 HG13 ' B' ' 27' ' ' VAL . 12.6 t -64.46 -40.59 89.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.292 0.567 . . . . 0.0 109.501 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 25' ' ' THR . 67.4 mtt -67.45 -31.34 71.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.876 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.1 mt -76.06 -8.62 57.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.025 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -60.97 -36.79 80.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.716 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -101.98 17.12 23.98 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.731 0.3 . . . . 0.0 110.59 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.602 179.832 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.78 -22.72 66.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.06 -30.86 68.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.661 0.267 . . . . 0.0 111.056 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.13 -59.48 3.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.421 HG23 ' N ' ' B' ' 10' ' ' GLY . 6.0 tp -65.93 -39.53 84.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.228 0.537 . . . . 0.0 110.23 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.421 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -42.99 -45.68 6.05 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.96 -33.54 63.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.747 0.308 . . . . 0.0 111.193 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' MET . . . . . 0.437 ' C ' ' SD ' ' B' ' 12' ' ' MET . 0.1 OUTLIER -57.29 -63.04 1.36 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.28 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -58.24 -21.81 18.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.197 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.05 -38.52 40.19 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.3 -55.09 31.3 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.49 ' O ' HG22 ' B' ' 20' ' ' THR . 22.5 m -51.2 -21.66 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 122.874 -0.192 . . . . 0.0 111.182 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 70.3 t -85.6 -47.8 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.239 0.542 . . . . 0.0 111.401 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.76 -47.15 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.943 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.54 -41.17 66.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.642 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.703 ' OG1' HG11 ' A' ' 23' ' ' VAL . 4.0 t -78.76 -19.93 51.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.105 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 22.0 mmt -78.35 -35.16 47.85 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.975 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.47 ' O ' HG22 ' B' ' 25' ' ' THR . 96.9 mt -62.91 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.713 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.703 HG11 ' OG1' ' A' ' 20' ' ' THR . 34.1 m -63.72 -34.76 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.093 0.473 . . . . 0.0 110.314 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.401 ' N ' HG23 ' B' ' 23' ' ' VAL . 1.2 tp -43.82 -22.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.479 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.0 OUTLIER -79.56 -43.0 23.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.622 178.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.703 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.5 tm? -47.81 -31.96 5.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.661 0.744 . . . . 0.0 110.55 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.445 HG13 HG13 ' A' ' 27' ' ' VAL . 12.3 t -64.43 -40.61 89.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.582 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' MET . . . . . 0.426 ' N ' ' O ' ' B' ' 25' ' ' THR . 67.5 mtt -67.42 -31.35 71.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.871 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 82.0 mt -75.95 -8.84 57.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.032 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -60.88 -36.8 80.15 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.728 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -101.92 17.17 23.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.544 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.615 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.765 0.317 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.17 -42.91 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.246 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.495 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -59.91 -41.2 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.297 0.57 . . . . 0.0 109.532 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.8 -59.56 8.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 48.4 tp -72.89 -28.21 62.35 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.405 ' SD ' ' C ' ' A' ' 12' ' ' MET . 0.0 OUTLIER -42.48 -53.92 4.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.832 ' O ' HG13 ' A' ' 16' ' ' VAL . 34.2 m -72.92 -51.63 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.4 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.62 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -29.48 -47.15 0.1 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 123.694 0.621 . . . . 0.0 112.65 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.4 -1.79 0.21 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.593 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 13' ' ' VAL . 33.6 m -80.71 -51.13 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.66 ' N ' HG23 ' A' ' 16' ' ' VAL . 86.8 t -43.43 -37.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.828 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.53 -49.54 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.848 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.84 -52.04 67.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.534 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -64.93 -19.09 65.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.609 0.242 . . . . 0.0 110.705 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -82.03 -36.82 27.35 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.306 178.683 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 25' ' ' THR . 90.5 mt -64.96 -44.27 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 26' ' ' LEU . 14.0 m -62.96 -40.58 89.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 CA-C-O 121.143 0.497 . . . . 0.0 110.516 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.475 ' N ' HG23 ' A' ' 23' ' ' VAL . 2.1 tp -40.83 -24.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.306 0.575 . . . . 0.0 110.195 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -82.47 -37.64 25.07 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.381 179.041 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.633 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.5 tm? -48.83 -40.42 29.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.704 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.945 HG21 HG21 ' B' ' 27' ' ' VAL . 88.1 t -61.74 -44.7 99.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.33 0.586 . . . . 0.0 109.685 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 82.2 mmm -65.4 -37.32 86.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.485 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.8 -5.65 59.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 110.405 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -61.85 -32.34 72.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.856 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.65 37.35 2.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.169 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.526 179.707 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.44 -34.17 89.18 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.16 -24.41 54.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.713 0.292 . . . . 0.0 110.7 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.11 -42.91 96.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.241 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.478 HD13 ' O ' ' B' ' 9' ' ' ILE . 0.2 OUTLIER -59.99 -41.24 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 121.288 0.566 . . . . 0.0 109.495 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.71 -59.53 8.48 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 48.7 tp -72.95 -28.28 62.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' MET . . . . . 0.404 ' C ' ' SD ' ' B' ' 12' ' ' MET . 0.0 OUTLIER -42.53 -53.78 4.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -178.56 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.86 ' O ' HG13 ' B' ' 16' ' ' VAL . 34.1 m -72.95 -51.82 25.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.379 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.624 ' N ' HG23 ' B' ' 13' ' ' VAL . . . -29.38 -47.04 0.09 OUTLIER Glycine 0 CA--C 1.531 1.061 0 O-C-N 123.764 0.665 . . . . 0.0 112.63 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.41 -1.92 0.22 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.524 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.86 HG13 ' O ' ' B' ' 13' ' ' VAL . 33.5 m -80.74 -51.03 16.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.014 0.435 . . . . 0.0 109.874 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.662 ' N ' HG23 ' B' ' 16' ' ' VAL . 86.0 t -43.48 -37.97 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.726 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.43 -49.48 80.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.798 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -51.89 67.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.661 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' THR . . . . . 0.475 HG22 ' O ' ' B' ' 16' ' ' VAL . 0.5 OUTLIER -64.87 -19.2 65.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.694 0.283 . . . . 0.0 110.781 -179.112 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -82.05 -36.63 27.51 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.272 178.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.435 ' O ' HG22 ' B' ' 25' ' ' THR . 90.0 mt -65.09 -44.22 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' B' ' 26' ' ' LEU . 13.9 m -62.96 -40.69 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.139 0.495 . . . . 0.0 110.463 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.482 ' N ' HG23 ' B' ' 23' ' ' VAL . 2.1 tp -40.83 -24.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.199 0.523 . . . . 0.0 110.167 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.506 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -82.43 -37.63 25.18 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.355 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.636 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.5 tm? -48.85 -40.28 28.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.783 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.945 HG21 HG21 ' A' ' 27' ' ' VAL . 89.4 t -61.84 -44.71 99.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.289 0.566 . . . . 0.0 109.623 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 82.3 mmm -65.45 -37.27 86.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.451 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.87 -5.65 59.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.794 0.33 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -61.96 -32.45 72.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.934 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.36 37.17 2.16 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.219 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.559 179.744 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.798 0.332 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 mm -63.17 -49.83 81.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.498 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 10' ' ' GLY . 11.0 tp -68.54 -40.36 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.429 0.633 . . . . 0.0 110.226 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -48.41 -60.54 5.69 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -70.24 -29.39 66.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.2 -58.0 3.12 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 120.669 0.271 . . . . 0.0 111.671 -178.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.813 ' O ' HG13 ' A' ' 16' ' ' VAL . 17.1 m -75.49 -49.69 26.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.604 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.603 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -30.94 -45.98 0.13 Allowed Glycine 0 CA--C 1.527 0.808 0 O-C-N 123.427 0.455 . . . . 0.0 112.284 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.51 -0.51 0.14 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.641 -178.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 13' ' ' VAL . 35.1 m -82.47 -50.22 16.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.628 ' N ' HG23 ' A' ' 16' ' ' VAL . 79.6 t -42.88 -37.08 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.048 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.66 -49.29 78.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.913 -179.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.96 -52.09 66.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.268 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -18.35 64.19 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.006 -178.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.63 -38.24 20.1 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.29 0.369 . . . . 0.0 110.889 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.78 -43.15 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.354 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.501 HG21 HG21 ' B' ' 23' ' ' VAL . 35.2 m -55.76 -41.9 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.547 -178.592 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.493 ' N ' HG23 ' A' ' 23' ' ' VAL . 39.8 mm -40.3 -46.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.154 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -63.59 -43.16 97.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.35 178.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.713 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.4 tm? -56.06 -45.12 79.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.011 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.512 HG11 HG11 ' B' ' 27' ' ' VAL . 98.8 t -63.9 -44.14 97.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.448 0.642 . . . . 0.0 109.59 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 91.0 mtp -61.13 -30.52 70.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.233 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 31' ' ' LYS . 41.6 mt -71.22 -33.11 69.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.844 178.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -44.29 -15.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.798 -179.18 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 65.0 mttp -103.9 27.88 7.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.734 0.302 . . . . 0.0 110.336 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 29' ' ' LEU . 29.2 mmtp . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.267 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.3 mttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.54 -20.78 78.21 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.0 -24.98 35.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.754 0.312 . . . . 0.0 110.269 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.13 -49.83 81.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.591 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.437 HG23 ' N ' ' B' ' 10' ' ' GLY . 11.0 tp -68.69 -40.3 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.454 0.645 . . . . 0.0 110.154 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 10' ' ' GLY . . . . . 0.437 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -48.28 -60.5 5.65 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.469 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.2 mm? -70.52 -29.09 65.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -58.0 3.22 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.669 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 13' ' ' VAL . . . . . 0.802 ' O ' HG13 ' B' ' 16' ' ' VAL . 17.5 m -75.33 -49.91 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.594 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.595 ' N ' HG23 ' B' ' 13' ' ' VAL . . . -30.69 -45.9 0.12 Allowed Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.569 0.543 . . . . 0.0 112.395 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.61 -0.73 0.15 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.57 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.802 HG13 ' O ' ' B' ' 13' ' ' VAL . 35.1 m -82.08 -50.29 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 120.698 0.285 . . . . 0.0 110.241 179.094 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.631 ' N ' HG23 ' B' ' 16' ' ' VAL . 73.2 t -42.97 -36.97 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.052 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.8 -49.08 79.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.96 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.07 -52.29 66.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.256 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -18.24 63.92 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.054 -178.699 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.76 -38.16 19.98 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.309 0.381 . . . . 0.0 110.935 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.82 -43.23 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.353 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.501 HG21 HG21 ' A' ' 23' ' ' VAL . 35.9 m -55.72 -41.97 67.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.502 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 24' ' ' ILE . . . . . 0.489 ' N ' HG23 ' B' ' 23' ' ' VAL . 39.5 mm -40.04 -46.74 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.168 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -63.74 -43.2 97.19 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.375 178.139 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.705 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.4 tm? -56.05 -45.1 79.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.982 -179.081 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 27' ' ' VAL . 99.0 t -63.91 -44.19 97.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.463 0.649 . . . . 0.0 109.545 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 91.0 mtp -61.06 -30.34 70.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.212 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' B' ' 32' ' ' LYS . 43.0 mt -71.4 -33.1 69.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.898 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -44.28 -15.64 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.777 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.1 mttp -103.93 27.97 7.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.703 0.287 . . . . 0.0 110.378 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 32' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 29' ' ' LEU . 28.9 mmtp . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.268 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.2 mttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.393 -0.595 . . . . 958.39 109.393 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.66 -19.72 79.74 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.176 -0.77 . . . . 165.47 111.176 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.8 81.71 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.706 -0.397 . . . . 71.6 110.732 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.9 mt -64.0 -52.58 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.399 -0.364 . . . . 200.66 111.76 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.441 HG23 ' N ' ' A' ' 10' ' ' GLY . 8.4 tp -67.08 -42.19 88.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.188 -0.605 . . . . 74.61 109.617 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -46.97 -47.34 19.79 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.301 -1.12 . . . . 50.55 110.301 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 11' ' ' LEU . 18.7 tp -70.68 -37.27 73.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.753 0.311 . . . . 340.02 110.536 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -57.74 10.48 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.948 0.404 . . . . 67.5 110.874 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 9' ' ' ILE . 21.4 m -66.54 -17.78 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.941 -0.572 . . . . 56.2 111.284 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.52 -42.57 7.78 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.849 -0.901 . . . . 17.23 110.849 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.48 -53.26 32.9 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.381 -1.088 . . . . 25.06 110.381 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.901 ' O ' HG23 ' A' ' 20' ' ' THR . 23.5 m -46.09 -52.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.884 -0.327 . . . . 30.97 110.171 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.547 ' N ' HG23 ' A' ' 16' ' ' VAL . 94.8 t -56.03 -46.08 80.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.526 -0.47 . . . . 35.41 110.954 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.37 -47.17 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.021 -0.671 . . . . 142.96 109.603 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.88 -40.02 69.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.647 -0.706 . . . . 25.01 110.017 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 16' ' ' VAL . 29.9 p -70.19 -20.01 63.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 130.55 111.022 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.58 -34.9 27.57 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.508 -0.477 . . . . 113.59 110.888 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.7 -44.86 93.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 120.816 -0.354 . . . . 72.54 111.064 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.56 HG11 ' HB ' ' B' ' 20' ' ' THR . 30.1 m -61.78 -35.8 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.596 -0.442 . . . . 28.81 110.85 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.634 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -48.53 -23.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.66 -0.496 . . . . 102.06 109.66 178.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.12 -47.59 12.37 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.002 -0.74 . . . . 114.84 109.002 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.71 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.8 tm? -47.79 -36.27 11.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.547 0.689 . . . . 154.31 109.432 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.695 HG21 HG21 ' B' ' 27' ' ' VAL . 74.0 t -63.66 -65.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.741 -0.663 . . . . 155.81 110.221 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 82.7 mtp -48.21 -26.83 2.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.673 -0.694 . . . . 479.64 110.769 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 54.6 mt -75.09 -19.91 59.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.461 -0.336 . . . . 94.79 111.121 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -51.16 -22.33 2.5 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.596 -0.442 . . . . 870.34 110.825 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -105.01 22.05 15.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.646 0.26 . . . . 892.32 110.574 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.961 -1.018 . . . . 999.99 110.564 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 mttt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.398 -0.593 . . . . 957.99 109.398 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.56 -19.75 79.74 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.235 -0.746 . . . . 165.68 111.235 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.82 81.75 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.719 -0.392 . . . . 71.79 110.759 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 21.9 mt -64.02 -52.55 55.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.332 -0.395 . . . . 202.4 111.807 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.432 ' O ' HG22 ' B' ' 13' ' ' VAL . 8.4 tp -67.09 -42.24 88.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.174 -0.611 . . . . 74.94 109.569 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.432 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -47.02 -47.25 20.14 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.312 -1.115 . . . . 50.24 110.312 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' B' ' 11' ' ' LEU . 18.7 tp -70.66 -37.34 73.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 120.737 0.303 . . . . 339.95 110.47 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -57.72 10.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.957 0.408 . . . . 66.95 110.902 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.432 HG22 ' O ' ' B' ' 9' ' ' ILE . 21.7 m -66.53 -17.69 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.902 -0.59 . . . . 56.24 111.33 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.56 -42.51 7.79 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.843 -0.903 . . . . 17.19 110.843 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.56 -53.26 33.18 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.401 -1.08 . . . . 25.14 110.401 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.905 ' O ' HG23 ' B' ' 20' ' ' THR . 23.6 m -46.12 -52.0 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.802 -0.359 . . . . 30.99 110.202 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.545 ' N ' HG23 ' B' ' 16' ' ' VAL . 94.3 t -56.01 -46.08 80.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.568 -0.453 . . . . 35.55 110.961 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 90.2 mt -63.36 -47.22 92.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.031 -0.668 . . . . 142.35 109.659 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.75 -40.08 68.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.577 -0.738 . . . . 25.02 110.108 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.905 HG23 ' O ' ' B' ' 16' ' ' VAL . 29.9 p -70.13 -20.0 63.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 129.97 111.024 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.62 -34.91 27.43 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.546 -0.462 . . . . 113.52 110.844 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.75 -44.83 93.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 120.833 -0.347 . . . . 73.86 111.051 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.582 HG11 ' HB ' ' A' ' 20' ' ' THR . 30.2 m -61.72 -35.93 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.599 -0.44 . . . . 28.73 110.847 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.651 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -48.49 -23.01 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.463 -0.495 . . . . 102.81 109.71 178.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.11 -47.61 12.35 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.997 -0.742 . . . . 116.39 108.997 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.715 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.8 tm? -47.82 -36.21 11.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.518 0.675 . . . . 155.23 109.41 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.695 HG21 HG21 ' A' ' 27' ' ' VAL . 74.3 t -63.68 -65.72 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.75 -0.659 . . . . 156.82 110.281 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 82.7 mtp -48.23 -26.89 2.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 481.58 110.765 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 55.0 mt -75.03 -19.89 59.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.446 -0.343 . . . . 95.14 111.165 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -51.16 -22.32 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.542 -0.463 . . . . 870.37 110.811 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -105.03 22.05 16.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 121.065 -0.254 . . . . 889.68 110.522 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.933 -1.032 . . . . 999.99 110.497 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.04 -32.66 84.93 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.35 -21.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.605 0.241 . . . . 0.0 111.001 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.564 HD13 HD13 ' B' ' 8' ' ' ILE . 97.7 mt -63.3 -43.7 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.482 ' O ' HG22 ' A' ' 13' ' ' VAL . 5.9 tp -61.01 -36.76 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 109.793 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.63 -66.38 2.88 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 11' ' ' LEU . 4.2 mm? -60.16 -32.79 71.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 110.982 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.23 -63.84 1.16 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 120.863 0.363 . . . . 0.0 110.97 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 9' ' ' ILE . 12.6 m -68.39 -20.82 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.35 -39.81 12.09 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.93 -54.33 26.09 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.7 m -44.51 -49.79 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.95 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -60.49 -42.88 92.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.057 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.0 -51.35 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.465 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.43 -36.8 76.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.149 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -18.52 58.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.998 0.428 . . . . 0.0 110.401 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -32.64 36.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.397 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.434 ' O ' HG22 ' A' ' 25' ' ' THR . 96.7 mt -64.7 -46.34 92.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.375 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.465 ' C ' ' N ' ' A' ' 25' ' ' THR . 29.6 m -66.13 -35.56 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.329 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 24' ' ' ILE . 1.2 tp -49.07 -20.41 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.465 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -74.74 -40.69 61.1 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.649 179.137 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.913 HD22 ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.92 -25.37 42.78 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 121.396 0.617 . . . . 0.0 109.959 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.569 ' N ' HD13 ' A' ' 26' ' ' LEU . 15.1 t -66.42 -46.47 86.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.738 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.6 mtt -68.3 -33.31 74.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.266 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.9 mt -82.58 -3.37 55.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.265 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -61.83 -37.04 82.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.092 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.8 23.26 4.24 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.58 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.377 179.566 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.08 -32.61 84.77 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.34 -21.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.582 0.229 . . . . 0.0 110.94 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.564 HD13 HD13 ' A' ' 8' ' ' ILE . 97.8 mt -63.2 -43.74 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.493 ' O ' HG22 ' B' ' 13' ' ' VAL . 5.9 tp -60.9 -36.74 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.813 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.68 -66.38 2.88 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.426 ' N ' HD22 ' B' ' 11' ' ' LEU . 4.2 mm? -60.18 -32.82 71.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 0.0 111.015 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.4 tpt -60.05 -63.89 1.14 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 120.901 0.381 . . . . 0.0 111.004 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.493 HG22 ' O ' ' B' ' 9' ' ' ILE . 12.5 m -68.36 -20.83 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.44 -39.78 12.0 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.86 -54.35 25.78 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.7 m -44.57 -49.69 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.618 -0.291 . . . . 0.0 110.904 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.59 -42.87 93.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.007 0.432 . . . . 0.0 111.144 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.9 -51.37 72.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.549 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.83 76.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.18 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.12 -18.46 57.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.942 0.401 . . . . 0.0 110.359 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.68 -32.59 35.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.449 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.433 ' O ' HG22 ' B' ' 25' ' ' THR . 96.7 mt -64.61 -46.41 92.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.365 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.457 ' C ' ' N ' ' B' ' 25' ' ' THR . 29.6 m -66.2 -35.39 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.328 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' B' ' 24' ' ' ILE . 1.2 tp -49.15 -20.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.457 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -74.65 -40.73 61.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.631 179.191 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.914 ' O ' HD22 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -55.95 -25.21 42.53 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 121.367 0.603 . . . . 0.0 109.94 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.557 ' N ' HD13 ' B' ' 26' ' ' LEU . 15.2 t -66.55 -46.37 86.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.781 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 59.4 mtt -68.48 -33.27 73.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.176 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.52 -3.46 55.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.205 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -61.82 -37.08 83.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.081 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.71 23.2 4.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.585 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.324 179.623 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.6 tttp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.01 -24.97 67.5 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.43 -36.64 84.41 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.296 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.23 -53.44 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.472 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 10' ' ' GLY . 3.6 tp -71.07 -42.17 76.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.167 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -39.5 -46.97 2.87 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 46.9 tp -72.56 -39.48 67.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.735 0.302 . . . . 0.0 110.702 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -59.21 4.46 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.936 0.398 . . . . 0.0 111.47 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.13 -22.18 29.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.034 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.58 -45.36 18.17 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.72 -54.15 29.39 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 20' ' ' THR . 5.5 m -48.23 -51.54 9.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.198 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.408 ' O ' ' OG1' ' A' ' 20' ' ' THR . 91.9 t -59.06 -45.0 92.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.095 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.1 -46.93 95.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.181 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.542 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.01 -39.04 71.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.248 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 16' ' ' VAL . 46.3 p -67.15 -21.32 65.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.182 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.44 -38.6 19.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.2 mt -69.64 -45.13 78.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.552 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.909 HG21 HG21 ' B' ' 23' ' ' VAL . 29.2 m -51.8 -37.86 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.713 0.292 . . . . 0.0 111.054 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.47 ' N ' HG23 ' A' ' 23' ' ' VAL . 37.6 mm -48.25 -45.9 13.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.417 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.29 -52.35 65.63 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.0 tm? -51.04 -40.97 59.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.051 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG11 HG11 ' B' ' 27' ' ' VAL . 92.0 t -65.94 -65.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm -48.54 -26.16 2.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.976 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 32' ' ' LYS . 20.2 mt -72.15 -28.03 62.98 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.354 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -45.53 -14.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.671 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 29' ' ' LEU . 98.9 mttt -98.27 20.18 12.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 32.7 ttpt . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.523 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 56.6 tttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.99 -25.08 67.58 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.54 84.07 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.357 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.2 -53.54 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.433 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.459 HG23 ' N ' ' B' ' 10' ' ' GLY . 3.6 tp -70.95 -42.23 77.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 110.193 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.459 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -39.51 -46.91 2.86 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -72.59 -39.63 67.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.749 0.309 . . . . 0.0 110.605 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -59.06 4.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 111.52 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -66.33 -22.02 29.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.994 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.65 -45.39 17.77 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.51 -54.38 27.68 Favored Glycine 0 C--O 1.224 -0.514 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.882 ' O ' HG23 ' B' ' 20' ' ' THR . 5.4 m -47.95 -51.59 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.325 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.404 ' H ' HG23 ' B' ' 16' ' ' VAL . 91.9 t -59.24 -44.89 93.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.041 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.14 -47.04 95.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.629 0.728 . . . . 0.0 109.158 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.538 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -55.92 -38.86 70.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.287 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.882 HG23 ' O ' ' B' ' 16' ' ' VAL . 46.7 p -67.24 -21.33 65.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.19 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.55 -38.48 19.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 93.1 mt -69.82 -45.21 77.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.485 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.909 HG21 HG21 ' A' ' 23' ' ' VAL . 29.7 m -51.64 -37.72 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.69 0.281 . . . . 0.0 111.088 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.463 ' N ' HG23 ' B' ' 23' ' ' VAL . 37.8 mm -48.48 -45.8 14.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.338 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.42 -52.49 65.0 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.717 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.0 tm? -50.95 -40.81 58.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.054 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.402 HG11 HG11 ' A' ' 27' ' ' VAL . 92.8 t -66.02 -65.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm -48.46 -26.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.01 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 32' ' ' LYS . 20.5 mt -72.22 -27.94 62.85 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.343 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -45.62 -14.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.691 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 98.9 mttt -98.32 20.2 13.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 29' ' ' LEU . 32.8 ttpt . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.498 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 10' ' ' GLY . . . -62.66 -24.08 65.84 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.94 81.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.767 0.317 . . . . 0.0 110.239 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.05 -49.46 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -82.05 -25.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.338 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . -51.8 -45.81 55.08 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.97 -35.26 32.35 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.577 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -54.74 17.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 120.963 0.411 . . . . 0.0 111.28 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.413 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 34.5 m -67.62 -20.92 26.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.766 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.28 -48.8 7.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.284 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.0 -54.39 14.74 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.885 ' O ' HG23 ' A' ' 20' ' ' THR . 5.0 m -46.28 -49.54 5.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.17 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.4 t -58.79 -45.55 91.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.771 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -62.09 -48.41 88.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.324 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -54.65 -36.86 65.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.454 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 16' ' ' VAL . 44.8 p -68.9 -21.15 64.25 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.171 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.2 mmt -82.8 -38.19 23.46 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.16 -45.76 74.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.824 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.889 HG21 HG21 ' B' ' 23' ' ' VAL . 26.2 m -51.25 -37.31 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 120.698 0.285 . . . . 0.0 110.867 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.473 ' N ' HG23 ' A' ' 23' ' ' VAL . 39.3 mm -48.08 -45.79 12.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.438 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -61.84 -52.67 63.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.2 tm? -49.66 -41.45 42.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.123 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 30' ' ' LYS . 99.6 t -65.93 -65.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.2 mmm -48.59 -24.28 1.28 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 32' ' ' LYS . 25.0 mt -74.69 -26.45 59.84 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.607 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 27' ' ' VAL . 67.1 mttm -44.44 -15.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 71.4 mmtt -100.5 22.85 11.12 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 110.095 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . 22.8 pttp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.718 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' B' ' 10' ' ' GLY . . . -62.75 -24.19 66.14 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.98 82.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.777 0.322 . . . . 0.0 110.197 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.81 -50.16 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.797 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -81.28 -26.07 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.467 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 6' ' ' GLY . . . -51.71 -46.1 54.34 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.77 -35.12 33.61 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -54.8 17.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.955 0.407 . . . . 0.0 111.193 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 34.4 m -67.45 -20.87 27.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.838 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.58 -48.65 7.83 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.0 -54.45 14.51 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.895 ' O ' HG23 ' B' ' 20' ' ' THR . 5.1 m -46.19 -49.6 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.202 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 91.7 t -58.69 -45.64 90.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.775 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.0 -48.42 88.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.411 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.545 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -54.6 -37.1 65.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.467 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.895 HG23 ' O ' ' B' ' 16' ' ' VAL . 44.3 p -68.64 -21.2 64.48 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.151 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.1 mmt -82.85 -38.19 23.33 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 92.3 mt -70.06 -45.78 75.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.827 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 23' ' ' VAL . 25.4 m -51.19 -37.49 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.734 0.302 . . . . 0.0 110.815 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.483 ' N ' HG23 ' B' ' 23' ' ' VAL . 39.2 mm -47.88 -45.9 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.428 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -61.74 -52.68 63.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.693 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.2 tm? -49.67 -41.69 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.154 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.6 -65.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 93.2 mmm -48.44 -24.27 1.21 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.692 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' B' ' 32' ' ' LYS . 24.3 mt -74.74 -26.68 59.95 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.57 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -44.14 -15.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.962 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 71.3 mmtt -100.14 23.01 10.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.922 0.392 . . . . 0.0 110.174 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 29' ' ' LEU . 22.8 pttp . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.617 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.77 -22.26 69.95 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.39 -21.85 35.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.865 0.364 . . . . 0.0 110.2 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.32 -48.08 86.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' MET . 5.2 tp -67.98 -43.16 85.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.104 0.478 . . . . 0.0 109.976 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.45 -43.32 0.73 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.612 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.3 mt -78.23 -35.1 48.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.998 0.427 . . . . 0.0 110.609 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -58.98 -63.73 1.19 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.191 -179.261 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.79 -22.45 21.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.134 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.41 -47.81 20.89 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.31 -51.87 44.44 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.889 ' O ' HG23 ' A' ' 20' ' ' THR . 6.6 m -50.78 -48.24 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.098 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.5 t -58.75 -45.36 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.034 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mm -63.08 -45.72 97.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.586 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.4 -38.11 71.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.642 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.889 HG23 ' O ' ' A' ' 16' ' ' VAL . 44.3 p -68.23 -26.01 65.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.396 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.7 mmt -85.92 -38.54 17.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -69.16 -45.96 78.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.587 HG21 HG21 ' B' ' 23' ' ' VAL . 31.7 m -56.85 -34.67 44.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 23' ' ' VAL . 26.2 mm -43.58 -38.99 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.227 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -62.34 -52.2 64.57 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.734 179.035 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.741 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.7 tm? -48.43 -40.48 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.115 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 t -66.14 -66.17 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.215 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mmm -49.8 -24.79 2.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.017 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 31' ' ' LYS . 34.6 mt -73.92 -25.59 60.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.155 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -45.56 -13.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.724 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . 8.6 mtmp? -97.53 20.57 11.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.287 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 29' ' ' LEU . 17.2 mtmm . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.447 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.63 -22.32 69.74 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.42 -21.85 35.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.898 0.38 . . . . 0.0 110.214 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.17 -48.2 86.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.074 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' B' ' 12' ' ' MET . 5.2 tp -67.97 -43.26 85.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.115 0.483 . . . . 0.0 109.952 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.502 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.35 -43.14 0.69 Allowed Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.708 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt -78.38 -35.15 47.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.989 0.423 . . . . 0.0 110.613 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' MET . . . . . 0.516 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -58.94 -63.7 1.21 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.231 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.63 -22.43 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.138 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.5 -47.74 20.65 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.26 -51.87 44.23 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.904 ' O ' HG23 ' B' ' 20' ' ' THR . 6.2 m -50.79 -48.31 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.064 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 80.4 t -58.93 -45.25 92.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.982 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mm -63.14 -45.72 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.581 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -56.39 -38.01 70.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.678 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.904 HG23 ' O ' ' B' ' 16' ' ' VAL . 44.5 p -68.36 -25.9 65.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 24.7 mmt -86.09 -38.43 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -69.28 -45.92 78.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.932 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.587 HG21 HG21 ' A' ' 23' ' ' VAL . 32.3 m -56.92 -34.65 44.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mm -43.65 -38.76 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.262 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' B' ' 26' ' ' LEU . 0.6 OUTLIER -62.61 -52.03 64.96 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.721 179.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.739 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.7 tm? -48.67 -40.39 27.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.091 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 t -66.13 -66.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.246 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mmm -49.82 -24.73 2.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.062 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 32' ' ' LYS . 34.9 mt -73.99 -25.46 59.92 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.117 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -45.6 -13.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.588 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' B' ' 29' ' ' LEU . 8.6 mtmp? -97.6 20.7 11.4 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 29' ' ' LEU . 17.2 mtmm . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.497 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.1 -27.3 72.15 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.13 -34.96 79.24 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.357 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.706 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.0 mp -65.23 -53.89 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.213 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' MET . 3.9 tp -70.88 -41.91 77.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.932 0.396 . . . . 0.0 110.537 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.42 -46.26 1.03 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.471 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.3 mm? -77.1 -32.51 56.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.48 0.181 . . . . 0.0 110.947 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -60.92 -62.49 1.82 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.793 0.33 . . . . 0.0 111.341 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -66.72 -21.93 29.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.817 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.85 -45.93 10.07 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.513 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.4 -53.07 37.04 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.883 ' O ' HG23 ' A' ' 20' ' ' THR . 4.5 m -47.36 -51.35 6.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.187 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.45 ' H ' HG23 ' A' ' 16' ' ' VAL . 73.9 t -58.01 -45.11 88.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.568 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.12 -48.07 90.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.674 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.14 -36.77 68.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.268 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 16' ' ' VAL . 44.8 p -67.79 -21.61 65.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.031 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.9 -38.3 23.05 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.328 0.392 . . . . 0.0 111.742 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.37 -46.19 72.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.874 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.958 HG21 HG21 ' B' ' 23' ' ' VAL . 31.5 m -50.47 -37.24 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.819 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.488 ' N ' HG23 ' A' ' 23' ' ' VAL . 38.7 mm -47.96 -46.28 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 m -60.95 -52.71 63.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.715 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.3 tm? -50.53 -41.1 53.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.339 0.59 . . . . 0.0 109.939 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.528 HG11 HG11 ' B' ' 27' ' ' VAL . 84.2 t -66.48 -66.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.874 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.1 mtp -47.96 -24.03 0.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.665 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 32' ' ' LYS . 19.8 mt -73.61 -26.92 61.02 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.711 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 27' ' ' VAL . 66.9 mttm -44.9 -14.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.707 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 29' ' ' LEU . 53.0 mtmt -99.18 21.93 11.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.767 0.318 . . . . 0.0 110.395 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 29' ' ' LEU . 66.0 tttm . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.623 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.0 -27.66 72.53 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.97 -34.69 78.56 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.281 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.69 HD12 ' N ' ' B' ' 8' ' ' ILE . 2.0 mp -65.5 -53.95 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.182 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 12' ' ' MET . 3.8 tp -70.92 -41.8 77.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.853 0.358 . . . . 0.0 110.502 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.464 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.55 -45.9 1.03 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.467 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.3 mm? -77.51 -32.41 54.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.178 . . . . 0.0 110.887 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' MET . . . . . 0.528 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -61.08 -62.73 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.748 0.308 . . . . 0.0 111.273 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 m -66.37 -22.03 29.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.815 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.82 -45.96 10.08 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.452 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.35 -53.08 36.8 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.89 ' O ' HG23 ' B' ' 20' ' ' THR . 4.6 m -47.34 -51.44 6.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.125 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.471 ' O ' ' OG1' ' B' ' 20' ' ' THR . 73.4 t -57.98 -45.1 87.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.6 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.25 -47.89 90.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.739 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.536 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -56.15 -37.05 68.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.22 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.89 HG23 ' O ' ' B' ' 16' ' ' VAL . 45.9 p -67.61 -21.63 65.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.075 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.91 -38.21 23.15 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.242 0.339 . . . . 0.0 111.72 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 94.7 mt -70.36 -46.13 72.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.97 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.958 HG21 HG21 ' A' ' 23' ' ' VAL . 31.6 m -50.64 -37.44 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.712 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.49 ' N ' HG23 ' B' ' 23' ' ' VAL . 38.9 mm -47.73 -46.34 11.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -60.86 -52.58 64.46 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.729 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.3 tm? -50.73 -41.32 56.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.867 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.528 HG11 HG11 ' A' ' 27' ' ' VAL . 84.0 t -66.19 -66.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.914 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 96.9 mtp -47.88 -24.04 0.91 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.657 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 32' ' ' LYS . 19.5 mt -73.66 -27.12 61.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.654 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -44.68 -14.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.771 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 53.3 mtmt -99.19 22.02 11.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.822 0.344 . . . . 0.0 110.346 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.9 tttm . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.595 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.92 -23.9 71.27 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.2 -23.76 43.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.43 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.05 -48.9 83.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.024 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 10' ' ' GLY . 3.8 tp -69.84 -44.14 79.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.295 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.58 -47.56 1.2 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.431 ' N ' HD22 ' A' ' 11' ' ' LEU . 4.3 mm? -73.3 -36.26 66.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.726 0.298 . . . . 0.0 110.706 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -57.44 -63.16 1.32 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.925 0.393 . . . . 0.0 111.567 -179.08 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.74 -21.98 26.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.218 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.49 -47.64 10.14 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.264 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.21 -52.45 31.78 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.887 ' O ' HG23 ' A' ' 20' ' ' THR . 5.5 m -47.86 -48.58 11.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.793 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.529 ' O ' ' SD ' ' A' ' 21' ' ' MET . 93.9 t -59.21 -46.52 92.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.994 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.6 -47.49 93.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -52.8 -38.47 61.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.375 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.887 HG23 ' O ' ' A' ' 16' ' ' VAL . 39.7 p -69.39 -24.38 63.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.221 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -79.97 -39.94 29.06 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.7 mt -70.43 -45.36 75.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.94 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.754 HG21 HG21 ' B' ' 23' ' ' VAL . 28.8 m -54.77 -37.78 41.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.039 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -46.54 -47.21 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 29' ' ' LEU . 2.5 m -60.11 -53.24 60.06 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.707 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.9 tm? -49.99 -38.07 35.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.702 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.545 HG11 HG11 ' B' ' 27' ' ' VAL . 58.9 t -63.83 -68.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.648 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 16.1 ptm -48.81 -20.86 0.54 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.222 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 32' ' ' LYS . 8.6 mt -74.61 -25.85 59.52 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.126 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -45.23 -15.01 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.45 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' LEU . 98.9 mttt -99.86 23.86 9.19 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.079 0.466 . . . . 0.0 109.86 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 29' ' ' LEU . 24.8 mtmm . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.9 71.07 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.81 43.55 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.416 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 37.7 mm -63.91 -49.08 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.03 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.509 HG23 ' N ' ' B' ' 10' ' ' GLY . 3.8 tp -69.71 -44.06 79.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.383 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.509 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.83 -47.2 1.24 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.433 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.3 mm? -73.57 -36.2 65.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 110.698 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' MET . . . . . 0.497 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -57.45 -63.35 1.26 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 120.96 0.41 . . . . 0.0 111.512 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -68.73 -21.89 26.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.171 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.32 -47.78 10.28 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.286 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.25 33.39 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.877 ' O ' HG23 ' B' ' 20' ' ' THR . 5.5 m -47.85 -48.7 11.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.765 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.531 ' O ' ' SD ' ' B' ' 21' ' ' MET . 93.8 t -59.18 -46.41 92.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.038 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mm -61.74 -47.42 93.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.521 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -52.83 -38.51 61.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.359 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.877 HG23 ' O ' ' B' ' 16' ' ' VAL . 40.3 p -69.27 -24.43 63.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.263 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -80.02 -39.91 28.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 92.7 mt -70.44 -45.35 75.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.936 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 23' ' ' VAL . 29.7 m -54.8 -37.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.97 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.586 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -46.46 -47.04 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.683 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.434 HG22 HD12 ' B' ' 29' ' ' LEU . 2.5 m -60.24 -53.15 61.12 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.715 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.9 tm? -50.12 -38.06 37.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.697 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 27' ' ' VAL . 58.7 t -63.85 -68.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.653 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 16.2 ptm -48.82 -20.95 0.55 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.214 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 32' ' ' LYS . 8.5 mt -74.62 -25.78 59.46 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.027 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -45.35 -14.69 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.452 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 99.0 mttt -100.13 23.74 9.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.092 0.472 . . . . 0.0 109.874 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' B' ' 29' ' ' LEU . 24.8 mtmm . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.801 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.19 -37.75 81.8 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.21 -22.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.872 0.367 . . . . 0.0 110.853 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.4 mp -63.6 -45.07 98.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.073 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.48 -25.22 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.051 0.453 . . . . 0.0 110.693 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.05 -43.49 62.16 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.591 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -82.16 -27.01 32.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 110.646 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -61.68 2.4 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.65 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.35 -23.5 28.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.063 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.37 -43.21 79.68 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.27 -61.42 6.98 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.0 m -50.02 -26.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.185 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.32 -46.92 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.2 mt -67.91 -45.0 84.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.863 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.58 -40.81 72.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.676 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.888 ' OG1' HG11 ' B' ' 23' ' ' VAL . 4.2 t -75.93 -27.5 57.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.22 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.6 mmt -72.16 -40.15 68.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.76 -46.15 79.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.682 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.918 HG11 ' OG1' ' B' ' 20' ' ' THR . 21.9 m -65.24 -33.48 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -43.78 -50.09 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.904 -179.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.466 ' OG1' HD11 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -66.22 -49.7 66.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.837 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.712 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.1 tm? -41.97 -37.84 1.44 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.079 0.466 . . . . 0.0 110.684 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.622 HG11 HG11 ' B' ' 27' ' ' VAL . 58.2 t -69.01 -58.27 6.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 73.9 mtm -59.68 -22.21 61.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.41 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.466 HD11 ' OG1' ' A' ' 25' ' ' THR . 74.8 mt -79.91 -5.98 56.58 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.37 -9.49 8.38 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.833 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -102.74 19.87 18.38 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.65 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.848 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.99 -37.78 83.71 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.28 -22.47 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 0.0 110.801 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.555 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.4 mp -63.45 -45.08 98.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.077 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.45 -25.38 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.081 0.467 . . . . 0.0 110.728 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.94 -43.3 61.23 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.72 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -82.37 -26.92 32.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.856 0.36 . . . . 0.0 110.75 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -61.85 2.26 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.17 -23.38 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.058 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.32 -43.28 79.83 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.2 -60.97 7.41 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 m -50.47 -26.27 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 122.695 -0.297 . . . . 0.0 111.191 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -82.23 -46.92 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.061 0.458 . . . . 0.0 111.229 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.11 -44.98 84.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.931 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.54 -40.78 72.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.736 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.918 ' OG1' HG11 ' A' ' 23' ' ' VAL . 3.8 t -75.85 -27.59 57.89 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.269 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 29.6 mmt -72.18 -40.23 68.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.78 -46.1 79.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.724 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.888 HG11 ' OG1' ' A' ' 20' ' ' THR . 22.1 m -65.33 -33.58 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.478 -0.489 . . . . 0.0 112.277 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.555 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -43.66 -50.14 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 120.491 -0.483 . . . . 0.0 109.867 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.467 ' OG1' HD11 ' B' ' 29' ' ' LEU . 0.5 OUTLIER -66.3 -49.56 66.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.923 179.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.724 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.1 tm? -42.16 -37.77 1.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.637 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.622 HG11 HG11 ' A' ' 27' ' ' VAL . 58.7 t -69.0 -58.34 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 74.1 mtm -59.54 -22.39 61.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.438 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.467 HD11 ' OG1' ' B' ' 25' ' ' THR . 74.7 mt -79.86 -5.88 56.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -62.48 -9.39 8.39 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -102.83 19.68 18.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.712 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.792 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 9' ' ' ILE . . . -64.96 -33.19 86.58 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.94 -25.32 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.608 0.242 . . . . 0.0 111.223 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.586 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.5 mp -62.36 -44.0 98.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.15 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 6' ' ' GLY . 2.5 tp -51.64 -32.5 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.43 99.06 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.227 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.46 -24.92 34.01 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.36 -63.83 1.16 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.177 0.513 . . . . 0.0 110.593 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.1 m -67.42 -22.23 28.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.863 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.79 -40.04 15.77 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.34 -54.91 29.39 Favored Glycine 0 C--N 1.331 0.262 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.915 ' O ' HG23 ' A' ' 20' ' ' THR . 6.5 m -45.6 -51.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.551 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.4 -42.1 89.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.21 -50.12 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.321 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.76 -34.22 69.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.426 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.915 HG23 ' O ' ' A' ' 16' ' ' VAL . 34.2 p -74.6 -20.53 59.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.584 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.9 mmt -82.45 -31.55 29.39 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.373 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.98 -47.46 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.951 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.47 HG11 ' HB ' ' B' ' 20' ' ' THR . 18.9 m -63.94 -31.71 54.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.695 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 20' ' ' THR . 0.9 OUTLIER -54.64 -21.02 6.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.42 -43.89 59.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.028 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.738 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -58.92 -27.33 65.17 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.273 0.558 . . . . 0.0 110.625 -179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.4 t -65.26 -44.83 94.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.955 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.6 mtp -72.53 -29.21 63.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.365 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.47 -3.28 33.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.319 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -68.57 -18.18 64.29 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.494 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 32' ' ' LYS . 46.8 tttp -95.65 15.3 20.36 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.664 0.269 . . . . 0.0 110.717 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 31' ' ' LYS . 22.0 pttp . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.957 -1.02 . . . . 0.0 111.696 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.405 ' O ' HG22 ' B' ' 9' ' ' ILE . . . -64.98 -33.12 86.4 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.99 -25.38 58.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.63 0.252 . . . . 0.0 111.199 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.566 ' N ' HD12 ' B' ' 8' ' ' ILE . 1.5 mp -62.33 -43.95 98.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.168 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.405 HG22 ' O ' ' B' ' 6' ' ' GLY . 2.5 tp -51.54 -32.57 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.41 -43.45 99.04 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.19 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.48 -24.92 33.96 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.877 0.37 . . . . 0.0 110.892 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.35 -63.82 1.17 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.622 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 23.4 m -67.45 -22.16 28.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.884 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.93 -39.79 15.95 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.236 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.28 -55.08 28.3 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.915 ' O ' HG23 ' B' ' 20' ' ' THR . 6.5 m -45.52 -51.81 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.549 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.5 -42.09 90.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.067 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.14 -50.21 81.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.321 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.75 -34.09 69.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.572 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.915 HG23 ' O ' ' B' ' 16' ' ' VAL . 33.8 p -74.7 -20.35 59.89 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.651 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.9 mmt -82.49 -31.59 29.22 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.343 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.87 -47.6 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.017 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.47 HG11 ' HB ' ' A' ' 20' ' ' THR . 19.0 m -63.79 -31.73 54.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.795 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.625 HD13 ' O ' ' B' ' 20' ' ' THR . 0.9 OUTLIER -54.6 -20.99 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -43.93 59.1 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.954 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.736 HD13 ' C ' ' B' ' 26' ' ' LEU . 0.3 OUTLIER -58.91 -27.33 65.15 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.245 0.545 . . . . 0.0 110.662 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.3 -44.82 94.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.983 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 77.7 mtp -72.53 -29.1 63.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.364 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.7 -3.14 33.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.22 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -68.64 -18.07 64.22 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.547 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' B' ' 32' ' ' LYS . 46.9 tttp -95.74 15.3 20.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.688 0.28 . . . . 0.0 110.664 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' B' ' 31' ' ' LYS . 22.0 pttp . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.755 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.48 -26.95 72.05 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.22 83.58 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.205 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.43 -53.2 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.484 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.1 tp -70.91 -42.8 77.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.458 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -35.71 -48.58 0.99 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mt -72.81 -38.27 67.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.825 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.501 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -55.74 -61.56 2.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 120.745 0.307 . . . . 0.0 111.636 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.99 -22.63 30.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.74 -45.85 16.03 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.389 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.34 -53.83 32.89 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.879 ' O ' HG23 ' A' ' 20' ' ' THR . 4.8 m -49.22 -50.71 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.013 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.522 ' O ' ' SD ' ' A' ' 21' ' ' MET . 58.2 t -57.84 -45.62 87.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.642 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.39 -46.44 96.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.383 0.611 . . . . 0.0 109.827 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.514 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.51 -38.25 71.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.139 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.879 HG23 ' O ' ' A' ' 16' ' ' VAL . 41.7 p -67.31 -25.4 66.01 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.678 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -80.86 -39.13 26.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -71.23 -46.59 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.8 HG21 HG21 ' B' ' 23' ' ' VAL . 34.8 m -51.31 -37.11 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.946 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 20' ' ' THR . 1.2 mp -47.44 -46.2 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -60.15 -53.3 59.41 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.585 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.713 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.2 tm? -50.75 -40.91 56.0 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.133 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.94 -67.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.62 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.9 mtt -48.7 -23.07 0.91 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.214 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 31' ' ' LYS . 16.3 mt -72.53 -26.63 61.82 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.702 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -45.78 -13.2 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.762 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 29' ' ' LEU . 27.9 ttpt -98.28 19.56 14.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.85 0.357 . . . . 0.0 110.252 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LEU . 65.2 tttm . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.631 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.63 -27.22 72.41 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.48 84.49 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.283 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.04 -53.27 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.473 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.1 tp -70.94 -42.71 77.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.429 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.48 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.06 -48.13 1.07 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.7 mt -73.15 -38.19 66.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.824 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -55.59 -61.72 2.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.793 0.33 . . . . 0.0 111.622 -179.353 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.91 -22.39 30.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.795 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.92 -45.92 15.14 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.381 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.37 -53.75 33.34 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.886 ' O ' HG23 ' B' ' 20' ' ' THR . 4.9 m -49.04 -50.93 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.057 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.526 ' O ' ' SD ' ' B' ' 21' ' ' MET . 58.8 t -57.77 -45.55 87.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.72 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.45 -46.54 96.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.833 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.498 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -56.41 -38.44 71.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.059 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.886 HG23 ' O ' ' B' ' 16' ' ' VAL . 41.2 p -67.05 -25.37 66.22 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.802 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.533 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -80.93 -39.19 26.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.18 -46.69 64.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.096 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.8 HG21 HG21 ' A' ' 23' ' ' VAL . 35.1 m -51.24 -37.16 17.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.872 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.692 HD13 ' O ' ' B' ' 20' ' ' THR . 1.2 mp -47.42 -46.01 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -60.4 -53.13 61.24 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.707 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.2 tm? -50.88 -40.85 57.54 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.079 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.98 -67.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.549 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 68.0 mtt -48.5 -23.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.207 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' B' ' 32' ' ' LYS . 15.8 mt -72.43 -26.69 61.94 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.686 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -45.67 -13.33 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.803 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' B' ' 29' ' ' LEU . 27.9 ttpt -98.33 19.74 13.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 110.281 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.1 tttm . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.616 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.6 -33.56 87.56 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.55 75.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.465 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.682 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.8 mp -68.56 -54.61 20.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.876 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.2 tp -69.67 -41.99 80.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.254 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -34.31 -60.73 0.58 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.66 -29.26 70.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.591 0.234 . . . . 0.0 111.242 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -66.05 -63.66 1.03 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.084 0.469 . . . . 0.0 111.267 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.88 -20.01 23.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.547 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.84 -40.59 5.87 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.48 -49.23 57.95 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 20' ' ' THR . 9.6 m -44.98 -49.64 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.725 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.406 ' N ' HG23 ' A' ' 16' ' ' VAL . 62.9 t -58.68 -43.41 87.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.862 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.98 -49.1 86.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.39 -36.28 71.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.962 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.893 HG23 ' O ' ' A' ' 16' ' ' VAL . 31.2 p -73.16 -18.43 61.27 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.696 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.7 -31.74 28.41 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.399 -0.52 . . . . 0.0 109.987 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 25' ' ' THR . 97.1 mt -63.35 -46.17 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.381 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' LEU . 27.2 m -64.41 -35.04 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.345 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 20' ' ' THR . 1.1 mp -46.87 -20.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -76.24 -40.68 51.36 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.207 178.316 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.717 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -54.4 -31.54 55.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.278 0.561 . . . . 0.0 109.87 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.7 t -63.25 -29.96 48.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.473 0.654 . . . . 0.0 109.826 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.9 mtp -84.38 -32.98 23.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.788 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 32' ' ' LYS . 59.2 mt -66.6 -41.88 87.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -49.43 -10.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.718 0.294 . . . . 0.0 111.001 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 29' ' ' LEU . 99.5 mttt -96.24 12.27 31.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.109 0.48 . . . . 0.0 109.982 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' LEU . 32.5 ttpt . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.301 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.63 -33.6 87.68 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.44 74.85 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.516 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.677 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.8 mp -68.67 -54.58 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.86 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.2 tp -69.6 -42.09 80.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.22 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.432 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -34.23 -61.08 0.55 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.4 -28.95 70.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.804 -0.198 . . . . 0.0 111.253 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' MET . . . . . 0.52 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -66.37 -63.79 1.0 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 111.203 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.76 -20.05 23.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.528 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.76 -40.6 5.89 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.44 -49.23 57.83 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.901 ' O ' HG23 ' B' ' 20' ' ' THR . 9.4 m -44.98 -49.75 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.217 -0.491 . . . . 0.0 110.698 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.41 ' N ' HG23 ' B' ' 16' ' ' VAL . 65.5 t -58.55 -43.48 87.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.872 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.92 -49.18 85.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.37 -36.18 70.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.052 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.901 HG23 ' O ' ' B' ' 16' ' ' VAL . 30.7 p -73.26 -18.29 61.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.653 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.72 -31.7 28.35 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.047 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.459 ' O ' HG22 ' B' ' 25' ' ' THR . 97.1 mt -63.47 -46.21 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' B' ' 26' ' ' LEU . 27.1 m -64.29 -35.25 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.389 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.656 HD13 ' O ' ' B' ' 20' ' ' THR . 1.1 mp -46.7 -20.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.459 HG22 ' O ' ' B' ' 22' ' ' ILE . 0.7 OUTLIER -76.45 -40.62 50.0 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.161 178.358 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.723 ' C ' HD13 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -54.5 -31.59 56.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.327 0.584 . . . . 0.0 109.825 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -63.21 -30.02 48.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.454 0.645 . . . . 0.0 109.778 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.1 mtp -84.28 -33.03 24.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.842 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' B' ' 31' ' ' LYS . 59.3 mt -66.62 -41.8 87.79 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -49.48 -10.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.699 0.285 . . . . 0.0 110.921 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' B' ' 29' ' ' LEU . 99.4 mttt -96.07 12.49 30.42 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.204 0.526 . . . . 0.0 110.014 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' B' ' 29' ' ' LEU . 32.4 ttpt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.339 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 8' ' ' ILE . . . -61.92 -34.03 87.47 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.41 -19.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 110.593 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.441 ' N ' ' O ' ' A' ' 6' ' ' GLY . 97.2 mt -64.27 -42.84 96.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.455 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 6' ' ' GLY . 3.0 tp -58.74 -37.67 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.0 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.56 -42.91 52.36 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.1 tp -73.38 -26.91 61.19 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.746 -0.267 . . . . 0.0 111.084 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.53 -60.25 3.69 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 120.802 0.334 . . . . 0.0 110.847 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -55.33 -23.47 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.024 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.19 -40.5 29.05 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.343 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.441 ' C ' HG12 ' B' ' 16' ' ' VAL . . . -58.19 -43.67 95.26 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.366 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 20' ' ' THR . 11.0 m -61.74 -24.15 33.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.606 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.455 ' O ' ' SD ' ' A' ' 21' ' ' MET . 54.3 t -86.08 -39.97 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 123.461 0.476 . . . . 0.0 111.341 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.84 -52.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.635 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.839 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -54.67 -46.39 74.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.779 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.862 ' OG1' HG11 ' B' ' 23' ' ' VAL . 4.2 t -68.96 -17.62 63.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.48 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.455 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -85.0 -29.04 25.33 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.288 0.367 . . . . 0.0 111.373 -179.029 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.31 -39.19 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.863 HG11 ' OG1' ' B' ' 20' ' ' THR . 13.6 m -56.57 -39.24 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.105 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.498 ' N ' HG23 ' A' ' 23' ' ' VAL . 37.2 mm -40.73 -49.77 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -60.28 -41.02 92.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.972 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.736 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.5 tm? -60.07 -48.36 82.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.866 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.541 HG11 HG11 ' B' ' 27' ' ' VAL . 93.2 t -62.19 -42.92 97.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.344 0.592 . . . . 0.0 109.996 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.9 mmm -63.55 -18.56 63.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.761 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 31' ' ' LYS . 34.6 mt -87.5 -49.86 6.92 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.427 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.612 ' HE2' HD11 ' A' ' 26' ' ' LEU . 66.2 mttm -55.76 -4.28 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.535 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 29' ' ' LEU . 16.9 tptm -156.29 60.64 0.56 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.117 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.471 179.498 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 6' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' B' ' 8' ' ' ILE . . . -61.8 -34.01 87.23 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.41 -19.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.735 0.303 . . . . 0.0 110.657 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.432 ' N ' ' C ' ' B' ' 6' ' ' GLY . 96.9 mt -64.16 -42.9 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.414 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.404 HG22 ' O ' ' B' ' 6' ' ' GLY . 3.0 tp -58.72 -37.53 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.002 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.64 -42.96 52.92 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.3 tp -73.4 -26.91 61.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.749 -0.265 . . . . 0.0 111.118 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -60.28 3.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.791 0.329 . . . . 0.0 110.763 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 29.8 m -55.36 -23.34 13.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.104 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.23 -40.61 28.54 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.352 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.434 ' C ' HG12 ' A' ' 16' ' ' VAL . . . -58.02 -43.65 94.96 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.434 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.614 ' O ' HG22 ' B' ' 20' ' ' THR . 10.8 m -61.83 -24.11 33.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.596 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.453 ' O ' ' SD ' ' B' ' 21' ' ' MET . 54.8 t -86.23 -39.93 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 123.517 0.511 . . . . 0.0 111.324 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.83 -52.61 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.587 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.848 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -54.59 -46.4 73.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.743 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.863 ' OG1' HG11 ' A' ' 23' ' ' VAL . 4.1 t -68.87 -17.64 64.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.407 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.1 OUTLIER -85.13 -29.08 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.325 0.39 . . . . 0.0 111.285 -178.898 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.14 -39.37 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 111.199 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.862 HG11 ' OG1' ' A' ' 20' ' ' THR . 13.5 m -56.37 -39.35 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.058 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.493 ' N ' HG23 ' B' ' 23' ' ' VAL . 37.0 mm -40.65 -49.85 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -60.29 -41.01 92.47 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.978 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.718 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.5 tm? -60.01 -48.4 81.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.851 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.541 HG11 HG11 ' A' ' 27' ' ' VAL . 96.1 t -62.21 -42.87 96.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.216 0.532 . . . . 0.0 110.055 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 94.2 mmm -63.52 -18.72 64.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.785 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' B' ' 31' ' ' LYS . 34.5 mt -87.43 -49.76 7.0 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.432 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.594 ' HE2' HD11 ' B' ' 26' ' ' LEU . 66.4 mttm -55.8 -4.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.54 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' B' ' 29' ' ' LEU . 16.9 tptm -156.51 60.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.122 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.432 179.526 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.25 -26.42 70.51 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.6 -23.07 15.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.687 0.279 . . . . 0.0 110.652 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -62.71 -44.1 99.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.59 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.498 ' O ' HG22 ' A' ' 13' ' ' VAL . 6.0 tp -56.12 -33.78 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.8 -45.06 96.99 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.005 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.55 -29.56 37.1 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 120.905 0.383 . . . . 0.0 111.097 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.3 tpt -64.31 -63.61 1.1 Allowed 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.489 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 9' ' ' ILE . 4.7 m -66.84 -22.15 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.528 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.04 -41.48 10.35 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.23 -54.25 35.38 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.888 ' O ' HG23 ' A' ' 20' ' ' THR . 6.3 m -45.57 -51.04 3.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.874 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.512 ' O ' ' SD ' ' A' ' 21' ' ' MET . 85.8 t -59.1 -43.59 89.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.947 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.8 -49.05 85.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.686 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.28 -34.18 68.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.396 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.888 HG23 ' O ' ' A' ' 16' ' ' VAL . 33.2 p -74.16 -20.67 60.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.63 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' OG1' ' A' ' 20' ' ' THR . 0.0 OUTLIER -81.9 -31.7 31.31 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.622 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 25' ' ' THR . 96.8 mt -62.91 -48.56 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.524 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.434 ' C ' ' N ' ' A' ' 25' ' ' THR . 23.8 m -63.3 -31.99 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.968 0.413 . . . . 0.0 110.759 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.597 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -50.19 -19.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.401 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 22' ' ' ILE . 1.2 t -74.56 -42.08 59.42 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.348 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.706 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -56.39 -29.92 62.08 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.244 0.545 . . . . 0.0 110.436 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.74 -46.49 92.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.378 0.608 . . . . 0.0 109.711 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 90.0 mtp -70.28 -33.97 72.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.031 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.36 -2.95 54.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.32 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -61.45 -37.51 83.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.95 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.66 23.2 3.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.269 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.383 179.406 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.22 -26.52 70.55 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.54 -23.03 14.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.72 0.295 . . . . 0.0 110.639 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -62.67 -44.13 99.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.62 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.495 ' O ' HG22 ' B' ' 13' ' ' VAL . 6.0 tp -56.13 -33.8 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.71 -45.2 96.75 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.059 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.47 -29.57 37.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.86 0.362 . . . . 0.0 111.123 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 8.3 tpt -64.3 -63.64 1.09 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.545 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 9' ' ' ILE . 4.7 m -66.76 -22.28 29.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.513 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.01 -41.36 10.49 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.22 -54.3 35.0 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.89 ' O ' HG23 ' B' ' 20' ' ' THR . 6.6 m -45.59 -50.99 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.953 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.508 ' O ' ' SD ' ' B' ' 21' ' ' MET . 85.3 t -59.13 -43.65 89.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.904 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.72 -49.07 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.681 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.32 -34.23 68.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.341 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.89 HG23 ' O ' ' B' ' 16' ' ' VAL . 33.4 p -74.16 -20.74 60.12 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.693 0.282 . . . . 0.0 110.607 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.53 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -81.82 -31.67 31.61 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.626 179.261 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.487 ' O ' HG22 ' B' ' 25' ' ' THR . 96.8 mt -62.97 -48.52 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.499 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.431 ' C ' ' N ' ' B' ' 25' ' ' THR . 24.3 m -63.34 -31.91 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.936 0.398 . . . . 0.0 110.829 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.598 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -50.18 -19.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.317 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.487 HG22 ' O ' ' B' ' 22' ' ' ILE . 1.2 t -74.5 -42.05 59.61 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.309 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.707 ' C ' HD13 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -56.43 -29.89 62.16 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.284 0.564 . . . . 0.0 110.48 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.81 -46.38 92.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.277 0.561 . . . . 0.0 109.714 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 89.8 mtp -70.38 -33.85 71.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.977 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 93.2 mt -82.42 -2.92 54.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.298 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -61.51 -37.55 84.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.878 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.6 23.24 3.11 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.323 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.307 179.479 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.517 ' HZ1' ' HZ1' ' B' ' 5' ' ' LYS . 32.2 mmtp . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.76 -33.37 87.06 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.4 -22.99 46.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.629 0.252 . . . . 0.0 110.827 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.496 HD13 HD13 ' B' ' 8' ' ' ILE . 91.9 mt -62.7 -43.61 98.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.23 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 13' ' ' VAL . 5.1 tp -60.0 -33.2 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.146 0.498 . . . . 0.0 109.799 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.75 -68.72 1.55 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.319 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -60.98 -27.49 68.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.051 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.07 -63.84 1.05 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 120.854 0.359 . . . . 0.0 110.727 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 9' ' ' ILE . 7.5 m -70.21 -21.16 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.05 -39.32 8.61 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.72 -53.17 40.88 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.885 ' O ' HG23 ' A' ' 20' ' ' THR . 4.8 m -45.45 -48.4 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.9 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.524 ' O ' ' SD ' ' A' ' 21' ' ' MET . 97.4 t -58.72 -44.09 89.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.755 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.44 -48.02 90.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.58 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.65 68.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.543 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 16' ' ' VAL . 31.1 p -74.81 -18.95 60.38 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.653 0.263 . . . . 0.0 110.783 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -83.75 -30.84 26.35 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.221 179.227 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 25' ' ' THR . 96.7 mt -62.99 -48.24 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.368 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.438 ' C ' ' N ' ' A' ' 25' ' ' THR . 25.0 m -63.77 -32.64 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.078 0.466 . . . . 0.0 110.72 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -48.82 -21.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.582 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -75.84 -41.19 53.22 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.611 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.729 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -56.72 -30.25 63.3 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.451 0.643 . . . . 0.0 110.389 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.2 t -61.84 -38.65 81.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.51 0.672 . . . . 0.0 109.391 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.5 mmm -72.88 -28.43 62.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.79 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.75 -6.59 56.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.013 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.14 -39.01 91.15 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.782 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -94.0 18.03 11.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.793 0.33 . . . . 0.0 110.42 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.647 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 5' ' ' LYS . . . . . 0.517 ' HZ1' ' HZ1' ' A' ' 5' ' ' LYS . 32.1 mmtp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.82 -33.39 87.12 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.4 -23.03 46.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.69 0.281 . . . . 0.0 110.85 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.496 HD13 HD13 ' A' ' 8' ' ' ILE . 91.3 mt -62.55 -43.65 98.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.288 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.466 ' O ' HG22 ' B' ' 13' ' ' VAL . 5.1 tp -59.97 -33.22 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.169 0.509 . . . . 0.0 109.817 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.81 -68.71 1.56 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.257 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.484 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.2 mm? -60.96 -27.5 68.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.034 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.16 -63.82 1.05 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 120.841 0.353 . . . . 0.0 110.724 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.466 HG22 ' O ' ' B' ' 9' ' ' ILE . 7.3 m -70.1 -21.13 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.14 -39.38 8.52 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.58 -53.16 40.52 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.884 ' O ' HG23 ' B' ' 20' ' ' THR . 4.8 m -45.49 -48.35 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.877 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.515 ' O ' ' SD ' ' B' ' 21' ' ' MET . 97.2 t -58.91 -43.85 89.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.765 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.61 -48.02 90.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.504 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.71 69.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.47 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.884 HG23 ' O ' ' B' ' 16' ' ' VAL . 31.0 p -74.68 -19.08 60.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.817 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -83.54 -30.99 26.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.279 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.44 ' O ' HG22 ' B' ' 25' ' ' THR . 96.7 mt -62.91 -48.22 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.453 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.449 ' C ' ' N ' ' B' ' 25' ' ' THR . 25.5 m -63.73 -32.65 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.158 0.504 . . . . 0.0 110.751 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.552 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -48.91 -20.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.624 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.449 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -75.95 -41.21 52.22 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.594 179.058 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.727 ' C ' HD13 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -56.66 -30.15 63.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.424 0.63 . . . . 0.0 110.43 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.3 t -61.93 -39.05 82.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.49 0.662 . . . . 0.0 109.291 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.5 mmm -72.39 -28.52 63.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.825 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.79 -6.48 56.05 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.992 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.26 -38.86 90.9 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.708 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -94.03 17.91 11.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.771 0.32 . . . . 0.0 110.396 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.554 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.37 -25.66 65.21 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.3 83.93 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.168 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.13 -53.77 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.52 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 tp -70.17 -38.56 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 109.976 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.5 -46.12 8.61 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.5 tp -73.03 -38.47 66.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 121.189 -0.204 . . . . 0.0 110.79 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -57.27 8.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.982 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 27.0 m -65.4 -20.72 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.211 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.15 -40.81 10.93 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.53 -54.89 25.25 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.7 m -44.49 -51.29 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.452 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.13 -42.24 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.58 -49.91 60.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.374 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.22 77.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.869 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.429 ' OG1' HG11 ' B' ' 23' ' ' VAL . 14.2 t -80.07 -17.25 53.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 110.235 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.44 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -79.36 -31.81 43.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.284 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 25' ' ' THR . 97.1 mt -63.53 -46.81 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.066 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.457 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' C ' ' N ' ' A' ' 25' ' ' THR . 33.6 m -64.8 -35.12 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.061 0.457 . . . . 0.0 110.198 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 21' ' ' MET . 1.6 tp -45.05 -22.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 22' ' ' ILE . 1.3 t -72.07 -41.04 67.83 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.669 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.691 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -53.0 -30.49 35.5 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.875 0.47 . . . . 0.0 110.688 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.572 HG22 HG22 ' B' ' 27' ' ' VAL . 11.0 t -64.96 -45.93 93.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.28 0.562 . . . . 0.0 109.493 177.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.7 mtt -71.47 -34.67 70.41 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.917 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.8 mt -83.75 -2.96 57.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.78 -37.44 86.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.77 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.59 23.79 4.44 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.398 179.749 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.41 -25.35 64.88 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.19 83.47 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.104 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.17 -54.03 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.463 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.4 HG23 ' N ' ' B' ' 10' ' ' GLY . 6.0 tp -70.02 -38.58 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.129 0.49 . . . . 0.0 109.944 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.4 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -44.39 -46.48 8.51 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 44.8 tp -72.66 -38.52 67.6 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.848 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' MET . . . . . 0.401 ' SD ' ' C ' ' B' ' 12' ' ' MET . 0.0 OUTLIER -50.53 -57.23 8.6 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.058 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 27.0 m -65.4 -20.75 28.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.12 -40.77 11.02 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.59 -54.87 25.53 Favored Glycine 0 C--O 1.223 -0.587 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.7 m -44.59 -51.22 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.49 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.401 ' H ' HG23 ' B' ' 16' ' ' VAL . 69.5 t -56.21 -42.11 72.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.771 0.319 . . . . 0.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.79 -49.76 61.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.33 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.25 77.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.801 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.43 ' OG1' HG11 ' A' ' 23' ' ' VAL . 14.3 t -80.04 -17.38 52.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.212 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.451 ' O ' HG22 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -79.19 -31.93 43.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.341 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.523 ' O ' HG22 ' B' ' 25' ' ' THR . 97.5 mt -63.49 -46.78 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.074 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.55 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.455 ' C ' ' N ' ' B' ' 25' ' ' THR . 32.7 m -64.83 -34.98 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.187 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.451 HG22 ' O ' ' B' ' 21' ' ' MET . 1.6 tp -45.21 -22.93 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.492 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.523 HG22 ' O ' ' B' ' 22' ' ' ILE . 1.3 t -71.83 -41.14 68.53 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.742 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.691 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.0 OUTLIER -52.84 -30.59 34.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.956 0.502 . . . . 0.0 110.657 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 27' ' ' VAL . 10.7 t -64.96 -45.92 93.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 65.4 mtt -71.59 -34.79 70.21 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.835 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -83.7 -2.68 56.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.749 0.309 . . . . 0.0 110.563 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -63.06 -37.31 86.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.746 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.66 23.59 4.61 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.059 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.4 179.687 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.51 -33.49 87.4 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.76 -22.54 36.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.6 0.238 . . . . 0.0 110.733 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.56 HD13 HD13 ' B' ' 8' ' ' ILE . 88.4 mt -62.28 -44.04 98.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.26 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 13' ' ' VAL . 5.4 tp -59.76 -35.8 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.83 -69.21 1.34 Allowed Glycine 0 CA--C 1.532 1.153 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.66 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.84 -28.41 68.81 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 120.79 0.329 . . . . 0.0 111.062 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.9 tpt -63.54 -63.64 1.12 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.002 0.43 . . . . 0.0 110.545 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 9' ' ' ILE . 10.5 m -67.84 -20.63 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.82 -39.83 7.4 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.5 -52.04 44.02 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.894 ' O ' HG23 ' A' ' 20' ' ' THR . 3.4 m -44.72 -49.04 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.579 -0.311 . . . . 0.0 110.725 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.0 t -58.63 -43.63 87.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.02 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.22 -49.66 83.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -35.9 70.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.166 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.894 HG23 ' O ' ' A' ' 16' ' ' VAL . 30.2 p -73.52 -18.51 61.09 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.955 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -84.3 -31.94 24.62 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.124 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.45 -47.66 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.447 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.447 ' C ' ' N ' ' A' ' 25' ' ' THR . 29.9 m -63.37 -34.92 70.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.172 0.51 . . . . 0.0 110.532 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 20' ' ' THR . 0.9 OUTLIER -46.04 -22.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.447 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -79.26 -42.31 26.15 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.774 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.1 tm? -51.35 -31.19 21.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.324 0.583 . . . . 0.0 110.393 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG11 ' NZ ' ' B' ' 30' ' ' LYS . 14.0 t -64.67 -35.69 75.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.515 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mtp -71.94 -29.6 64.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.28 -9.63 59.31 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.235 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' NZ ' HG11 ' B' ' 27' ' ' VAL . 97.3 mttt -62.17 -36.49 82.02 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.723 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -89.54 18.66 5.16 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.674 0.273 . . . . 0.0 110.674 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.25 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.62 -33.46 87.3 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.88 -22.6 38.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.669 0.271 . . . . 0.0 110.674 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.56 HD13 HD13 ' A' ' 8' ' ' ILE . 89.2 mt -62.23 -43.98 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.252 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.483 ' O ' HG22 ' B' ' 13' ' ' VAL . 5.4 tp -59.74 -35.88 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.78 -69.18 1.34 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.687 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -60.78 -28.51 68.8 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 8.9 tpt -63.49 -63.74 1.1 Allowed 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.012 0.434 . . . . 0.0 110.457 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.483 HG22 ' O ' ' B' ' 9' ' ' ILE . 10.4 m -67.81 -20.59 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.41 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.75 -39.9 7.41 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.5 -52.06 43.91 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.886 ' O ' HG23 ' B' ' 20' ' ' THR . 3.4 m -44.71 -49.12 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.66 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 64.3 t -58.64 -43.57 87.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.004 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.22 -49.65 83.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.74 70.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.213 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.886 HG23 ' O ' ' B' ' 16' ' ' VAL . 30.4 p -73.59 -18.49 61.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.845 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -84.3 -31.85 24.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.132 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.48 -47.66 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.473 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.445 HG11 ' HB ' ' A' ' 20' ' ' THR . 30.1 m -63.35 -35.0 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.168 0.509 . . . . 0.0 110.502 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.414 HD13 ' O ' ' B' ' 20' ' ' THR . 0.9 OUTLIER -45.98 -22.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.439 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -79.24 -42.33 26.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.79 178.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.71 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.1 tm? -51.28 -31.27 20.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.322 0.582 . . . . 0.0 110.423 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.442 HG11 ' NZ ' ' A' ' 30' ' ' LYS . 14.2 t -64.6 -35.69 75.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.595 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.8 mtp -71.9 -29.6 64.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.726 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.25 -9.53 59.26 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.247 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.444 ' NZ ' HG11 ' A' ' 27' ' ' VAL . 97.3 mttt -62.31 -36.57 82.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.694 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -89.45 18.6 5.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.622 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.312 179.879 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.2 -34.07 88.94 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.87 -30.01 70.57 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.505 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.695 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.8 mp -70.54 -55.77 13.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.775 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.1 tp -69.28 -42.31 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.238 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.49 -58.46 1.1 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -64.97 -29.03 69.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.819 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -66.09 -63.78 1.0 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 0.0 111.205 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 26.1 m -67.07 -20.12 26.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.871 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.16 -41.09 6.33 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.24 -49.82 54.67 Favored Glycine 0 C--N 1.333 0.369 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 20' ' ' THR . 5.1 m -44.6 -51.03 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.647 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 16' ' ' VAL . 91.4 t -57.64 -43.8 84.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.745 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.98 -49.87 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -36.75 68.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.866 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 16' ' ' VAL . 28.9 p -72.59 -18.51 61.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.045 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.3 mmt -82.44 -32.57 28.91 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.218 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 25' ' ' THR . 97.1 mt -63.53 -46.57 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.633 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 25' ' ' THR . 30.1 m -63.12 -36.1 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.283 0.563 . . . . 0.0 110.571 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -43.77 -22.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.7 OUTLIER -81.57 -42.78 19.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.504 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.679 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.2 tm? -47.44 -33.73 6.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.617 0.723 . . . . 0.0 110.475 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 30' ' ' LYS . 48.5 t -66.0 -42.56 91.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.164 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.402 ' N ' ' O ' ' A' ' 25' ' ' THR . 67.3 mtt -65.97 -33.66 76.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.412 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.59 0.75 11.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.356 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 27' ' ' VAL . 24.6 mmtp -62.01 -38.17 87.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.554 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -132.74 17.33 4.28 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.821 0.344 . . . . 0.0 110.479 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.041 179.566 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.04 -34.15 89.16 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.89 -29.94 70.54 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.468 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.695 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.8 mp -70.56 -55.79 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.738 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.0 tp -69.36 -42.31 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.269 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.452 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.44 -58.35 1.1 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.465 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.2 mm? -65.16 -28.92 69.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.792 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' MET . . . . . 0.505 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -66.17 -63.84 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.997 0.427 . . . . 0.0 111.239 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 26.4 m -67.06 -20.07 26.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.861 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.1 -41.12 6.34 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.21 -49.76 54.82 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.905 ' O ' HG23 ' B' ' 20' ' ' THR . 5.3 m -44.9 -50.86 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.641 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 16' ' ' VAL . 91.8 t -57.66 -43.91 84.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.697 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.89 -49.81 83.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.97 68.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.959 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.905 HG23 ' O ' ' B' ' 16' ' ' VAL . 28.9 p -72.43 -18.55 61.7 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.967 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.3 mmt -82.37 -32.76 29.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.203 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.406 ' O ' HG22 ' B' ' 25' ' ' THR . 97.0 mt -63.22 -46.7 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.672 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' B' ' 25' ' ' THR . 30.1 m -63.14 -36.11 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.339 0.59 . . . . 0.0 110.629 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -43.79 -22.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.582 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.467 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -81.62 -42.65 19.72 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.498 179.444 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.682 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.2 tm? -47.66 -33.6 7.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.745 0.783 . . . . 0.0 110.513 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' B' ' 30' ' ' LYS . 50.0 t -66.02 -42.54 91.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.18 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 67.3 mtt -65.86 -33.78 76.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.471 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.5 0.6 11.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.333 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' B' ' 27' ' ' VAL . 24.7 mmtp -61.78 -38.4 87.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.543 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -132.59 17.48 4.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.888 0.375 . . . . 0.0 110.492 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.057 179.579 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.8 -25.62 69.28 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.16 79.51 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.55 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.644 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.8 mp -65.8 -53.09 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.91 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.5 tp -71.15 -41.68 75.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.05 0.452 . . . . 0.0 110.308 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -39.97 -46.24 3.13 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.1 tp -73.82 -41.95 61.58 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.652 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.01 -54.23 13.63 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.083 0.468 . . . . 0.0 111.013 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.17 -21.83 27.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.818 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.58 -46.61 14.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -50.97 -54.82 21.09 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.874 ' O ' HG23 ' A' ' 20' ' ' THR . 6.9 m -48.23 -49.26 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.26 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.509 ' O ' ' SD ' ' A' ' 21' ' ' MET . 85.4 t -59.81 -45.03 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.929 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.29 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.765 -0.774 . . . . 0.0 108.966 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.523 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -57.18 -38.26 73.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.671 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 16' ' ' VAL . 66.4 p -68.05 -24.98 65.14 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.054 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' OG1' ' A' ' 20' ' ' THR . 0.0 OUTLIER -82.04 -38.9 24.28 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.319 0.387 . . . . 0.0 112.038 -179.616 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.3 mt -69.08 -46.54 78.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.761 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.83 HG21 HG21 ' B' ' 23' ' ' VAL . 31.5 m -52.69 -34.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.939 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.439 ' N ' HG23 ' A' ' 23' ' ' VAL . 33.5 mm -49.0 -45.99 16.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -59.6 -55.08 38.96 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.6 tm? -46.93 -37.67 9.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.246 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG11 HG11 ' B' ' 27' ' ' VAL . 58.9 t -71.3 -56.67 9.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.395 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.522 ' O ' ' N ' ' A' ' 32' ' ' LYS . 98.6 mmm -58.11 -29.54 65.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.697 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.746 ' O ' HD23 ' A' ' 29' ' ' LEU . 3.5 tt -63.79 -36.0 82.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.994 0.426 . . . . 0.0 109.87 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -45.4 -11.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.258 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 29' ' ' LEU . 34.1 ttmt -156.72 -13.43 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.371 0.605 . . . . 0.0 110.12 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' MET . 55.1 mtpt . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.483 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.78 69.21 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.29 -35.04 79.06 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.594 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.647 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.8 mp -66.0 -53.16 40.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.908 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.453 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.5 tp -70.94 -41.73 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.297 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.453 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -40.07 -46.06 3.18 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 43.0 tp -74.05 -41.92 61.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.709 0.29 . . . . 0.0 110.661 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 -54.29 13.04 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.106 0.479 . . . . 0.0 110.967 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.0 m -68.16 -21.78 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.846 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.55 -46.63 14.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.1 -54.89 21.2 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.873 ' O ' HG23 ' B' ' 20' ' ' THR . 7.1 m -47.98 -49.34 11.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.383 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.525 ' O ' ' SD ' ' B' ' 21' ' ' MET . 85.9 t -59.88 -44.98 95.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.939 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.33 -45.97 97.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.518 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -57.16 -38.26 73.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.615 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.873 HG23 ' O ' ' B' ' 16' ' ' VAL . 69.1 p -68.06 -24.93 65.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.096 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.529 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -82.11 -38.9 24.1 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.42 0.45 . . . . 0.0 112.032 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.13 -46.51 77.96 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.765 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.83 HG21 HG21 ' A' ' 23' ' ' VAL . 31.9 m -52.67 -34.91 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.013 -178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.431 ' N ' HG23 ' B' ' 23' ' ' VAL . 33.0 mm -49.1 -45.9 17.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.427 ' O ' ' N ' ' B' ' 29' ' ' LEU . 1.5 m -59.71 -55.31 35.97 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.707 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.6 tm? -46.79 -37.49 8.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.295 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 27' ' ' VAL . 59.6 t -71.45 -56.53 10.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.466 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' MET . . . . . 0.528 ' O ' ' N ' ' B' ' 32' ' ' LYS . 98.6 mmm -58.23 -29.4 65.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.715 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.737 ' O ' HD23 ' B' ' 29' ' ' LEU . 3.5 tt -63.84 -36.14 82.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.024 0.44 . . . . 0.0 109.861 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -45.29 -11.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.361 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' B' ' 29' ' ' LEU . 34.0 ttmt -156.73 -13.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.241 0.543 . . . . 0.0 109.965 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' B' ' 28' ' ' MET . 55.0 mtpt . . . . . 0 C--N 1.322 -0.63 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.43 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.72 -22.65 66.42 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.17 -31.03 68.63 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.996 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.02 -59.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 10' ' ' GLY . 6.0 tp -66.09 -39.75 85.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.22 0.533 . . . . 0.0 110.198 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -42.62 -45.99 5.7 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.75 -33.65 64.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 111.204 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.436 ' SD ' ' C ' ' A' ' 12' ' ' MET . 0.1 OUTLIER -57.23 -62.94 1.41 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.302 -179.548 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 m -58.27 -21.91 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.178 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.13 -38.45 39.98 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.31 -55.25 30.5 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 20' ' ' THR . 23.2 m -51.05 -21.72 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.19 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.1 t -85.56 -47.77 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.205 0.526 . . . . 0.0 111.376 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.8 mm -69.7 -47.14 72.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.02 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.5 -41.11 65.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.707 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.703 ' OG1' HG11 ' B' ' 23' ' ' VAL . 4.0 t -78.88 -19.93 50.72 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.047 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.0 mmt -78.33 -35.14 48.01 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.951 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.482 ' O ' HG22 ' A' ' 25' ' ' THR . 96.9 mt -62.92 -48.45 87.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.65 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.703 HG11 ' OG1' ' B' ' 20' ' ' THR . 34.1 m -63.87 -34.71 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 110.3 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -43.59 -22.44 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -79.46 -43.03 24.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.57 178.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.702 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.5 tm? -47.83 -31.83 5.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.67 0.747 . . . . 0.0 110.479 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.445 HG13 HG13 ' B' ' 27' ' ' VAL . 12.6 t -64.46 -40.59 89.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.292 0.567 . . . . 0.0 109.501 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 25' ' ' THR . 67.4 mtt -67.45 -31.34 71.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.876 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.1 mt -76.06 -8.62 57.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.025 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -60.97 -36.79 80.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.716 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -101.98 17.12 23.98 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.731 0.3 . . . . 0.0 110.59 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.602 179.832 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.78 -22.72 66.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.06 -30.86 68.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.661 0.267 . . . . 0.0 111.056 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.13 -59.48 3.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.421 HG23 ' N ' ' B' ' 10' ' ' GLY . 6.0 tp -65.93 -39.53 84.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.228 0.537 . . . . 0.0 110.23 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.421 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -42.99 -45.68 6.05 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.96 -33.54 63.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.747 0.308 . . . . 0.0 111.193 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' MET . . . . . 0.437 ' C ' ' SD ' ' B' ' 12' ' ' MET . 0.1 OUTLIER -57.29 -63.04 1.36 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.28 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -58.24 -21.81 18.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.197 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.05 -38.52 40.19 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.3 -55.09 31.3 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.49 ' O ' HG22 ' B' ' 20' ' ' THR . 22.5 m -51.2 -21.66 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 122.874 -0.192 . . . . 0.0 111.182 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 70.3 t -85.6 -47.8 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.239 0.542 . . . . 0.0 111.401 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.76 -47.15 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.943 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.54 -41.17 66.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.642 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.703 ' OG1' HG11 ' A' ' 23' ' ' VAL . 4.0 t -78.76 -19.93 51.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.105 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 22.0 mmt -78.35 -35.16 47.85 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.975 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.47 ' O ' HG22 ' B' ' 25' ' ' THR . 96.9 mt -62.91 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.713 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.703 HG11 ' OG1' ' A' ' 20' ' ' THR . 34.1 m -63.72 -34.76 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.093 0.473 . . . . 0.0 110.314 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.401 ' N ' HG23 ' B' ' 23' ' ' VAL . 1.2 tp -43.82 -22.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.479 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.0 OUTLIER -79.56 -43.0 23.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.622 178.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.703 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.5 tm? -47.81 -31.96 5.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.661 0.744 . . . . 0.0 110.55 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.445 HG13 HG13 ' A' ' 27' ' ' VAL . 12.3 t -64.43 -40.61 89.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.582 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' MET . . . . . 0.426 ' N ' ' O ' ' B' ' 25' ' ' THR . 67.5 mtt -67.42 -31.35 71.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.871 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 82.0 mt -75.95 -8.84 57.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.032 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -60.88 -36.8 80.15 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.728 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -101.92 17.17 23.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.544 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.615 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.36 89.71 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.05 -24.45 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.765 0.317 . . . . 0.0 110.769 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.17 -42.91 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.246 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.495 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -59.91 -41.2 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.297 0.57 . . . . 0.0 109.532 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.8 -59.56 8.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 48.4 tp -72.89 -28.21 62.35 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.405 ' SD ' ' C ' ' A' ' 12' ' ' MET . 0.0 OUTLIER -42.48 -53.92 4.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.832 ' O ' HG13 ' A' ' 16' ' ' VAL . 34.2 m -72.92 -51.63 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.4 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.62 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -29.48 -47.15 0.1 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 123.694 0.621 . . . . 0.0 112.65 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.4 -1.79 0.21 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.593 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 13' ' ' VAL . 33.6 m -80.71 -51.13 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.66 ' N ' HG23 ' A' ' 16' ' ' VAL . 86.8 t -43.43 -37.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.828 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.53 -49.54 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.848 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.84 -52.04 67.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.534 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -64.93 -19.09 65.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.609 0.242 . . . . 0.0 110.705 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -82.03 -36.82 27.35 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.306 178.683 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 25' ' ' THR . 90.5 mt -64.96 -44.27 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 26' ' ' LEU . 14.0 m -62.96 -40.58 89.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 CA-C-O 121.143 0.497 . . . . 0.0 110.516 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.475 ' N ' HG23 ' A' ' 23' ' ' VAL . 2.1 tp -40.83 -24.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.306 0.575 . . . . 0.0 110.195 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -82.47 -37.64 25.07 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.381 179.041 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.633 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.5 tm? -48.83 -40.42 29.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.704 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.945 HG21 HG21 ' B' ' 27' ' ' VAL . 88.1 t -61.74 -44.7 99.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.33 0.586 . . . . 0.0 109.685 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 82.2 mmm -65.4 -37.32 86.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.485 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.8 -5.65 59.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 110.405 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -61.85 -32.34 72.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.856 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.65 37.35 2.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.169 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.526 179.707 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.44 -34.17 89.18 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.16 -24.41 54.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.713 0.292 . . . . 0.0 110.7 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.11 -42.91 96.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.241 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.478 HD13 ' O ' ' B' ' 9' ' ' ILE . 0.2 OUTLIER -59.99 -41.24 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 121.288 0.566 . . . . 0.0 109.495 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.71 -59.53 8.48 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 48.7 tp -72.95 -28.28 62.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' MET . . . . . 0.404 ' C ' ' SD ' ' B' ' 12' ' ' MET . 0.0 OUTLIER -42.53 -53.78 4.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -178.56 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.86 ' O ' HG13 ' B' ' 16' ' ' VAL . 34.1 m -72.95 -51.82 25.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.379 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.624 ' N ' HG23 ' B' ' 13' ' ' VAL . . . -29.38 -47.04 0.09 OUTLIER Glycine 0 CA--C 1.531 1.061 0 O-C-N 123.764 0.665 . . . . 0.0 112.63 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.41 -1.92 0.22 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.524 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.86 HG13 ' O ' ' B' ' 13' ' ' VAL . 33.5 m -80.74 -51.03 16.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.014 0.435 . . . . 0.0 109.874 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.662 ' N ' HG23 ' B' ' 16' ' ' VAL . 86.0 t -43.48 -37.97 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.726 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.43 -49.48 80.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.798 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -51.89 67.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.661 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.475 HG22 ' O ' ' B' ' 16' ' ' VAL . 0.5 OUTLIER -64.87 -19.2 65.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.694 0.283 . . . . 0.0 110.781 -179.112 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -82.05 -36.63 27.51 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.272 178.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.435 ' O ' HG22 ' B' ' 25' ' ' THR . 90.0 mt -65.09 -44.22 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' B' ' 26' ' ' LEU . 13.9 m -62.96 -40.69 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.139 0.495 . . . . 0.0 110.463 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.482 ' N ' HG23 ' B' ' 23' ' ' VAL . 2.1 tp -40.83 -24.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.199 0.523 . . . . 0.0 110.167 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.506 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -82.43 -37.63 25.18 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.355 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.636 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.5 tm? -48.85 -40.28 28.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.783 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.945 HG21 HG21 ' A' ' 27' ' ' VAL . 89.4 t -61.84 -44.71 99.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.289 0.566 . . . . 0.0 109.623 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 82.3 mmm -65.45 -37.27 86.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.451 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.87 -5.65 59.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.794 0.33 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -61.96 -32.45 72.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.934 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.36 37.17 2.16 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.219 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.559 179.744 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.2 mttp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.02 -20.76 77.31 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.21 -24.79 34.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.317 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 mm -63.17 -49.83 81.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.498 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 10' ' ' GLY . 11.0 tp -68.54 -40.36 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.429 0.633 . . . . 0.0 110.226 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -48.41 -60.54 5.69 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -70.24 -29.39 66.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.2 -58.0 3.12 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 120.669 0.271 . . . . 0.0 111.671 -178.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.813 ' O ' HG13 ' A' ' 16' ' ' VAL . 17.1 m -75.49 -49.69 26.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.604 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.603 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -30.94 -45.98 0.13 Allowed Glycine 0 CA--C 1.527 0.808 0 O-C-N 123.427 0.455 . . . . 0.0 112.284 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.51 -0.51 0.14 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.641 -178.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 13' ' ' VAL . 35.1 m -82.47 -50.22 16.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.628 ' N ' HG23 ' A' ' 16' ' ' VAL . 79.6 t -42.88 -37.08 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.048 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.66 -49.29 78.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.913 -179.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.96 -52.09 66.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.268 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -18.35 64.19 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.006 -178.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.63 -38.24 20.1 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.29 0.369 . . . . 0.0 110.889 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.78 -43.15 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.354 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.501 HG21 HG21 ' B' ' 23' ' ' VAL . 35.2 m -55.76 -41.9 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.547 -178.592 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.493 ' N ' HG23 ' A' ' 23' ' ' VAL . 39.8 mm -40.3 -46.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.154 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -63.59 -43.16 97.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.35 178.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.713 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.4 tm? -56.06 -45.12 79.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.011 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.512 HG11 HG11 ' B' ' 27' ' ' VAL . 98.8 t -63.9 -44.14 97.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.448 0.642 . . . . 0.0 109.59 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 91.0 mtp -61.13 -30.52 70.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.233 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 31' ' ' LYS . 41.6 mt -71.22 -33.11 69.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.844 178.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -44.29 -15.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.798 -179.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 65.0 mttp -103.9 27.88 7.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.734 0.302 . . . . 0.0 110.336 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 29' ' ' LEU . 29.2 mmtp . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.267 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.3 mttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.54 -20.78 78.21 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.0 -24.98 35.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.754 0.312 . . . . 0.0 110.269 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.13 -49.83 81.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.591 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.437 HG23 ' N ' ' B' ' 10' ' ' GLY . 11.0 tp -68.69 -40.3 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.454 0.645 . . . . 0.0 110.154 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 10' ' ' GLY . . . . . 0.437 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -48.28 -60.5 5.65 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.469 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.2 mm? -70.52 -29.09 65.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -58.0 3.22 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.669 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 13' ' ' VAL . . . . . 0.802 ' O ' HG13 ' B' ' 16' ' ' VAL . 17.5 m -75.33 -49.91 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.594 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.595 ' N ' HG23 ' B' ' 13' ' ' VAL . . . -30.69 -45.9 0.12 Allowed Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.569 0.543 . . . . 0.0 112.395 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.61 -0.73 0.15 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.57 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.802 HG13 ' O ' ' B' ' 13' ' ' VAL . 35.1 m -82.08 -50.29 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 120.698 0.285 . . . . 0.0 110.241 179.094 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.631 ' N ' HG23 ' B' ' 16' ' ' VAL . 73.2 t -42.97 -36.97 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.052 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.8 -49.08 79.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.96 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.07 -52.29 66.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.256 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -18.24 63.92 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.054 -178.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.76 -38.16 19.98 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.309 0.381 . . . . 0.0 110.935 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.82 -43.23 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.353 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.501 HG21 HG21 ' A' ' 23' ' ' VAL . 35.9 m -55.72 -41.97 67.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.502 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 24' ' ' ILE . . . . . 0.489 ' N ' HG23 ' B' ' 23' ' ' VAL . 39.5 mm -40.04 -46.74 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.168 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -63.74 -43.2 97.19 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.375 178.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.705 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.4 tm? -56.05 -45.1 79.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.982 -179.081 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 27' ' ' VAL . 99.0 t -63.91 -44.19 97.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.463 0.649 . . . . 0.0 109.545 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 91.0 mtp -61.06 -30.34 70.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.212 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' B' ' 32' ' ' LYS . 43.0 mt -71.4 -33.1 69.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.898 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -44.28 -15.64 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.777 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.1 mttp -103.93 27.97 7.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.703 0.287 . . . . 0.0 110.378 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 32' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 29' ' ' LEU . 28.9 mmtp . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.268 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.711 0.291 . . . . 71.6 110.732 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.9 mt -64.0 -52.58 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.399 -0.364 . . . . 200.66 111.76 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.441 HG23 ' N ' ' A' ' 10' ' ' GLY . 8.4 tp -67.08 -42.19 88.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.188 -0.605 . . . . 74.61 109.617 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -46.97 -47.34 19.79 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.301 -1.12 . . . . 50.55 110.301 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 11' ' ' LEU . 18.7 tp -70.68 -37.27 73.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.753 0.311 . . . . 340.02 110.536 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -57.74 10.48 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.948 0.404 . . . . 67.5 110.874 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 9' ' ' ILE . 21.4 m -66.54 -17.78 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.941 -0.572 . . . . 56.2 111.284 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.52 -42.57 7.78 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.849 -0.901 . . . . 17.23 110.849 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.48 -53.26 32.9 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.381 -1.088 . . . . 25.06 110.381 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.901 ' O ' HG23 ' A' ' 20' ' ' THR . 23.5 m -46.09 -52.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.884 -0.327 . . . . 30.97 110.171 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.547 ' N ' HG23 ' A' ' 16' ' ' VAL . 94.8 t -56.03 -46.08 80.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.526 -0.47 . . . . 35.41 110.954 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.37 -47.17 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.021 -0.671 . . . . 142.96 109.603 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.88 -40.02 69.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.647 -0.706 . . . . 25.01 110.017 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 16' ' ' VAL . 29.9 p -70.19 -20.01 63.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 130.55 111.022 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.58 -34.9 27.57 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.508 -0.477 . . . . 113.59 110.888 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.7 -44.86 93.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 120.816 -0.354 . . . . 72.54 111.064 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.56 HG11 ' HB ' ' B' ' 20' ' ' THR . 30.1 m -61.78 -35.8 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.596 -0.442 . . . . 28.81 110.85 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.634 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -48.53 -23.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.66 -0.496 . . . . 102.06 109.66 178.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.12 -47.59 12.37 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.002 -0.74 . . . . 114.84 109.002 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.71 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.8 tm? -47.79 -36.27 11.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.547 0.689 . . . . 154.31 109.432 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.695 HG21 HG21 ' B' ' 27' ' ' VAL . 74.0 t -63.66 -65.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.741 -0.663 . . . . 155.81 110.221 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 82.7 mtp -48.21 -26.83 2.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.673 -0.694 . . . . 479.64 110.769 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 54.6 mt -75.09 -19.91 59.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.461 -0.336 . . . . 94.79 111.121 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -51.16 -22.33 2.5 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.596 -0.442 . . . . 870.34 110.825 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -105.01 22.05 15.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.646 0.26 . . . . 892.32 110.574 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.961 -1.018 . . . . 999.99 110.564 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 mttt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.398 -0.593 . . . . 957.99 109.398 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.56 -19.75 79.74 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.235 -0.746 . . . . 165.68 111.235 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.82 81.75 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.719 -0.392 . . . . 71.79 110.759 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 21.9 mt -64.02 -52.55 55.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.332 -0.395 . . . . 202.4 111.807 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.432 ' O ' HG22 ' B' ' 13' ' ' VAL . 8.4 tp -67.09 -42.24 88.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.174 -0.611 . . . . 74.94 109.569 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.432 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -47.02 -47.25 20.14 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.312 -1.115 . . . . 50.24 110.312 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' B' ' 11' ' ' LEU . 18.7 tp -70.66 -37.34 73.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 120.737 0.303 . . . . 339.95 110.47 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -57.72 10.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.957 0.408 . . . . 66.95 110.902 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.432 HG22 ' O ' ' B' ' 9' ' ' ILE . 21.7 m -66.53 -17.69 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.902 -0.59 . . . . 56.24 111.33 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.56 -42.51 7.79 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.843 -0.903 . . . . 17.19 110.843 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.56 -53.26 33.18 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.401 -1.08 . . . . 25.14 110.401 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.905 ' O ' HG23 ' B' ' 20' ' ' THR . 23.6 m -46.12 -52.0 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.802 -0.359 . . . . 30.99 110.202 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.545 ' N ' HG23 ' B' ' 16' ' ' VAL . 94.3 t -56.01 -46.08 80.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.568 -0.453 . . . . 35.55 110.961 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 90.2 mt -63.36 -47.22 92.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.031 -0.668 . . . . 142.35 109.659 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.75 -40.08 68.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.577 -0.738 . . . . 25.02 110.108 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.905 HG23 ' O ' ' B' ' 16' ' ' VAL . 29.9 p -70.13 -20.0 63.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 129.97 111.024 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.62 -34.91 27.43 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.546 -0.462 . . . . 113.52 110.844 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.75 -44.83 93.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 120.833 -0.347 . . . . 73.86 111.051 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.582 HG11 ' HB ' ' A' ' 20' ' ' THR . 30.2 m -61.72 -35.93 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.599 -0.44 . . . . 28.73 110.847 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.651 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -48.49 -23.01 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.463 -0.495 . . . . 102.81 109.71 178.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.11 -47.61 12.35 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.997 -0.742 . . . . 116.39 108.997 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.715 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.8 tm? -47.82 -36.21 11.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.518 0.675 . . . . 155.23 109.41 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.695 HG21 HG21 ' A' ' 27' ' ' VAL . 74.3 t -63.68 -65.72 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.75 -0.659 . . . . 156.82 110.281 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 82.7 mtp -48.23 -26.89 2.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 481.58 110.765 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 55.0 mt -75.03 -19.89 59.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.446 -0.343 . . . . 95.14 111.165 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -51.16 -22.32 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.542 -0.463 . . . . 870.37 110.811 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -105.03 22.05 16.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 121.065 -0.254 . . . . 889.68 110.522 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.933 -1.032 . . . . 999.99 110.497 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.605 0.241 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.564 HD13 HD13 ' B' ' 8' ' ' ILE . 97.7 mt -63.3 -43.7 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.482 ' O ' HG22 ' A' ' 13' ' ' VAL . 5.9 tp -61.01 -36.76 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 109.793 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.63 -66.38 2.88 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 11' ' ' LEU . 4.2 mm? -60.16 -32.79 71.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 110.982 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.23 -63.84 1.16 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 120.863 0.363 . . . . 0.0 110.97 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 9' ' ' ILE . 12.6 m -68.39 -20.82 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.35 -39.81 12.09 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.93 -54.33 26.09 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.7 m -44.51 -49.79 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.95 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -60.49 -42.88 92.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.057 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.0 -51.35 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.465 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.43 -36.8 76.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.149 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -18.52 58.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.998 0.428 . . . . 0.0 110.401 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -32.64 36.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.397 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.434 ' O ' HG22 ' A' ' 25' ' ' THR . 96.7 mt -64.7 -46.34 92.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.375 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.465 ' C ' ' N ' ' A' ' 25' ' ' THR . 29.6 m -66.13 -35.56 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.329 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 24' ' ' ILE . 1.2 tp -49.07 -20.41 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.465 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -74.74 -40.69 61.1 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.649 179.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.913 HD22 ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.92 -25.37 42.78 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 121.396 0.617 . . . . 0.0 109.959 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.569 ' N ' HD13 ' A' ' 26' ' ' LEU . 15.1 t -66.42 -46.47 86.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.738 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.6 mtt -68.3 -33.31 74.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.266 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.9 mt -82.58 -3.37 55.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.265 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -61.83 -37.04 82.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.092 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.8 23.26 4.24 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.58 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.377 179.566 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.08 -32.61 84.77 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.34 -21.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.582 0.229 . . . . 0.0 110.94 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.564 HD13 HD13 ' A' ' 8' ' ' ILE . 97.8 mt -63.2 -43.74 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.493 ' O ' HG22 ' B' ' 13' ' ' VAL . 5.9 tp -60.9 -36.74 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.813 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.68 -66.38 2.88 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.426 ' N ' HD22 ' B' ' 11' ' ' LEU . 4.2 mm? -60.18 -32.82 71.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 0.0 111.015 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.4 tpt -60.05 -63.89 1.14 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 120.901 0.381 . . . . 0.0 111.004 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.493 HG22 ' O ' ' B' ' 9' ' ' ILE . 12.5 m -68.36 -20.83 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.44 -39.78 12.0 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.86 -54.35 25.78 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.7 m -44.57 -49.69 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.618 -0.291 . . . . 0.0 110.904 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.59 -42.87 93.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.007 0.432 . . . . 0.0 111.144 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.9 -51.37 72.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.549 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.83 76.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.18 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.12 -18.46 57.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.942 0.401 . . . . 0.0 110.359 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.68 -32.59 35.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.449 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.433 ' O ' HG22 ' B' ' 25' ' ' THR . 96.7 mt -64.61 -46.41 92.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.365 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.457 ' C ' ' N ' ' B' ' 25' ' ' THR . 29.6 m -66.2 -35.39 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.328 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' B' ' 24' ' ' ILE . 1.2 tp -49.15 -20.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.457 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -74.65 -40.73 61.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.631 179.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.914 ' O ' HD22 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -55.95 -25.21 42.53 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 121.367 0.603 . . . . 0.0 109.94 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.557 ' N ' HD13 ' B' ' 26' ' ' LEU . 15.2 t -66.55 -46.37 86.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.781 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 59.4 mtt -68.48 -33.27 73.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.176 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.52 -3.46 55.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.205 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -61.82 -37.08 83.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.081 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.71 23.2 4.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.585 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.324 179.623 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 120.687 0.28 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.23 -53.44 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.472 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 10' ' ' GLY . 3.6 tp -71.07 -42.17 76.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.167 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -39.5 -46.97 2.87 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 46.9 tp -72.56 -39.48 67.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.735 0.302 . . . . 0.0 110.702 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -59.21 4.46 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.936 0.398 . . . . 0.0 111.47 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.13 -22.18 29.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.034 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.58 -45.36 18.17 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.72 -54.15 29.39 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 20' ' ' THR . 5.5 m -48.23 -51.54 9.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.198 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.408 ' O ' ' OG1' ' A' ' 20' ' ' THR . 91.9 t -59.06 -45.0 92.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.095 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.1 -46.93 95.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.181 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.542 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.01 -39.04 71.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.248 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 16' ' ' VAL . 46.3 p -67.15 -21.32 65.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.182 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.44 -38.6 19.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.2 mt -69.64 -45.13 78.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.552 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.909 HG21 HG21 ' B' ' 23' ' ' VAL . 29.2 m -51.8 -37.86 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.713 0.292 . . . . 0.0 111.054 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.47 ' N ' HG23 ' A' ' 23' ' ' VAL . 37.6 mm -48.25 -45.9 13.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.417 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.29 -52.35 65.63 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.0 tm? -51.04 -40.97 59.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.051 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG11 HG11 ' B' ' 27' ' ' VAL . 92.0 t -65.94 -65.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm -48.54 -26.16 2.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.976 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 32' ' ' LYS . 20.2 mt -72.15 -28.03 62.98 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.354 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -45.53 -14.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.671 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 29' ' ' LEU . 98.9 mttt -98.27 20.18 12.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 32.7 ttpt . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.523 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 56.6 tttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.99 -25.08 67.58 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.54 84.07 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.357 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.2 -53.54 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.433 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.459 HG23 ' N ' ' B' ' 10' ' ' GLY . 3.6 tp -70.95 -42.23 77.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 110.193 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.459 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -39.51 -46.91 2.86 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -72.59 -39.63 67.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.749 0.309 . . . . 0.0 110.605 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -59.06 4.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 111.52 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -66.33 -22.02 29.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.994 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.65 -45.39 17.77 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.51 -54.38 27.68 Favored Glycine 0 C--O 1.224 -0.514 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.882 ' O ' HG23 ' B' ' 20' ' ' THR . 5.4 m -47.95 -51.59 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.325 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.404 ' H ' HG23 ' B' ' 16' ' ' VAL . 91.9 t -59.24 -44.89 93.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.041 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.14 -47.04 95.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.629 0.728 . . . . 0.0 109.158 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.538 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -55.92 -38.86 70.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.287 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.882 HG23 ' O ' ' B' ' 16' ' ' VAL . 46.7 p -67.24 -21.33 65.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.19 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.55 -38.48 19.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 93.1 mt -69.82 -45.21 77.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.485 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.909 HG21 HG21 ' A' ' 23' ' ' VAL . 29.7 m -51.64 -37.72 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.69 0.281 . . . . 0.0 111.088 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.463 ' N ' HG23 ' B' ' 23' ' ' VAL . 37.8 mm -48.48 -45.8 14.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.338 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.42 -52.49 65.0 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.717 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.0 tm? -50.95 -40.81 58.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.054 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.402 HG11 HG11 ' A' ' 27' ' ' VAL . 92.8 t -66.02 -65.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm -48.46 -26.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.01 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 32' ' ' LYS . 20.5 mt -72.22 -27.94 62.85 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.343 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -45.62 -14.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.691 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 98.9 mttt -98.32 20.2 13.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 29' ' ' LEU . 32.8 ttpt . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.498 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.767 0.317 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.05 -49.46 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -82.05 -25.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.338 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.8 -45.81 55.08 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.97 -35.26 32.35 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.577 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -54.74 17.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 120.963 0.411 . . . . 0.0 111.28 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.413 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 34.5 m -67.62 -20.92 26.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.766 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.28 -48.8 7.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.284 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.0 -54.39 14.74 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.885 ' O ' HG23 ' A' ' 20' ' ' THR . 5.0 m -46.28 -49.54 5.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.17 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.4 t -58.79 -45.55 91.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.771 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -62.09 -48.41 88.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.324 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -54.65 -36.86 65.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.454 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 16' ' ' VAL . 44.8 p -68.9 -21.15 64.25 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.171 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.2 mmt -82.8 -38.19 23.46 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.16 -45.76 74.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.824 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.889 HG21 HG21 ' B' ' 23' ' ' VAL . 26.2 m -51.25 -37.31 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 120.698 0.285 . . . . 0.0 110.867 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.473 ' N ' HG23 ' A' ' 23' ' ' VAL . 39.3 mm -48.08 -45.79 12.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.438 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -61.84 -52.67 63.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.2 tm? -49.66 -41.45 42.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.123 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 30' ' ' LYS . 99.6 t -65.93 -65.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.2 mmm -48.59 -24.28 1.28 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 32' ' ' LYS . 25.0 mt -74.69 -26.45 59.84 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.607 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 27' ' ' VAL . 67.1 mttm -44.44 -15.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 71.4 mmtt -100.5 22.85 11.12 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 110.095 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . 22.8 pttp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.718 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' B' ' 10' ' ' GLY . . . -62.75 -24.19 66.14 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.98 82.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.777 0.322 . . . . 0.0 110.197 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.81 -50.16 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.797 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -81.28 -26.07 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.467 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 6' ' ' GLY . . . -51.71 -46.1 54.34 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.77 -35.12 33.61 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -54.8 17.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.955 0.407 . . . . 0.0 111.193 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 34.4 m -67.45 -20.87 27.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.838 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.58 -48.65 7.83 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.0 -54.45 14.51 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.895 ' O ' HG23 ' B' ' 20' ' ' THR . 5.1 m -46.19 -49.6 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.202 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 91.7 t -58.69 -45.64 90.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.775 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.0 -48.42 88.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.411 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.545 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -54.6 -37.1 65.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.467 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.895 HG23 ' O ' ' B' ' 16' ' ' VAL . 44.3 p -68.64 -21.2 64.48 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.151 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.1 mmt -82.85 -38.19 23.33 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 92.3 mt -70.06 -45.78 75.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.827 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 23' ' ' VAL . 25.4 m -51.19 -37.49 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.734 0.302 . . . . 0.0 110.815 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.483 ' N ' HG23 ' B' ' 23' ' ' VAL . 39.2 mm -47.88 -45.9 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.428 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -61.74 -52.68 63.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.693 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.2 tm? -49.67 -41.69 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.154 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.6 -65.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 93.2 mmm -48.44 -24.27 1.21 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.692 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' B' ' 32' ' ' LYS . 24.3 mt -74.74 -26.68 59.95 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.57 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -44.14 -15.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.962 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 71.3 mmtt -100.14 23.01 10.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.922 0.392 . . . . 0.0 110.174 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 29' ' ' LEU . 22.8 pttp . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.617 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.865 0.364 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.32 -48.08 86.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' MET . 5.2 tp -67.98 -43.16 85.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.104 0.478 . . . . 0.0 109.976 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.45 -43.32 0.73 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.612 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.3 mt -78.23 -35.1 48.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.998 0.427 . . . . 0.0 110.609 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -58.98 -63.73 1.19 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.191 -179.261 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.79 -22.45 21.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.134 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.41 -47.81 20.89 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.31 -51.87 44.44 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.889 ' O ' HG23 ' A' ' 20' ' ' THR . 6.6 m -50.78 -48.24 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.098 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.5 t -58.75 -45.36 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.034 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mm -63.08 -45.72 97.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.586 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.4 -38.11 71.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.642 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.889 HG23 ' O ' ' A' ' 16' ' ' VAL . 44.3 p -68.23 -26.01 65.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.396 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.7 mmt -85.92 -38.54 17.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -69.16 -45.96 78.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.587 HG21 HG21 ' B' ' 23' ' ' VAL . 31.7 m -56.85 -34.67 44.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 23' ' ' VAL . 26.2 mm -43.58 -38.99 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.227 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -62.34 -52.2 64.57 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.734 179.035 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.741 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.7 tm? -48.43 -40.48 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.115 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 t -66.14 -66.17 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.215 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mmm -49.8 -24.79 2.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.017 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 31' ' ' LYS . 34.6 mt -73.92 -25.59 60.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.155 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -45.56 -13.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.724 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . 8.6 mtmp? -97.53 20.57 11.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.287 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 29' ' ' LEU . 17.2 mtmm . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.447 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.63 -22.32 69.74 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.42 -21.85 35.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.898 0.38 . . . . 0.0 110.214 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.17 -48.2 86.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.074 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' B' ' 12' ' ' MET . 5.2 tp -67.97 -43.26 85.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.115 0.483 . . . . 0.0 109.952 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.502 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.35 -43.14 0.69 Allowed Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.708 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt -78.38 -35.15 47.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.989 0.423 . . . . 0.0 110.613 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . 0.516 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -58.94 -63.7 1.21 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.231 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.63 -22.43 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.138 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.5 -47.74 20.65 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.26 -51.87 44.23 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.904 ' O ' HG23 ' B' ' 20' ' ' THR . 6.2 m -50.79 -48.31 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.064 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 80.4 t -58.93 -45.25 92.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.982 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mm -63.14 -45.72 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.581 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -56.39 -38.01 70.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.678 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.904 HG23 ' O ' ' B' ' 16' ' ' VAL . 44.5 p -68.36 -25.9 65.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 24.7 mmt -86.09 -38.43 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -69.28 -45.92 78.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.932 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.587 HG21 HG21 ' A' ' 23' ' ' VAL . 32.3 m -56.92 -34.65 44.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mm -43.65 -38.76 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.262 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' B' ' 26' ' ' LEU . 0.6 OUTLIER -62.61 -52.03 64.96 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.721 179.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.739 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.7 tm? -48.67 -40.39 27.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.091 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 t -66.13 -66.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.246 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mmm -49.82 -24.73 2.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.062 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 32' ' ' LYS . 34.9 mt -73.99 -25.46 59.92 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.117 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -45.6 -13.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.588 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' B' ' 29' ' ' LEU . 8.6 mtmp? -97.6 20.7 11.4 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 29' ' ' LEU . 17.2 mtmm . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.497 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.801 0.334 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.706 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.0 mp -65.23 -53.89 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.213 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' MET . 3.9 tp -70.88 -41.91 77.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.932 0.396 . . . . 0.0 110.537 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.42 -46.26 1.03 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.471 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.3 mm? -77.1 -32.51 56.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.48 0.181 . . . . 0.0 110.947 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -60.92 -62.49 1.82 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.793 0.33 . . . . 0.0 111.341 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -66.72 -21.93 29.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.817 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.85 -45.93 10.07 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.513 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.4 -53.07 37.04 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.883 ' O ' HG23 ' A' ' 20' ' ' THR . 4.5 m -47.36 -51.35 6.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.187 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.45 ' H ' HG23 ' A' ' 16' ' ' VAL . 73.9 t -58.01 -45.11 88.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.568 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.12 -48.07 90.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.674 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.14 -36.77 68.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.268 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 16' ' ' VAL . 44.8 p -67.79 -21.61 65.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.031 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.9 -38.3 23.05 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.328 0.392 . . . . 0.0 111.742 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.37 -46.19 72.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.874 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.958 HG21 HG21 ' B' ' 23' ' ' VAL . 31.5 m -50.47 -37.24 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.819 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.488 ' N ' HG23 ' A' ' 23' ' ' VAL . 38.7 mm -47.96 -46.28 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 m -60.95 -52.71 63.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.715 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.3 tm? -50.53 -41.1 53.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.339 0.59 . . . . 0.0 109.939 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.528 HG11 HG11 ' B' ' 27' ' ' VAL . 84.2 t -66.48 -66.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.874 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.1 mtp -47.96 -24.03 0.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.665 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 32' ' ' LYS . 19.8 mt -73.61 -26.92 61.02 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.711 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 27' ' ' VAL . 66.9 mttm -44.9 -14.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.707 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 29' ' ' LEU . 53.0 mtmt -99.18 21.93 11.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.767 0.318 . . . . 0.0 110.395 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 29' ' ' LEU . 66.0 tttm . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.623 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.0 -27.66 72.53 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.97 -34.69 78.56 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.281 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.69 HD12 ' N ' ' B' ' 8' ' ' ILE . 2.0 mp -65.5 -53.95 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.182 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 12' ' ' MET . 3.8 tp -70.92 -41.8 77.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.853 0.358 . . . . 0.0 110.502 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.464 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.55 -45.9 1.03 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.467 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.3 mm? -77.51 -32.41 54.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.178 . . . . 0.0 110.887 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . 0.528 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -61.08 -62.73 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.748 0.308 . . . . 0.0 111.273 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 m -66.37 -22.03 29.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.815 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.82 -45.96 10.08 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.452 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.35 -53.08 36.8 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.89 ' O ' HG23 ' B' ' 20' ' ' THR . 4.6 m -47.34 -51.44 6.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.125 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.471 ' O ' ' OG1' ' B' ' 20' ' ' THR . 73.4 t -57.98 -45.1 87.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.6 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.25 -47.89 90.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.739 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.536 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -56.15 -37.05 68.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.22 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.89 HG23 ' O ' ' B' ' 16' ' ' VAL . 45.9 p -67.61 -21.63 65.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.075 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.91 -38.21 23.15 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.242 0.339 . . . . 0.0 111.72 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 94.7 mt -70.36 -46.13 72.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.97 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.958 HG21 HG21 ' A' ' 23' ' ' VAL . 31.6 m -50.64 -37.44 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.712 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.49 ' N ' HG23 ' B' ' 23' ' ' VAL . 38.9 mm -47.73 -46.34 11.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -60.86 -52.58 64.46 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.729 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.3 tm? -50.73 -41.32 56.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.867 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.528 HG11 HG11 ' A' ' 27' ' ' VAL . 84.0 t -66.19 -66.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.914 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 96.9 mtp -47.88 -24.04 0.91 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.657 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 32' ' ' LYS . 19.5 mt -73.66 -27.12 61.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.654 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -44.68 -14.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.771 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 53.3 mtmt -99.19 22.02 11.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.822 0.344 . . . . 0.0 110.346 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.9 tttm . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.595 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.694 0.283 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.05 -48.9 83.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.024 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 10' ' ' GLY . 3.8 tp -69.84 -44.14 79.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.295 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.58 -47.56 1.2 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.431 ' N ' HD22 ' A' ' 11' ' ' LEU . 4.3 mm? -73.3 -36.26 66.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.726 0.298 . . . . 0.0 110.706 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -57.44 -63.16 1.32 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.925 0.393 . . . . 0.0 111.567 -179.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.74 -21.98 26.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.218 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.49 -47.64 10.14 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.264 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.21 -52.45 31.78 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.887 ' O ' HG23 ' A' ' 20' ' ' THR . 5.5 m -47.86 -48.58 11.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.793 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.529 ' O ' ' SD ' ' A' ' 21' ' ' MET . 93.9 t -59.21 -46.52 92.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.994 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.6 -47.49 93.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -52.8 -38.47 61.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.375 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.887 HG23 ' O ' ' A' ' 16' ' ' VAL . 39.7 p -69.39 -24.38 63.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.221 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -79.97 -39.94 29.06 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.7 mt -70.43 -45.36 75.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.94 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.754 HG21 HG21 ' B' ' 23' ' ' VAL . 28.8 m -54.77 -37.78 41.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.039 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -46.54 -47.21 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 29' ' ' LEU . 2.5 m -60.11 -53.24 60.06 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.707 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.9 tm? -49.99 -38.07 35.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.702 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.545 HG11 HG11 ' B' ' 27' ' ' VAL . 58.9 t -63.83 -68.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.648 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 16.1 ptm -48.81 -20.86 0.54 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.222 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 32' ' ' LYS . 8.6 mt -74.61 -25.85 59.52 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.126 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -45.23 -15.01 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.45 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' LEU . 98.9 mttt -99.86 23.86 9.19 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.079 0.466 . . . . 0.0 109.86 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 29' ' ' LEU . 24.8 mtmm . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.9 71.07 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.81 43.55 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.416 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 37.7 mm -63.91 -49.08 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.03 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.509 HG23 ' N ' ' B' ' 10' ' ' GLY . 3.8 tp -69.71 -44.06 79.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.383 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.509 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.83 -47.2 1.24 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.433 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.3 mm? -73.57 -36.2 65.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 110.698 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . 0.497 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -57.45 -63.35 1.26 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 120.96 0.41 . . . . 0.0 111.512 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -68.73 -21.89 26.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.171 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.32 -47.78 10.28 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.286 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.25 33.39 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.877 ' O ' HG23 ' B' ' 20' ' ' THR . 5.5 m -47.85 -48.7 11.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.765 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.531 ' O ' ' SD ' ' B' ' 21' ' ' MET . 93.8 t -59.18 -46.41 92.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.038 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mm -61.74 -47.42 93.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.521 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -52.83 -38.51 61.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.359 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.877 HG23 ' O ' ' B' ' 16' ' ' VAL . 40.3 p -69.27 -24.43 63.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.263 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -80.02 -39.91 28.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 92.7 mt -70.44 -45.35 75.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.936 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 23' ' ' VAL . 29.7 m -54.8 -37.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.97 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.586 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -46.46 -47.04 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.434 HG22 HD12 ' B' ' 29' ' ' LEU . 2.5 m -60.24 -53.15 61.12 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.715 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.9 tm? -50.12 -38.06 37.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.697 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 27' ' ' VAL . 58.7 t -63.85 -68.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.653 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 16.2 ptm -48.82 -20.95 0.55 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.214 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 32' ' ' LYS . 8.5 mt -74.62 -25.78 59.46 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.027 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -45.35 -14.69 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.452 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 99.0 mttt -100.13 23.74 9.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.092 0.472 . . . . 0.0 109.874 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' B' ' 29' ' ' LEU . 24.8 mtmm . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.801 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.872 0.367 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.4 mp -63.6 -45.07 98.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.073 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.48 -25.22 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.051 0.453 . . . . 0.0 110.693 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.05 -43.49 62.16 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.591 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -82.16 -27.01 32.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 110.646 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -61.68 2.4 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.65 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.35 -23.5 28.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.063 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.37 -43.21 79.68 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.27 -61.42 6.98 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.0 m -50.02 -26.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.185 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.32 -46.92 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.2 mt -67.91 -45.0 84.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.863 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.58 -40.81 72.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.676 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.888 ' OG1' HG11 ' B' ' 23' ' ' VAL . 4.2 t -75.93 -27.5 57.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.22 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.6 mmt -72.16 -40.15 68.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.76 -46.15 79.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.682 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.918 HG11 ' OG1' ' B' ' 20' ' ' THR . 21.9 m -65.24 -33.48 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -43.78 -50.09 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.904 -179.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.466 ' OG1' HD11 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -66.22 -49.7 66.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.837 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.712 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.1 tm? -41.97 -37.84 1.44 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.079 0.466 . . . . 0.0 110.684 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.622 HG11 HG11 ' B' ' 27' ' ' VAL . 58.2 t -69.01 -58.27 6.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 73.9 mtm -59.68 -22.21 61.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.41 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.466 HD11 ' OG1' ' A' ' 25' ' ' THR . 74.8 mt -79.91 -5.98 56.58 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.37 -9.49 8.38 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.833 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -102.74 19.87 18.38 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.65 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.848 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.99 -37.78 83.71 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.28 -22.47 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 0.0 110.801 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.555 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.4 mp -63.45 -45.08 98.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.077 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.45 -25.38 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.081 0.467 . . . . 0.0 110.728 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.94 -43.3 61.23 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.72 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -82.37 -26.92 32.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.856 0.36 . . . . 0.0 110.75 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -61.85 2.26 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.17 -23.38 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.058 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.32 -43.28 79.83 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.2 -60.97 7.41 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 m -50.47 -26.27 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 122.695 -0.297 . . . . 0.0 111.191 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -82.23 -46.92 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.061 0.458 . . . . 0.0 111.229 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.11 -44.98 84.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.931 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.54 -40.78 72.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.736 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.918 ' OG1' HG11 ' A' ' 23' ' ' VAL . 3.8 t -75.85 -27.59 57.89 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.269 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 29.6 mmt -72.18 -40.23 68.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.78 -46.1 79.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.724 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.888 HG11 ' OG1' ' A' ' 20' ' ' THR . 22.1 m -65.33 -33.58 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.478 -0.489 . . . . 0.0 112.277 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.555 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -43.66 -50.14 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 120.491 -0.483 . . . . 0.0 109.867 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.467 ' OG1' HD11 ' B' ' 29' ' ' LEU . 0.5 OUTLIER -66.3 -49.56 66.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.923 179.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.724 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.1 tm? -42.16 -37.77 1.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.637 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.622 HG11 HG11 ' A' ' 27' ' ' VAL . 58.7 t -69.0 -58.34 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 74.1 mtm -59.54 -22.39 61.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.438 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.467 HD11 ' OG1' ' B' ' 25' ' ' THR . 74.7 mt -79.86 -5.88 56.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -62.48 -9.39 8.39 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -102.83 19.68 18.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.712 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.792 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.608 0.242 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.586 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.5 mp -62.36 -44.0 98.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.15 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.5 tp -51.64 -32.5 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.43 99.06 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.227 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.46 -24.92 34.01 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.36 -63.83 1.16 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.177 0.513 . . . . 0.0 110.593 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.1 m -67.42 -22.23 28.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.863 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.79 -40.04 15.77 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.34 -54.91 29.39 Favored Glycine 0 C--N 1.331 0.262 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.915 ' O ' HG23 ' A' ' 20' ' ' THR . 6.5 m -45.6 -51.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.551 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.4 -42.1 89.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.21 -50.12 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.321 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.76 -34.22 69.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.426 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.915 HG23 ' O ' ' A' ' 16' ' ' VAL . 34.2 p -74.6 -20.53 59.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.584 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.9 mmt -82.45 -31.55 29.39 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.373 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.98 -47.46 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.951 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.47 HG11 ' HB ' ' B' ' 20' ' ' THR . 18.9 m -63.94 -31.71 54.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.695 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 20' ' ' THR . 0.9 OUTLIER -54.64 -21.02 6.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.42 -43.89 59.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.028 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.738 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -58.92 -27.33 65.17 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.273 0.558 . . . . 0.0 110.625 -179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.4 t -65.26 -44.83 94.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.955 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.6 mtp -72.53 -29.21 63.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.365 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.47 -3.28 33.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.319 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -68.57 -18.18 64.29 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.494 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 32' ' ' LYS . 46.8 tttp -95.65 15.3 20.36 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.664 0.269 . . . . 0.0 110.717 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 31' ' ' LYS . 22.0 pttp . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.957 -1.02 . . . . 0.0 111.696 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.405 ' O ' HG22 ' B' ' 9' ' ' ILE . . . -64.98 -33.12 86.4 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.99 -25.38 58.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.63 0.252 . . . . 0.0 111.199 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.566 ' N ' HD12 ' B' ' 8' ' ' ILE . 1.5 mp -62.33 -43.95 98.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.168 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.405 HG22 ' O ' ' B' ' 6' ' ' GLY . 2.5 tp -51.54 -32.57 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.41 -43.45 99.04 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.19 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.48 -24.92 33.96 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.877 0.37 . . . . 0.0 110.892 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.35 -63.82 1.17 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.622 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 23.4 m -67.45 -22.16 28.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.884 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.93 -39.79 15.95 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.236 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.28 -55.08 28.3 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.915 ' O ' HG23 ' B' ' 20' ' ' THR . 6.5 m -45.52 -51.81 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.549 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.5 -42.09 90.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.067 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.14 -50.21 81.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.321 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.75 -34.09 69.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.572 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.915 HG23 ' O ' ' B' ' 16' ' ' VAL . 33.8 p -74.7 -20.35 59.89 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.651 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.9 mmt -82.49 -31.59 29.22 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.343 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.87 -47.6 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.017 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.47 HG11 ' HB ' ' A' ' 20' ' ' THR . 19.0 m -63.79 -31.73 54.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.795 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.625 HD13 ' O ' ' B' ' 20' ' ' THR . 0.9 OUTLIER -54.6 -20.99 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -43.93 59.1 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.954 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.736 HD13 ' C ' ' B' ' 26' ' ' LEU . 0.3 OUTLIER -58.91 -27.33 65.15 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.245 0.545 . . . . 0.0 110.662 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.3 -44.82 94.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.983 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 77.7 mtp -72.53 -29.1 63.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.364 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.7 -3.14 33.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.22 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -68.64 -18.07 64.22 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.547 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' B' ' 32' ' ' LYS . 46.9 tttp -95.74 15.3 20.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.688 0.28 . . . . 0.0 110.664 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' B' ' 31' ' ' LYS . 22.0 pttp . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.755 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.43 -53.2 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.484 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.1 tp -70.91 -42.8 77.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.458 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -35.71 -48.58 0.99 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mt -72.81 -38.27 67.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.825 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.501 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -55.74 -61.56 2.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 120.745 0.307 . . . . 0.0 111.636 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.99 -22.63 30.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.74 -45.85 16.03 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.389 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.34 -53.83 32.89 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.879 ' O ' HG23 ' A' ' 20' ' ' THR . 4.8 m -49.22 -50.71 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.013 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.522 ' O ' ' SD ' ' A' ' 21' ' ' MET . 58.2 t -57.84 -45.62 87.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.642 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.39 -46.44 96.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.383 0.611 . . . . 0.0 109.827 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.514 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.51 -38.25 71.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.139 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.879 HG23 ' O ' ' A' ' 16' ' ' VAL . 41.7 p -67.31 -25.4 66.01 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.678 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -80.86 -39.13 26.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -71.23 -46.59 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.8 HG21 HG21 ' B' ' 23' ' ' VAL . 34.8 m -51.31 -37.11 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.946 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 20' ' ' THR . 1.2 mp -47.44 -46.2 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -60.15 -53.3 59.41 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.585 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.713 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.2 tm? -50.75 -40.91 56.0 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.133 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.94 -67.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.62 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.9 mtt -48.7 -23.07 0.91 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.214 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 31' ' ' LYS . 16.3 mt -72.53 -26.63 61.82 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.702 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -45.78 -13.2 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.762 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 29' ' ' LEU . 27.9 ttpt -98.28 19.56 14.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.85 0.357 . . . . 0.0 110.252 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LEU . 65.2 tttm . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.631 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.63 -27.22 72.41 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.48 84.49 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.283 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.04 -53.27 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.473 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.1 tp -70.94 -42.71 77.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.429 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.48 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.06 -48.13 1.07 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.7 mt -73.15 -38.19 66.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.824 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -55.59 -61.72 2.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.793 0.33 . . . . 0.0 111.622 -179.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.91 -22.39 30.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.795 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.92 -45.92 15.14 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.381 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.37 -53.75 33.34 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.886 ' O ' HG23 ' B' ' 20' ' ' THR . 4.9 m -49.04 -50.93 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.057 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.526 ' O ' ' SD ' ' B' ' 21' ' ' MET . 58.8 t -57.77 -45.55 87.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.72 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.45 -46.54 96.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.833 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.498 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -56.41 -38.44 71.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.059 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.886 HG23 ' O ' ' B' ' 16' ' ' VAL . 41.2 p -67.05 -25.37 66.22 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.802 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.533 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -80.93 -39.19 26.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.18 -46.69 64.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.096 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.8 HG21 HG21 ' A' ' 23' ' ' VAL . 35.1 m -51.24 -37.16 17.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.872 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.692 HD13 ' O ' ' B' ' 20' ' ' THR . 1.2 mp -47.42 -46.01 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -60.4 -53.13 61.24 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.707 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.2 tm? -50.88 -40.85 57.54 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.079 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.98 -67.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.549 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 68.0 mtt -48.5 -23.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.207 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' B' ' 32' ' ' LYS . 15.8 mt -72.43 -26.69 61.94 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.686 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -45.67 -13.33 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.803 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' B' ' 29' ' ' LEU . 27.9 ttpt -98.33 19.74 13.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 110.281 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.1 tttm . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.616 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.688 0.28 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.682 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.8 mp -68.56 -54.61 20.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.876 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.2 tp -69.67 -41.99 80.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.254 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.436 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -34.31 -60.73 0.58 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.66 -29.26 70.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.591 0.234 . . . . 0.0 111.242 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -66.05 -63.66 1.03 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.084 0.469 . . . . 0.0 111.267 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.88 -20.01 23.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.547 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.84 -40.59 5.87 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.48 -49.23 57.95 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 20' ' ' THR . 9.6 m -44.98 -49.64 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.725 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.406 ' N ' HG23 ' A' ' 16' ' ' VAL . 62.9 t -58.68 -43.41 87.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.862 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.98 -49.1 86.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.39 -36.28 71.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.962 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.893 HG23 ' O ' ' A' ' 16' ' ' VAL . 31.2 p -73.16 -18.43 61.27 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.696 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.7 -31.74 28.41 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.399 -0.52 . . . . 0.0 109.987 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 25' ' ' THR . 97.1 mt -63.35 -46.17 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.381 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' LEU . 27.2 m -64.41 -35.04 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.345 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 20' ' ' THR . 1.1 mp -46.87 -20.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -76.24 -40.68 51.36 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.207 178.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.717 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -54.4 -31.54 55.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.278 0.561 . . . . 0.0 109.87 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.7 t -63.25 -29.96 48.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.473 0.654 . . . . 0.0 109.826 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.9 mtp -84.38 -32.98 23.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.788 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 32' ' ' LYS . 59.2 mt -66.6 -41.88 87.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -49.43 -10.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.718 0.294 . . . . 0.0 111.001 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 29' ' ' LEU . 99.5 mttt -96.24 12.27 31.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.109 0.48 . . . . 0.0 109.982 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' LEU . 32.5 ttpt . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.301 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.63 -33.6 87.68 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.44 74.85 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.516 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.677 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.8 mp -68.67 -54.58 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.86 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.2 tp -69.6 -42.09 80.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.22 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.432 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -34.23 -61.08 0.55 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.4 -28.95 70.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.804 -0.198 . . . . 0.0 111.253 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . 0.52 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -66.37 -63.79 1.0 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 111.203 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.76 -20.05 23.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.528 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.76 -40.6 5.89 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.44 -49.23 57.83 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.901 ' O ' HG23 ' B' ' 20' ' ' THR . 9.4 m -44.98 -49.75 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.217 -0.491 . . . . 0.0 110.698 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.41 ' N ' HG23 ' B' ' 16' ' ' VAL . 65.5 t -58.55 -43.48 87.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.872 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.92 -49.18 85.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.37 -36.18 70.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.052 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.901 HG23 ' O ' ' B' ' 16' ' ' VAL . 30.7 p -73.26 -18.29 61.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.653 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.72 -31.7 28.35 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.047 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.459 ' O ' HG22 ' B' ' 25' ' ' THR . 97.1 mt -63.47 -46.21 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' B' ' 26' ' ' LEU . 27.1 m -64.29 -35.25 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.389 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.656 HD13 ' O ' ' B' ' 20' ' ' THR . 1.1 mp -46.7 -20.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.459 HG22 ' O ' ' B' ' 22' ' ' ILE . 0.7 OUTLIER -76.45 -40.62 50.0 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.161 178.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.723 ' C ' HD13 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -54.5 -31.59 56.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.327 0.584 . . . . 0.0 109.825 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -63.21 -30.02 48.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.454 0.645 . . . . 0.0 109.778 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.1 mtp -84.28 -33.03 24.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.842 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' B' ' 31' ' ' LYS . 59.3 mt -66.62 -41.8 87.79 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -49.48 -10.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.699 0.285 . . . . 0.0 110.921 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' B' ' 29' ' ' LEU . 99.4 mttt -96.07 12.49 30.42 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.204 0.526 . . . . 0.0 110.014 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' B' ' 29' ' ' LEU . 32.4 ttpt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.339 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.816 0.341 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.27 -42.84 96.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.455 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 tp -58.74 -37.67 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.0 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.56 -42.91 52.36 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.1 tp -73.38 -26.91 61.19 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.746 -0.267 . . . . 0.0 111.084 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.53 -60.25 3.69 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 120.802 0.334 . . . . 0.0 110.847 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -55.33 -23.47 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.024 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.19 -40.5 29.05 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.343 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.441 ' C ' HG12 ' B' ' 16' ' ' VAL . . . -58.19 -43.67 95.26 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.366 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 20' ' ' THR . 11.0 m -61.74 -24.15 33.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.606 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.455 ' O ' ' SD ' ' A' ' 21' ' ' MET . 54.3 t -86.08 -39.97 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 123.461 0.476 . . . . 0.0 111.341 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.84 -52.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.635 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.839 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -54.67 -46.39 74.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.779 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.862 ' OG1' HG11 ' B' ' 23' ' ' VAL . 4.2 t -68.96 -17.62 63.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.48 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.455 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -85.0 -29.04 25.33 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.288 0.367 . . . . 0.0 111.373 -179.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.31 -39.19 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.863 HG11 ' OG1' ' B' ' 20' ' ' THR . 13.6 m -56.57 -39.24 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.105 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.498 ' N ' HG23 ' A' ' 23' ' ' VAL . 37.2 mm -40.73 -49.77 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -60.28 -41.02 92.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.972 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.736 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.5 tm? -60.07 -48.36 82.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.866 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.541 HG11 HG11 ' B' ' 27' ' ' VAL . 93.2 t -62.19 -42.92 97.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.344 0.592 . . . . 0.0 109.996 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.9 mmm -63.55 -18.56 63.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.761 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 31' ' ' LYS . 34.6 mt -87.5 -49.86 6.92 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.427 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.612 ' HE2' HD11 ' A' ' 26' ' ' LEU . 66.2 mttm -55.76 -4.28 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.535 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 29' ' ' LEU . 16.9 tptm -156.29 60.64 0.56 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.117 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.471 179.498 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' B' ' 8' ' ' ILE . . . -61.8 -34.01 87.23 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.41 -19.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.735 0.303 . . . . 0.0 110.657 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.432 ' N ' ' C ' ' B' ' 6' ' ' GLY . 96.9 mt -64.16 -42.9 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.414 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.404 HG22 ' O ' ' B' ' 6' ' ' GLY . 3.0 tp -58.72 -37.53 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.002 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.64 -42.96 52.92 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.3 tp -73.4 -26.91 61.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.749 -0.265 . . . . 0.0 111.118 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -60.28 3.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.791 0.329 . . . . 0.0 110.763 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 29.8 m -55.36 -23.34 13.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.104 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.23 -40.61 28.54 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.352 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.434 ' C ' HG12 ' A' ' 16' ' ' VAL . . . -58.02 -43.65 94.96 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.434 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.614 ' O ' HG22 ' B' ' 20' ' ' THR . 10.8 m -61.83 -24.11 33.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.596 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.453 ' O ' ' SD ' ' B' ' 21' ' ' MET . 54.8 t -86.23 -39.93 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 123.517 0.511 . . . . 0.0 111.324 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.83 -52.61 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.587 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.848 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -54.59 -46.4 73.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.743 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.863 ' OG1' HG11 ' A' ' 23' ' ' VAL . 4.1 t -68.87 -17.64 64.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.407 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.1 OUTLIER -85.13 -29.08 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.325 0.39 . . . . 0.0 111.285 -178.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.14 -39.37 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 111.199 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.862 HG11 ' OG1' ' A' ' 20' ' ' THR . 13.5 m -56.37 -39.35 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.058 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.493 ' N ' HG23 ' B' ' 23' ' ' VAL . 37.0 mm -40.65 -49.85 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -60.29 -41.01 92.47 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.978 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.718 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.5 tm? -60.01 -48.4 81.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.851 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.541 HG11 HG11 ' A' ' 27' ' ' VAL . 96.1 t -62.21 -42.87 96.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.216 0.532 . . . . 0.0 110.055 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 94.2 mmm -63.52 -18.72 64.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.785 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' B' ' 31' ' ' LYS . 34.5 mt -87.43 -49.76 7.0 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.432 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.594 ' HE2' HD11 ' B' ' 26' ' ' LEU . 66.4 mttm -55.8 -4.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.54 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' B' ' 29' ' ' LEU . 16.9 tptm -156.51 60.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.122 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.432 179.526 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.687 0.279 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -62.71 -44.1 99.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.59 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.498 ' O ' HG22 ' A' ' 13' ' ' VAL . 6.0 tp -56.12 -33.78 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.8 -45.06 96.99 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.005 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.55 -29.56 37.1 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 120.905 0.383 . . . . 0.0 111.097 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.3 tpt -64.31 -63.61 1.1 Allowed 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.489 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 9' ' ' ILE . 4.7 m -66.84 -22.15 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.528 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.04 -41.48 10.35 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.23 -54.25 35.38 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.888 ' O ' HG23 ' A' ' 20' ' ' THR . 6.3 m -45.57 -51.04 3.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.874 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.512 ' O ' ' SD ' ' A' ' 21' ' ' MET . 85.8 t -59.1 -43.59 89.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.947 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.8 -49.05 85.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.686 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.28 -34.18 68.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.396 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.888 HG23 ' O ' ' A' ' 16' ' ' VAL . 33.2 p -74.16 -20.67 60.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.63 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' OG1' ' A' ' 20' ' ' THR . 0.0 OUTLIER -81.9 -31.7 31.31 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.622 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 25' ' ' THR . 96.8 mt -62.91 -48.56 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.524 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.434 ' C ' ' N ' ' A' ' 25' ' ' THR . 23.8 m -63.3 -31.99 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.968 0.413 . . . . 0.0 110.759 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.597 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -50.19 -19.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 22' ' ' ILE . 1.2 t -74.56 -42.08 59.42 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.348 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.706 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -56.39 -29.92 62.08 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.244 0.545 . . . . 0.0 110.436 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.74 -46.49 92.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.378 0.608 . . . . 0.0 109.711 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 90.0 mtp -70.28 -33.97 72.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.031 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.36 -2.95 54.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.32 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -61.45 -37.51 83.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.95 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.66 23.2 3.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.269 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.383 179.406 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.22 -26.52 70.55 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.54 -23.03 14.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.72 0.295 . . . . 0.0 110.639 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -62.67 -44.13 99.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.62 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.495 ' O ' HG22 ' B' ' 13' ' ' VAL . 6.0 tp -56.13 -33.8 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.71 -45.2 96.75 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.059 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.47 -29.57 37.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.86 0.362 . . . . 0.0 111.123 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 8.3 tpt -64.3 -63.64 1.09 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.545 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 9' ' ' ILE . 4.7 m -66.76 -22.28 29.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.513 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.01 -41.36 10.49 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.22 -54.3 35.0 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.89 ' O ' HG23 ' B' ' 20' ' ' THR . 6.6 m -45.59 -50.99 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.953 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.508 ' O ' ' SD ' ' B' ' 21' ' ' MET . 85.3 t -59.13 -43.65 89.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.904 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.72 -49.07 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.681 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.32 -34.23 68.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.341 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.89 HG23 ' O ' ' B' ' 16' ' ' VAL . 33.4 p -74.16 -20.74 60.12 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.693 0.282 . . . . 0.0 110.607 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.53 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -81.82 -31.67 31.61 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.626 179.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.487 ' O ' HG22 ' B' ' 25' ' ' THR . 96.8 mt -62.97 -48.52 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.499 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.431 ' C ' ' N ' ' B' ' 25' ' ' THR . 24.3 m -63.34 -31.91 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.936 0.398 . . . . 0.0 110.829 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.598 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -50.18 -19.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.487 HG22 ' O ' ' B' ' 22' ' ' ILE . 1.2 t -74.5 -42.05 59.61 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.309 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.707 ' C ' HD13 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -56.43 -29.89 62.16 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.284 0.564 . . . . 0.0 110.48 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.81 -46.38 92.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.277 0.561 . . . . 0.0 109.714 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 89.8 mtp -70.38 -33.85 71.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.977 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 93.2 mt -82.42 -2.92 54.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.298 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -61.51 -37.55 84.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.878 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.6 23.24 3.11 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.323 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.307 179.479 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.629 0.252 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.496 HD13 HD13 ' B' ' 8' ' ' ILE . 91.9 mt -62.7 -43.61 98.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.23 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 13' ' ' VAL . 5.1 tp -60.0 -33.2 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.146 0.498 . . . . 0.0 109.799 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.75 -68.72 1.55 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.319 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -60.98 -27.49 68.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.051 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.07 -63.84 1.05 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 120.854 0.359 . . . . 0.0 110.727 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 9' ' ' ILE . 7.5 m -70.21 -21.16 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.05 -39.32 8.61 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.72 -53.17 40.88 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.885 ' O ' HG23 ' A' ' 20' ' ' THR . 4.8 m -45.45 -48.4 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.9 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.524 ' O ' ' SD ' ' A' ' 21' ' ' MET . 97.4 t -58.72 -44.09 89.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.755 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.44 -48.02 90.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.58 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.65 68.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.543 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 16' ' ' VAL . 31.1 p -74.81 -18.95 60.38 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.653 0.263 . . . . 0.0 110.783 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -83.75 -30.84 26.35 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.221 179.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 25' ' ' THR . 96.7 mt -62.99 -48.24 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.368 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.438 ' C ' ' N ' ' A' ' 25' ' ' THR . 25.0 m -63.77 -32.64 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.078 0.466 . . . . 0.0 110.72 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -48.82 -21.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -75.84 -41.19 53.22 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.611 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.729 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -56.72 -30.25 63.3 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.451 0.643 . . . . 0.0 110.389 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.2 t -61.84 -38.65 81.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.51 0.672 . . . . 0.0 109.391 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.5 mmm -72.88 -28.43 62.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.79 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.75 -6.59 56.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.013 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.14 -39.01 91.15 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.782 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -94.0 18.03 11.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.793 0.33 . . . . 0.0 110.42 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.647 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.82 -33.39 87.12 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.4 -23.03 46.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.69 0.281 . . . . 0.0 110.85 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.496 HD13 HD13 ' A' ' 8' ' ' ILE . 91.3 mt -62.55 -43.65 98.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.288 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.466 ' O ' HG22 ' B' ' 13' ' ' VAL . 5.1 tp -59.97 -33.22 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.169 0.509 . . . . 0.0 109.817 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.81 -68.71 1.56 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.257 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.484 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.2 mm? -60.96 -27.5 68.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.034 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.16 -63.82 1.05 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 120.841 0.353 . . . . 0.0 110.724 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.466 HG22 ' O ' ' B' ' 9' ' ' ILE . 7.3 m -70.1 -21.13 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.14 -39.38 8.52 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.58 -53.16 40.52 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.884 ' O ' HG23 ' B' ' 20' ' ' THR . 4.8 m -45.49 -48.35 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.877 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.515 ' O ' ' SD ' ' B' ' 21' ' ' MET . 97.2 t -58.91 -43.85 89.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.765 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.61 -48.02 90.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.504 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.71 69.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.47 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.884 HG23 ' O ' ' B' ' 16' ' ' VAL . 31.0 p -74.68 -19.08 60.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.817 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -83.54 -30.99 26.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.279 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.44 ' O ' HG22 ' B' ' 25' ' ' THR . 96.7 mt -62.91 -48.22 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.453 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.449 ' C ' ' N ' ' B' ' 25' ' ' THR . 25.5 m -63.73 -32.65 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.158 0.504 . . . . 0.0 110.751 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.552 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -48.91 -20.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.449 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -75.95 -41.21 52.22 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.594 179.058 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.727 ' C ' HD13 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -56.66 -30.15 63.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.424 0.63 . . . . 0.0 110.43 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.3 t -61.93 -39.05 82.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.49 0.662 . . . . 0.0 109.291 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.5 mmm -72.39 -28.52 63.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.825 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.79 -6.48 56.05 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.992 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.26 -38.86 90.9 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.708 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -94.03 17.91 11.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.771 0.32 . . . . 0.0 110.396 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.554 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.13 -53.77 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.52 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 tp -70.17 -38.56 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 109.976 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.5 -46.12 8.61 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.5 tp -73.03 -38.47 66.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 121.189 -0.204 . . . . 0.0 110.79 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -57.27 8.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.982 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 27.0 m -65.4 -20.72 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.211 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.15 -40.81 10.93 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.53 -54.89 25.25 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.7 m -44.49 -51.29 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.452 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.13 -42.24 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.58 -49.91 60.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.374 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.22 77.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.869 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.429 ' OG1' HG11 ' B' ' 23' ' ' VAL . 14.2 t -80.07 -17.25 53.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 110.235 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.44 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -79.36 -31.81 43.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.284 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 25' ' ' THR . 97.1 mt -63.53 -46.81 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.066 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.457 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' C ' ' N ' ' A' ' 25' ' ' THR . 33.6 m -64.8 -35.12 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.061 0.457 . . . . 0.0 110.198 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 21' ' ' MET . 1.6 tp -45.05 -22.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 22' ' ' ILE . 1.3 t -72.07 -41.04 67.83 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.669 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.691 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -53.0 -30.49 35.5 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.875 0.47 . . . . 0.0 110.688 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.572 HG22 HG22 ' B' ' 27' ' ' VAL . 11.0 t -64.96 -45.93 93.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.28 0.562 . . . . 0.0 109.493 177.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.7 mtt -71.47 -34.67 70.41 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.917 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.8 mt -83.75 -2.96 57.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.78 -37.44 86.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.77 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.59 23.79 4.44 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.398 179.749 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.41 -25.35 64.88 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.19 83.47 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.104 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.17 -54.03 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.463 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.4 HG23 ' N ' ' B' ' 10' ' ' GLY . 6.0 tp -70.02 -38.58 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.129 0.49 . . . . 0.0 109.944 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.4 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -44.39 -46.48 8.51 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 44.8 tp -72.66 -38.52 67.6 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.848 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . 0.401 ' SD ' ' C ' ' B' ' 12' ' ' MET . 0.0 OUTLIER -50.53 -57.23 8.6 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.058 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 27.0 m -65.4 -20.75 28.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.12 -40.77 11.02 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.59 -54.87 25.53 Favored Glycine 0 C--O 1.223 -0.587 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.7 m -44.59 -51.22 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.49 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.401 ' H ' HG23 ' B' ' 16' ' ' VAL . 69.5 t -56.21 -42.11 72.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.771 0.319 . . . . 0.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.79 -49.76 61.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.33 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.25 77.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.801 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.43 ' OG1' HG11 ' A' ' 23' ' ' VAL . 14.3 t -80.04 -17.38 52.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.212 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.451 ' O ' HG22 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -79.19 -31.93 43.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.341 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.523 ' O ' HG22 ' B' ' 25' ' ' THR . 97.5 mt -63.49 -46.78 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.074 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.55 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.455 ' C ' ' N ' ' B' ' 25' ' ' THR . 32.7 m -64.83 -34.98 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.187 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.451 HG22 ' O ' ' B' ' 21' ' ' MET . 1.6 tp -45.21 -22.93 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.492 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.523 HG22 ' O ' ' B' ' 22' ' ' ILE . 1.3 t -71.83 -41.14 68.53 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.742 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.691 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.0 OUTLIER -52.84 -30.59 34.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.956 0.502 . . . . 0.0 110.657 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 27' ' ' VAL . 10.7 t -64.96 -45.92 93.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 65.4 mtt -71.59 -34.79 70.21 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.835 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -83.7 -2.68 56.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.749 0.309 . . . . 0.0 110.563 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -63.06 -37.31 86.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.746 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.66 23.59 4.61 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.059 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.4 179.687 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.6 0.238 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.56 HD13 HD13 ' B' ' 8' ' ' ILE . 88.4 mt -62.28 -44.04 98.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.26 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 13' ' ' VAL . 5.4 tp -59.76 -35.8 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.83 -69.21 1.34 Allowed Glycine 0 CA--C 1.532 1.153 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.66 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.84 -28.41 68.81 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 120.79 0.329 . . . . 0.0 111.062 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.9 tpt -63.54 -63.64 1.12 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.002 0.43 . . . . 0.0 110.545 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 9' ' ' ILE . 10.5 m -67.84 -20.63 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.82 -39.83 7.4 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.5 -52.04 44.02 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.894 ' O ' HG23 ' A' ' 20' ' ' THR . 3.4 m -44.72 -49.04 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.579 -0.311 . . . . 0.0 110.725 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.0 t -58.63 -43.63 87.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.02 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.22 -49.66 83.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -35.9 70.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.166 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.894 HG23 ' O ' ' A' ' 16' ' ' VAL . 30.2 p -73.52 -18.51 61.09 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.955 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -84.3 -31.94 24.62 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.124 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.45 -47.66 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.447 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.447 ' C ' ' N ' ' A' ' 25' ' ' THR . 29.9 m -63.37 -34.92 70.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.172 0.51 . . . . 0.0 110.532 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 20' ' ' THR . 0.9 OUTLIER -46.04 -22.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.447 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -79.26 -42.31 26.15 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.774 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.1 tm? -51.35 -31.19 21.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.324 0.583 . . . . 0.0 110.393 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.444 HG11 ' NZ ' ' B' ' 30' ' ' LYS . 14.0 t -64.67 -35.69 75.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.515 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mtp -71.94 -29.6 64.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.28 -9.63 59.31 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.235 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' NZ ' HG11 ' B' ' 27' ' ' VAL . 97.3 mttt -62.17 -36.49 82.02 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.723 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -89.54 18.66 5.16 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.674 0.273 . . . . 0.0 110.674 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.25 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.62 -33.46 87.3 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.88 -22.6 38.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.669 0.271 . . . . 0.0 110.674 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.56 HD13 HD13 ' A' ' 8' ' ' ILE . 89.2 mt -62.23 -43.98 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.252 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.483 ' O ' HG22 ' B' ' 13' ' ' VAL . 5.4 tp -59.74 -35.88 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.78 -69.18 1.34 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.687 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -60.78 -28.51 68.8 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 8.9 tpt -63.49 -63.74 1.1 Allowed 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.012 0.434 . . . . 0.0 110.457 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.483 HG22 ' O ' ' B' ' 9' ' ' ILE . 10.4 m -67.81 -20.59 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.41 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.75 -39.9 7.41 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.5 -52.06 43.91 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.886 ' O ' HG23 ' B' ' 20' ' ' THR . 3.4 m -44.71 -49.12 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.66 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 64.3 t -58.64 -43.57 87.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.004 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.22 -49.65 83.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.74 70.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.213 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.886 HG23 ' O ' ' B' ' 16' ' ' VAL . 30.4 p -73.59 -18.49 61.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.845 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -84.3 -31.85 24.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.132 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.48 -47.66 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.473 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.445 HG11 ' HB ' ' A' ' 20' ' ' THR . 30.1 m -63.35 -35.0 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.168 0.509 . . . . 0.0 110.502 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.414 HD13 ' O ' ' B' ' 20' ' ' THR . 0.9 OUTLIER -45.98 -22.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.439 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -79.24 -42.33 26.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.79 178.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.71 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.1 tm? -51.28 -31.27 20.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.322 0.582 . . . . 0.0 110.423 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.442 HG11 ' NZ ' ' A' ' 30' ' ' LYS . 14.2 t -64.6 -35.69 75.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.595 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.8 mtp -71.9 -29.6 64.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.726 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.25 -9.53 59.26 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.247 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.444 ' NZ ' HG11 ' A' ' 27' ' ' VAL . 97.3 mttt -62.31 -36.57 82.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.694 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -89.45 18.6 5.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.622 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.312 179.879 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 120.599 0.238 . . . . 0.0 110.505 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.695 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.8 mp -70.54 -55.77 13.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.775 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.1 tp -69.28 -42.31 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.238 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.49 -58.46 1.1 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -64.97 -29.03 69.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.819 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -66.09 -63.78 1.0 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 0.0 111.205 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 26.1 m -67.07 -20.12 26.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.871 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.16 -41.09 6.33 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.24 -49.82 54.67 Favored Glycine 0 C--N 1.333 0.369 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 20' ' ' THR . 5.1 m -44.6 -51.03 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.647 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 16' ' ' VAL . 91.4 t -57.64 -43.8 84.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.745 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.98 -49.87 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -36.75 68.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.866 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 16' ' ' VAL . 28.9 p -72.59 -18.51 61.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.045 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.3 mmt -82.44 -32.57 28.91 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.218 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 25' ' ' THR . 97.1 mt -63.53 -46.57 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.633 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 25' ' ' THR . 30.1 m -63.12 -36.1 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.283 0.563 . . . . 0.0 110.571 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -43.77 -22.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.7 OUTLIER -81.57 -42.78 19.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.504 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.679 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.2 tm? -47.44 -33.73 6.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.617 0.723 . . . . 0.0 110.475 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 30' ' ' LYS . 48.5 t -66.0 -42.56 91.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.164 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.402 ' N ' ' O ' ' A' ' 25' ' ' THR . 67.3 mtt -65.97 -33.66 76.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.412 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.59 0.75 11.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.356 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 27' ' ' VAL . 24.6 mmtp -62.01 -38.17 87.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.554 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -132.74 17.33 4.28 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.821 0.344 . . . . 0.0 110.479 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.041 179.566 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.04 -34.15 89.16 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.89 -29.94 70.54 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.468 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.695 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.8 mp -70.56 -55.79 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.738 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.0 tp -69.36 -42.31 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.269 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.452 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.44 -58.35 1.1 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.465 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.2 mm? -65.16 -28.92 69.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.792 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . 0.505 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -66.17 -63.84 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.997 0.427 . . . . 0.0 111.239 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 26.4 m -67.06 -20.07 26.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.861 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.1 -41.12 6.34 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.21 -49.76 54.82 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.905 ' O ' HG23 ' B' ' 20' ' ' THR . 5.3 m -44.9 -50.86 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.641 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 16' ' ' VAL . 91.8 t -57.66 -43.91 84.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.697 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.89 -49.81 83.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.97 68.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.959 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.905 HG23 ' O ' ' B' ' 16' ' ' VAL . 28.9 p -72.43 -18.55 61.7 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.967 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.3 mmt -82.37 -32.76 29.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.203 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.406 ' O ' HG22 ' B' ' 25' ' ' THR . 97.0 mt -63.22 -46.7 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.672 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' B' ' 25' ' ' THR . 30.1 m -63.14 -36.11 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.339 0.59 . . . . 0.0 110.629 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -43.79 -22.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.582 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.467 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -81.62 -42.65 19.72 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.498 179.444 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.682 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.2 tm? -47.66 -33.6 7.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.745 0.783 . . . . 0.0 110.513 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' B' ' 30' ' ' LYS . 50.0 t -66.02 -42.54 91.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.18 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 67.3 mtt -65.86 -33.78 76.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.471 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.5 0.6 11.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.333 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' B' ' 27' ' ' VAL . 24.7 mmtp -61.78 -38.4 87.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.543 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -132.59 17.48 4.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.888 0.375 . . . . 0.0 110.492 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.057 179.579 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.601 0.239 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.644 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.8 mp -65.8 -53.09 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.91 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.5 tp -71.15 -41.68 75.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.05 0.452 . . . . 0.0 110.308 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -39.97 -46.24 3.13 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.1 tp -73.82 -41.95 61.58 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.652 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.01 -54.23 13.63 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.083 0.468 . . . . 0.0 111.013 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.17 -21.83 27.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.818 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.58 -46.61 14.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -50.97 -54.82 21.09 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.874 ' O ' HG23 ' A' ' 20' ' ' THR . 6.9 m -48.23 -49.26 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.26 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.509 ' O ' ' SD ' ' A' ' 21' ' ' MET . 85.4 t -59.81 -45.03 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.929 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.29 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.765 -0.774 . . . . 0.0 108.966 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.523 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -57.18 -38.26 73.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.671 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 16' ' ' VAL . 66.4 p -68.05 -24.98 65.14 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.054 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' OG1' ' A' ' 20' ' ' THR . 0.0 OUTLIER -82.04 -38.9 24.28 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.319 0.387 . . . . 0.0 112.038 -179.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.3 mt -69.08 -46.54 78.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.761 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.83 HG21 HG21 ' B' ' 23' ' ' VAL . 31.5 m -52.69 -34.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.939 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.439 ' N ' HG23 ' A' ' 23' ' ' VAL . 33.5 mm -49.0 -45.99 16.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -59.6 -55.08 38.96 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.6 tm? -46.93 -37.67 9.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.246 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.434 HG11 HG11 ' B' ' 27' ' ' VAL . 58.9 t -71.3 -56.67 9.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.395 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.522 ' O ' ' N ' ' A' ' 32' ' ' LYS . 98.6 mmm -58.11 -29.54 65.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.697 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.746 ' O ' HD23 ' A' ' 29' ' ' LEU . 3.5 tt -63.79 -36.0 82.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.994 0.426 . . . . 0.0 109.87 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -45.4 -11.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.258 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 29' ' ' LEU . 34.1 ttmt -156.72 -13.43 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.371 0.605 . . . . 0.0 110.12 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' MET . 55.1 mtpt . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.483 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.78 69.21 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.29 -35.04 79.06 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.594 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.647 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.8 mp -66.0 -53.16 40.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.908 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.453 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.5 tp -70.94 -41.73 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.297 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.453 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -40.07 -46.06 3.18 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 43.0 tp -74.05 -41.92 61.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.709 0.29 . . . . 0.0 110.661 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 -54.29 13.04 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.106 0.479 . . . . 0.0 110.967 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.0 m -68.16 -21.78 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.846 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.55 -46.63 14.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.1 -54.89 21.2 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.873 ' O ' HG23 ' B' ' 20' ' ' THR . 7.1 m -47.98 -49.34 11.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.383 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.525 ' O ' ' SD ' ' B' ' 21' ' ' MET . 85.9 t -59.88 -44.98 95.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.939 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.33 -45.97 97.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.518 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -57.16 -38.26 73.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.615 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.873 HG23 ' O ' ' B' ' 16' ' ' VAL . 69.1 p -68.06 -24.93 65.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.096 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.529 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -82.11 -38.9 24.1 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.42 0.45 . . . . 0.0 112.032 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.13 -46.51 77.96 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.765 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.83 HG21 HG21 ' A' ' 23' ' ' VAL . 31.9 m -52.67 -34.91 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.013 -178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.431 ' N ' HG23 ' B' ' 23' ' ' VAL . 33.0 mm -49.1 -45.9 17.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.427 ' O ' ' N ' ' B' ' 29' ' ' LEU . 1.5 m -59.71 -55.31 35.97 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.707 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.6 tm? -46.79 -37.49 8.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.295 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 27' ' ' VAL . 59.6 t -71.45 -56.53 10.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.466 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . 0.528 ' O ' ' N ' ' B' ' 32' ' ' LYS . 98.6 mmm -58.23 -29.4 65.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.715 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.737 ' O ' HD23 ' B' ' 29' ' ' LEU . 3.5 tt -63.84 -36.14 82.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.024 0.44 . . . . 0.0 109.861 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -45.29 -11.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.361 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' B' ' 29' ' ' LEU . 34.0 ttmt -156.73 -13.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.241 0.543 . . . . 0.0 109.965 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' B' ' 28' ' ' MET . 55.0 mtpt . . . . . 0 C--N 1.322 -0.63 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.43 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.532 0.206 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.02 -59.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 10' ' ' GLY . 6.0 tp -66.09 -39.75 85.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.22 0.533 . . . . 0.0 110.198 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -42.62 -45.99 5.7 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.75 -33.65 64.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 111.204 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.436 ' SD ' ' C ' ' A' ' 12' ' ' MET . 0.1 OUTLIER -57.23 -62.94 1.41 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.302 -179.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 m -58.27 -21.91 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.178 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.13 -38.45 39.98 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.31 -55.25 30.5 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 20' ' ' THR . 23.2 m -51.05 -21.72 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.19 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.1 t -85.56 -47.77 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.205 0.526 . . . . 0.0 111.376 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.8 mm -69.7 -47.14 72.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.02 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.5 -41.11 65.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.707 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.703 ' OG1' HG11 ' B' ' 23' ' ' VAL . 4.0 t -78.88 -19.93 50.72 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.047 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.0 mmt -78.33 -35.14 48.01 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.951 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.482 ' O ' HG22 ' A' ' 25' ' ' THR . 96.9 mt -62.92 -48.45 87.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.65 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.703 HG11 ' OG1' ' B' ' 20' ' ' THR . 34.1 m -63.87 -34.71 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 110.3 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -43.59 -22.44 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -79.46 -43.03 24.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.57 178.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.702 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.5 tm? -47.83 -31.83 5.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.67 0.747 . . . . 0.0 110.479 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.445 HG13 HG13 ' B' ' 27' ' ' VAL . 12.6 t -64.46 -40.59 89.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.292 0.567 . . . . 0.0 109.501 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 25' ' ' THR . 67.4 mtt -67.45 -31.34 71.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.876 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.1 mt -76.06 -8.62 57.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.025 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -60.97 -36.79 80.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.716 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -101.98 17.12 23.98 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.731 0.3 . . . . 0.0 110.59 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.602 179.832 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.78 -22.72 66.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.06 -30.86 68.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.661 0.267 . . . . 0.0 111.056 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.13 -59.48 3.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.421 HG23 ' N ' ' B' ' 10' ' ' GLY . 6.0 tp -65.93 -39.53 84.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.228 0.537 . . . . 0.0 110.23 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.421 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -42.99 -45.68 6.05 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.96 -33.54 63.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.747 0.308 . . . . 0.0 111.193 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . 0.437 ' C ' ' SD ' ' B' ' 12' ' ' MET . 0.1 OUTLIER -57.29 -63.04 1.36 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.28 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -58.24 -21.81 18.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.197 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.05 -38.52 40.19 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.3 -55.09 31.3 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.49 ' O ' HG22 ' B' ' 20' ' ' THR . 22.5 m -51.2 -21.66 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 122.874 -0.192 . . . . 0.0 111.182 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 70.3 t -85.6 -47.8 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.239 0.542 . . . . 0.0 111.401 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.76 -47.15 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.943 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.54 -41.17 66.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.642 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.703 ' OG1' HG11 ' A' ' 23' ' ' VAL . 4.0 t -78.76 -19.93 51.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.105 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 22.0 mmt -78.35 -35.16 47.85 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.975 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.47 ' O ' HG22 ' B' ' 25' ' ' THR . 96.9 mt -62.91 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.713 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.703 HG11 ' OG1' ' A' ' 20' ' ' THR . 34.1 m -63.72 -34.76 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.093 0.473 . . . . 0.0 110.314 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.401 ' N ' HG23 ' B' ' 23' ' ' VAL . 1.2 tp -43.82 -22.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.479 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.0 OUTLIER -79.56 -43.0 23.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.622 178.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.703 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.5 tm? -47.81 -31.96 5.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.661 0.744 . . . . 0.0 110.55 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.445 HG13 HG13 ' A' ' 27' ' ' VAL . 12.3 t -64.43 -40.61 89.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.582 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . 0.426 ' N ' ' O ' ' B' ' 25' ' ' THR . 67.5 mtt -67.42 -31.35 71.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.871 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 82.0 mt -75.95 -8.84 57.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.032 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -60.88 -36.8 80.15 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.728 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -101.92 17.17 23.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.544 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.615 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.765 0.317 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.17 -42.91 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.246 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.495 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -59.91 -41.2 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.297 0.57 . . . . 0.0 109.532 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.8 -59.56 8.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 48.4 tp -72.89 -28.21 62.35 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.405 ' SD ' ' C ' ' A' ' 12' ' ' MET . 0.0 OUTLIER -42.48 -53.92 4.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.832 ' O ' HG13 ' A' ' 16' ' ' VAL . 34.2 m -72.92 -51.63 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.4 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.62 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -29.48 -47.15 0.1 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 123.694 0.621 . . . . 0.0 112.65 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.4 -1.79 0.21 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.593 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 13' ' ' VAL . 33.6 m -80.71 -51.13 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.66 ' N ' HG23 ' A' ' 16' ' ' VAL . 86.8 t -43.43 -37.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.828 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.53 -49.54 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.848 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.84 -52.04 67.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.534 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -64.93 -19.09 65.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.609 0.242 . . . . 0.0 110.705 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -82.03 -36.82 27.35 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.306 178.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 25' ' ' THR . 90.5 mt -64.96 -44.27 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 26' ' ' LEU . 14.0 m -62.96 -40.58 89.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 CA-C-O 121.143 0.497 . . . . 0.0 110.516 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.475 ' N ' HG23 ' A' ' 23' ' ' VAL . 2.1 tp -40.83 -24.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.306 0.575 . . . . 0.0 110.195 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -82.47 -37.64 25.07 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.381 179.041 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.633 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.5 tm? -48.83 -40.42 29.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.704 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.945 HG21 HG21 ' B' ' 27' ' ' VAL . 88.1 t -61.74 -44.7 99.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.33 0.586 . . . . 0.0 109.685 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 82.2 mmm -65.4 -37.32 86.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.485 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.8 -5.65 59.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 110.405 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -61.85 -32.34 72.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.856 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.65 37.35 2.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.169 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.526 179.707 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.44 -34.17 89.18 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.16 -24.41 54.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.713 0.292 . . . . 0.0 110.7 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.11 -42.91 96.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.241 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.478 HD13 ' O ' ' B' ' 9' ' ' ILE . 0.2 OUTLIER -59.99 -41.24 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 121.288 0.566 . . . . 0.0 109.495 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.71 -59.53 8.48 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 48.7 tp -72.95 -28.28 62.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . 0.404 ' C ' ' SD ' ' B' ' 12' ' ' MET . 0.0 OUTLIER -42.53 -53.78 4.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -178.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.86 ' O ' HG13 ' B' ' 16' ' ' VAL . 34.1 m -72.95 -51.82 25.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.379 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.624 ' N ' HG23 ' B' ' 13' ' ' VAL . . . -29.38 -47.04 0.09 OUTLIER Glycine 0 CA--C 1.531 1.061 0 O-C-N 123.764 0.665 . . . . 0.0 112.63 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.41 -1.92 0.22 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.524 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.86 HG13 ' O ' ' B' ' 13' ' ' VAL . 33.5 m -80.74 -51.03 16.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.014 0.435 . . . . 0.0 109.874 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.662 ' N ' HG23 ' B' ' 16' ' ' VAL . 86.0 t -43.48 -37.97 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.726 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.43 -49.48 80.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.798 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -51.89 67.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.661 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . 0.475 HG22 ' O ' ' B' ' 16' ' ' VAL . 0.5 OUTLIER -64.87 -19.2 65.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.694 0.283 . . . . 0.0 110.781 -179.112 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -82.05 -36.63 27.51 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.272 178.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.435 ' O ' HG22 ' B' ' 25' ' ' THR . 90.0 mt -65.09 -44.22 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' B' ' 26' ' ' LEU . 13.9 m -62.96 -40.69 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.139 0.495 . . . . 0.0 110.463 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.482 ' N ' HG23 ' B' ' 23' ' ' VAL . 2.1 tp -40.83 -24.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.199 0.523 . . . . 0.0 110.167 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.506 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -82.43 -37.63 25.18 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.355 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.636 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.5 tm? -48.85 -40.28 28.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.783 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.945 HG21 HG21 ' A' ' 27' ' ' VAL . 89.4 t -61.84 -44.71 99.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.289 0.566 . . . . 0.0 109.623 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 82.3 mmm -65.45 -37.27 86.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.451 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.87 -5.65 59.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.794 0.33 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -61.96 -32.45 72.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.934 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.36 37.17 2.16 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.219 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.559 179.744 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.159 0 CA-C-O 120.798 0.332 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 mm -63.17 -49.83 81.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.498 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 10' ' ' GLY . 11.0 tp -68.54 -40.36 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.429 0.633 . . . . 0.0 110.226 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -48.41 -60.54 5.69 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -70.24 -29.39 66.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.2 -58.0 3.12 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 120.669 0.271 . . . . 0.0 111.671 -178.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.813 ' O ' HG13 ' A' ' 16' ' ' VAL . 17.1 m -75.49 -49.69 26.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.604 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.603 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -30.94 -45.98 0.13 Allowed Glycine 0 CA--C 1.527 0.808 0 O-C-N 123.427 0.455 . . . . 0.0 112.284 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.51 -0.51 0.14 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.641 -178.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 13' ' ' VAL . 35.1 m -82.47 -50.22 16.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.628 ' N ' HG23 ' A' ' 16' ' ' VAL . 79.6 t -42.88 -37.08 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.048 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.66 -49.29 78.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.913 -179.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.96 -52.09 66.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.268 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -18.35 64.19 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.006 -178.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.63 -38.24 20.1 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.29 0.369 . . . . 0.0 110.889 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.78 -43.15 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.354 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.501 HG21 HG21 ' B' ' 23' ' ' VAL . 35.2 m -55.76 -41.9 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.547 -178.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.493 ' N ' HG23 ' A' ' 23' ' ' VAL . 39.8 mm -40.3 -46.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.154 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -63.59 -43.16 97.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.35 178.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.713 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.4 tm? -56.06 -45.12 79.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.011 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.512 HG11 HG11 ' B' ' 27' ' ' VAL . 98.8 t -63.9 -44.14 97.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.448 0.642 . . . . 0.0 109.59 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 91.0 mtp -61.13 -30.52 70.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.233 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 31' ' ' LYS . 41.6 mt -71.22 -33.11 69.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.844 178.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -44.29 -15.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.798 -179.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 65.0 mttp -103.9 27.88 7.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.734 0.302 . . . . 0.0 110.336 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 29' ' ' LEU . 29.2 mmtp . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.267 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.3 mttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.54 -20.78 78.21 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.0 -24.98 35.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.754 0.312 . . . . 0.0 110.269 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.13 -49.83 81.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.591 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.437 HG23 ' N ' ' B' ' 10' ' ' GLY . 11.0 tp -68.69 -40.3 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.454 0.645 . . . . 0.0 110.154 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . 0.437 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -48.28 -60.5 5.65 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.469 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.2 mm? -70.52 -29.09 65.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -58.0 3.22 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.669 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 13' ' ' VAL . . . . . 0.802 ' O ' HG13 ' B' ' 16' ' ' VAL . 17.5 m -75.33 -49.91 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.594 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.595 ' N ' HG23 ' B' ' 13' ' ' VAL . . . -30.69 -45.9 0.12 Allowed Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.569 0.543 . . . . 0.0 112.395 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.61 -0.73 0.15 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.57 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.802 HG13 ' O ' ' B' ' 13' ' ' VAL . 35.1 m -82.08 -50.29 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 120.698 0.285 . . . . 0.0 110.241 179.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.631 ' N ' HG23 ' B' ' 16' ' ' VAL . 73.2 t -42.97 -36.97 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.052 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.8 -49.08 79.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.96 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.07 -52.29 66.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.256 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -18.24 63.92 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.054 -178.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.76 -38.16 19.98 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.309 0.381 . . . . 0.0 110.935 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.82 -43.23 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.353 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.501 HG21 HG21 ' A' ' 23' ' ' VAL . 35.9 m -55.72 -41.97 67.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.502 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 24' ' ' ILE . . . . . 0.489 ' N ' HG23 ' B' ' 23' ' ' VAL . 39.5 mm -40.04 -46.74 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.168 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -63.74 -43.2 97.19 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.375 178.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.705 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.4 tm? -56.05 -45.1 79.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.982 -179.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 27' ' ' VAL . 99.0 t -63.91 -44.19 97.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.463 0.649 . . . . 0.0 109.545 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 91.0 mtp -61.06 -30.34 70.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.212 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' B' ' 32' ' ' LYS . 43.0 mt -71.4 -33.1 69.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.898 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -44.28 -15.64 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.777 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.1 mttp -103.93 27.97 7.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.703 0.287 . . . . 0.0 110.378 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 32' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 29' ' ' LEU . 28.9 mmtp . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.268 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.2 mttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.393 -0.595 . . . . 958.39 109.393 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.66 -19.72 79.74 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.176 -0.77 . . . . 165.47 111.176 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.63 -35.8 81.71 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.706 -0.397 . . . . 71.6 110.732 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.9 mt -64.0 -52.58 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.399 -0.364 . . . . 200.66 111.76 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.441 HG23 ' N ' ' A' ' 10' ' ' GLY . 8.4 tp -67.08 -42.19 88.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.188 -0.605 . . . . 74.61 109.617 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -46.97 -47.34 19.79 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.301 -1.12 . . . . 50.55 110.301 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 11' ' ' LEU . 18.7 tp -70.68 -37.27 73.61 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.753 0.311 . . . . 340.02 110.536 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -57.74 10.48 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.948 0.404 . . . . 67.5 110.874 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 9' ' ' ILE . 21.4 m -66.54 -17.78 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.941 -0.572 . . . . 56.2 111.284 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.52 -42.57 7.78 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 110.849 -0.901 . . . . 17.23 110.849 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.48 -53.26 32.9 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.381 -1.088 . . . . 25.06 110.381 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.901 ' O ' HG23 ' A' ' 20' ' ' THR . 23.5 m -46.09 -52.04 3.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.884 -0.327 . . . . 30.97 110.171 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.547 ' N ' HG23 ' A' ' 16' ' ' VAL . 94.8 t -56.03 -46.08 80.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 C-N-CA 120.526 -0.47 . . . . 35.41 110.954 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 89.9 mt -63.37 -47.17 93.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.021 -0.671 . . . . 142.96 109.603 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.88 -40.02 69.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.647 -0.706 . . . . 25.01 110.017 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 16' ' ' VAL . 29.9 p -70.19 -20.01 63.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 130.55 111.022 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.58 -34.9 27.57 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.508 -0.477 . . . . 113.59 110.888 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.7 -44.86 93.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 C-N-CA 120.816 -0.354 . . . . 72.54 111.064 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.56 HG11 ' HB ' ' B' ' 20' ' ' THR . 30.1 m -61.78 -35.8 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.596 -0.442 . . . . 28.81 110.85 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.634 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -48.53 -23.04 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.66 -0.496 . . . . 102.06 109.66 178.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.12 -47.59 12.37 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.002 -0.74 . . . . 114.84 109.002 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.71 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.8 tm? -47.79 -36.27 11.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.547 0.689 . . . . 154.31 109.432 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.695 HG21 HG21 ' B' ' 27' ' ' VAL . 74.0 t -63.66 -65.76 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.741 -0.663 . . . . 155.81 110.221 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 82.7 mtp -48.21 -26.83 2.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.673 -0.694 . . . . 479.64 110.769 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 54.6 mt -75.09 -19.91 59.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.461 -0.336 . . . . 94.79 111.121 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -51.16 -22.33 2.5 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.596 -0.442 . . . . 870.34 110.825 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -105.01 22.05 15.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.646 0.26 . . . . 892.32 110.574 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.961 -1.018 . . . . 999.99 110.564 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 21.3 mttt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.398 -0.593 . . . . 957.99 109.398 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -73.56 -19.75 79.74 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.235 -0.746 . . . . 165.68 111.235 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.58 -35.82 81.75 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.719 -0.392 . . . . 71.79 110.759 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 21.9 mt -64.02 -52.55 55.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.332 -0.395 . . . . 202.4 111.807 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.432 ' O ' HG22 ' B' ' 13' ' ' VAL . 8.4 tp -67.09 -42.24 88.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.174 -0.611 . . . . 74.94 109.569 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.432 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -47.02 -47.25 20.14 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.312 -1.115 . . . . 50.24 110.312 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' B' ' 11' ' ' LEU . 18.7 tp -70.66 -37.34 73.69 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 120.737 0.303 . . . . 339.95 110.47 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.02 -57.72 10.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.957 0.408 . . . . 66.95 110.902 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.432 HG22 ' O ' ' B' ' 9' ' ' ILE . 21.7 m -66.53 -17.69 22.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.902 -0.59 . . . . 56.24 111.33 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.56 -42.51 7.79 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.843 -0.903 . . . . 17.19 110.843 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.56 -53.26 33.18 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.401 -1.08 . . . . 25.14 110.401 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.905 ' O ' HG23 ' B' ' 20' ' ' THR . 23.6 m -46.12 -52.0 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.802 -0.359 . . . . 30.99 110.202 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.545 ' N ' HG23 ' B' ' 16' ' ' VAL . 94.3 t -56.01 -46.08 80.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.568 -0.453 . . . . 35.55 110.961 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 90.2 mt -63.36 -47.22 92.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.031 -0.668 . . . . 142.35 109.659 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.75 -40.08 68.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.577 -0.738 . . . . 25.02 110.108 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.905 HG23 ' O ' ' B' ' 16' ' ' VAL . 29.9 p -70.13 -20.0 63.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 129.97 111.024 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.62 -34.91 27.43 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.546 -0.462 . . . . 113.52 110.844 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.75 -44.83 93.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 120.833 -0.347 . . . . 73.86 111.051 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.582 HG11 ' HB ' ' A' ' 20' ' ' THR . 30.2 m -61.72 -35.93 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.599 -0.44 . . . . 28.73 110.847 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.651 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -48.49 -23.01 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 120.463 -0.495 . . . . 102.81 109.71 178.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.11 -47.61 12.35 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.997 -0.742 . . . . 116.39 108.997 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.715 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.8 tm? -47.82 -36.21 11.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.518 0.675 . . . . 155.23 109.41 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.695 HG21 HG21 ' A' ' 27' ' ' VAL . 74.3 t -63.68 -65.72 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.75 -0.659 . . . . 156.82 110.281 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 82.7 mtp -48.23 -26.89 2.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 481.58 110.765 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 55.0 mt -75.03 -19.89 59.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.446 -0.343 . . . . 95.14 111.165 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -51.16 -22.32 2.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.542 -0.463 . . . . 870.37 110.811 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -105.03 22.05 16.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 121.065 -0.254 . . . . 889.68 110.522 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.933 -1.032 . . . . 999.99 110.497 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.04 -32.66 84.93 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.35 -21.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.605 0.241 . . . . 0.0 111.001 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.564 HD13 HD13 ' B' ' 8' ' ' ILE . 97.7 mt -63.3 -43.7 98.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.482 ' O ' HG22 ' A' ' 13' ' ' VAL . 5.9 tp -61.01 -36.76 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-O 121.138 0.494 . . . . 0.0 109.793 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.63 -66.38 2.88 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 11' ' ' LEU . 4.2 mm? -60.16 -32.79 71.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.742 0.306 . . . . 0.0 110.982 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.23 -63.84 1.16 Allowed 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 120.863 0.363 . . . . 0.0 110.97 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 9' ' ' ILE . 12.6 m -68.39 -20.82 25.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.35 -39.81 12.09 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.93 -54.33 26.09 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.7 m -44.51 -49.79 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.95 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 87.6 t -60.49 -42.88 92.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.057 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.0 -51.35 72.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.465 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.43 -36.8 76.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.149 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -18.52 58.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.998 0.428 . . . . 0.0 110.401 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -32.64 36.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.397 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.434 ' O ' HG22 ' A' ' 25' ' ' THR . 96.7 mt -64.7 -46.34 92.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.375 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.465 ' C ' ' N ' ' A' ' 25' ' ' THR . 29.6 m -66.13 -35.56 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.329 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 24' ' ' ILE . 1.2 tp -49.07 -20.41 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.465 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -74.74 -40.69 61.1 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.649 179.137 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.913 HD22 ' O ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.92 -25.37 42.78 Favored 'General case' 0 C--O 1.23 0.062 0 CA-C-O 121.396 0.617 . . . . 0.0 109.959 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.569 ' N ' HD13 ' A' ' 26' ' ' LEU . 15.1 t -66.42 -46.47 86.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.738 178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 59.6 mtt -68.3 -33.31 74.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.266 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 90.9 mt -82.58 -3.37 55.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.265 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -61.83 -37.04 82.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.092 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.8 23.26 4.24 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.58 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.377 179.566 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.08 -32.61 84.77 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.34 -21.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.582 0.229 . . . . 0.0 110.94 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.564 HD13 HD13 ' A' ' 8' ' ' ILE . 97.8 mt -63.2 -43.74 98.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.493 ' O ' HG22 ' B' ' 13' ' ' VAL . 5.9 tp -60.9 -36.74 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.813 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.68 -66.38 2.88 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.426 ' N ' HD22 ' B' ' 11' ' ' LEU . 4.2 mm? -60.18 -32.82 71.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 0.0 111.015 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.4 tpt -60.05 -63.89 1.14 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 120.901 0.381 . . . . 0.0 111.004 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.493 HG22 ' O ' ' B' ' 9' ' ' ILE . 12.5 m -68.36 -20.83 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.44 -39.78 12.0 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.86 -54.35 25.78 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.7 m -44.57 -49.69 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.618 -0.291 . . . . 0.0 110.904 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -60.59 -42.87 93.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.007 0.432 . . . . 0.0 111.144 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.9 -51.37 72.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.549 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.39 -36.83 76.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.012 -0.994 . . . . 0.0 112.18 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.12 -18.46 57.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.942 0.401 . . . . 0.0 110.359 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.68 -32.59 35.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.449 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.433 ' O ' HG22 ' B' ' 25' ' ' THR . 96.7 mt -64.61 -46.41 92.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.234 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.365 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.457 ' C ' ' N ' ' B' ' 25' ' ' THR . 29.6 m -66.2 -35.39 74.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.328 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' B' ' 24' ' ' ILE . 1.2 tp -49.15 -20.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.457 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -74.65 -40.73 61.29 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.631 179.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.914 ' O ' HD22 ' B' ' 26' ' ' LEU . 0.0 OUTLIER -55.95 -25.21 42.53 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-O 121.367 0.603 . . . . 0.0 109.94 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.557 ' N ' HD13 ' B' ' 26' ' ' LEU . 15.2 t -66.55 -46.37 86.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.781 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 59.4 mtt -68.48 -33.27 73.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.176 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 91.1 mt -82.52 -3.46 55.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.205 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -61.82 -37.08 83.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.081 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.71 23.2 4.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.585 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.324 179.623 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.6 tttp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.01 -24.97 67.5 Favored Glycine 0 CA--C 1.521 0.426 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.43 -36.64 84.41 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.296 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.23 -53.44 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.472 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 10' ' ' GLY . 3.6 tp -71.07 -42.17 76.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.167 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -39.5 -46.97 2.87 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 46.9 tp -72.56 -39.48 67.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.735 0.302 . . . . 0.0 110.702 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -59.21 4.46 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 120.936 0.398 . . . . 0.0 111.47 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.13 -22.18 29.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.034 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.58 -45.36 18.17 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.72 -54.15 29.39 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 20' ' ' THR . 5.5 m -48.23 -51.54 9.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.198 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.408 ' O ' ' OG1' ' A' ' 20' ' ' THR . 91.9 t -59.06 -45.0 92.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.095 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.1 -46.93 95.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.181 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.542 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.01 -39.04 71.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.248 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 16' ' ' VAL . 46.3 p -67.15 -21.32 65.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.182 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.44 -38.6 19.99 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.2 mt -69.64 -45.13 78.67 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.147 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.552 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.909 HG21 HG21 ' B' ' 23' ' ' VAL . 29.2 m -51.8 -37.86 21.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.713 0.292 . . . . 0.0 111.054 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.47 ' N ' HG23 ' A' ' 23' ' ' VAL . 37.6 mm -48.25 -45.9 13.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.417 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.29 -52.35 65.63 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.0 tm? -51.04 -40.97 59.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.051 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG11 HG11 ' B' ' 27' ' ' VAL . 92.0 t -65.94 -65.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm -48.54 -26.16 2.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.976 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 32' ' ' LYS . 20.2 mt -72.15 -28.03 62.98 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.354 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -45.53 -14.23 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.671 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 29' ' ' LEU . 98.9 mttt -98.27 20.18 12.97 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.899 0.38 . . . . 0.0 110.253 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 32.7 ttpt . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.523 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 56.6 tttp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.99 -25.08 67.58 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.54 84.07 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.357 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 89.6 mt -65.2 -53.54 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.433 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.459 HG23 ' N ' ' B' ' 10' ' ' GLY . 3.6 tp -70.95 -42.23 77.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.119 0.485 . . . . 0.0 110.193 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.459 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -39.51 -46.91 2.86 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -72.59 -39.63 67.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.749 0.309 . . . . 0.0 110.605 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.2 -59.06 4.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 111.52 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 18.5 m -66.33 -22.02 29.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.994 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.65 -45.39 17.77 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.51 -54.38 27.68 Favored Glycine 0 C--O 1.224 -0.514 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.882 ' O ' HG23 ' B' ' 20' ' ' THR . 5.4 m -47.95 -51.59 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.325 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.404 ' H ' HG23 ' B' ' 16' ' ' VAL . 91.9 t -59.24 -44.89 93.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.041 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.14 -47.04 95.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.629 0.728 . . . . 0.0 109.158 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.538 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -55.92 -38.86 70.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.287 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.882 HG23 ' O ' ' B' ' 16' ' ' VAL . 46.7 p -67.24 -21.33 65.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.19 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.55 -38.48 19.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 93.1 mt -69.82 -45.21 77.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.485 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.909 HG21 HG21 ' A' ' 23' ' ' VAL . 29.7 m -51.64 -37.72 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.69 0.281 . . . . 0.0 111.088 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.463 ' N ' HG23 ' B' ' 23' ' ' VAL . 37.8 mm -48.48 -45.8 14.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.338 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.5 m -60.42 -52.49 65.0 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.717 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.0 tm? -50.95 -40.81 58.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.054 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.402 HG11 HG11 ' A' ' 27' ' ' VAL . 92.8 t -66.02 -65.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.7 mmm -48.46 -26.09 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.01 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 32' ' ' LYS . 20.5 mt -72.22 -27.94 62.85 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.343 178.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -45.62 -14.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.691 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 98.9 mttt -98.32 20.2 13.0 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.249 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 29' ' ' LEU . 32.8 ttpt . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.498 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 10' ' ' GLY . . . -62.66 -24.08 65.84 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.09 -35.94 81.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.767 0.317 . . . . 0.0 110.239 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.05 -49.46 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -82.05 -25.89 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.338 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 6' ' ' GLY . . . -51.8 -45.81 55.08 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.97 -35.26 32.35 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.577 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -54.74 17.48 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 120.963 0.411 . . . . 0.0 111.28 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.413 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 34.5 m -67.62 -20.92 26.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.766 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.28 -48.8 7.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.284 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.0 -54.39 14.74 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.885 ' O ' HG23 ' A' ' 20' ' ' THR . 5.0 m -46.28 -49.54 5.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.17 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.4 t -58.79 -45.55 91.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 120.721 -0.391 . . . . 0.0 110.771 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -62.09 -48.41 88.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.324 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -54.65 -36.86 65.02 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.454 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 16' ' ' VAL . 44.8 p -68.9 -21.15 64.25 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.171 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.2 mmt -82.8 -38.19 23.46 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.0 mt -70.16 -45.76 74.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.131 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.824 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.889 HG21 HG21 ' B' ' 23' ' ' VAL . 26.2 m -51.25 -37.31 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 120.698 0.285 . . . . 0.0 110.867 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.473 ' N ' HG23 ' A' ' 23' ' ' VAL . 39.3 mm -48.08 -45.79 12.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.438 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -61.84 -52.67 63.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.2 tm? -49.66 -41.45 42.78 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.123 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 30' ' ' LYS . 99.6 t -65.93 -65.38 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.2 mmm -48.59 -24.28 1.28 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 32' ' ' LYS . 25.0 mt -74.69 -26.45 59.84 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.607 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 27' ' ' VAL . 67.1 mttm -44.44 -15.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 71.4 mmtt -100.5 22.85 11.12 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.953 0.406 . . . . 0.0 110.095 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 29' ' ' LEU . 22.8 pttp . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.718 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' B' ' 10' ' ' GLY . . . -62.75 -24.19 66.14 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.98 82.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.777 0.322 . . . . 0.0 110.197 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.81 -50.16 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.797 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 tp -81.28 -26.07 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.467 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' B' ' 6' ' ' GLY . . . -51.71 -46.1 54.34 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.77 -35.12 33.61 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.584 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.05 -54.8 17.93 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 120.955 0.407 . . . . 0.0 111.193 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 34.4 m -67.45 -20.87 27.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.838 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.58 -48.65 7.83 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.0 -54.45 14.51 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.895 ' O ' HG23 ' B' ' 20' ' ' THR . 5.1 m -46.19 -49.6 5.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.202 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 91.7 t -58.69 -45.64 90.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.775 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 41.7 mm -62.0 -48.42 88.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.411 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.545 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -54.6 -37.1 65.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.467 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.895 HG23 ' O ' ' B' ' 16' ' ' VAL . 44.3 p -68.64 -21.2 64.48 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.151 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.1 mmt -82.85 -38.19 23.33 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 92.3 mt -70.06 -45.78 75.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.19 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.827 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.889 HG21 HG21 ' A' ' 23' ' ' VAL . 25.4 m -51.19 -37.49 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.734 0.302 . . . . 0.0 110.815 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.483 ' N ' HG23 ' B' ' 23' ' ' VAL . 39.2 mm -47.88 -45.9 11.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.428 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.4 m -61.74 -52.68 63.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.693 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.2 tm? -49.67 -41.69 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.154 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 96.9 t -65.6 -65.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 93.2 mmm -48.44 -24.27 1.21 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.692 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' B' ' 32' ' ' LYS . 24.3 mt -74.74 -26.68 59.95 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.829 -0.349 . . . . 0.0 110.57 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -44.14 -15.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.962 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 71.3 mmtt -100.14 23.01 10.54 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.922 0.392 . . . . 0.0 110.174 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.553 ' N ' ' O ' ' B' ' 29' ' ' LEU . 22.8 pttp . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.617 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.77 -22.26 69.95 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.39 -21.85 35.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.865 0.364 . . . . 0.0 110.2 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.32 -48.08 86.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.096 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 12' ' ' MET . 5.2 tp -67.98 -43.16 85.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 121.104 0.478 . . . . 0.0 109.976 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.45 -43.32 0.73 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.612 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.3 mt -78.23 -35.1 48.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.998 0.427 . . . . 0.0 110.609 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.518 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -58.98 -63.73 1.19 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.191 -179.261 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.79 -22.45 21.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.134 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.41 -47.81 20.89 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.31 -51.87 44.44 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.889 ' O ' HG23 ' A' ' 20' ' ' THR . 6.6 m -50.78 -48.24 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.098 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 80.5 t -58.75 -45.36 91.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.034 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mm -63.08 -45.72 97.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.586 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.4 -38.11 71.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.642 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.889 HG23 ' O ' ' A' ' 16' ' ' VAL . 44.3 p -68.23 -26.01 65.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.396 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.7 mmt -85.92 -38.54 17.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -69.16 -45.96 78.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.916 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.587 HG21 HG21 ' B' ' 23' ' ' VAL . 31.7 m -56.85 -34.67 44.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 23' ' ' VAL . 26.2 mm -43.58 -38.99 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.227 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.484 ' CG2' ' N ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -62.34 -52.2 64.57 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.734 179.035 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.741 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.7 tm? -48.43 -40.48 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.115 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 t -66.14 -66.17 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.215 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mmm -49.8 -24.79 2.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.017 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 31' ' ' LYS . 34.6 mt -73.92 -25.59 60.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.155 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -45.56 -13.75 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.724 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 29' ' ' LEU . 8.6 mtmp? -97.53 20.57 11.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.287 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 29' ' ' LEU . 17.2 mtmm . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.447 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.63 -22.32 69.74 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.014 -0.835 . . . . 0.0 111.014 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.42 -21.85 35.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.898 0.38 . . . . 0.0 110.214 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 5.6 mm -64.17 -48.2 86.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.074 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' B' ' 12' ' ' MET . 5.2 tp -67.97 -43.26 85.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.115 0.483 . . . . 0.0 109.952 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.502 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.35 -43.14 0.69 Allowed Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.708 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 88.2 mt -78.38 -35.15 47.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.989 0.423 . . . . 0.0 110.613 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . 0.516 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -58.94 -63.7 1.21 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.231 -179.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -71.63 -22.43 21.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.138 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.5 -47.74 20.65 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.26 -51.87 44.23 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.904 ' O ' HG23 ' B' ' 20' ' ' THR . 6.2 m -50.79 -48.31 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.064 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 80.4 t -58.93 -45.25 92.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.982 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 7.6 mm -63.14 -45.72 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.581 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -56.39 -38.01 70.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.678 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.904 HG23 ' O ' ' B' ' 16' ' ' VAL . 44.5 p -68.36 -25.9 65.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 24.7 mmt -86.09 -38.43 17.81 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.5 mt -69.28 -45.92 78.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.932 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.587 HG21 HG21 ' A' ' 23' ' ' VAL . 32.3 m -56.92 -34.65 44.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mm -43.65 -38.76 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.262 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' B' ' 26' ' ' LEU . 0.6 OUTLIER -62.61 -52.03 64.96 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.721 179.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.739 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.7 tm? -48.67 -40.39 27.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.091 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 t -66.13 -66.19 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.246 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mmm -49.82 -24.73 2.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.062 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' B' ' 32' ' ' LYS . 34.9 mt -73.99 -25.46 59.92 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.117 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -45.6 -13.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.588 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' B' ' 29' ' ' LEU . 8.6 mtmp? -97.6 20.7 11.4 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' B' ' 29' ' ' LEU . 17.2 mtmm . . . . . 0 C--O 1.219 -0.516 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.497 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.1 -27.3 72.15 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.13 -34.96 79.24 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.357 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.706 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.0 mp -65.23 -53.89 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.213 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 12' ' ' MET . 3.9 tp -70.88 -41.91 77.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.932 0.396 . . . . 0.0 110.537 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.42 -46.26 1.03 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.471 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.3 mm? -77.1 -32.51 56.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.48 0.181 . . . . 0.0 110.947 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.522 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -60.92 -62.49 1.82 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.793 0.33 . . . . 0.0 111.341 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -66.72 -21.93 29.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.817 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.85 -45.93 10.07 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.513 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.4 -53.07 37.04 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.883 ' O ' HG23 ' A' ' 20' ' ' THR . 4.5 m -47.36 -51.35 6.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 120.901 -0.319 . . . . 0.0 110.187 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.45 ' H ' HG23 ' A' ' 16' ' ' VAL . 73.9 t -58.01 -45.11 88.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.568 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.12 -48.07 90.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.674 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.14 -36.77 68.65 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.268 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.883 HG23 ' O ' ' A' ' 16' ' ' VAL . 44.8 p -67.79 -21.61 65.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.031 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.9 -38.3 23.05 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.328 0.392 . . . . 0.0 111.742 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.37 -46.19 72.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.696 -0.401 . . . . 0.0 111.874 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.958 HG21 HG21 ' B' ' 23' ' ' VAL . 31.5 m -50.47 -37.24 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.819 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.488 ' N ' HG23 ' A' ' 23' ' ' VAL . 38.7 mm -47.96 -46.28 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 m -60.95 -52.71 63.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.715 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.3 tm? -50.53 -41.1 53.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.339 0.59 . . . . 0.0 109.939 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.528 HG11 HG11 ' B' ' 27' ' ' VAL . 84.2 t -66.48 -66.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.874 178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.1 mtp -47.96 -24.03 0.94 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.665 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 32' ' ' LYS . 19.8 mt -73.61 -26.92 61.02 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.055 -0.258 . . . . 0.0 110.711 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 27' ' ' VAL . 66.9 mttm -44.9 -14.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.707 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 29' ' ' LEU . 53.0 mtmt -99.18 21.93 11.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.767 0.318 . . . . 0.0 110.395 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.529 ' N ' ' O ' ' A' ' 29' ' ' LEU . 66.0 tttm . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.623 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.0 -27.66 72.53 Favored Glycine 0 CA--C 1.521 0.462 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.97 -34.69 78.56 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.281 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.69 HD12 ' N ' ' B' ' 8' ' ' ILE . 2.0 mp -65.5 -53.95 33.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.182 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 12' ' ' MET . 3.8 tp -70.92 -41.8 77.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.853 0.358 . . . . 0.0 110.502 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.464 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.55 -45.9 1.03 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.467 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.3 mm? -77.51 -32.41 54.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.178 . . . . 0.0 110.887 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . 0.528 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -61.08 -62.73 1.64 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.748 0.308 . . . . 0.0 111.273 -179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 m -66.37 -22.03 29.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.815 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.82 -45.96 10.08 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.833 -0.698 . . . . 0.0 111.452 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.35 -53.08 36.8 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.89 ' O ' HG23 ' B' ' 20' ' ' THR . 4.6 m -47.34 -51.44 6.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.125 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.471 ' O ' ' OG1' ' B' ' 20' ' ' THR . 73.4 t -57.98 -45.1 87.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.6 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.25 -47.89 90.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.739 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.536 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -56.15 -37.05 68.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.22 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.89 HG23 ' O ' ' B' ' 16' ' ' VAL . 45.9 p -67.61 -21.63 65.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.075 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.91 -38.21 23.15 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.242 0.339 . . . . 0.0 111.72 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 94.7 mt -70.36 -46.13 72.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.97 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.958 HG21 HG21 ' A' ' 23' ' ' VAL . 31.6 m -50.64 -37.44 15.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.712 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.49 ' N ' HG23 ' B' ' 23' ' ' VAL . 38.9 mm -47.73 -46.34 11.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.9 m -60.86 -52.58 64.46 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.729 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.3 tm? -50.73 -41.32 56.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.867 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.528 HG11 HG11 ' A' ' 27' ' ' VAL . 84.0 t -66.19 -66.43 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.914 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 96.9 mtp -47.88 -24.04 0.91 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.657 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 32' ' ' LYS . 19.5 mt -73.66 -27.12 61.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.654 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -44.68 -14.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.771 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 53.3 mtmt -99.19 22.02 11.05 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.822 0.344 . . . . 0.0 110.346 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.9 tttm . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.595 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.92 -23.9 71.27 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.2 -23.76 43.59 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.43 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.6 mm -64.05 -48.9 83.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.024 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 10' ' ' GLY . 3.8 tp -69.84 -44.14 79.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.295 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.58 -47.56 1.2 Allowed Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.431 ' N ' HD22 ' A' ' 11' ' ' LEU . 4.3 mm? -73.3 -36.26 66.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.726 0.298 . . . . 0.0 110.706 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -57.44 -63.16 1.32 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.925 0.393 . . . . 0.0 111.567 -179.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.5 m -68.74 -21.98 26.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.218 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.49 -47.64 10.14 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.264 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.21 -52.45 31.78 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.887 ' O ' HG23 ' A' ' 20' ' ' THR . 5.5 m -47.86 -48.58 11.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.793 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.529 ' O ' ' SD ' ' A' ' 21' ' ' MET . 93.9 t -59.21 -46.52 92.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.994 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 mm -61.6 -47.49 93.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.522 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -52.8 -38.47 61.22 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.375 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.887 HG23 ' O ' ' A' ' 16' ' ' VAL . 39.7 p -69.39 -24.38 63.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.221 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -79.97 -39.94 29.06 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 92.7 mt -70.43 -45.36 75.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.94 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.754 HG21 HG21 ' B' ' 23' ' ' VAL . 28.8 m -54.77 -37.78 41.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.039 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -46.54 -47.21 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 29' ' ' LEU . 2.5 m -60.11 -53.24 60.06 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.707 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.9 tm? -49.99 -38.07 35.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.702 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.545 HG11 HG11 ' B' ' 27' ' ' VAL . 58.9 t -63.83 -68.59 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.648 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 16.1 ptm -48.81 -20.86 0.54 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.222 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 32' ' ' LYS . 8.6 mt -74.61 -25.85 59.52 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.126 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -45.23 -15.01 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.45 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.518 ' N ' ' O ' ' A' ' 29' ' ' LEU . 98.9 mttt -99.86 23.86 9.19 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.079 0.466 . . . . 0.0 109.86 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 29' ' ' LEU . 24.8 mtmm . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.844 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.79 -23.9 71.07 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.21 -23.81 43.55 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.416 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 37.7 mm -63.91 -49.08 83.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.03 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.509 HG23 ' N ' ' B' ' 10' ' ' GLY . 3.8 tp -69.71 -44.06 79.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.383 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.509 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.83 -47.2 1.24 Allowed Glycine 0 CA--C 1.529 0.91 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.433 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.3 mm? -73.57 -36.2 65.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.791 0.329 . . . . 0.0 110.698 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . 0.497 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -57.45 -63.35 1.26 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 120.96 0.41 . . . . 0.0 111.512 -179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 35.6 m -68.73 -21.89 26.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.171 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.32 -47.78 10.28 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.286 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.25 33.39 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.877 ' O ' HG23 ' B' ' 20' ' ' THR . 5.5 m -47.85 -48.7 11.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.765 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.531 ' O ' ' SD ' ' B' ' 21' ' ' MET . 93.8 t -59.18 -46.41 92.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.038 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 38.3 mm -61.74 -47.42 93.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.521 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -52.83 -38.51 61.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.359 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.877 HG23 ' O ' ' B' ' 16' ' ' VAL . 40.3 p -69.27 -24.43 63.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.263 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -80.02 -39.91 28.94 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 92.7 mt -70.44 -45.35 75.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.936 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 23' ' ' VAL . 29.7 m -54.8 -37.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.97 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.586 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -46.46 -47.04 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.434 HG22 HD12 ' B' ' 29' ' ' LEU . 2.5 m -60.24 -53.15 61.12 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.715 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.9 tm? -50.12 -38.06 37.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.697 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 27' ' ' VAL . 58.7 t -63.85 -68.49 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.653 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 16.2 ptm -48.82 -20.95 0.55 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.214 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 32' ' ' LYS . 8.5 mt -74.62 -25.78 59.46 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.027 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -45.35 -14.69 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.452 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 99.0 mttt -100.13 23.74 9.58 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.092 0.472 . . . . 0.0 109.874 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.57 ' N ' ' O ' ' B' ' 29' ' ' LEU . 24.8 mtmm . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.801 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.19 -37.75 81.8 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.21 -22.37 0.64 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.872 0.367 . . . . 0.0 110.853 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.4 mp -63.6 -45.07 98.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.073 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.48 -25.22 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.051 0.453 . . . . 0.0 110.693 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.05 -43.49 62.16 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.591 -178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -82.16 -27.01 32.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 0.0 110.646 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.29 -61.68 2.4 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.65 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.35 -23.5 28.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.063 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.37 -43.21 79.68 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.27 -61.42 6.98 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.0 m -50.02 -26.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.185 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.8 t -82.32 -46.92 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.992 0.425 . . . . 0.0 111.245 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.2 mt -67.91 -45.0 84.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.863 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.58 -40.81 72.47 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.676 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.888 ' OG1' HG11 ' B' ' 23' ' ' VAL . 4.2 t -75.93 -27.5 57.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.22 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 29.6 mmt -72.16 -40.15 68.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.075 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.76 -46.15 79.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.333 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.682 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.918 HG11 ' OG1' ' B' ' 20' ' ' THR . 21.9 m -65.24 -33.48 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -43.78 -50.09 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.904 -179.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.466 ' OG1' HD11 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -66.22 -49.7 66.36 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.24 -0.584 . . . . 0.0 109.837 179.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.712 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.1 tm? -41.97 -37.84 1.44 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.079 0.466 . . . . 0.0 110.684 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.622 HG11 HG11 ' B' ' 27' ' ' VAL . 58.2 t -69.01 -58.27 6.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 73.9 mtm -59.68 -22.21 61.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.41 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.466 HD11 ' OG1' ' A' ' 25' ' ' THR . 74.8 mt -79.91 -5.98 56.58 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -62.37 -9.49 8.38 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.833 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -102.74 19.87 18.38 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.65 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.848 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.99 -37.78 83.71 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.346 -0.701 . . . . 0.0 111.346 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.28 -22.47 0.68 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.774 0.321 . . . . 0.0 110.801 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.555 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.4 mp -63.45 -45.08 98.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.077 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 2.8 tp -69.45 -25.38 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.081 0.467 . . . . 0.0 110.728 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.94 -43.3 61.23 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.72 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 pp -82.37 -26.92 32.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.856 0.36 . . . . 0.0 110.75 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.21 -61.85 2.26 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.607 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.17 -23.38 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.058 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.32 -43.28 79.83 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.2 -60.97 7.41 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 m -50.47 -26.27 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 O-C-N 122.695 -0.297 . . . . 0.0 111.191 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 42.7 t -82.23 -46.92 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.061 0.458 . . . . 0.0 111.229 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.11 -44.98 84.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.931 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.54 -40.78 72.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.736 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.918 ' OG1' HG11 ' A' ' 23' ' ' VAL . 3.8 t -75.85 -27.59 57.89 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 119.712 -0.795 . . . . 0.0 110.269 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 29.6 mmt -72.18 -40.23 68.06 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.78 -46.1 79.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.724 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.888 HG11 ' OG1' ' A' ' 20' ' ' THR . 22.1 m -65.33 -33.58 64.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.478 -0.489 . . . . 0.0 112.277 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.555 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -43.66 -50.14 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 120.491 -0.483 . . . . 0.0 109.867 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.467 ' OG1' HD11 ' B' ' 29' ' ' LEU . 0.5 OUTLIER -66.3 -49.56 66.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 120.383 -0.527 . . . . 0.0 109.923 179.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.724 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.1 tm? -42.16 -37.77 1.54 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.637 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.622 HG11 HG11 ' A' ' 27' ' ' VAL . 58.7 t -69.0 -58.34 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 74.1 mtm -59.54 -22.39 61.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.438 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.467 HD11 ' OG1' ' B' ' 25' ' ' THR . 74.7 mt -79.86 -5.88 56.32 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -62.48 -9.39 8.39 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -102.83 19.68 18.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.712 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.792 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 9' ' ' ILE . . . -64.96 -33.19 86.58 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.94 -25.32 57.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.608 0.242 . . . . 0.0 111.223 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.586 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.5 mp -62.36 -44.0 98.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.15 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 6' ' ' GLY . 2.5 tp -51.64 -32.5 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.43 99.06 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.227 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.46 -24.92 34.01 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.36 -63.83 1.16 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 121.177 0.513 . . . . 0.0 110.593 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.1 m -67.42 -22.23 28.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.863 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.79 -40.04 15.77 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.34 -54.91 29.39 Favored Glycine 0 C--N 1.331 0.262 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.915 ' O ' HG23 ' A' ' 20' ' ' THR . 6.5 m -45.6 -51.86 2.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.551 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.4 -42.1 89.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.21 -50.12 81.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.321 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.76 -34.22 69.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.426 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.915 HG23 ' O ' ' A' ' 16' ' ' VAL . 34.2 p -74.6 -20.53 59.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.584 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 33.9 mmt -82.45 -31.55 29.39 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.373 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.98 -47.46 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.951 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.47 HG11 ' HB ' ' B' ' 20' ' ' THR . 18.9 m -63.94 -31.71 54.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.695 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 20' ' ' THR . 0.9 OUTLIER -54.64 -21.02 6.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.42 -43.89 59.48 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.028 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.738 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -58.92 -27.33 65.17 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.273 0.558 . . . . 0.0 110.625 -179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.4 t -65.26 -44.83 94.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.955 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 77.6 mtp -72.53 -29.21 63.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.365 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.47 -3.28 33.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.319 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -68.57 -18.18 64.29 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.494 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 32' ' ' LYS . 46.8 tttp -95.65 15.3 20.36 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.664 0.269 . . . . 0.0 110.717 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 31' ' ' LYS . 22.0 pttp . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.957 -1.02 . . . . 0.0 111.696 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.405 ' O ' HG22 ' B' ' 9' ' ' ILE . . . -64.98 -33.12 86.4 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.99 -25.38 58.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.63 0.252 . . . . 0.0 111.199 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.566 ' N ' HD12 ' B' ' 8' ' ' ILE . 1.5 mp -62.33 -43.95 98.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.168 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.405 HG22 ' O ' ' B' ' 6' ' ' GLY . 2.5 tp -51.54 -32.57 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.41 -43.45 99.04 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.19 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 51.2 tp -82.48 -24.92 33.96 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.877 0.37 . . . . 0.0 110.892 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.3 tpt -60.35 -63.82 1.17 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.622 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 23.4 m -67.45 -22.16 28.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.884 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.93 -39.79 15.95 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.236 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.28 -55.08 28.3 Favored Glycine 0 C--N 1.332 0.318 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.915 ' O ' HG23 ' B' ' 20' ' ' THR . 6.5 m -45.52 -51.81 2.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.549 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 60.6 t -60.5 -42.09 90.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.067 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.14 -50.21 81.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.321 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.75 -34.09 69.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.572 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.915 HG23 ' O ' ' B' ' 16' ' ' VAL . 33.8 p -74.7 -20.35 59.89 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.651 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.9 mmt -82.49 -31.59 29.22 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.343 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.87 -47.6 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.017 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.47 HG11 ' HB ' ' A' ' 20' ' ' THR . 19.0 m -63.79 -31.73 54.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.795 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.625 HD13 ' O ' ' B' ' 20' ' ' THR . 0.9 OUTLIER -54.6 -20.99 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.48 -43.93 59.1 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.954 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.736 HD13 ' C ' ' B' ' 26' ' ' LEU . 0.3 OUTLIER -58.91 -27.33 65.15 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.245 0.545 . . . . 0.0 110.662 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 66.7 t -65.3 -44.82 94.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.983 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 77.7 mtp -72.53 -29.1 63.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.364 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 97.5 mt -75.7 -3.14 33.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.22 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -68.64 -18.07 64.22 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.547 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.411 ' O ' ' C ' ' B' ' 32' ' ' LYS . 46.9 tttp -95.74 15.3 20.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.688 0.28 . . . . 0.0 110.664 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' B' ' 31' ' ' LYS . 22.0 pttp . . . . . 0 C--O 1.219 -0.531 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.755 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.48 -26.95 72.05 Favored Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.14 -36.22 83.58 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.205 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.43 -53.2 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.484 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.1 tp -70.91 -42.8 77.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.458 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -35.71 -48.58 0.99 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 mt -72.81 -38.27 67.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.825 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.501 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -55.74 -61.56 2.28 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 120.745 0.307 . . . . 0.0 111.636 -179.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.99 -22.63 30.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.722 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.74 -45.85 16.03 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.389 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.34 -53.83 32.89 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.879 ' O ' HG23 ' A' ' 20' ' ' THR . 4.8 m -49.22 -50.71 15.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.013 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.522 ' O ' ' SD ' ' A' ' 21' ' ' MET . 58.2 t -57.84 -45.62 87.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.642 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 97.5 mt -62.39 -46.44 96.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.383 0.611 . . . . 0.0 109.827 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.514 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -56.51 -38.25 71.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.139 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.879 HG23 ' O ' ' A' ' 16' ' ' VAL . 41.7 p -67.31 -25.4 66.01 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.678 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -80.86 -39.13 26.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.6 mt -71.23 -46.59 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.8 HG21 HG21 ' B' ' 23' ' ' VAL . 34.8 m -51.31 -37.11 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.946 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 20' ' ' THR . 1.2 mp -47.44 -46.2 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -60.15 -53.3 59.41 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.585 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.713 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.2 tm? -50.75 -40.91 56.0 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.133 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.0 t -65.94 -67.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.62 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 67.9 mtt -48.7 -23.07 0.91 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.214 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.534 ' O ' ' N ' ' A' ' 31' ' ' LYS . 16.3 mt -72.53 -26.63 61.82 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.702 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -45.78 -13.2 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.762 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 29' ' ' LEU . 27.9 ttpt -98.28 19.56 14.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.85 0.357 . . . . 0.0 110.252 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 29' ' ' LEU . 65.2 tttm . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.631 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -65.63 -27.22 72.41 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.84 -36.48 84.49 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.283 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.04 -53.27 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.103 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.473 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.1 tp -70.94 -42.71 77.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.429 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.48 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.06 -48.13 1.07 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 6.7 mt -73.15 -38.19 66.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.824 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . 0.499 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -55.59 -61.72 2.16 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.793 0.33 . . . . 0.0 111.622 -179.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 17.2 m -65.91 -22.39 30.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.795 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.92 -45.92 15.14 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.381 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.37 -53.75 33.34 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.886 ' O ' HG23 ' B' ' 20' ' ' THR . 4.9 m -49.04 -50.93 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.057 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.526 ' O ' ' SD ' ' B' ' 21' ' ' MET . 58.8 t -57.77 -45.55 87.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.72 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.45 -46.54 96.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.833 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.498 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -56.41 -38.44 71.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.059 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.886 HG23 ' O ' ' B' ' 16' ' ' VAL . 41.2 p -67.05 -25.37 66.22 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.802 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.533 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -80.93 -39.19 26.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 95.0 mt -71.18 -46.69 64.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.096 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.8 HG21 HG21 ' A' ' 23' ' ' VAL . 35.1 m -51.24 -37.16 17.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.872 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.692 HD13 ' O ' ' B' ' 20' ' ' THR . 1.2 mp -47.42 -46.01 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -60.4 -53.13 61.24 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.707 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.2 tm? -50.88 -40.85 57.54 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.079 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -65.98 -67.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.549 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 68.0 mtt -48.5 -23.25 0.91 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.207 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' B' ' 32' ' ' LYS . 15.8 mt -72.43 -26.69 61.94 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.686 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -45.67 -13.33 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.803 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' B' ' 29' ' ' LEU . 27.9 ttpt -98.33 19.74 13.82 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 110.281 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.1 tttm . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.079 -0.962 . . . . 0.0 110.616 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.6 -33.56 87.56 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.55 75.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.465 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.682 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.8 mp -68.56 -54.61 20.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.876 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.2 tp -69.67 -41.99 80.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 C-N-CA 120.339 -0.545 . . . . 0.0 110.254 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -34.31 -60.73 0.58 Allowed Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.66 -29.26 70.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.591 0.234 . . . . 0.0 111.242 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.521 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -66.05 -63.66 1.03 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.084 0.469 . . . . 0.0 111.267 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.88 -20.01 23.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.547 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.84 -40.59 5.87 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.48 -49.23 57.95 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.893 ' O ' HG23 ' A' ' 20' ' ' THR . 9.6 m -44.98 -49.64 2.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.725 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.406 ' N ' HG23 ' A' ' 16' ' ' VAL . 62.9 t -58.68 -43.41 87.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.862 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.98 -49.1 86.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.39 -36.28 71.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.962 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.893 HG23 ' O ' ' A' ' 16' ' ' VAL . 31.2 p -73.16 -18.43 61.27 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.696 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -82.7 -31.74 28.41 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.399 -0.52 . . . . 0.0 109.987 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.459 ' O ' HG22 ' A' ' 25' ' ' THR . 97.1 mt -63.35 -46.17 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.381 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' LEU . 27.2 m -64.41 -35.04 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.345 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 20' ' ' THR . 1.1 mp -46.87 -20.97 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -76.24 -40.68 51.36 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.207 178.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.717 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -54.4 -31.54 55.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.278 0.561 . . . . 0.0 109.87 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.7 t -63.25 -29.96 48.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.473 0.654 . . . . 0.0 109.826 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 97.9 mtp -84.38 -32.98 23.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.788 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 32' ' ' LYS . 59.2 mt -66.6 -41.88 87.75 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -49.43 -10.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.718 0.294 . . . . 0.0 111.001 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 29' ' ' LEU . 99.5 mttt -96.24 12.27 31.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.109 0.48 . . . . 0.0 109.982 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 29' ' ' LEU . 32.5 ttpt . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.301 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.63 -33.6 87.68 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.44 74.85 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.516 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.677 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.8 mp -68.67 -54.58 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.86 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.2 tp -69.6 -42.09 80.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.22 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.432 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -34.23 -61.08 0.55 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.4 -28.95 70.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.804 -0.198 . . . . 0.0 111.253 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . 0.52 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -66.37 -63.79 1.0 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.046 0.45 . . . . 0.0 111.203 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.76 -20.05 23.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.528 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -89.76 -40.6 5.89 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.44 -49.23 57.83 Favored Glycine 0 C--N 1.335 0.482 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.901 ' O ' HG23 ' B' ' 20' ' ' THR . 9.4 m -44.98 -49.75 2.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.217 -0.491 . . . . 0.0 110.698 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.41 ' N ' HG23 ' B' ' 16' ' ' VAL . 65.5 t -58.55 -43.48 87.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.872 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -60.92 -49.18 85.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.37 -36.18 70.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.052 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.901 HG23 ' O ' ' B' ' 16' ' ' VAL . 30.7 p -73.26 -18.29 61.24 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.653 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 33.0 mmt -82.72 -31.7 28.35 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.047 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.459 ' O ' HG22 ' B' ' 25' ' ' THR . 97.1 mt -63.47 -46.21 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.322 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' B' ' 26' ' ' LEU . 27.1 m -64.29 -35.25 73.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.389 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.656 HD13 ' O ' ' B' ' 20' ' ' THR . 1.1 mp -46.7 -20.84 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.459 HG22 ' O ' ' B' ' 22' ' ' ILE . 0.7 OUTLIER -76.45 -40.62 50.0 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.161 178.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.723 ' C ' HD13 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -54.5 -31.59 56.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.327 0.584 . . . . 0.0 109.825 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.5 t -63.21 -30.02 48.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.454 0.645 . . . . 0.0 109.778 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.1 mtp -84.28 -33.03 24.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.842 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' B' ' 31' ' ' LYS . 59.3 mt -66.62 -41.8 87.79 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 15.8 ptmt -49.48 -10.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.699 0.285 . . . . 0.0 110.921 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' B' ' 29' ' ' LEU . 99.4 mttt -96.07 12.49 30.42 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.204 0.526 . . . . 0.0 110.014 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' B' ' 29' ' ' LEU . 32.4 ttpt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.339 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 8' ' ' ILE . . . -61.92 -34.03 87.47 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.41 -19.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.816 0.341 . . . . 0.0 110.593 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.441 ' N ' ' O ' ' A' ' 6' ' ' GLY . 97.2 mt -64.27 -42.84 96.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.455 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 6' ' ' GLY . 3.0 tp -58.74 -37.67 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.0 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.56 -42.91 52.36 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.1 tp -73.38 -26.91 61.19 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.746 -0.267 . . . . 0.0 111.084 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.53 -60.25 3.69 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 120.802 0.334 . . . . 0.0 110.847 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -55.33 -23.47 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.024 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.19 -40.5 29.05 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.343 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.441 ' C ' HG12 ' B' ' 16' ' ' VAL . . . -58.19 -43.67 95.26 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.366 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 20' ' ' THR . 11.0 m -61.74 -24.15 33.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.606 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.455 ' O ' ' SD ' ' A' ' 21' ' ' MET . 54.3 t -86.08 -39.97 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 O-C-N 123.461 0.476 . . . . 0.0 111.341 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.5 mt -67.84 -52.51 39.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.635 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.839 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -54.67 -46.39 74.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.779 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.862 ' OG1' HG11 ' B' ' 23' ' ' VAL . 4.2 t -68.96 -17.62 63.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.48 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.455 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -85.0 -29.04 25.33 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.288 0.367 . . . . 0.0 111.373 -179.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.31 -39.19 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.882 0.372 . . . . 0.0 111.225 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.863 HG11 ' OG1' ' B' ' 20' ' ' THR . 13.6 m -56.57 -39.24 61.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.105 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.498 ' N ' HG23 ' A' ' 23' ' ' VAL . 37.2 mm -40.73 -49.77 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -60.28 -41.02 92.43 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.972 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.736 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.5 tm? -60.07 -48.36 82.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.866 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.541 HG11 HG11 ' B' ' 27' ' ' VAL . 93.2 t -62.19 -42.92 97.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.344 0.592 . . . . 0.0 109.996 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 93.9 mmm -63.55 -18.56 63.98 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.761 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 31' ' ' LYS . 34.6 mt -87.5 -49.86 6.92 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.427 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.612 ' HE2' HD11 ' A' ' 26' ' ' LEU . 66.2 mttm -55.76 -4.28 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.535 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 29' ' ' LEU . 16.9 tptm -156.29 60.64 0.56 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.117 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.471 179.498 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' B' ' 8' ' ' ILE . . . -61.8 -34.01 87.23 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.41 -19.75 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.735 0.303 . . . . 0.0 110.657 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.432 ' N ' ' C ' ' B' ' 6' ' ' GLY . 96.9 mt -64.16 -42.9 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.414 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.404 HG22 ' O ' ' B' ' 6' ' ' GLY . 3.0 tp -58.72 -37.53 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.002 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.64 -42.96 52.92 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 56.3 tp -73.4 -26.91 61.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.749 -0.265 . . . . 0.0 111.118 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -60.28 3.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.791 0.329 . . . . 0.0 110.763 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 29.8 m -55.36 -23.34 13.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.104 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.23 -40.61 28.54 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.352 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.434 ' C ' HG12 ' A' ' 16' ' ' VAL . . . -58.02 -43.65 94.96 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.434 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.614 ' O ' HG22 ' B' ' 20' ' ' THR . 10.8 m -61.83 -24.11 33.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.596 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.453 ' O ' ' SD ' ' B' ' 21' ' ' MET . 54.8 t -86.23 -39.93 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 O-C-N 123.517 0.511 . . . . 0.0 111.324 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.4 mt -67.83 -52.61 38.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.587 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.848 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -54.59 -46.4 73.76 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.743 -178.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.863 ' OG1' HG11 ' A' ' 23' ' ' VAL . 4.1 t -68.87 -17.64 64.01 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.407 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.453 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.1 OUTLIER -85.13 -29.08 25.1 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 123.325 0.39 . . . . 0.0 111.285 -178.898 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.14 -39.37 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 111.199 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.862 HG11 ' OG1' ' A' ' 20' ' ' THR . 13.5 m -56.37 -39.35 60.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.058 -178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.493 ' N ' HG23 ' B' ' 23' ' ' VAL . 37.0 mm -40.65 -49.85 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -60.29 -41.01 92.47 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.978 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.718 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.5 tm? -60.01 -48.4 81.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.851 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.541 HG11 HG11 ' A' ' 27' ' ' VAL . 96.1 t -62.21 -42.87 96.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.216 0.532 . . . . 0.0 110.055 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 94.2 mmm -63.52 -18.72 64.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.785 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' B' ' 31' ' ' LYS . 34.5 mt -87.43 -49.76 7.0 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.432 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.594 ' HE2' HD11 ' B' ' 26' ' ' LEU . 66.4 mttm -55.8 -4.06 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.54 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.501 ' H ' ' C ' ' B' ' 29' ' ' LEU . 16.9 tptm -156.51 60.72 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.122 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.432 179.526 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.25 -26.42 70.51 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.6 -23.07 15.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.687 0.279 . . . . 0.0 110.652 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -62.71 -44.1 99.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.59 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.498 ' O ' HG22 ' A' ' 13' ' ' VAL . 6.0 tp -56.12 -33.78 37.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.8 -45.06 96.99 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.005 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.55 -29.56 37.1 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 120.905 0.383 . . . . 0.0 111.097 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.3 tpt -64.31 -63.61 1.1 Allowed 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.489 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 9' ' ' ILE . 4.7 m -66.84 -22.15 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.528 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.04 -41.48 10.35 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.23 -54.25 35.38 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.888 ' O ' HG23 ' A' ' 20' ' ' THR . 6.3 m -45.57 -51.04 3.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.874 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.512 ' O ' ' SD ' ' A' ' 21' ' ' MET . 85.8 t -59.1 -43.59 89.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.947 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.8 -49.05 85.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.686 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.28 -34.18 68.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.396 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.888 HG23 ' O ' ' A' ' 16' ' ' VAL . 33.2 p -74.16 -20.67 60.14 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.63 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' OG1' ' A' ' 20' ' ' THR . 0.0 OUTLIER -81.9 -31.7 31.31 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.622 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 25' ' ' THR . 96.8 mt -62.91 -48.56 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.524 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.434 ' C ' ' N ' ' A' ' 25' ' ' THR . 23.8 m -63.3 -31.99 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.968 0.413 . . . . 0.0 110.759 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.597 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -50.19 -19.12 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.487 HG22 ' O ' ' A' ' 22' ' ' ILE . 1.2 t -74.56 -42.08 59.42 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.348 178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.706 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -56.39 -29.92 62.08 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.244 0.545 . . . . 0.0 110.436 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.74 -46.49 92.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.378 0.608 . . . . 0.0 109.711 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 90.0 mtp -70.28 -33.97 72.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.031 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.36 -2.95 54.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.32 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -61.45 -37.51 83.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.95 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.66 23.2 3.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.269 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.221 -0.434 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.383 179.406 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.22 -26.52 70.55 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.54 -23.03 14.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.72 0.295 . . . . 0.0 110.639 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.9 mt -62.67 -44.13 99.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.62 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.495 ' O ' HG22 ' B' ' 13' ' ' VAL . 6.0 tp -56.13 -33.8 37.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.71 -45.2 96.75 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.059 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 52.0 tp -80.47 -29.57 37.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.86 0.362 . . . . 0.0 111.123 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 8.3 tpt -64.3 -63.64 1.09 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.545 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.495 HG22 ' O ' ' B' ' 9' ' ' ILE . 4.7 m -66.76 -22.28 29.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.513 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.01 -41.36 10.49 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.22 -54.3 35.0 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.89 ' O ' HG23 ' B' ' 20' ' ' THR . 6.6 m -45.59 -50.99 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.953 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.508 ' O ' ' SD ' ' B' ' 21' ' ' MET . 85.3 t -59.13 -43.65 89.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.904 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.72 -49.07 85.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.294 -0.562 . . . . 0.0 109.681 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.32 -34.23 68.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.341 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.89 HG23 ' O ' ' B' ' 16' ' ' VAL . 33.4 p -74.16 -20.74 60.12 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.693 0.282 . . . . 0.0 110.607 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.53 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -81.82 -31.67 31.61 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.626 179.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.487 ' O ' HG22 ' B' ' 25' ' ' THR . 96.8 mt -62.97 -48.52 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.499 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.431 ' C ' ' N ' ' B' ' 25' ' ' THR . 24.3 m -63.34 -31.91 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 120.936 0.398 . . . . 0.0 110.829 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.598 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -50.18 -19.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.487 HG22 ' O ' ' B' ' 22' ' ' ILE . 1.2 t -74.5 -42.05 59.61 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.309 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.707 ' C ' HD13 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -56.43 -29.89 62.16 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 121.284 0.564 . . . . 0.0 110.48 -179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.4 t -64.81 -46.38 92.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.277 0.561 . . . . 0.0 109.714 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 89.8 mtp -70.38 -33.85 71.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.977 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 93.2 mt -82.42 -2.92 54.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.298 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -61.51 -37.55 84.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.878 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -90.6 23.24 3.11 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.323 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 65.7 tttm . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.307 179.479 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.517 ' HZ1' ' HZ1' ' B' ' 5' ' ' LYS . 32.2 mmtp . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.76 -33.37 87.06 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.4 -22.99 46.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.629 0.252 . . . . 0.0 110.827 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.496 HD13 HD13 ' B' ' 8' ' ' ILE . 91.9 mt -62.7 -43.61 98.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.23 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.464 ' O ' HG22 ' A' ' 13' ' ' VAL . 5.1 tp -60.0 -33.2 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.146 0.498 . . . . 0.0 109.799 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.75 -68.72 1.55 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.319 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -60.98 -27.49 68.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.697 0.284 . . . . 0.0 111.051 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.07 -63.84 1.05 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 120.854 0.359 . . . . 0.0 110.727 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 9' ' ' ILE . 7.5 m -70.21 -21.16 23.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.05 -39.32 8.61 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.72 -53.17 40.88 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.885 ' O ' HG23 ' A' ' 20' ' ' THR . 4.8 m -45.45 -48.4 3.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.541 -0.329 . . . . 0.0 110.9 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.524 ' O ' ' SD ' ' A' ' 21' ' ' MET . 97.4 t -58.72 -44.09 89.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.755 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.44 -48.02 90.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.58 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.65 68.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.543 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.885 HG23 ' O ' ' A' ' 16' ' ' VAL . 31.1 p -74.81 -18.95 60.38 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.653 0.263 . . . . 0.0 110.783 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -83.75 -30.84 26.35 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.221 179.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.442 ' O ' HG22 ' A' ' 25' ' ' THR . 96.7 mt -62.99 -48.24 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.368 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.438 ' C ' ' N ' ' A' ' 25' ' ' THR . 25.0 m -63.77 -32.64 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-O 121.078 0.466 . . . . 0.0 110.72 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.554 HD13 ' O ' ' A' ' 20' ' ' THR . 1.0 OUTLIER -48.82 -21.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -75.84 -41.19 53.22 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.611 179.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.729 HD13 ' C ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -56.72 -30.25 63.3 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.451 0.643 . . . . 0.0 110.389 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.2 t -61.84 -38.65 81.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.51 0.672 . . . . 0.0 109.391 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.5 mmm -72.88 -28.43 62.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.79 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.75 -6.59 56.27 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.013 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.14 -39.01 91.15 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.782 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -94.0 18.03 11.32 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.793 0.33 . . . . 0.0 110.42 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.647 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . 0.517 ' HZ1' ' HZ1' ' A' ' 5' ' ' LYS . 32.1 mmtp . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.82 -33.39 87.12 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.4 -23.03 46.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.69 0.281 . . . . 0.0 110.85 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.496 HD13 HD13 ' A' ' 8' ' ' ILE . 91.3 mt -62.55 -43.65 98.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.288 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.466 ' O ' HG22 ' B' ' 13' ' ' VAL . 5.1 tp -59.97 -33.22 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.169 0.509 . . . . 0.0 109.817 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.81 -68.71 1.56 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.257 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.484 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.2 mm? -60.96 -27.5 68.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.034 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.16 -63.82 1.05 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 120.841 0.353 . . . . 0.0 110.724 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.466 HG22 ' O ' ' B' ' 9' ' ' ILE . 7.3 m -70.1 -21.13 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.14 -39.38 8.52 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.58 -53.16 40.52 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.884 ' O ' HG23 ' B' ' 20' ' ' THR . 4.8 m -45.49 -48.35 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.528 -0.336 . . . . 0.0 110.877 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.515 ' O ' ' SD ' ' B' ' 21' ' ' MET . 97.2 t -58.91 -43.85 89.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.765 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.61 -48.02 90.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.504 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -33.71 69.0 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.47 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.884 HG23 ' O ' ' B' ' 16' ' ' VAL . 31.0 p -74.68 -19.08 60.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.817 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -83.54 -30.99 26.65 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.279 179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.44 ' O ' HG22 ' B' ' 25' ' ' THR . 96.7 mt -62.91 -48.22 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.453 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.449 ' C ' ' N ' ' B' ' 25' ' ' THR . 25.5 m -63.73 -32.65 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.158 0.504 . . . . 0.0 110.751 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.552 HD13 ' O ' ' B' ' 20' ' ' THR . 1.0 OUTLIER -48.91 -20.94 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.449 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -75.95 -41.21 52.22 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.594 179.058 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.727 ' C ' HD13 ' B' ' 26' ' ' LEU . 0.8 OUTLIER -56.66 -30.15 63.05 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.424 0.63 . . . . 0.0 110.43 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.3 t -61.93 -39.05 82.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.49 0.662 . . . . 0.0 109.291 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.5 mmm -72.39 -28.52 63.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.825 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 86.6 mt -78.79 -6.48 56.05 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.992 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.26 -38.86 90.9 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.708 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -94.03 17.91 11.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.771 0.32 . . . . 0.0 110.396 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 63.9 tttp . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.554 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.37 -25.66 65.21 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.456 -1.057 . . . . 0.0 110.456 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.93 -36.3 83.93 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.168 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.13 -53.77 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.52 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.1 tp -70.17 -38.56 75.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 109.976 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.5 -46.12 8.61 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.5 tp -73.03 -38.47 66.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 121.189 -0.204 . . . . 0.0 110.79 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.58 -57.27 8.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.954 0.407 . . . . 0.0 110.982 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 27.0 m -65.4 -20.72 27.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.211 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.15 -40.81 10.93 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.53 -54.89 25.25 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 3.7 m -44.49 -51.29 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.452 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.13 -42.24 72.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.846 0.355 . . . . 0.0 110.871 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.58 -49.91 60.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.374 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.91 -39.22 77.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.869 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.429 ' OG1' HG11 ' B' ' 23' ' ' VAL . 14.2 t -80.07 -17.25 53.17 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 120.944 0.402 . . . . 0.0 110.235 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.44 ' O ' HG22 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -79.36 -31.81 43.04 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.284 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 25' ' ' THR . 97.1 mt -63.53 -46.81 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.066 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.457 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' C ' ' N ' ' A' ' 25' ' ' THR . 33.6 m -64.8 -35.12 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 CA-C-O 121.061 0.457 . . . . 0.0 110.198 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 21' ' ' MET . 1.6 tp -45.05 -22.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 22' ' ' ILE . 1.3 t -72.07 -41.04 67.83 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.669 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.691 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -53.0 -30.49 35.5 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.875 0.47 . . . . 0.0 110.688 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.572 HG22 HG22 ' B' ' 27' ' ' VAL . 11.0 t -64.96 -45.93 93.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.28 0.562 . . . . 0.0 109.493 177.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 65.7 mtt -71.47 -34.67 70.41 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.917 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 88.8 mt -83.75 -2.96 57.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.819 0.342 . . . . 0.0 110.575 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -62.78 -37.44 86.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.77 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.59 23.79 4.44 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.398 179.749 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.4 mttm . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -61.41 -25.35 64.88 Favored Glycine 0 CA--C 1.52 0.35 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.19 83.47 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.104 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.17 -54.03 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.463 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.4 HG23 ' N ' ' B' ' 10' ' ' GLY . 6.0 tp -70.02 -38.58 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.129 0.49 . . . . 0.0 109.944 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.4 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -44.39 -46.48 8.51 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 44.8 tp -72.66 -38.52 67.6 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.848 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . 0.401 ' SD ' ' C ' ' B' ' 12' ' ' MET . 0.0 OUTLIER -50.53 -57.23 8.6 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.971 0.415 . . . . 0.0 111.058 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' B' ' 16' ' ' VAL . 27.0 m -65.4 -20.75 28.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.219 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.12 -40.77 11.02 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.59 -54.87 25.53 Favored Glycine 0 C--O 1.223 -0.587 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' B' ' 13' ' ' VAL . 3.7 m -44.59 -51.22 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.49 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.401 ' H ' HG23 ' B' ' 16' ' ' VAL . 69.5 t -56.21 -42.11 72.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.771 0.319 . . . . 0.0 110.874 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.79 -49.76 61.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.33 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.25 77.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.801 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.43 ' OG1' HG11 ' A' ' 23' ' ' VAL . 14.3 t -80.04 -17.38 52.9 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.212 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.451 ' O ' HG22 ' B' ' 24' ' ' ILE . 0.2 OUTLIER -79.19 -31.93 43.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.341 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.523 ' O ' HG22 ' B' ' 25' ' ' THR . 97.5 mt -63.49 -46.78 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.074 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.55 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.455 ' C ' ' N ' ' B' ' 25' ' ' THR . 32.7 m -64.83 -34.98 73.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.187 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.451 HG22 ' O ' ' B' ' 21' ' ' MET . 1.6 tp -45.21 -22.93 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.492 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.523 HG22 ' O ' ' B' ' 22' ' ' ILE . 1.3 t -71.83 -41.14 68.53 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.742 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.691 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.0 OUTLIER -52.84 -30.59 34.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.956 0.502 . . . . 0.0 110.657 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 27' ' ' VAL . 10.7 t -64.96 -45.92 93.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 65.4 mtt -71.59 -34.79 70.21 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.835 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 88.4 mt -83.7 -2.68 56.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.749 0.309 . . . . 0.0 110.563 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -63.06 -37.31 86.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.746 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -93.66 23.59 4.61 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.059 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.4 179.687 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.51 -33.49 87.4 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.76 -22.54 36.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.6 0.238 . . . . 0.0 110.733 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.56 HD13 HD13 ' B' ' 8' ' ' ILE . 88.4 mt -62.28 -44.04 98.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.26 -179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 13' ' ' VAL . 5.4 tp -59.76 -35.8 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.83 -69.21 1.34 Allowed Glycine 0 CA--C 1.532 1.153 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.66 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 47.3 tp -60.84 -28.41 68.81 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 120.79 0.329 . . . . 0.0 111.062 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 8.9 tpt -63.54 -63.64 1.12 Allowed 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.002 0.43 . . . . 0.0 110.545 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 9' ' ' ILE . 10.5 m -67.84 -20.63 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.82 -39.83 7.4 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.5 -52.04 44.02 Favored Glycine 0 C--N 1.333 0.392 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.894 ' O ' HG23 ' A' ' 20' ' ' THR . 3.4 m -44.72 -49.04 2.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.579 -0.311 . . . . 0.0 110.725 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 65.0 t -58.63 -43.63 87.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.02 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.22 -49.66 83.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -35.9 70.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.166 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.894 HG23 ' O ' ' A' ' 16' ' ' VAL . 30.2 p -73.52 -18.51 61.09 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.955 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -84.3 -31.94 24.62 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.124 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.45 -47.66 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.447 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.447 ' C ' ' N ' ' A' ' 25' ' ' THR . 29.9 m -63.37 -34.92 70.1 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 121.172 0.51 . . . . 0.0 110.532 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 20' ' ' THR . 0.9 OUTLIER -46.04 -22.17 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.447 ' N ' ' C ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -79.26 -42.31 26.15 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.774 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.714 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.1 tm? -51.35 -31.19 21.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.324 0.583 . . . . 0.0 110.393 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG11 ' NZ ' ' B' ' 30' ' ' LYS . 14.0 t -64.67 -35.69 75.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.515 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.9 mtp -71.94 -29.6 64.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.667 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.28 -9.63 59.31 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.235 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' NZ ' HG11 ' B' ' 27' ' ' VAL . 97.3 mttt -62.17 -36.49 82.02 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.723 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -89.54 18.66 5.16 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.674 0.273 . . . . 0.0 110.674 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.25 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.62 -33.46 87.3 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.88 -22.6 38.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.669 0.271 . . . . 0.0 110.674 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.56 HD13 HD13 ' A' ' 8' ' ' ILE . 89.2 mt -62.23 -43.98 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.252 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.483 ' O ' HG22 ' B' ' 13' ' ' VAL . 5.4 tp -59.74 -35.88 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -55.78 -69.18 1.34 Allowed Glycine 0 CA--C 1.533 1.184 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.687 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 47.1 tp -60.78 -28.51 68.8 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-O 120.767 0.318 . . . . 0.0 111.084 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 8.9 tpt -63.49 -63.74 1.1 Allowed 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 121.012 0.434 . . . . 0.0 110.457 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.483 HG22 ' O ' ' B' ' 9' ' ' ILE . 10.4 m -67.81 -20.59 26.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.41 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.75 -39.9 7.41 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.5 -52.06 43.91 Favored Glycine 0 C--N 1.334 0.452 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.886 ' O ' HG23 ' B' ' 20' ' ' THR . 3.4 m -44.71 -49.12 2.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.66 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 64.3 t -58.64 -43.57 87.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.004 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 36.2 mm -60.22 -49.65 83.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.74 70.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.213 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.886 HG23 ' O ' ' B' ' 16' ' ' VAL . 30.4 p -73.59 -18.49 61.05 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.845 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.8 mmt -84.3 -31.85 24.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.132 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.48 -47.66 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 120.631 -0.427 . . . . 0.0 110.473 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.445 HG11 ' HB ' ' A' ' 20' ' ' THR . 30.1 m -63.35 -35.0 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-O 121.168 0.509 . . . . 0.0 110.502 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.414 HD13 ' O ' ' B' ' 20' ' ' THR . 0.9 OUTLIER -45.98 -22.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.819 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.439 ' N ' ' C ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -79.24 -42.33 26.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.79 178.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.71 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.1 tm? -51.28 -31.27 20.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.322 0.582 . . . . 0.0 110.423 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.442 HG11 ' NZ ' ' A' ' 30' ' ' LYS . 14.2 t -64.6 -35.69 75.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.595 177.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 98.8 mtp -71.9 -29.6 64.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.726 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.25 -9.53 59.26 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.247 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.444 ' NZ ' HG11 ' A' ' 27' ' ' VAL . 97.3 mttt -62.31 -36.57 82.56 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.694 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -89.45 18.6 5.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.622 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 21.1 tptm . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.312 179.879 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.2 -34.07 88.94 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.87 -30.01 70.57 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.505 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.695 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.8 mp -70.54 -55.77 13.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.775 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 12' ' ' MET . 4.1 tp -69.28 -42.31 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.238 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -36.49 -58.46 1.1 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -64.97 -29.03 69.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.656 -0.272 . . . . 0.0 110.819 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.507 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -66.09 -63.78 1.0 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 0.0 111.205 -179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' A' ' 16' ' ' VAL . 26.1 m -67.07 -20.12 26.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.871 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.16 -41.09 6.33 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.24 -49.82 54.67 Favored Glycine 0 C--N 1.333 0.369 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.892 ' O ' HG23 ' A' ' 20' ' ' THR . 5.1 m -44.6 -51.03 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.314 -0.443 . . . . 0.0 110.647 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 16' ' ' VAL . 91.4 t -57.64 -43.8 84.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.745 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.98 -49.87 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -36.75 68.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.866 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 16' ' ' VAL . 28.9 p -72.59 -18.51 61.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.045 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.3 mmt -82.44 -32.57 28.91 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.218 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 25' ' ' THR . 97.1 mt -63.53 -46.57 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.633 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 25' ' ' THR . 30.1 m -63.12 -36.1 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.283 0.563 . . . . 0.0 110.571 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -43.77 -22.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.446 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.7 OUTLIER -81.57 -42.78 19.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.504 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.679 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.2 tm? -47.44 -33.73 6.46 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.617 0.723 . . . . 0.0 110.475 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.44 ' O ' ' CG ' ' A' ' 30' ' ' LYS . 48.5 t -66.0 -42.56 91.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.164 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.402 ' N ' ' O ' ' A' ' 25' ' ' THR . 67.3 mtt -65.97 -33.66 76.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.412 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.59 0.75 11.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.356 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 27' ' ' VAL . 24.6 mmtp -62.01 -38.17 87.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.554 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -132.74 17.33 4.28 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.821 0.344 . . . . 0.0 110.479 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 N--CA 1.469 0.482 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.041 179.566 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.04 -34.15 89.16 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.89 -29.94 70.54 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.046 -0.262 . . . . 0.0 110.468 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.695 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.8 mp -70.56 -55.79 13.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.738 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' B' ' 12' ' ' MET . 4.0 tp -69.36 -42.31 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.269 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.452 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -36.44 -58.35 1.1 Allowed Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.465 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.2 mm? -65.16 -28.92 69.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.678 -0.261 . . . . 0.0 110.792 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . 0.505 ' N ' ' O ' ' B' ' 9' ' ' ILE . 0.0 OUTLIER -66.17 -63.84 0.99 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.997 0.427 . . . . 0.0 111.239 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 26.4 m -67.06 -20.07 26.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.861 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.1 -41.12 6.34 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.21 -49.76 54.82 Favored Glycine 0 C--N 1.332 0.32 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.905 ' O ' HG23 ' B' ' 20' ' ' THR . 5.3 m -44.9 -50.86 2.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.641 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 16' ' ' VAL . 91.8 t -57.66 -43.91 84.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.697 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.89 -49.81 83.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.97 68.98 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.959 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.905 HG23 ' O ' ' B' ' 16' ' ' VAL . 28.9 p -72.43 -18.55 61.7 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.967 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 32.3 mmt -82.37 -32.76 29.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.203 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.406 ' O ' HG22 ' B' ' 25' ' ' THR . 97.0 mt -63.22 -46.7 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.672 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' B' ' 25' ' ' THR . 30.1 m -63.14 -36.11 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-O 121.339 0.59 . . . . 0.0 110.629 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -43.79 -22.03 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.582 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.467 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.7 OUTLIER -81.62 -42.65 19.72 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.498 179.444 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.682 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.2 tm? -47.66 -33.6 7.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.745 0.783 . . . . 0.0 110.513 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' B' ' 30' ' ' LYS . 50.0 t -66.02 -42.54 91.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.18 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 67.3 mtt -65.86 -33.78 76.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.471 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 89.2 mt -73.5 0.6 11.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.333 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' B' ' 27' ' ' VAL . 24.7 mmtp -61.78 -38.4 87.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.543 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -132.59 17.48 4.34 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.888 0.375 . . . . 0.0 110.492 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 C--O 1.219 -0.543 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.057 179.579 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.8 -25.62 69.28 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.16 79.51 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.55 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.644 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.8 mp -65.8 -53.09 42.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.91 -179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 10' ' ' GLY . 5.5 tp -71.15 -41.68 75.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.05 0.452 . . . . 0.0 110.308 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -39.97 -46.24 3.13 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.1 tp -73.82 -41.95 61.58 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.76 0.314 . . . . 0.0 110.652 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.01 -54.23 13.63 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.083 0.468 . . . . 0.0 111.013 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.2 m -68.17 -21.83 27.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.818 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.58 -46.61 14.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -50.97 -54.82 21.09 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.874 ' O ' HG23 ' A' ' 20' ' ' THR . 6.9 m -48.23 -49.26 12.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.26 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.509 ' O ' ' SD ' ' A' ' 21' ' ' MET . 85.4 t -59.81 -45.03 95.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.929 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.29 -45.92 97.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 119.765 -0.774 . . . . 0.0 108.966 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.523 ' O ' HG13 ' A' ' 23' ' ' VAL . . . -57.18 -38.26 73.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.671 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.874 HG23 ' O ' ' A' ' 16' ' ' VAL . 66.4 p -68.05 -24.98 65.14 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.054 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.526 ' SD ' ' OG1' ' A' ' 20' ' ' THR . 0.0 OUTLIER -82.04 -38.9 24.28 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.319 0.387 . . . . 0.0 112.038 -179.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.3 mt -69.08 -46.54 78.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.761 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.83 HG21 HG21 ' B' ' 23' ' ' VAL . 31.5 m -52.69 -34.97 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.939 -178.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.439 ' N ' HG23 ' A' ' 23' ' ' VAL . 33.5 mm -49.0 -45.99 16.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 m -59.6 -55.08 38.96 Favored 'General case' 0 C--O 1.224 -0.282 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.716 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.6 tm? -46.93 -37.67 9.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.246 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG11 HG11 ' B' ' 27' ' ' VAL . 58.9 t -71.3 -56.67 9.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.395 177.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.522 ' O ' ' N ' ' A' ' 32' ' ' LYS . 98.6 mmm -58.11 -29.54 65.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.697 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.746 ' O ' HD23 ' A' ' 29' ' ' LEU . 3.5 tt -63.79 -36.0 82.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.994 0.426 . . . . 0.0 109.87 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -45.4 -11.84 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.258 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 29' ' ' LEU . 34.1 ttmt -156.72 -13.43 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.371 0.605 . . . . 0.0 110.12 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 28' ' ' MET . 55.1 mtpt . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.483 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.78 69.21 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.29 -35.04 79.06 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.594 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.647 HD12 ' N ' ' B' ' 8' ' ' ILE . 1.8 mp -66.0 -53.16 40.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.908 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.453 HG23 ' N ' ' B' ' 10' ' ' GLY . 5.5 tp -70.94 -41.73 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.297 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.453 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -40.07 -46.06 3.18 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 43.0 tp -74.05 -41.92 61.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.709 0.29 . . . . 0.0 110.661 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 -54.29 13.04 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.106 0.479 . . . . 0.0 110.967 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 31.0 m -68.16 -21.78 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.846 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.55 -46.63 14.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.1 -54.89 21.2 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.873 ' O ' HG23 ' B' ' 20' ' ' THR . 7.1 m -47.98 -49.34 11.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.383 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.525 ' O ' ' SD ' ' B' ' 21' ' ' MET . 85.9 t -59.88 -44.98 95.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.939 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 98.1 mt -62.33 -45.97 97.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.518 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -57.16 -38.26 73.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.615 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.873 HG23 ' O ' ' B' ' 16' ' ' VAL . 69.1 p -68.06 -24.93 65.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.096 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.529 ' SD ' ' OG1' ' B' ' 20' ' ' THR . 0.0 OUTLIER -82.11 -38.9 24.1 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.42 0.45 . . . . 0.0 112.032 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 88.5 mt -69.13 -46.51 77.96 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.765 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.83 HG21 HG21 ' A' ' 23' ' ' VAL . 31.9 m -52.67 -34.91 20.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.013 -178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.431 ' N ' HG23 ' B' ' 23' ' ' VAL . 33.0 mm -49.1 -45.9 17.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.427 ' O ' ' N ' ' B' ' 29' ' ' LEU . 1.5 m -59.71 -55.31 35.97 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.707 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.6 tm? -46.79 -37.49 8.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.295 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.434 HG11 HG11 ' A' ' 27' ' ' VAL . 59.6 t -71.45 -56.53 10.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.466 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . 0.528 ' O ' ' N ' ' B' ' 32' ' ' LYS . 98.6 mmm -58.23 -29.4 65.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.715 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.737 ' O ' HD23 ' B' ' 29' ' ' LEU . 3.5 tt -63.84 -36.14 82.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.024 0.44 . . . . 0.0 109.861 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -45.29 -11.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.361 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.542 ' N ' ' O ' ' B' ' 29' ' ' LEU . 34.0 ttmt -156.73 -13.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.241 0.543 . . . . 0.0 109.965 179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' B' ' 28' ' ' MET . 55.0 mtpt . . . . . 0 C--N 1.322 -0.63 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.43 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.72 -22.65 66.42 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.17 -31.03 68.63 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.996 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.02 -59.29 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.746 0.308 . . . . 0.0 111.004 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 10' ' ' GLY . 6.0 tp -66.09 -39.75 85.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.22 0.533 . . . . 0.0 110.198 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -42.62 -45.99 5.7 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.75 -33.65 64.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 111.204 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.436 ' SD ' ' C ' ' A' ' 12' ' ' MET . 0.1 OUTLIER -57.23 -62.94 1.41 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.302 -179.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.9 m -58.27 -21.91 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.178 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.13 -38.45 39.98 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.31 -55.25 30.5 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 20' ' ' THR . 23.2 m -51.05 -21.72 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.19 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.1 t -85.56 -47.77 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.205 0.526 . . . . 0.0 111.376 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.8 mm -69.7 -47.14 72.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.02 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.5 -41.11 65.95 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.707 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.703 ' OG1' HG11 ' B' ' 23' ' ' VAL . 4.0 t -78.88 -19.93 50.72 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.047 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 22.0 mmt -78.33 -35.14 48.01 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.951 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.482 ' O ' HG22 ' A' ' 25' ' ' THR . 96.9 mt -62.92 -48.45 87.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.65 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.703 HG11 ' OG1' ' B' ' 20' ' ' THR . 34.1 m -63.87 -34.71 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.174 0.511 . . . . 0.0 110.3 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 1.2 tp -43.59 -22.44 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -79.46 -43.03 24.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.57 178.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.702 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.5 tm? -47.83 -31.83 5.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.67 0.747 . . . . 0.0 110.479 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.445 HG13 HG13 ' B' ' 27' ' ' VAL . 12.6 t -64.46 -40.59 89.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.292 0.567 . . . . 0.0 109.501 177.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.436 ' N ' ' O ' ' A' ' 25' ' ' THR . 67.4 mtt -67.45 -31.34 71.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.003 -0.998 . . . . 0.0 110.876 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 81.1 mt -76.06 -8.62 57.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.025 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -60.97 -36.79 80.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.716 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -101.98 17.12 23.98 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.731 0.3 . . . . 0.0 110.59 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.602 179.832 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.78 -22.72 66.61 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.06 -30.86 68.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.661 0.267 . . . . 0.0 111.056 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.13 -59.48 3.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.938 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.421 HG23 ' N ' ' B' ' 10' ' ' GLY . 6.0 tp -65.93 -39.53 84.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.228 0.537 . . . . 0.0 110.23 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.421 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -42.99 -45.68 6.05 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.96 -33.54 63.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.747 0.308 . . . . 0.0 111.193 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . 0.437 ' C ' ' SD ' ' B' ' 12' ' ' MET . 0.1 OUTLIER -57.29 -63.04 1.36 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.28 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . . . . . . . . . 22.4 m -58.24 -21.81 18.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.197 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.05 -38.52 40.19 Favored Glycine 0 CA--C 1.53 0.991 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 179.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.3 -55.09 31.3 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.49 ' O ' HG22 ' B' ' 20' ' ' THR . 22.5 m -51.2 -21.66 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 122.874 -0.192 . . . . 0.0 111.182 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 70.3 t -85.6 -47.8 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.239 0.542 . . . . 0.0 111.401 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.76 -47.15 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.943 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.54 -41.17 66.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.642 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.703 ' OG1' HG11 ' A' ' 23' ' ' VAL . 4.0 t -78.76 -19.93 51.1 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.105 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 22.0 mmt -78.35 -35.16 47.85 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.975 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.47 ' O ' HG22 ' B' ' 25' ' ' THR . 96.9 mt -62.91 -48.4 88.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.713 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.703 HG11 ' OG1' ' A' ' 20' ' ' THR . 34.1 m -63.72 -34.76 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.093 0.473 . . . . 0.0 110.314 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.401 ' N ' HG23 ' B' ' 23' ' ' VAL . 1.2 tp -43.82 -22.14 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.479 ' N ' ' O ' ' B' ' 23' ' ' VAL . 1.0 OUTLIER -79.56 -43.0 23.85 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.622 178.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.703 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.5 tm? -47.81 -31.96 5.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.661 0.744 . . . . 0.0 110.55 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.445 HG13 HG13 ' A' ' 27' ' ' VAL . 12.3 t -64.43 -40.61 89.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.582 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . 0.426 ' N ' ' O ' ' B' ' 25' ' ' THR . 67.5 mtt -67.42 -31.35 71.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.871 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 82.0 mt -75.95 -8.84 57.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.032 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -60.88 -36.8 80.15 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.728 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -101.92 17.17 23.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.544 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.615 179.887 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.4 -34.36 89.71 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.05 -24.45 53.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.765 0.317 . . . . 0.0 110.769 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.17 -42.91 96.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.246 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.495 ' O ' HD13 ' A' ' 9' ' ' ILE . 0.2 OUTLIER -59.91 -41.2 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.297 0.57 . . . . 0.0 109.532 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.8 -59.56 8.5 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 48.4 tp -72.89 -28.21 62.35 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.405 ' SD ' ' C ' ' A' ' 12' ' ' MET . 0.0 OUTLIER -42.48 -53.92 4.1 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.832 ' O ' HG13 ' A' ' 16' ' ' VAL . 34.2 m -72.92 -51.63 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.4 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.62 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -29.48 -47.15 0.1 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 123.694 0.621 . . . . 0.0 112.65 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.4 -1.79 0.21 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.593 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 13' ' ' VAL . 33.6 m -80.71 -51.13 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.66 ' N ' HG23 ' A' ' 16' ' ' VAL . 86.8 t -43.43 -37.82 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.828 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.53 -49.54 80.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.848 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.84 -52.04 67.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.534 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -64.93 -19.09 65.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.609 0.242 . . . . 0.0 110.705 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -82.03 -36.82 27.35 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.306 178.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 25' ' ' THR . 90.5 mt -64.96 -44.27 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 26' ' ' LEU . 14.0 m -62.96 -40.58 89.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 CA-C-O 121.143 0.497 . . . . 0.0 110.516 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.475 ' N ' HG23 ' A' ' 23' ' ' VAL . 2.1 tp -40.83 -24.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.306 0.575 . . . . 0.0 110.195 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.508 ' N ' ' O ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER -82.47 -37.64 25.07 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.381 179.041 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.633 HD13 ' C ' ' A' ' 26' ' ' LEU . 1.5 tm? -48.83 -40.42 29.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.704 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.945 HG21 HG21 ' B' ' 27' ' ' VAL . 88.1 t -61.74 -44.7 99.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.33 0.586 . . . . 0.0 109.685 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 82.2 mmm -65.4 -37.32 86.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.485 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -82.8 -5.65 59.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 110.405 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -61.85 -32.34 72.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.856 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.65 37.35 2.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.169 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.526 179.707 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.44 -34.17 89.18 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.16 -24.41 54.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.713 0.292 . . . . 0.0 110.7 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.11 -42.91 96.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.241 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.478 HD13 ' O ' ' B' ' 9' ' ' ILE . 0.2 OUTLIER -59.99 -41.24 85.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 121.288 0.566 . . . . 0.0 109.495 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -51.71 -59.53 8.48 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 48.7 tp -72.95 -28.28 62.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . 0.404 ' C ' ' SD ' ' B' ' 12' ' ' MET . 0.0 OUTLIER -42.53 -53.78 4.21 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -178.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.86 ' O ' HG13 ' B' ' 16' ' ' VAL . 34.1 m -72.95 -51.82 25.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.379 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.624 ' N ' HG23 ' B' ' 13' ' ' VAL . . . -29.38 -47.04 0.09 OUTLIER Glycine 0 CA--C 1.531 1.061 0 O-C-N 123.764 0.665 . . . . 0.0 112.63 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.41 -1.92 0.22 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.524 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.86 HG13 ' O ' ' B' ' 13' ' ' VAL . 33.5 m -80.74 -51.03 16.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.014 0.435 . . . . 0.0 109.874 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.662 ' N ' HG23 ' B' ' 16' ' ' VAL . 86.0 t -43.48 -37.97 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.726 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 34.5 mm -64.43 -49.48 80.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.798 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -51.89 67.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.661 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.475 HG22 ' O ' ' B' ' 16' ' ' VAL . 0.5 OUTLIER -64.87 -19.2 65.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.694 0.283 . . . . 0.0 110.781 -179.112 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.476 ' SD ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -82.05 -36.63 27.51 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.272 178.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.435 ' O ' HG22 ' B' ' 25' ' ' THR . 90.0 mt -65.09 -44.22 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' B' ' 26' ' ' LEU . 13.9 m -62.96 -40.69 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 121.139 0.495 . . . . 0.0 110.463 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.482 ' N ' HG23 ' B' ' 23' ' ' VAL . 2.1 tp -40.83 -24.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.199 0.523 . . . . 0.0 110.167 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.506 ' N ' ' O ' ' B' ' 23' ' ' VAL . 0.6 OUTLIER -82.43 -37.63 25.18 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.355 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.636 ' C ' HD13 ' B' ' 26' ' ' LEU . 1.5 tm? -48.85 -40.28 28.91 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.783 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.945 HG21 HG21 ' A' ' 27' ' ' VAL . 89.4 t -61.84 -44.71 99.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.289 0.566 . . . . 0.0 109.623 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 82.3 mmm -65.45 -37.27 86.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.451 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.87 -5.65 59.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.794 0.33 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -61.96 -32.45 72.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.934 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -104.36 37.17 2.16 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.219 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.559 179.744 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.2 mttp . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.02 -20.76 77.31 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.21 -24.79 34.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.317 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 mm -63.17 -49.83 81.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.498 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.444 HG23 ' N ' ' A' ' 10' ' ' GLY . 11.0 tp -68.54 -40.36 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.429 0.633 . . . . 0.0 110.226 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 9' ' ' ILE . . . -48.41 -60.54 5.69 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 11' ' ' LEU . 4.2 mm? -70.24 -29.39 66.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.2 -58.0 3.12 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 120.669 0.271 . . . . 0.0 111.671 -178.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.813 ' O ' HG13 ' A' ' 16' ' ' VAL . 17.1 m -75.49 -49.69 26.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.604 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.603 ' N ' HG23 ' A' ' 13' ' ' VAL . . . -30.94 -45.98 0.13 Allowed Glycine 0 CA--C 1.527 0.808 0 O-C-N 123.427 0.455 . . . . 0.0 112.284 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.51 -0.51 0.14 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.641 -178.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 13' ' ' VAL . 35.1 m -82.47 -50.22 16.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.628 ' N ' HG23 ' A' ' 16' ' ' VAL . 79.6 t -42.88 -37.08 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.048 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.66 -49.29 78.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.913 -179.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.96 -52.09 66.88 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.268 -178.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -18.35 64.19 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.006 -178.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.63 -38.24 20.1 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.29 0.369 . . . . 0.0 110.889 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -67.78 -43.15 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.354 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.501 HG21 HG21 ' B' ' 23' ' ' VAL . 35.2 m -55.76 -41.9 67.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.547 -178.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.493 ' N ' HG23 ' A' ' 23' ' ' VAL . 39.8 mm -40.3 -46.77 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.154 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.7 m -63.59 -43.16 97.74 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.35 178.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.713 HD13 ' C ' ' A' ' 26' ' ' LEU . 2.4 tm? -56.06 -45.12 79.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.011 -179.123 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.512 HG11 HG11 ' B' ' 27' ' ' VAL . 98.8 t -63.9 -44.14 97.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.448 0.642 . . . . 0.0 109.59 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 91.0 mtp -61.13 -30.52 70.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.233 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 31' ' ' LYS . 41.6 mt -71.22 -33.11 69.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.844 178.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -44.29 -15.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.798 -179.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' LEU . 65.0 mttp -103.9 27.88 7.19 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.734 0.302 . . . . 0.0 110.336 179.572 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 29' ' ' LEU . 29.2 mmtp . . . . . 0 C--O 1.221 -0.438 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.267 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 63.3 mttp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.54 -20.78 78.21 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -82.0 -24.98 35.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.754 0.312 . . . . 0.0 110.269 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.13 -49.83 81.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.591 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.437 HG23 ' N ' ' B' ' 10' ' ' GLY . 11.0 tp -68.69 -40.3 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 121.454 0.645 . . . . 0.0 110.154 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . 0.437 ' N ' HG23 ' B' ' 9' ' ' ILE . . . -48.28 -60.5 5.65 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.469 HD22 ' N ' ' B' ' 11' ' ' LEU . 4.2 mm? -70.52 -29.09 65.5 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -58.0 3.22 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.938 -0.305 . . . . 0.0 111.669 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 13' ' ' VAL . . . . . 0.802 ' O ' HG13 ' B' ' 16' ' ' VAL . 17.5 m -75.33 -49.91 25.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.594 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.595 ' N ' HG23 ' B' ' 13' ' ' VAL . . . -30.69 -45.9 0.12 Allowed Glycine 0 CA--C 1.528 0.861 0 O-C-N 123.569 0.543 . . . . 0.0 112.395 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.61 -0.73 0.15 Allowed Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.57 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.802 HG13 ' O ' ' B' ' 13' ' ' VAL . 35.1 m -82.08 -50.29 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 120.698 0.285 . . . . 0.0 110.241 179.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.631 ' N ' HG23 ' B' ' 16' ' ' VAL . 73.2 t -42.97 -36.97 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.052 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 36.4 mm -65.8 -49.08 79.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.96 -179.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.07 -52.29 66.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.256 -178.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.81 -18.24 63.92 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.054 -178.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . . . . . . . . . 14.2 mmt -84.76 -38.16 19.98 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.309 0.381 . . . . 0.0 110.935 179.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.82 -43.23 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.353 -179.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.501 HG21 HG21 ' A' ' 23' ' ' VAL . 35.9 m -55.72 -41.97 67.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.502 -178.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 24' ' ' ILE . . . . . 0.489 ' N ' HG23 ' B' ' 23' ' ' VAL . 39.5 mm -40.04 -46.74 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.168 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 2.8 m -63.74 -43.2 97.19 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.375 178.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.705 ' C ' HD13 ' B' ' 26' ' ' LEU . 2.4 tm? -56.05 -45.1 79.33 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.982 -179.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 27' ' ' VAL . 99.0 t -63.91 -44.19 97.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.463 0.649 . . . . 0.0 109.545 179.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 28' ' ' MET . . . . . . . . . . . . . 91.0 mtp -61.06 -30.34 70.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.212 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' B' ' 32' ' ' LYS . 43.0 mt -71.4 -33.1 69.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.898 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -44.28 -15.64 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.777 -179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' B' ' 29' ' ' LEU . 65.1 mttp -103.93 27.97 7.12 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.703 0.287 . . . . 0.0 110.378 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 32' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' B' ' 29' ' ' LEU . 28.9 mmtp . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.007 -0.996 . . . . 0.0 110.268 179.749 . . . . . . . . 1 1 . 1 stop_ save_